<SEC-DOCUMENT>0001398344-25-006954.txt : 20250411
<SEC-HEADER>0001398344-25-006954.hdr.sgml : 20250411
<ACCEPTANCE-DATETIME>20250411154221
ACCESSION NUMBER:		0001398344-25-006954
CONFORMED SUBMISSION TYPE:	N-2
PUBLIC DOCUMENT COUNT:		20
FILED AS OF DATE:		20250410
DATE AS OF CHANGE:		20250411

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NXG Cushing Midstream Energy Fund
		CENTRAL INDEX KEY:			0001400897
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		N-2
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-22072
		FILM NUMBER:		25831377

	BUSINESS ADDRESS:	
		STREET 1:		300 CRESCENT COURT, SUITE 1700
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		214-692-6334

	MAIL ADDRESS:	
		STREET 1:		300 CRESCENT COURT, SUITE 1700
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CUSHING MLP & INFRASTRUCTURE TOTAL RETURN FUND
		DATE OF NAME CHANGE:	20180315

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cushing MLP & Infrastructure Total Return Fund
		DATE OF NAME CHANGE:	20180307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cushing MLP Total Return Fund
		DATE OF NAME CHANGE:	20070524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NXG Cushing Midstream Energy Fund
		CENTRAL INDEX KEY:			0001400897
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		N-2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286482
		FILM NUMBER:		25831376

	BUSINESS ADDRESS:	
		STREET 1:		300 CRESCENT COURT, SUITE 1700
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		214-692-6334

	MAIL ADDRESS:	
		STREET 1:		300 CRESCENT COURT, SUITE 1700
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CUSHING MLP & INFRASTRUCTURE TOTAL RETURN FUND
		DATE OF NAME CHANGE:	20180315

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cushing MLP & Infrastructure Total Return Fund
		DATE OF NAME CHANGE:	20180307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cushing MLP Total Return Fund
		DATE OF NAME CHANGE:	20070524
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2
<SEQUENCE>1
<FILENAME>fp0092922-1_n2ixbrl.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srv="http://cushingcef.com/20250410">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_CEF%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_srv_cushingcef.com_20250410 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250410_20250410 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DDocumentType_N%2D2 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001400897 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000004" name="dei:DocumentType">N-2</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000005" name="dei:EntityCentralIndexKey">0001400897</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-10" id="xdx2ixbrl0047" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="srv-20250410.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-04-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-10</xbrli:startDate>
        <xbrli:endDate>2025-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-102025-04-10_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-10</xbrli:startDate>
        <xbrli:endDate>2025-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-30_custom_SeniorSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-102025-04-10_custom_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">srv:RisksAssociatedwithOfferingsofAdditionalCommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-10</xbrli:startDate>
        <xbrli:endDate>2025-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-102025-04-10_custom_AdditionalRisksofRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400897</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">srv:AdditionalRisksofRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-10</xbrli:startDate>
        <xbrli:endDate>2025-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000055" toRefs="Footnote000071"/>
  <ix:relationship fromRefs="Fact000056" toRefs="Footnote000071"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">As filed with the Securities and Exchange Commission
on April 10, 2025</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Securities Act File No.&#160;333-______</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Investment Company Act File No.&#160;811-22072</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_90C_edei--EntityInvCompanyType_c20250410__20250410_zZcRwghvt7sk"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000011" name="dei:EntityInvCompanyType">N-2</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: left; text-indent: 0.5in"><span id="xdx_90D_edei--DocumentRegistrationStatement_c20250410__20250410_zYvLp8AKiSAl"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000012" name="dei:DocumentRegistrationStatement">[X]</ix:nonNumeric></span> Registration Statement
under the Securities Act of 1933</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.25in">[&#160;&#160;&#160;] Pre-Effective
Amendment No.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left; text-indent: 0.5in">[&#160;&#160;&#160;] Post-Effective
Amendment No.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and/or</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left"><span><span id="xdx_90F_edei--InvestmentCompanyActRegistration_c20250410__20250410_zcGeP1vKigG6"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000013" name="dei:InvestmentCompanyActRegistration">[X]</ix:nonNumeric></span></span> Registration Statement under the Investment
Company Act of 1940</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: left"><span id="xdx_90E_edei--InvestmentCompanyRegistrationAmendment_c20250410__20250410_znzqgbKTqotj"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000014" name="dei:InvestmentCompanyRegistrationAmendment">[X]</ix:nonNumeric></span> Amendment No.&#160;<span id="xdx_907_edei--InvestmentCompanyRegistrationAmendmentNumber_c20250410__20250410_zxogJBJ0xxp"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000015" name="dei:InvestmentCompanyRegistrationAmendmentNumber">27</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityRegistrantName_c20250410__20250410_zJl1CufxjRqi" style="display: none"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000016" name="dei:EntityRegistrantName">NXG Cushing Midstream Energy Fund</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span>&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NXG
CUSHING<sup>&#174;</sup> MIDSTREAM ENERGY FUND</b><b><br/>
</b>(Registrant&#8217;s Exact Name as Specified in Charter)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250410__20250410_zhlIXoGGkIR2"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000017" name="dei:EntityAddressAddressLine1">One Energy Square</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine2_c20250410__20250410_zfDNTr3yysi4"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000018" name="dei:EntityAddressAddressLine2">4925 Greenville Avenue</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine3_c20250410__20250410_zdbFMzFlXgi8"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000019" name="dei:EntityAddressAddressLine3">Suite 1310</ix:nonNumeric></span><br/>
<span id="xdx_908_edei--EntityAddressCityOrTown_c20250410__20250410_z9qBoSebGsel"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000020" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20250410__20250410_zzY5zhMxFkMa"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt-sec:stateprovnameen" id="Fact000021" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20250410__20250410_z9YE74pL4Mr2"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000022" name="dei:EntityAddressPostalZipCode">75206</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90D_edei--CityAreaCode_c20250410__20250410_z04wshaGzNn5"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000023" name="dei:CityAreaCode">214</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20250410__20250410_zqtKJbPOlXjf"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000024" name="dei:LocalPhoneNumber">692-6334</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone Number, including
Area Code)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--ContactPersonnelName_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKWPpxlUZnN5"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000025" name="dei:ContactPersonnelName">John Musgrave</ix:nonNumeric></span><br/>
Cushing&#174; Asset Management, LP<br/>
<span id="xdx_90B_edei--EntityAddressAddressLine1_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zd1LWlvIXYnl"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressAddressLine1">One Energy Square</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressAddressLine2_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zcB9p1XyP3sf"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000027" name="dei:EntityAddressAddressLine2">4925 Greenville Avenue</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine3_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zuwmefej57Cc"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000028" name="dei:EntityAddressAddressLine3">Suite 1310</ix:nonNumeric></span><br/>
<span id="xdx_90E_edei--EntityAddressCityOrTown_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zrMqepm5FUei"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000029" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zIePfPiuUAye"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000030" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20250410__20250410__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z3lOsyWHaVGd"><ix:nonNumeric contextRef="From2025-04-102025-04-10_dei_BusinessContactMember" id="Fact000031" name="dei:EntityAddressPostalZipCode">75206</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name and Address of Agent for Service)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Copies to</i>:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Kevin T. Hardy, Esq.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Skadden, Arps, Slate, Meagher &amp; Flom LLP</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>320 South Canal Street</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chicago, Illinois 60606</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Approximate date of proposed public offering: <b><span id="xdx_90C_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20250410__20250410_zqxZyN94vd5a"><ix:nonNumeric contextRef="AsOf2025-04-10" id="Fact000032" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">From
time to time after the effective date of this Registration Statement.</ix:nonNumeric></span></b></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_901_edei--DividendOrInterestReinvestmentPlanOnly_dbF_c20250410__20250410_z43zmy8JTlpe"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000033" name="dei:DividendOrInterestReinvestmentPlanOnly">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Check box if the only securities being registered on this Form are being offered pursuant to dividend or
interest reinvestment plans.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="width: 20pt"><span id="xdx_908_edei--DelayedOrContinuousOffering_c20250410__20250410_zXDzJolD07xa"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000034" name="dei:DelayedOrContinuousOffering">[X]</ix:nonNumeric></span></td><td style="text-align: left">Check box if any securities being registered on this Form will be offered on a delayed or continuous basis
in reliance on Rule&#160;415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection
with a dividend reinvestment plan.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="width: 20pt"><span id="xdx_909_ecef--PrimaryShelfFlag_c20250410__20250410_zEQhWBQ1dAD8"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000035" name="cef:PrimaryShelfFlag">[X]</ix:nonNumeric></span></td><td style="text-align: left">Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective
amendment thereto.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_90D_edei--DividendOrInterestReinvestmentPlanOnly_dbF_c20250410__20250410_zPW3r3sgSmlk"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000036" name="dei:DividendOrInterestReinvestmentPlanOnly">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective
amendment thereto that will become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_907_edei--EffectiveUponFiling462e_dbF_c20250410__20250410_z1lHNOZHWl3k"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000037" name="dei:EffectiveUponFiling462e">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General
Instruction B to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities
Act.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>It is proposed that this filing will become effective
(check appropriate box):</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="width: 20pt"><span id="xdx_902_edei--EffectiveWhenDeclaredSection8c_c20250410__20250410_zKKyTDODeu4c"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000038" name="dei:EffectiveWhenDeclaredSection8c">[X]</ix:nonNumeric></span></td><td style="text-align: left">When declared effective pursuant to Section&#160;8(c) of the Securities Act.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>If appropriate, check the following box:</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_903_edei--DividendOrInterestReinvestmentPlanOnly_dbF_c20250410__20250410_zgcVlLHWMUT3"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000039" name="dei:DividendOrInterestReinvestmentPlanOnly">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment]
[registration statement].</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_902_edei--AdditionalSecurities462b_dbF_c20250410__20250410_zhzSar5P2F0f"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000040" name="dei:AdditionalSecurities462b">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">This Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the
Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering
is ___________.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_909_edei--NoSubstantiveChanges462c_dbF_c20250410__20250410_zTSaCtOQlEM2"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000041" name="dei:NoSubstantiveChanges462c">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">This Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, and
the Securities Act registration statement number of the earlier effective registration statement for the same offering is ___________.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_909_edei--ExhibitsOnly462d_dbF_c20250410__20250410_zk1q5yxzL2g"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000042" name="dei:ExhibitsOnly462d">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">This Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, and
the Securities Act registration statement number of the earlier effective registration statement for the same offering is ___________.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Check each box that appropriately characterizes
the Registrant:</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="width: 20pt"><span id="xdx_908_ecef--RegisteredClosedEndFundFlag_c20250410__20250410_zySW0FJMHh2a"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000043" name="cef:RegisteredClosedEndFundFlag">[X]</ix:nonNumeric></span></td><td style="text-align: left">Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940
(&#8220;Investment Company Act&#8221;)).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_908_ecef--BusinessDevelopmentCompanyFlag_dbF_c20250410__20250410_z5zITuh9G0C"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000044" name="cef:BusinessDevelopmentCompanyFlag">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Business Development Company (closed-end company that intends or has elected to be regulated as a business
development company under the Investment Company Act).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_90B_ecef--IntervalFundFlag_dbF_c20250410__20250410_z5mEtusIfWod"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000045" name="cef:IntervalFundFlag">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase
offers under Rule&#160;23c-3 under the Investment Company Act).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="width: 20pt"><span id="xdx_90D_ecef--PrimaryShelfQualifiedFlag_c20250410__20250410_zi15J5yz0yLa"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleantrue" id="Fact000046" name="cef:PrimaryShelfQualifiedFlag">[X]</ix:nonNumeric></span></td><td style="text-align: left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_902_edei--EntityWellKnownSeasonedIssuer_c20250410__20250410_zXsE6WrMxJ8d"><span style="-sec-ix-hidden: xdx2ixbrl0047">[&#160;
                               ]</span></span></td><td style="text-align: left">Well-Known Seasoned Issuer (as defined by Rule&#160;405 under the Securities Act).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_906_edei--EntityEmergingGrowthCompany_dbF_c20250410__20250410_zT02KWa7FdN1"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000048" name="dei:EntityEmergingGrowthCompany">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">Emerging Growth Company (as defined by Rule&#160;12b-2 under the Securities Exchange Act of 1934 (&#8220;Exchange
Act&#8221;)).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt">[&#160;
                               ]</td><td style="text-align: left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of
Securities Act.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"/><td style="word-spacing: 1.5pt; width: 20pt"><span id="xdx_90E_ecef--NewCefOrBdcRegistrantFlag_dbF_c20250410__20250410_zgjkK8VVjWdk"><ix:nonNumeric contextRef="AsOf2025-04-10" format="ixt:booleanfalse" id="Fact000049" name="cef:NewCefOrBdcRegistrantFlag">[&#160;
                               ]</ix:nonNumeric></span></td><td style="text-align: left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months
preceding this filing).</td></tr></table>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Registrant hereby amends this Registration Statement
on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically
states that the Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of
1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant
to said Section&#160;8(a), may determine.</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red; text-align: justify"><b>The information in this Prospectus is not complete
and may be changed. We may not sell these securities until the Registration Statement filed with the Securities and Exchange Commission
is effective. This Prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state
where the offer or sale is not permitted.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red; text-align: center"><b>Subject To Completion Prospectus dated April
10, 2025</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>BASE PROSPECTUS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$500,000,000</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NXG Cushing<sup>&#174;</sup> Midstream Energy
Fund</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Shares<br/>
Subscription Rights for Common Shares</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investment Objective.</i> NXG Cushing&#174;
Midstream Energy Fund (the &#8220;Fund&#8221;) is a non-diversified, closed-end management investment company. The Fund&#8217;s investment
objective is to obtain a high after-tax total return from a combination of capital appreciation and current income.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investment Strategy.</i> The Fund seeks to
achieve its investment objective by investing, under normal market conditions, at least 80% of Managed Assets (as defined in this Prospectus)
in a portfolio of midstream energy investments (the &#8220;80% policy&#8221;). For purposes of the Fund&#8217;s 80% policy, the Fund considers
midstream energy investments to be investments that offer economic exposure to securities of midstream energy companies, which are companies
that provide midstream energy services, including the gathering, transporting, processing, fractionation, storing, refining and distribution
of natural resources, such as natural gas, natural gas liquids, crude oil refined petroleum products, biofuels, carbon sequestration,
solar, and wind. The Fund considers a company to be a midstream energy company if at least 50% of its assets, income, sales or profits
are committed to or derived from otherwise related to midstream energy services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><i>(continued on inside front cover)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Fund has previously qualified, and intends
to continue to qualify, to be treated as a regulated investment company (&#8220;RIC&#8221;) under the Internal Revenue Code of 1986, as
amended (the &#8220;Code&#8221;). The Fund pursues its investment objective by generally investing in master limited partnerships (&#8220;MLPs&#8221;)
up to the maximum extent permitted of a RIC under the Code. Accordingly, the Fund will, as of the end of each fiscal quarter, invest no
more than 25% of Managed Assets in securities of MLPs and other entities that are &#8220;qualified publicly traded partnerships&#8221;
under the Code.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investment Adviser.</i> The Fund is managed
by Cushing<sup>&#174;</sup> Asset Management, LP d/b/a NXG Investment Management (the &#8220;Investment Adviser&#8221;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offering. </i>The Fund may offer, from time
to time, up to $500,000,000 aggregate initial offering price of common shares of beneficial interest, par value $0.001 per share (&#8220;Common
Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights&#8221; and together with the Common Shares, &#8220;Securities&#8221;)
in one or more offerings in amounts, at prices and on terms set forth in one or more supplements to this Prospectus (each a &#8220;Prospectus
Supplement&#8221;). You should read this Prospectus and any related Prospectus Supplement carefully before you decide to invest in the
Securities.</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Fund may offer Securities (1) directly to
one or more purchasers, (2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers.
The Prospectus Supplement relating to a particular offering of Securities will identify any agents or underwriters involved in the sale
of Securities, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or
underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Securities through agents,
underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement. See &#8220;Plan of Distribution.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investing in the Fund&#8217;s Securities involves
a high degree of risk. See &#8220;<span style="text-decoration: underline">Risks</span>&#8221; on page&#160;[12] of this Prospectus.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined that this Prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Prospectus dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2025</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(continued from front cover)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investment Strategy (continued)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Fund invests in equity and debt securities
of U.S. and non-U.S. midstream energy companies of any market capitalization size.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>As </i>an alternative to holding investments
directly, the Fund may obtain investment exposure through derivatives transactions intended to replicate, modify or replace the economic
attributes associated with investment in securities in which the Fund is permitted to invest directly. To the extent that the Fund invests
in synthetic investments with economic characteristics similar to investments in midstream energy companies, the market value (or, if
market value is unavailable, the fair value) of such investments will be counted for purposes of the Fund&#8217;s policy of investing
at least 80% of its Managed Assets in a portfolio of midstream energy investments. <i>For a discussion of derivative instruments in which
the Fund may invest, see &#8220;</i>Strategic Transactions&#8221; in the Statement of Additional Information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Fund invests, without limitation, in debt
securities rated, at the time of investment, at least (i) B3 by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;), (ii)
B- by Standard &amp; Poor&#8217;s Ratings Services (&#8220;S&amp;P&#8221;) or Fitch Ratings (&#8220;Fitch&#8221;), or (iii) a comparable
rating by another rating agency, and invests no more than 5% of its Managed Assets in debt securities rated below B3 by Moody&#8217;s,
B- by S&amp;P or Fitch or a comparable rating by another rating agency. Therefore, the Fund may invest in below investment grade debt
securities. A debt security is considered below investment grade if it is rated below Baa3- by Moody&#8217;s or below BBB- by S&amp;P
or Fitch or a comparable rating by another rating agency. Below investment grade debt securities are often referred to as &#8220;high
yield&#8221; securities or &#8220;junk bonds.&#8221; Below investment grade debt securities are regarded as having predominantly speculative
characteristics with respect to capacity to pay interest and to repay principal. Debt securities in which the Fund invests may be of any
maturity.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>NYSE Listing.</i> The Fund&#8217;s currently
outstanding Common Shares are, and the Common Shares offered by this Prospectus, will be, subject to notice of issuance, listed on the
New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;SRV.&#8221; As of March 17, 2025, the net asset value of the
Fund&#8217;s Common Shares was $42.77 per Common Share, and the last reported sale price for the Fund&#8217;s Common Shares on the NYSE
was $43.83 per Common Share, representing a premium to net asset value of 2.48%. In connection with any offering of Rights, the Fund will
provide information in the Prospectus Supplement for the expected trading market, if any, for Rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Leverage.</i> The Fund generally seeks to enhance
total return by utilizing leverage. The Fund may utilize leverage through the issuance of commercial paper or notes and other forms of
borrowing (&#8220;Indebtedness&#8221;) or the issuance of preferred shares, in each case to the maximum extent permitted by the Investment
Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). Under current market conditions, the Fund currently intends to utilize leverage
principally through Indebtedness. The amount of Indebtedness outstanding is expected to vary over time, but will not exceed 331&#8260;3%
of the Fund&#8217;s Managed Assets (<i>i.e.</i>, 50% of its net assets attributable to the Fund&#8217;s Common Shares), including the
proceeds of such leverage. The costs associated with the issuance and use of leverage will be borne by the holders of the Common Shares.
Leverage is a speculative technique and investors should note that there are special risks and costs associated with leverage. There can
be no assurance that a leveraging strategy will be successful during any period in which it is employed. As of November&#160;30, 2024,
the Fund had outstanding Indebtedness of approximately $48.315 million, which represents 20% of the Fund&#8217;s Managed Assets (or approximately
25% of its net assets attributable to the Fund&#8217;s Common Shares).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Distributions.</i> The Fund intends to pay
substantially all of its net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to
distribute any net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common
Shares will consist primarily of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term
capital gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term
capital gain over net short-term capital loss), and/or (iii) return of capital. Distributions paid by the Fund for any particular month
may be comprised of more or less than the amount of net investment income from that monthly period. As a result, all or a portion of a
distribution may be deemed a return of capital (which is in effect a partial return of the amount a Common Shareholder invested in the
Fund) up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. <b>The Fund&#8217;s
distributions have historically included, and may in the future include, a significant portion of return of capital. For the fiscal year
ended November&#160;30, 2024, the Fund&#8217;s distributions were comprised of approximately 69% ordinary income, 31% long-term capital
gains, and 0% return of capital. Accordingly, shareholders should not assume that the source of a distribution from the Fund is net income
or profit, and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income. </b>Although
a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the Common
Shareholder&#8217;s potential loss, on any subsequent sale or other disposition of Common Shares. Common Shareholders should not assume
that the source of a distribution from the Fund is net income or profit, and Common Shareholders who receive distributions that include
return of capital should not assume that such return of capital is derived from the Fund&#8217;s investments.</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration</i>. The Fund&#8217;s investments
will be concentrated in issuers in the industry or group of industries that make up the natural resources sector, and specifically in
midstream energy companies within the natural resources sector.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this Prospectus and the documents
incorporated herein by reference, which contain important information about the Fund that you should know before deciding whether to invest,
and retain it for future reference. A Statement of Additional Information, dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2025 (&#8220;SAI&#8221;), containing additional information about the Fund, has been filed with the Securities and Exchange Commission
(the &#8220;SEC&#8221;) and is incorporated by reference in its entirety into this Prospectus. You may request a free copy of the Statement
of Additional Information, the table of contents of which is on page&#160;[29] of this Prospectus, and the Fund&#8217;s annual and semi-annual
reports by calling toll-free (214) 692-6334, or you may obtain a copy of such reports, the SAI and other information regarding the Fund
from the SEC&#8217;s website (<i><span style="text-decoration: underline">http://www.sec.gov</span></i>). Free copies of the Fund&#8217;s annual and semi-annual reports are also
available from the Fund&#8217;s website at <i><span style="text-decoration: underline">www.nxgim.com</span></i>. Information on, or accessible through, the Fund&#8217;s website
is not a part of, and is not incorporated into, this Prospectus.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Fund&#8217;s securities do not represent
a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally
insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</b></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="width: 95%">PROSPECTUS SUMMARY</td>
    <td style="width: 5%; text-align: right">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>SUMMARY OF FUND EXPENSES</td>
    <td style="text-align: right">8</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>FINANCIAL HIGHLIGHTS</td>
    <td style="text-align: right">9</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>SENIOR SECURITIES</td>
    <td style="text-align: right">11</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>THE FUND</td>
    <td style="text-align: right">12</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>USE OF PROCEEDS</td>
    <td style="text-align: right">12</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>MARKET AND NET ASSET VALUE INFORMATION</td>
    <td style="text-align: right">12</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>INVESTMENT OBJECTIVE AND POLICIES</td>
    <td style="text-align: right">12</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>RISKS</td>
    <td style="text-align: right">12</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>MANAGEMENT OF THE FUND</td>
    <td style="text-align: right">13</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>NET ASSET VALUE</td>
    <td style="text-align: right">13</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>DISTRIBUTIONS</td>
    <td style="text-align: right">13</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>DIVIDEND REINVESTMENT PLAN</td>
    <td style="text-align: right">14</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>DESCRIPTION OF SHARES</td>
    <td style="text-align: right">15</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>ANTI-TAKEOVER PROVISIONS IN THE DECLARATION OF TRUST</td>
    <td style="text-align: right">18</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>CERTAIN PROVISIONS OF DELAWARE LAW, THE DECLARATION OF TRUST AND BY-LAWS</td>
    <td style="text-align: right">19</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>CLOSED-END FUND STRUCTURE</td>
    <td style="text-align: right">22</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>REPURCHASE OF COMMON SHARES</td>
    <td style="text-align: right">23</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>U.S. FEDERAL INCOME TAX CONSIDERATIONS</td>
    <td style="text-align: right">24</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>PLAN OF DISTRIBUTION</td>
    <td style="text-align: right">26</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>OTHER SERVICE PROVIDERS</td>
    <td style="text-align: right">28</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>LEGAL MATTERS</td>
    <td style="text-align: right">28</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</td>
    <td style="text-align: right">28</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>PRIVACY POLICY</td>
    <td style="text-align: right">28</td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>You should rely only on the information contained
or incorporated by reference in this Prospectus. The Fund has not authorized any other person to provide you with different information.
If anyone provides you with different or inconsistent information, you should not rely on it. The Fund is not making an offer to sell
these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this Prospectus and any related
Prospectus Supplement is accurate only as of the date of this Prospectus and any related Prospectus Supplement, regardless of the time
of delivery of this Prospectus and any related Prospectus Supplement or of any sale of Securities of the Fund. The Fund&#8217;s business,
financial condition and prospects may have changed since that date.</b></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ABOUT THIS PROSPECTUS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Prospectus is part of a
registration statement on Form&#160;N-2 that the Fund filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) using
a &#8220;shelf&#8221; registration process. Under this process, the Fund may offer, from time to time, up to $500,000,000 aggregate initial
offering price of Securities in one or more offerings in amounts, at prices and on terms set forth in one or more Prospectus Supplements.
The Prospectus Supplement may also add, update or change information contained in this Prospectus. You should carefully read this Prospectus
and any accompanying Prospectus Supplement, together with the additional information described under the heading &#8220;Where You Can
Find More Information.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Prospectus, any accompanying
Prospectus Supplement and the SAI, contain (or will contain) or incorporate (or will incorporate) by reference forward-looking statements,
within the meaning of the federal securities laws, that involve risks and uncertainties. These statements describe the Fund&#8217;s plans,
strategies, and goals and the Fund&#8217;s beliefs and assumptions concerning future economic and other conditions and the outlook for
the Fund, based on currently available information. In this Prospectus and any accompanying Prospectus Supplement, words such as &#8220;anticipates,&#8221;
&#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221; &#8220;goals,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221;
&#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; and similar expressions, and the
negative of such terms, are used in an effort to identify forward-looking statements, although some forward-looking statements may be
expressed differently. By their nature, all forward looking statements involve risks and uncertainties, and actual results could differ
materially from those contemplated by any forward looking statements. Although the Fund believes that the expectations expressed in these
forward looking statements are (or will be) reasonable, actual results could differ materially from those projected or assumed in these
forward looking statements. The Fund&#8217;s future financial condition and results of operations, as well as any forward looking statements,
are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221; sections
of this Prospectus and the Fund&#8217;s most recent Annual Report, which describe certain currently known risk factors that could cause
actual results to differ materially from the Fund&#8217;s expectations, and, if applicable, additional risk considerations described in
an accompanying Prospectus Supplement. The Fund urges you to review carefully that section for a more detailed discussion of the risks
associated with an investment in the Fund&#8217;s securities. All forward looking statements contained or incorporated by reference in
this Prospectus and any accompanying Prospectus Supplement are made as of the date of this Prospectus and any accompanying Prospectus
Supplement. The Fund does not intend, and undertakes no obligation, to update any forward looking statement. The Fund is not entitled
to the safe harbor for forward-looking statements pursuant to Section&#160;27A of the Securities Act of 1933.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">You should rely only on the information
contained or incorporated by reference in this Prospectus and any accompanying Prospectus Supplement. The Fund has not authorized any
other person to provide you with different information. If anyone provides you with different or inconsistent information, you should
not rely on it. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.
You should not assume that the information in this Prospectus and any accompanying Prospectus Supplement is accurate as of any date other
than the date of this Prospectus and any accompanying Prospectus Supplement. The Fund&#8217;s business, financial condition and results
of operations may have changed since that date. The Fund will amend this Prospectus and any accompanying Prospectus Supplement if, during
the period that this Prospectus and any accompanying Prospectus Supplement is required to be delivered, there are any subsequent material
changes.</p>


<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund is subject to the informational requirements
of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the 1940 Act and in accordance therewith files, or will file,
reports and other information with the SEC. The SEC maintains a web site at www.sec.gov containing reports, proxy and information statements
and other information regarding registrants, including the Fund, that file electronically with the SEC</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Prospectus constitutes part of a Registration
Statement filed by the Fund with the SEC under the Securities Act, and the 1940 Act. This Prospectus omits certain of the information
contained in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information
with respect to the Fund and the Common Shares offered hereby. Any statements contained herein concerning the provisions of any document
are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration
Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration
Statement may be obtained from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s
website (www.sec.gov).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Fund
will provide without charge to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral
request, a copy of any and all of the information that has been incorporated by reference in this Prospectus or any accompanying Prospectus
Supplement. You may request such information&#160;</span>by calling (214) 692-6334 or by writing to NXG Investment Management at One Energy
Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206, or you may obtain a copy (and other information regarding the Trust)
from the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s Prospectus, Statement of Additional Information and any incorporated
information will also be available from the Fund&#8217;s website at www.nxgim.com. <span style="background-color: white">Information contained
on the Fund&#8217;s website is not incorporated by reference into this Prospectus or any Prospectus Supplement and should not be considered
to be part of this Prospectus or any Prospectus Supplement.</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INCORPORATION BY REFERENCE</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">This Prospectus
is part of a registration statement that the Fund has filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221;
the information that it files with the SEC, which means that the Fund can disclose important information to you by referring you to those
documents. The information incorporated by reference is an important part of this Prospectus, and later information that the Fund files
with the SEC will automatically update and supersede this information.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The documents
listed below, and any reports and other documents subsequently filed by the Fund with the SEC pursuant to Rule&#160;30(b)(2) under the
1940 Act and Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, and any reports and
other documents subsequently filed by the Fund with the SEC pursuant to Rule&#160;30(b)(2) under the 1940 Act and Sections&#160;13(a),
13(c), 14 or 15(d) of the Exchange Act after the date of the initial registration statement and prior to effectiveness of the registration
statement, are incorporated by reference into this Prospectus and deemed to be part of this Prospectus from the date of the filing of
such reports and documents:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">&#9679;</td><td>the Fund&#8217;s Statement of Additional Information, dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2025, filed with this Prospectus (the &#8220;SAI&#8221;);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">&#9679;</td><td><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1400897/000139834425002262/fp0091448-3_ncsr.htm">the Fund&#8217;s Annual Report for the fiscal year ended November&#160;30, 2024 on Form&#160;N-CSR, filed with the SEC on February&#160;10, 2025 (the &#8220;Annual Report&#8221;);</a></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">&#9679;</td><td><a href="https://www.sec.gov/Archives/edgar/data/1400897/000139834424007404/fp0088142-1_def14a.htm">the Fund&#8217;s definitive proxy statement on Schedule&#160;14A for its 2024 annual meeting of shareholders, filed with the SEC on April&#160;19, 2024 (the &#8220;Proxy Statement&#8221;); and</a></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">&#9679;</td><td><a href="https://www.sec.gov/Archives/edgar/data/1400897/000095013407016605/d48446e8va12b.htm">the Fund&#8217;s description of Common Shares contained in its Registration Statement on Form&#160;8-A (File No.&#160;001-33641) filed with the SEC on August&#160;2, 2007.</a></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">To obtain
copies of these filings, see &#8220;Where You Can Find More Information.&#8221;</span></p>


<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING
STATEMENTS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Prospectus, including
documents incorporated by reference, contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by
the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221;
&#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. By their nature, all forward-looking statements
involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements.
Many factors that could materially affect the Fund&#8217;s actual results are the performance of the portfolio of securities held by the
Fund, the conditions in the U.S. and international financial, petroleum and other markets, the price at which the Fund&#8217;s Common
Shares will trade in the public markets and other factors discussed in this Prospectus and to be discussed in the Fund&#8217;s periodic
filings with the SEC.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although the Fund believes
that the expectations expressed in such forward-looking statements are reasonable, actual results could differ materially from those expressed
or implied in such forward-looking statements. The Fund&#8217;s future financial condition and results of operations, as well as any forward-looking
statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221;
section of this Prospectus. You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements
contained or incorporated by reference in this Prospectus are made as of the date of this Prospectus. Except for the Fund&#8217;s ongoing
obligations under the federal securities laws, the Fund does not intend, and the Fund undertakes no obligation, to update any forward-looking
statement. The forward-looking statements contained in this Prospectus are excluded from the safe harbor protection provided by section&#160;27A
of the Securities Act of 1933, as amended.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently known risk factors
that could cause actual results to differ materially from the Fund&#8217;s expectations include, but are not limited to, the factors described
in the &#8220;Risks&#8221; section of this Prospectus and in the Annual Report. The Fund urges you to review carefully this section for
a more detailed discussion of the risks of an investment in the Fund&#8217;s securities.</p>


<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">PROSPECTUS
SUMMARY</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>This is only a summary
of information contained elsewhere in this prospectus (the &#8220;Prospectus&#8221;). This summary does not contain all of the information
that you should consider before investing in the Fund&#8217;s securities. In particular, you should carefully read the more detailed information
contained in this Prospectus and the statement of additional information, dated 	, 2025 (the &#8220;SAI&#8221;), especially the information
set forth under the heading &#8220;Risks.&#8221;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify"><b>The Fund</b></td>
    <td style="width: 65%; text-align: justify">NXG Cushing<sup>&#174;</sup> Midstream Energy Fund is a non-diversified, closed-end management investment company registered under the 1940 Act that commenced investment operations on August&#160;27, 2007. The Fund&#8217;s Investment Adviser is Cushing<sup>&#174;</sup> Asset Management, LP d/b/a NXG Investment Management.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>The Offering</b></td>
    <td style="text-align: justify">The Fund may offer, from time to time, up to $500,000,000 aggregate initial offering price of common shares of beneficial interest, par value $0.001 per share (&#8220;Common Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights&#8221; and together with the Common Shares, &#8220;Securities&#8221;) in one or more offerings in amounts, at prices and on terms set forth in one or more supplements to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and any related Prospectus Supplement carefully before you decide to invest in the Securities.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund may offer Securities (1) directly to one or more purchasers, (2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers. The Prospectus Supplement relating to a particular offering of Securities will identify any agents or underwriters involved in the sale of Securities, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Securities through agents, underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement. See &#8220;Plan of Distribution.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Use of Proceeds</b></td>
    <td style="text-align: justify">Unless otherwise specified in a Prospectus Supplement, the Fund intends to invest the net proceeds of an offering of Securities in accordance with its investment objective and policies as stated in this Prospectus. It is currently anticipated that the Fund will be able to invest substantially all of the net proceeds of an offering of Securities in accordance with its investment objective and policies within three months after the completion of such offering. Prior to the time the proceeds of each offering are fully invested, such proceeds may temporarily be invested in cash, cash equivalents, or in debt securities that are rated AA or higher. Income received by the Fund from such temporary investments would likely be less than returns sought pursuant to the Fund&#8217;s investment objective and policies. A delay in the anticipated use of proceeds could lower returns and reduce the Fund&#8217;s distribution to holders of Common Shares (&#8220;Common Shareholders&#8221;).</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify"><b>Investment Objective</b></td>
    <td style="width: 65%; text-align: justify">The Fund&#8217;s investment objective is to obtain a high after-tax total return from a combination of capital appreciation and current income. There can be no assurance that the Fund&#8217;s investment objective will be achieved.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Principal Investment Policies</b></td>
    <td style="text-align: justify">The Fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of Managed Assets (as defined in this Prospectus) in a portfolio of midstream energy investments (the &#8220;80% policy&#8221;). For purposes of the Fund&#8217;s 80% policy, the Fund considers midstream energy investments to be investments that offer economic exposure to securities of midstream energy companies, which are companies that provide midstream energy services, including the gathering, transporting, processing, fractionation, storing, refining and distribution of natural resources, such as natural gas, natural gas liquids, crude oil refined petroleum products, biofuels, carbon sequestration, solar, and wind. The Fund considers a company to be a midstream energy company if at least 50% of its assets, income, sales or profits are committed to or derived from midstream energy services. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund invests in equity and debt securities of midstream energy companies, and invests in U.S. and non-U.S. securities and in issuers of any market capitalization size.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">As an alternative to holding investments directly, the Fund may obtain investment exposure through derivatives transactions intended to replicate, modify or replace the economic attributes associated with investment in securities in which the Fund is permitted to invest directly. To the extent that the Fund invests in synthetic investments with economic characteristics similar to investments in midstream energy companies, the market value (or, if market value is unavailable, the fair value) of such investments will be counted for purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in a portfolio of midstream energy investments. <i>For a discussion of derivative instruments in which the Fund may invest, see &#8220;</i>Strategic Transactions&#8221; in the SAI</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund has previously qualified, and intends to continue to qualify, to be treated as a regulated investment company (&#8220;RIC&#8221;) under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The Fund pursues its investment objective by generally investing in MLPs up to the maximum extent permitted of a RIC under the Code. Accordingly, the Fund will, as of the end of each fiscal quarter, invest no more than 25% of Managed Assets in securities of MLPs and other entities that are &#8220;qualified publicly traded partnerships&#8221; under the Code. </td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify">&#160;</td>
    <td style="width: 65%; text-align: justify">The Fund generally seeks to invest no more than 10% of Managed Assets (as defined below) in any one issue and no more than 15% of Managed Assets in any one issuer, in each case, determined at the time of investment. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund seeks attractive investment opportunities by investing in initial public offerings (&#8220;IPOs&#8221;) and secondary market issuances, private investment in public equity (&#8220;PIPE&#8221;) transactions and privately negotiated transactions, including pre-acquisition and pre-IPO equity issuances and investments in private companies. No more than 50% of the Fund&#8217;s portfolio will be in PIPE or other private or restricted securities at the time of investment. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund invests up to 20% of its Managed Assets in investments other than mid-stream energy investments, including equity securities of issuers other than midstream energy companies. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund&#8217;s investments in non-U.S. securities include securities of issuers in emerging markets. The Fund&#8217;s investments in non-U.S. securities also includes non-U.S. securities represented by American Depositary Receipts (&#8220;ADRs&#8221;), which are certificates evidencing ownership of shares of a non-U.S. issuer that are issued by depositary banks and generally trade on an established market in the United States or elsewhere.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund invests, without limitation, in debt securities rated, at the time of investment, at least (i) B3 by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;), (ii) B- by Standard &amp; Poor&#8217;s Ratings Services (&#8220;S&amp;P&#8221;) or Fitch Ratings (&#8220;Fitch&#8221;), or (iii) a comparable rating by another rating agency, and invests no more than 5% of its Managed Assets in debt securities rated below B3 by Moody&#8217;s, B- by S&amp;P or Fitch or a comparable rating by another rating agency. Therefore, the Fund may invest in below investment grade debt securities. A debt security is considered below investment grade if it is rated below Baa3- by Moody&#8217;s or below BBB- by S&amp;P or Fitch or a comparable rating by another rating agency. Below investment grade debt securities are often referred to as &#8220;high yield&#8221; securities or &#8220;junk bonds.&#8221; Below investment grade debt securities are regarded as having predominantly speculative characteristics with respect to capacity to pay interest and to repay principal. Debt securities in which the Fund invests may be of any maturity.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund&#8217;s investments will be concentrated in issuers in the industry or group of industries that make up the natural resources sector, and specifically in midstream energy companies within the natural resources sector. </td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify">&#160;</td>
    <td style="width: 65%; text-align: justify">As used in this Prospectus (excepted as noted below), &#8220;Managed Assets&#8221; means the total assets of the Fund, minus all accrued expenses incurred in the normal course of operations other than liabilities or obligations attributable to investment leverage, including, without limitation, investment leverage obtained through (i) indebtedness of any type (including, without limitation, borrowing through a credit facility or the issuance of debt securities), (ii) the issuance of shares of preferred stock (&#8220;preferred shares&#8221;) or other similar preference securities and/or (iii) the reinvestment of collateral received for securities loaned in accordance with the Fund&#8217;s investment objective and policies. Solely for purposes of the Fund&#8217;s 80% policy, &#8220;Managed Assets&#8221; means net assets, plus the amount of any borrowings for investment purposes. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund&#8217;s investment objective and percentage parameters, including its 80% policy, are not fundamental policies of the Fund and may be changed without shareholder approval. Shareholders, however, will be notified in writing of any change at least 60 days prior to effecting any such change.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Tax Treatment of the Fund</b></td>
    <td style="text-align: justify">The Fund has elected to be treated as, and intends to continue to qualify as, a RIC for U.S. federal income tax purposes. In order to qualify as a RIC, the Fund must, among other things, satisfy income, asset diversification and distribution requirements. As long as it so qualifies, the Fund will generally not be subject to U.S. federal income tax to the extent that it distributes annually its taxable income and gains. There can be no assurance that the Fund will qualify as a RIC for any given year.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">See &#8220;U.S. Federal Income Tax Considerations.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Investment Adviser</b></td>
    <td style="text-align: justify">The Fund&#8217;s investments are managed by its Investment Adviser, Cushing<sup>&#174;</sup> Asset Management, LP d/b/a NXG Investment Management, whose principal business address is One Energy Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206. The Investment Adviser is a majority-owned investment advisory subsidiary of Swank Capital, LLC, a Texas limited liability company wholly owned by Jerry V. Swank, the founder of the Adviser. Certain employees of the Investment Adviser also own an interest in the Investment Adviser through NXG Cushing, LLC, a Texas limited liability company owned by such employees. The Investment Adviser was founded in 2003 and serves as investment adviser to registered and unregistered funds. As of December&#160;31, 2024, the Investment Adviser managed approximately $1.3 billion in assets.</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify"><b>Distributions</b></td>
    <td style="width: 65%; text-align: justify">The Fund intends to pay substantially all of its net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will consist primarily of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term capital gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital gain over net short-term capital loss), and/or (iii) return of capital. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">The Fund&#8217;s net investment income can vary significantly over time; however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any particular month may be more or less than the amount of net investment income for that monthly period. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">In any given year, there can be no guarantee the Fund&#8217;s investment returns will exceed the amount of distributions. The Fund may distribute more than the entire amount of the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return of capital. <b>The Fund&#8217;s distributions have historically included, and may in the future include, a significant portion of return of capital. For the fiscal year ended November 30, 2024, the Fund&#8217;s distributions were comprised of approximately 69% ordinary income, 31% long-term capital gains, and 0% return of capital. Accordingly, shareholders should not assume that the source of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income. </b>Return of capital is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the Common Shareholder&#8217;s potential loss, on any subsequent sale or other disposition of Common Shares.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Alternatively, the Fund may also distribute less than its net investment income in a particular period. The undistributed net investment income may be available to supplement future common share distributions. Undistributed net investment income is included in the Common Shares&#8217; net asset value, and, correspondingly, distributions from net investment income will reduce the Common Shares&#8217; net asset value. </td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35%; text-align: justify">&#160;</td>
    <td style="width: 65%; text-align: justify">With each distribution that does not consist solely of net investment income, the Fund will issue a notice to shareholders that will provide estimated information regarding the amount and composition of the distribution. The amounts and sources of distributions reported in each notice will be estimated, are likely to change over time and are not provided for tax reporting purposes. The final determination of such amounts will be made and reported to shareholders after the end of the calendar year when the Fund determines its earnings and profits for the year. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s investment experience during its full fiscal year and may be subject to changes based on tax regulations. The Fund will send each shareholder a Form 1099-DIV for the calendar year that will tell shareholders how to report distributions for federal income tax purposes.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">See &#8220;Distributions.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Dividend Reinvestment Plan</b></td>
    <td style="text-align: justify">Shareholders will automatically have all distributions (including capital gain distributions and return of capital distributions) reinvested in Common Shares issued by the Fund or Common Shares of the Fund purchased on the open market in accordance with the Fund&#8217;s dividend reinvestment plan unless an election is made to receive cash. Common Shareholders who receive distributions in the form of additional Common Shares will be subject to the same U.S. federal income tax consequences as Common Shareholders who elect to receive their distributions in cash. See &#8220;Dividend Reinvestment Plan.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Listing and Symbol</b></td>
    <td style="text-align: justify">The Fund&#8217;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;SRV.&#8221; As of March 17, 2025, the net asset value of the Fund&#8217;s Common Shares was $42.77 per Common Share, and the last reported sale price for the Fund&#8217;s Common Shares on the NYSE was $43.83 per Common Share, representing a premium to net asset value of 2.48%. In connection with any offering of Rights, the Fund will provide information in the Prospectus Supplement for the expected trading market, if any, for Rights.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Special Risk Considerations</b></td>
    <td style="text-align: justify">Investors should consider the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment. <b>&#160;</b>See &#8220;Risks.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Other Service Providers</b></td>
    <td style="text-align: justify">Under a transfer agent servicing agreement among U.S. Bancorp Global Fund Services and the Fund, U.S. Bancorp Global Fund Services serves as the Fund&#8217;s transfer agent, registrar and distribution disbursing agent. U.S. Bancorp Global Fund Services (the &#8220;Administrator&#8221;) provides the Fund with administrative services. The Administrator also performs fund accounting.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">U.S. Bank National Association serves as the custodian of the Fund&#8217;s securities and other assets.</td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</div>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">SUMMARY
OF FUND EXPENSES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The information contained under the heading &#8220;Additional
Information (Unaudited)&#8212;Summary of Fund Expenses&#8221; in the Fund&#8217;s Annual Report is incorporated herein by reference.</p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">FINANCIAL
HIGHLIGHTS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The financial highlights
for the fiscal years ended November&#160;30, 2024, November&#160;30, 2023, November&#160;30, 2022, November&#160;30, 2021 and November&#160;30,
2020, are derived from the Fund&#8217;s financial statements audited by Ernst &amp; Young LLP, independent registered public accounting
firm for the Fund, whose report on such financial statements, together with the financial statements of the Fund, are incorporated herein
by reference to the Annual Report.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 11pt"><b>Fiscal<br/> Year<br/> Ended<br/> November<br/> 30,<br/> 2019<sup>(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 11pt"><b>Fiscal<br/> Year<br/> Ended<br/> November<br/> 30,<br/> 2018<sup>(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal<br/> Year<br/> Ended<br/> November<br/> 30,<br/> 2017</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal<br/> Year<br/> Ended<br/> November<br/> 30,<br/> 2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal<br/> Year<br/> Ended<br/> November<br/> 30,<br/> 2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left"><span style="font-size: 11pt"><b>Per Common Share Data<sup>(2)</sup></b></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 39%; text-align: left">Net Asset Value, beginning of fiscal year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45.36</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">48.12</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.84</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13.76</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29.70</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">Income from Investment Operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.48</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.42</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.29</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8.83</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt; text-align: left">Net realized and unrealized gain (loss) on investments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.84</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.72</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2.45</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4.90</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt; text-align: left">Total increase (decrease) from investment operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.56</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.73</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2.16</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13.73</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">Less Distributions and Dividends to Common Stockholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net investment income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.32</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Return of capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.28</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.21</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total distributions and dividends to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.32</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.32</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.21</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; text-align: left">Net Asset Value, end of fiscal year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41.40</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45.36</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.84</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13.76</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; text-align: left">Per common share fair value, end of fiscal year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37.84</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38.88</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10.73</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.02</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Total Investment Return Based on Fair Value<sup>(3)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">8.51</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.58</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(8.05</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.98</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(67.20</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">Supplemental Data and Ratios</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net assets applicable to common stockholders, end of fiscal year (000&#8217;s)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">69,718</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">76,382</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">81,002</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">99,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">92,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of expenses (including current and deferred income tax benefit/expense) to average net assets before waiver<sup>(4)(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.48</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.91</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.71</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of expenses (including current and deferred income tax benefit/expense) to average net assets after waiver<sup>(4)(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.35</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.04</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.14</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.11</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of net investment income (loss) to average net assets before waiver<sup>(4)(7)(8)(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.40</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.63</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.60</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.85</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.19</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of net investment income (loss) to average net assets after waiver<sup>(4)(7)(8)(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.05</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.27</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.16</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.08</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.58</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of net investment income (loss) to average net assets after current and deferred income tax benefit/expense, before waiver<sup>(4)(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.60</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.01</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.30</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Ratio of net investment income (loss) to average net assets after current and deferred income tax benefit/expense, after waiver<sup>(4)(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.16</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.24</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.70</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Portfolio turnover rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44.67</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95.57</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62.87</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97.78</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97.30</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total borrowings outstanding (in thousands)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">28,915</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">26,050</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">33,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">49,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,369</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="font-size: 11pt">Asset coverage per $1,000 of indebtedness<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,407</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,136</td><td style="text-align: left">&#160;</td></tr>
  </table>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(1)</td><td style="text-align: justify">Per share data adjusted for 1:4 reverse stock split completed as of June 12, 2020.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(2)</td><td style="text-align: justify">Information presented relates to a share of common stock outstanding for the entire fiscal year.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(3)</td><td style="text-align: justify">The calculation assumes reinvestment of dividends at actual prices pursuant to the Fund&#8217;s dividend
reinvestment plan. Total investment return does not reflect brokerage commissions.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(4)</td><td style="text-align: justify">The ratio of expenses to average net assets before waiver was 3.21%, 2.80%, 3.13%, 4.08%, and 3.71% for
the fiscal years ended November 30, 2022, 2021, 2020, 2019, and 2018, respectively. The ratio of expenses (including current and deferred
income tax benefit/expense) to average net assets before waiver was 4.48%, 3.91%, 2.71%, 3.41% and 4.64% for the fiscal years ended November
30, 2017, 2016, 2015, 2014 and 2013, respectively.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(5)</td><td style="text-align: justify">Calculated by subtracting the Fund&#8217;s total liabilities (not including borrowings) from the Fund&#8217;s
total assets and dividing by the total borrowings.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(6)</td><td style="text-align: justify">Per share data adjusted for 1:5 reverse stock split completed as of September 14, 2015.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(7)</td><td style="text-align: justify">For the fiscal year ended November 30, 2018, the Fund accrued $0 in net current and deferred tax expense.<br/>
For the fiscal year ended November 30, 2017, the Fund accrued $972,195 in net current and deferred tax expense.<br/>
For the fiscal year ended November 30, 2016, the Fund accrued $141,294 in net current and deferred tax expense.<br/>
For the fiscal year ended November 30, 2015, the Fund accrued $1,289,093 in net current and deferred tax benefit.<br/>
For the fiscal year ended November 30, 2014, the Fund accrued $1,115,507 in net current and deferred tax expense.<br/>
For the fiscal year ended November 30, 2013, the Fund accrued $5,743,456 in net current tax expense.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(8)</td><td style="text-align: justify">The ratio of expenses (excluding current and deferred income tax expense) to average net assets before
waiver was 3.48%, 3.75%, 3.60%, 2.93% and 2.18% for the fiscal years ended November 30, 2017, 2016, 2015, 2014 and 2013, respectively.<br/>
The ratio of expenses (excluding current and deferred income tax expense) to average net assets after waiver was 3.04%, 2.97%, 2.99%,
2.93% and 2.18% for the fiscal years ended November 30, 2017, 2016, 2015, 2014 and 2013, respectively.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(9)</td><td style="text-align: justify">This ratio excludes current and deferred income tax benefit/expense on net investment income.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.3in">(10)</td><td style="text-align: justify">Not annualized.</td></tr></table>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><b></b></span></p>

<ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000050" name="cef:SeniorSecuritiesTableTextBlock"><p id="xdx_A88_ecef--SeniorSecuritiesTableTextBlock_z3mHiEfZZW01" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">SENIOR
SECURITIES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table sets
forth information about the Fund&#8217;s outstanding senior securities as of the end of each fiscal period indicated. The information
in this table for the fiscal years ended November&#160;30, 2024, November&#160;30, 2023, November&#160;30, 2022, November&#160;30, 2021
and November&#160;30, 2020 is derived from the Fund&#8217;s financial statements audited by Ernst &amp; Young LLP, independent registered
public accounting firm for the Fund, whose report on such financial statements, together with the financial statements of the Fund, are
included in the Fund&#8217;s Annual Report and are incorporated herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Fiscal Period Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Title of<br/> Security</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> Principal<br/> Amount<br/> Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asset<br/> Coverage<br/> Per<br/> $1,000 of<br/> Principal<br/> Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 57%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center">Borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecef--SeniorSecuritiesAmt_iI_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zZyQBp7Szl4b" style="width: 12%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2024-11-30_custom_SeniorSecurityMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,315,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zpAsqnlRqb9h" style="width: 12%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2024-11-30_custom_SeniorSecurityMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5,035</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2023</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zFy7RYsW6u73" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-11-30_custom_SeniorSecurityMember" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zaZTr8qbkCw4" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-11-30_custom_SeniorSecurityMember" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5,391</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2022<sup>*</sup></td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecef--SeniorSecuritiesAmt_iI_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____zOeMYYV2Ksw7" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-11-30_custom_SeniorSecurityMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____ztR7tWujnGPf" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-11-30_custom_SeniorSecurityMember" id="Fact000056" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13,736</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2021</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zn41P3dDbVt9" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-11-30_custom_SeniorSecurityMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,715,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zq5kkxC4I4E4" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-11-30_custom_SeniorSecurityMember" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,399</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2020</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z1AY1TOuYhy5" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-11-30_custom_SeniorSecurityMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,915,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLEvuH7fmmqc" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-11-30_custom_SeniorSecurityMember" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5,287</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2019</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecef--SeniorSecuritiesAmt_iI_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zYIhi3KYKMYe" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-11-30_custom_SeniorSecurityMember" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,915,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z9sUhBht5Ykg" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-11-30_custom_SeniorSecurityMember" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,411</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2018</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesAmt_iI_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z5zv93OOwz3i" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-11-30_custom_SeniorSecurityMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,050,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLdx0SMcCs6j" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-11-30_custom_SeniorSecurityMember" id="Fact000064" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,932</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2017</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecef--SeniorSecuritiesAmt_iI_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zy1xARDXqA2c" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-11-30_custom_SeniorSecurityMember" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,650,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zdDPD6RTk705" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-11-30_custom_SeniorSecurityMember" id="Fact000066" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,407</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2016</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecef--SeniorSecuritiesAmt_iI_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zt2sdQb6pB17" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-11-30_custom_SeniorSecurityMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,454,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zxQ7bxjZxB1k" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-11-30_custom_SeniorSecurityMember" id="Fact000068" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,021</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2015</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z374dTwUUhi6" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-11-30_custom_SeniorSecurityMember" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,369,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zJYhi2abQNm8" style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-11-30_custom_SeniorSecurityMember" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,136</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: left; text-indent: -0.1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F08_zMiOvlhfUtJl" style="width: 0.25in">*</td><td id="xdx_F18_zO7tK8jc9Jyf" style="text-align: left"><ix:footnote id="Footnote000071" xml:lang="en-US">On November&#160;30, 2022 the Fund reduced its borrowings by paying down $22 million outstanding under its
borrowing facility. As a result of the timing of this transaction, the Fund&#8217;s balance sheet as of November&#160;30, 2022 includes
an amount due to the Fund&#8217;s custodian of $22 million, which amount was eliminated when the pay down process was completed on December&#160;1,
2022.</ix:footnote></td></tr></table>


<ix:exclude><!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><b></b></span></p>

</ix:nonNumeric><p id="xdx_A92_zdOqmssByxh3" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">THE
FUND</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">NXG Cushing<sup>&#174;</sup>
Midstream Energy Fund (the &#8220;Fund&#8221;) was formed as a Delaware statutory trust on May&#160;23, 2007 and is a non-diversified,
closed-end management investment company registered under the Investment Company Act of 1940 Act (the &#8220;1940 Act&#8221;). The Fund
commenced investment operations on August&#160;27, 2007. The Fund&#8217;s principal office is located at One Energy Square, 4925 Greenville
Avenue, Suite 1310, Dallas, Texas 75206.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">USE
OF PROCEEDS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise specified
in a Prospectus Supplement, the Fund intends to invest the net proceeds of an offering of Securities in accordance with its investment
objective and policies as stated in this Prospectus. It is currently anticipated that the Fund will be able to invest substantially all
of the net proceeds of an offering of Securities in accordance with its investment objective and policies within three months after the
completion of such offering. Prior to the time the proceeds of each offering are fully invested, such proceeds may temporarily be invested
in cash, cash equivalents, or in debt securities that are rated AA or higher. Income received by the Fund from such temporary investments
would likely be less than returns sought pursuant to the Fund&#8217;s investment objective and policies. A delay in the anticipated use
of proceeds could lower returns and reduce the Fund&#8217;s distribution to Common Shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">MARKET
AND NET ASSET VALUE INFORMATION</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Market and Net Asset Value Information&#8221; in the Fund&#8217;s Annual
Report is incorporated herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000072" name="cef:InvestmentObjectivesAndPracticesTextBlock"><p id="xdx_A87_ecef--InvestmentObjectivesAndPracticesTextBlock_zkb5ExMH65f5" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">INVESTMENT
OBJECTIVE AND POLICIES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Investment Objective and Policies&#8221; in the Fund&#8217;s Annual
Report is incorporated herein by reference.</p>

</ix:nonNumeric><p id="xdx_A9D_zlmFGPBbYCw7" style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000073" name="cef:RiskFactorsTableTextBlock"><p id="xdx_A84_ecef--RiskFactorsTableTextBlock_zL8dDfNudWIf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">RISKS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Investors should consider
the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment
risk, including the possible loss of your entire investment. A Prospectus Supplement relating to an offering of the Fund&#8217;s securities
may identify additional risk associated with such offering.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Risks&#8221; in the Fund&#8217;s Annual Report is incorporated herein
by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Additional risk factors associated
with offerings pursuant to this Prospectus include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<div id="xdx_980_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--RisksAssociatedwithOfferingsofAdditionalCommonSharesMember_zXYqrxuEB7v7"><ix:nonNumeric contextRef="From2025-04-102025-04-10_custom_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" escape="true" id="Fact000074" name="cef:RiskTextBlock">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Risks Associated with
Offerings of Additional Common Shares.</i> The voting power of current Common Shareholders will be diluted to the extent that current
Common Shareholders do not purchase Common Shares in any future offerings of Common Shares or do not purchase sufficient Common Shares
to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#8217;s per
Common Share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds were
fully invested as planned. If the Fund sells Common Shares at a price below net asset value per share pursuant to the consent of Common
Shareholders, shareholders will experience a dilution of the aggregate net asset value per Common Share because the sale price will be
less than the Fund&#8217;s then-current net asset value per Common Share. Similarly, were the expenses of the offering to exceed the amount
by which the sale price exceeded the Fund&#8217;s then current net asset value per Common Share, shareholders would experience a dilution
of the aggregate net asset value per Common Share. This dilution will be experienced by all shareholders, irrespective of whether they
purchase Common Shares in any such offering. See &#8220;Description of Shares&#8212;Common Shares&#8212;Issuance of Additional Common
Shares.&#8221;</p>

</ix:nonNumeric></div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<div id="xdx_985_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--AdditionalRisksofRightsMember_zj2X4bNOS2A4"><ix:nonNumeric contextRef="From2025-04-102025-04-10_custom_AdditionalRisksofRightsMember" escape="true" id="Fact000075" name="cef:RiskTextBlock">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Additional Risks of Rights.
</i>There are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion
of such an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering,
a shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price per share is below the net asset value per share of the Fund&#8217;s Common Shares
on the expiration date, a shareholder will experience an immediate dilution of the aggregate net asset value of such shareholder&#8217;s
Common Shares if the shareholder does not participate in such an offering and the shareholder will experience a reduction in the net asset
value per share of such shareholder&#8217;s Common Shares whether or not the shareholder participates in such an offering. Such a reduction
in net asset value per share may have the effect of reducing market price of the Common Share. The Fund cannot state precisely the extent
of this dilution (if any) if the shareholder does not exercise such shareholder&#8217;s Rights because the Fund does not know what the
net asset value per share will be when the offer expires or what proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per Common Share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i)&#160;such shareholders participate in the Rights offering
and (ii)&#160;the Fund&#8217;s net asset value per Common Share is above or below the subscription price on the expiration date of the
Rights offering. In addition to the economic dilution described above, if a Common Shareholder does not exercise all of their rights,
the Common Shareholder will incur voting dilution as a result of this rights offering. This voting dilution will occur because the Common
Shareholder will own a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is
a risk that changes in market conditions may result in the underlying Common Shares purchasable upon exercise of the subscription rights
being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription
rights. If investors exercise only a portion of the rights, the number of Common Shares issued may be reduced, and the Common Shares may
trade at less favorable prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable
or&#160;non-transferable&#160;rights. In a&#160;non-transferable&#160;rights offering, Common Shareholders who do not wish to exercise
their rights will be unable to sell their rights. In a transferrable rights offering, the Fund will use its best efforts to ensure an
adequate trading market for the rights; however, investors may find that there is no market to sell rights they do not wish to exercise.</p>

</ix:nonNumeric></div>


<ix:exclude><!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

</ix:nonNumeric><p id="xdx_A96_z1BIlXXQNQOf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">MANAGEMENT
OF THE FUND</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Management of the Fund&#8221; in the Fund&#8217;s Annual Report is incorporated
herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">NET
ASSET VALUE</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Net Asset Value&#8221; in the Fund&#8217;s Annual Report is incorporated
herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">DISTRIBUTIONS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund intends to pay substantially
all of its net investment income to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any
net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will
consist primarily of (i) investment company taxable income, which includes, among other things, ordinary income, net short-term capital
gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital
gain over net short-term capital loss), and/or (iii) return of capital.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund&#8217;s net investment
income can vary significantly over time; however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions
paid by the Fund for any particular month may be more or less than the amount of net investment income for that monthly period.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In any given year, there
can be no guarantee the Fund&#8217;s investment returns will exceed the amount of distributions. The Fund may distribute more than the
entire amount of the net investment income earned in a particular period, in which case all or a portion of a distribution may be a return
of capital. Return of capital is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common
Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may not be taxable,
it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the Common Shareholder&#8217;s potential loss, on
any subsequent sale or other disposition of Common Shares. <b>The Fund&#8217;s distributions have historically included, and may in the
future include, a significant portion of return of capital. For the fiscal year ended November&#160;30, 2024, the Fund&#8217;s distributions
were comprised of approximately 30% ordinary income and 70% return of capital. Accordingly, shareholders should not assume that the source
of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions should not be used as a measure of performance
or confused with yield or income.</b></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Alternatively, the Fund may
also distribute less than its net investment income in a particular period. The undistributed net investment income may be available to
supplement future common share distributions. Undistributed net investment income is included in the Common Shares&#8217; net asset value,
and, correspondingly, distributions from net investment income will reduce the Common Shares&#8217; net asset value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">With each distribution that
does not consist solely of net investment income, the Fund will issue a notice to shareholders that will provide estimated information
regarding the amount and composition of the distribution. The amounts and sources of distributions reported in each notice will be estimated,
are likely to change over time and are not provided for tax reporting purposes. The final determination of such amounts will be made and
reported to shareholders after the end of the calendar year when the Fund determines its earnings and profits for the year. The actual
amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s investment experience during
its full fiscal year and may be subject to changes based on tax regulations. The Fund will send each shareholder a Form&#160;1099-DIV
for the calendar year that will tell shareholders how to report distributions for federal income tax purposes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund reserves the right
to change its distribution policy and the basis for establishing the rate of distributions at any time and may do so without prior notice
to Common Shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Payment of future distributions
is subject to approval by the Fund&#8217;s Board of Trustees, as well as meeting the covenants of any outstanding Indebtedness or preferred
shares and the asset coverage requirements of the 1940 Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">DIVIDEND
REINVESTMENT PLAN</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Management of the Fund&#8212;Distribution and Dividend Reinvestment
Plan&#8221; in the Fund&#8217;s Annual Report is incorporated herein by reference.</p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000076" name="cef:CapitalStockTableTextBlock"><p id="xdx_A8F_ecef--CapitalStockTableTextBlock_zKjjMrb2nddj" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">DESCRIPTION
OF SHARES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a brief
description of the terms of the securities which may be issued by the Fund. This description does not purport to be complete and is qualified
by reference to the Fund&#8217;s governing documents. The Fund is a statutory trust organized under the laws of Delaware pursuant to a
Certificate of Trust dated May&#160;23, 2007, as filed with the State of Delaware on May&#160;23, 2007 and as amended through the date
hereof.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000077" name="cef:SecurityTitleTextBlock"><p id="xdx_A8E_ecef--SecurityTitleTextBlock_z5O1RghUR4ze" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Common Shares</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund is authorized to
issue an unlimited number of Common Shares of beneficial interest, par value $0.001 per share. <span id="xdx_901_ecef--SecurityVotingRightsTextBlock_c20250410__20250410_zkQSRM4jhudc"><ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000078" name="cef:SecurityVotingRightsTextBlock">Each Common Share has one vote.</ix:nonNumeric></span> Pursuant
to the Declaration of Trust, when issued and paid for in accordance with the terms of this offering, will be fully paid and non-assessable.
The Declaration of Trust provides that the Board of Trustees will have the power to cause shareholders to pay expenses of the Fund by
setting off charges due from shareholders from declared but unpaid distributions owed the shareholders and/or by reducing the number of
Common Shares owned by each respective shareholder. No expenses have been paid or are being paid pursuant to such provision, and the Board
of Trustees has no intention to cause expenses to be paid pursuant to such provision, which in any event may only be utilized to the extent
permitted by the 1940 Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund intends to hold
annual meetings of shareholders so long as the Common Shares are listed on a national securities exchange and such meetings are required
as a condition to such listing. <span id="xdx_90F_ecef--SecurityPreemptiveAndOtherRightsTextBlock_c20250410__20250410_zRerANUHKql2"><ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000079" name="cef:SecurityPreemptiveAndOtherRightsTextBlock">All Common Shares are equal as to distributions, assets and voting privileges and have no conversion,
preemptive or other subscription rights.</ix:nonNumeric></span> The Fund will furnish annual and semi-annual reports, including financial statements, to all
holders of its shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unlike open-end funds, closed-end
funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy
additional Common Shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise.
Shares of closed-end funds frequently trade on an exchange at prices lower than net asset value. Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), distribution stability, net
asset value, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond
the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than net asset value in
the future. The Common Shares are designed primarily for long-term investors, and you should not purchase the Common Shares if you intend
to sell them soon after purchase.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Issuance of Additional
Common Shares. </i>The provisions of the 1940 Act generally require that the public offering price (less underwriting commissions and
discounts) of common shares sold by a closed-end investment company must equal or exceed the net asset value of such company&#8217;s common
shares (calculated within 48 hours of the pricing of such offering), unless such sale is made with the consent of a majority of its common
shareholders. The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of
Common Shares at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions. If such consent is obtained,
the Fund may, contemporaneous with and in no event more than one year following the receipt of such consent, sell Common Shares at price
below net asset value in accordance with any conditions adopted in connection with the giving of such consent. Additional information
regarding any consent of Common Shareholders obtained by the Fund and the applicable conditions imposed on the issuance and sale by the
Fund of Common Shares at a price below net asset value will be disclosed in the Prospectus Supplement relating to any such offering of
Common Shares at a price below net asset value. Until such consent of Common Shareholders, if any, is obtained, the Fund may not sell
Common Shares at a price below net asset value. Because the Fund&#8217;s advisory fee is based upon average Managed Assets, the Investment
Adviser&#8217;s interest in recommending the issuance and sale of Common Shares at a price below net asset value may conflict with the
interests of the Fund and its Common Shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund will not sell Common
Shares at a price below its net asset value per Common Share (including with shareholder approval or pursuant to rights to purchase Common
Shares) under this Prospectus or an accompanying prospectus supplement without first filing a new post-effective amendment to the registration
statement if the cumulative dilution to the Fund&#8217;s net asset value per share from offerings under the registration statement exceeds
15%.</p>


<ix:exclude><!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><p id="xdx_A9C_zMAQj3Dwhrn5" style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000080" name="cef:OtherSecuritiesTableTextBlock"><p id="xdx_A8B_ecef--OtherSecuritiesTableTextBlock_zZNDztHwgjNf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_908_ecef--WarrantsOrRightsCalledTitleTextBlock_c20250410__20250410_zKPBI4wQFAG9"><ix:nonNumeric contextRef="AsOf2025-04-10" escape="true" id="Fact000081" name="cef:WarrantsOrRightsCalledTitleTextBlock">Subscription Rights to
Purchase Common Shares</ix:nonNumeric></span></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may issue subscription
rights to holders of Common Shares to purchase Common Shares. Subscription rights may be issued independently or together with any other
offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with
a subscription rights offering to holders of Common Shares, the Fund would distribute certificates evidencing the subscription rights
and a Prospectus Supplement to our common or preferred shareholders as of the record date that we set for determining the shareholders
eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer
to the actual terms of such subscription rights which will be set forth in the subscription rights agreement and/or subscription certificate
relating to such subscription rights. The Fund may only conduct a subscription rights offering to the extent that the Board of Trustees
makes a good faith determination that the offering would result in a net benefit to existing shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The applicable Prospectus
Supplement would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the period of time the offering would remain open (which will be open a minimum number of days such that
all record holders would be eligible to participate in the offering and will not be open longer than 120 days);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the exercise price for such subscription rights (or method of calculation thereof);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the number of such subscription rights issued in respect of each Common Share;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the extent to which such subscription rights are transferable and the market on which they may be traded
if they are transferable;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
or exercise of such subscription rights;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the date on which the right to exercise such subscription rights will commence, and the date on which
such right will expire (subject to any extension);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and
the terms of such over-subscription privilege;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any termination right the Fund may have in connection with such subscription rights offering;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the expected trading market, if any, for rights; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any other terms of such subscription rights, including exercise, settlement and other procedures and limitations
relating to the transfer and exercise of such subscription rights.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Exercise of Subscription
Rights. </i>Each subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such
exercise price as in each case is set forth in, or be determinable as set forth in the Prospectus Supplement relating to the subscription
rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such
subscription rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription
rights would become void.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon expiration of the rights
offering and the receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust
office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable,
the Common Shares purchased as a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer
any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through
a combination of such methods, as set forth in the applicable Prospectus Supplement</p>


<ix:exclude><!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: left">&#160;</p>

<div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Transferable Rights Offering</i>.
Subscription rights issued by the Fund may be transferrable. The terms of a transferrable rights offering will fully protect shareholders&#8217;
preemptive rights, if any, and will not discriminate among shareholders (except for the possible de minimis effect of not issuing fractional
rights). The distribution to Common Shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating
Common Shareholders the potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation
for any dilution of their interests that may occur as a result of the rights offering. In a transferrable rights offering, Fund management
will use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights.
However, there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price
of the transferable rights will be. In a transferrable rights offering, the subscription ratio will not be less than 1-for-3, that is
the holders of Common Shares of record on the record date of the rights offering will receive one right for each outstanding Common Share
owned on the record date and the rights will entitle their holders to purchase one new Common Share for every three rights held (provided
that any Common Shareholder who owns fewer than three Common Shares as of the record date may subscribe for one full Common Share). Assuming
the exercise of all rights, such a rights offering would result in an approximately 331&#8260;3% increase in the Fund&#8217;s Common Shares
outstanding.</p>

</div>

</ix:nonNumeric><p id="xdx_A9B_z6jFJVeMvUCd" style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Preferred Shares</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
provides that the Board of Trustees may authorize and issue preferred shares with rights as determined by the Board of Trustees, by action
of the Board of Trustees without the approval of the holders of the Common Shares. Holders of Common Shares have no preemptive right to
purchase any preferred shares that might be issued pursuant to such provision. Whenever preferred shares are outstanding, the holders
of Common Shares will not be entitled to receive any distributions from the Fund unless all accrued distributions on preferred shares
have been paid, unless asset coverage (as defined in the 1940 Act) with respect to preferred shares would be at least 200% after giving
effect to the distributions and unless certain other requirements imposed by any rating agencies rating the preferred shares have been
met. If the Board of Trustees determines to proceed with such an offering, the terms of the preferred shares may be the same as, or different
from, the terms described below, subject to applicable law and the Declaration of Trust. The Board of Trustees, without the approval of
the holders of Common Shares, may authorize an offering of preferred shares or may determine not to authorize such an offering and may
fix the terms of the preferred shares to be offered. As of the date of this Prospectus, the Fund has not issued any preferred shares and
has no current expectation to issue preferred shares in the next 12 months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Distributions</i>. Holders
of preferred shares will be entitled to receive cash distributions, when, as and if authorized by the Board of Trustees and declared by
the Fund, out of funds legally available therefor. The Prospectus Supplement for any offering of preferred shares will describe the distributions
payment provisions for those shares. Distributions so declared and payable shall be paid to the extent permitted under Delaware law and
to the extent available and in preference to and priority over any distribution declared and payable on the Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Limitations on Distributions</i>.
So long as the Fund has Indebtedness outstanding, holders of preferred shares will not be entitled to receive any distributions unless
asset coverage (as defined in the 1940 Act) with respect to outstanding Indebtedness would be at least 300% after giving effect to such
distributions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Liquidation Preference</i>.
In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred shares will
be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per preferred share
plus accrued and unpaid distributions, whether or not declared, before any distribution of assets is made to holders of Common Shares.
After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred shares will not
be entitled to any further participation in any distribution of assets by the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Voting Rights</i>. The
1940 Act requires that the holders of any preferred shares, voting separately as a single class, have the right to elect at least two
trustees at all times. The remaining trustees will be elected by holders of Common Shares and preferred shares, voting together as a single
class. In addition, subject to the prior rights, if any, of the holders of any other class of senior securities outstanding, the holders
of any preferred shares have the right to elect a majority of the trustees of the Fund at any time two years of distributions on any preferred
shares are unpaid. The 1940 Act also requires that, in addition to any approval by shareholders that might otherwise be required, the
approval of the holders of a majority of any outstanding preferred shares, voting separately as a class, would be required to (i) adopt
any plan of reorganization that would adversely affect the preferred shares, and (ii) take any action requiring a vote of security holders
under Section&#160;13(a) of the 1940 Act, including, among other things, changes in the Fund&#8217;s sub-classification as a closed-end
fund or changes in its fundamental investment restrictions. As a result of these voting rights, the Fund&#8217;s ability to take any such
actions may be impeded to the extent that there are any preferred shares outstanding.</p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Debt Securities</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board of Trustees (subject
to applicable law and the Declaration of Trust) may authorize an offering, without the approval of the holders of either Common Shares
or preferred shares, of other classes of shares, or other classes or series of shares, as they determine to be necessary, desirable or
appropriate, having such terms, rights, preferences, privileges, limitations and restrictions as the Board of Trustees deems appropriate.
The Fund currently does not expect to issue any other classes of shares, or series of shares, except for the Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Delaware law and the
Declaration of Trust, the Board of Trustees may cause the Fund to borrow money, without prior approval of holders of common and preferred
stock to the extent permitted by the Fund&#8217;s investment restrictions and the 1940 Act. The Fund may issue debt securities or other
evidence of Indebtedness (including bank borrowings or commercial paper) and may secure any such notes or borrowings by mortgaging, pledging
or otherwise subjecting as security Fund assets to the extent permitted by the 1940 Act or rating agency guidelines. Any borrowings will
rank senior to the preferred shares and the Common Shares. Under the 1940 Act, the Fund may only issue one class of senior securities
representing Indebtedness.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Limitations</i>. Under
the requirements of the 1940 Act the Fund, immediately after any issuance of debt securities, must have &#8220;asset coverage&#8221; of
at least 300% (<i>i.e.</i>, for every dollar of Indebtedness outstanding, the Fund is required to have at least three dollars of assets).
The issuance of debt securities also may result in the Fund being subject to covenants that may be more stringent than the restrictions
imposed by the 1940 Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Voting Rights</i>. Debt
securities are not expected to have any voting rights, except to the extent required by law or as otherwise provided in any documents
governing the debt securities. The 1940 Act does, in certain circumstances, grant to the lenders certain voting rights in the event of
default in the payment of interest on or repayment of principal.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ANTI-TAKEOVER
PROVISIONS IN THE DECLARATION OF TRUST</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
includes provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Fund or
to change the composition of its Board of Trustees. This could have the effect of depriving shareholders of an opportunity to sell their
shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Fund. Such attempts
could have the effect of increasing the expenses of the Fund and disrupting the normal operation of the Fund. In addition, these ownership
restrictions may reduce market demand for the Fund&#8217;s Common Shares, which could have the effect of increasing the likelihood that
the Fund&#8217;s Common Shares trade at a discount to net asset value and increasing the amount of any such discount.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board of Trustees is
divided into two classes, with the terms of one class expiring at each annual meeting of shareholders. At each annual meeting, one class
of Trustees is elected to a two-year term. This provision could delay for up to two years the replacement of a majority of the Board of
Trustees. A Trustee may be removed from office (with or without cause) by the action of a majority of the remaining Trustees followed
by a vote of the holders of at least 75% of the shares then entitled to vote for the election of the respective Trustee.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the Agreement
and Declaration of Trust requires the favorable vote of a majority of the Fund&#8217;s Board of Trustees followed by the favorable vote
of the holders of at least 75% of the outstanding shares of each affected class or series of the Fund, voting separately as a class or
series, to approve, adopt or authorize certain transactions with 5% or greater holders of a class or series of shares and their associates,
unless the transaction has been approved by at least 75% of the Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221;
(as defined in the 1940 Act) of the Fund will be required. For purposes of these provisions, a 5% or greater holder of a class or series
of shares (a &#8220;Principal Shareholder&#8221;) refers to any person who, whether directly or indirectly and whether alone or together
with its affiliates and associates, beneficially owns 5% or more of the outstanding shares of all outstanding classes or series of shares
of beneficial interest of the Fund.</p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The 5% holder transactions
subject to these special approval requirements are: the merger or consolidation of the Fund or any subsidiary of the Fund with or into
any Principal Shareholder; the issuance of any securities of the Fund to any Principal Shareholder for cash, except pursuant to any automatic
dividend reinvestment plan; the sale, lease or exchange of any assets of the Fund to any Principal Shareholder, except assets having an
aggregate fair market value of less than $1,000,000, aggregating for the purpose of such computation all assets sold, leased or exchanged
in any series of similar transactions within a twelve-month period; or the sale, lease or exchange to the Fund or any subsidiary of the
Fund, in exchange for securities of the Fund, of any assets of any Principal Shareholder, except assets having an aggregate fair market
value of less than $1,000,000, aggregating for purposes of such computation all assets sold, leased or exchanged in any series of similar
transactions within a twelve-month period.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
limits the ability of persons to beneficially own (within the meaning of Section&#160;382 of the Code) more than 4.99% of the outstanding
Common Shares of the Fund and could have an anti-takeover effect on the Fund, which could decrease the Fund&#8217;s market price in certain
circumstances or limit the ability of certain shareholders to influence the management of the Fund. This restriction was adopted in order
to reduce the risk of the Fund undergoing an &#8220;ownership change&#8221; within the meaning of Section&#160;382 of the Code, which
would limit the Fund&#8217;s ability to use a capital loss carryforward and certain unrealized losses (if such tax attributes exist).
These ownership restrictions could have the effect of depriving shareholders of an opportunity to sell their shares at a premium over
prevailing market prices by discouraging a third party from seeking to obtain control over the Fund. Such attempts could have the effect
of increasing the expenses of the Fund and disrupting the normal operation of the Fund. In addition, these ownership restrictions may
reduce market demand for the Fund&#8217;s Common Shares, which could have the effect of increasing the likelihood that the Fund&#8217;s
Common Shares trade at a discount to net asset value and increasing the amount of any such discount.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To convert the Fund to an
open-end investment company, the Declaration of Trust requires the favorable vote of a majority of the board of the Trustees followed
by the favorable vote of the holders of at least 75% of the outstanding shares of each affected class or series of shares of the Fund,
voting separately as a class or series, unless such amendment has been approved by 75% of the Trustees, in which case &#8220;a majority
of the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund will be required. The foregoing vote would satisfy
a separate requirement in the 1940 Act that any conversion of the Fund to an open-end investment company be approved by the shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the purposes of calculating
&#8220;a majority of the outstanding voting securities&#8221; under the Declaration of Trust, each class and series of the Fund will vote
together as a single class, except to the extent required by the 1940 Act or the Declaration of Trust, with respect to any class or series
of shares. If a separate class vote is required, the applicable proportion of shares of the class or series, voting as a separate class
or series, also will be required.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
also provides that the Fund may be dissolved and terminated upon the approval of 75% of the Trustees by written notice to the shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board of Trustees has
determined that provisions with respect to the Board of Trustees and the shareholder voting requirements described above, which voting
requirements are greater than the minimum requirements under Delaware law or the 1940 Act, are in the best interest of shareholders generally.
Reference should be made to the Declaration of Trust, on file with the SEC for the full text of these provisions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, as a Delaware
statutory trust, the Fund is subject to the Control Share Statute contained in Subchapter III of the DSTA, which became automatically
applicable to listed closed-end funds, such as the Fund, upon its Effective Date of August&#160;1, 2022. The Control Share Statute provides
that an acquirer of shares above a series of voting power thresholds has no voting rights under the DSTA or the governing documents of
the Fund with respect to shares acquired in excess of that threshold (i.e., the &#8220;control shares&#8221;) unless approved by shareholders.
See &#8220;Certain Provisions of Delaware Law, the Declaration of Trust and By-Laws&#8212;Delaware Control Share Statute.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">CERTAIN
PROVISIONS OF DELAWARE LAW, THE DECLARATION OF TRUST<br/>
AND BY-LAWS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Classified Board of Trustees</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board of Trustees is
divided into two classes of trustees serving staggered two-year terms. Upon expiration of their current terms, Trustees of each class
will be elected to serve for two-year terms and until their successors are duly elected and qualified or the Fund terminates, and each
year one class of Trustees will be elected by the shareholders. A classified board may render a change in control of the Fund or removal
of the Fund&#8217;s incumbent management more difficult. The Fund believes, however, that the longer time required to elect a majority
of a classified Board of Trustees will help to ensure the continuity and stability of its management and policies.</p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Election of Trustees</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
provides that the affirmative vote of the holders of a plurality of the outstanding shares entitled to vote in the election of Trustees
will be required to elect a Trustee.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Number of Trustees; Vacancies;
Removal</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
provides that the number of Trustees will be set by the Board of Trustees. The Declaration of Trust provides that a majority of the Fund&#8217;s
Trustees then in office may at any time increase or decrease the number of Trustees provided there will be at least one Trustee. As soon
as any such Trustee has accepted his appointment in writing, the trust estate will vest in the new Trustee, together with the continuing
Trustees, without any further act or conveyance, and he will be deemed a Trustee thereunder. The Trustees&#8217; power of appointment
is subject to Section&#160;16(a) of the 1940 Act. Whenever a vacancy in the number of Trustees will occur, until such vacancy is filled
as provided, the Trustees in office, regardless of their number, will have all the powers granted to the Trustees and will discharge all
the duties imposed upon the Trustees by the Declaration of Trust.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Action by Shareholders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Shareholder action can be
taken only at an annual or special meeting of shareholders or by written consent in lieu of a meeting.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Advance Notice Provisions
for Shareholder Nominations and Shareholder Proposals</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund&#8217;s By-Laws
provide that with respect to an annual meeting of shareholders, nominations of persons for election to the Board of Trustees and the proposal
of business to be considered by shareholders may be made only (1) pursuant to the Fund&#8217;s notice of the meeting, (2) by the Board
of Trustees or (3) by a shareholder of record both at the time of giving of notice and at the time of the annual meeting who is entitled
to vote at the meeting and who has complied with the advance notice procedures of the By-Laws. With respect to special meetings of shareholders,
only the business specified in the Fund&#8217;s notice of the meeting may be brought before the meeting. Nominations of persons for election
to the Board of Trustees at a special meeting may be made only (1) pursuant to the Fund&#8217;s notice of the meeting, (2) by the Board
of Trustees or (3) provided that the Board of Trustees has determined that Trustees will be elected at the meeting, by a shareholder of
record both at the time of giving of notice and at the time of the annual meeting who is entitled to vote at the meeting and who has complied
with the advance notice provisions of the By-Laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Calling of Special Meetings
of Shareholders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund&#8217;s By-Laws
provide that special meetings of shareholders may be called at any time by the Chairman, the President or the Trustees of the Fund. By
following certain procedures, a special meeting of shareholders will also be called by the Secretary of the Fund upon the written request
of the Common Shareholders entitled to cast not less than a majority of all the votes entitled to be cast at such meeting.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Additional Provisions of
the Declaration of Trust</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Declaration of Trust
provides that there shall not be applicable to the Fund, the Fund&#8217;s trustees or the Declaration of Trust the establishment of fiduciary
or other standards of responsibilities or limitations on the acts or powers of trustees, which are inconsistent with the limitations or
liabilities or authorities and powers of the Trustees set out or referenced in the Declaration of Trust. Notwithstanding the foregoing,
no provision of the Declaration of Trust shall limit, waive or modify the duties of the Fund&#8217;s trustees, officers, members of any
advisory board, investment adviser or depositor arising under the federal securities laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Declaration of
Trust and By-Laws, and under Delaware law, the Trustees, officers, employees and certain agents of the Fund are entitled to indemnification
under certain circumstances against liabilities, claims and expenses arising from any threatened, pending or completed action, suit or
proceeding to which they are made parties by reason of the fact that they are or were such Trustees, officers, employees or agents of
the Fund, subject to the limitations of the 1940 Act that prohibit indemnification that would protect such persons against liabilities
to the Fund or its shareholders to which they would otherwise be subject by reason of their own bad faith, willful misfeasance, gross
negligence or reckless disregard of duties.</p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the Declaration
of Trust, in order to bring a derivative action on behalf of the Trust a shareholder or shareholders must make a pre-suit demand upon
the Trustees to bring the subject action unless an effort to cause the Trustees to bring such an action is not likely to succeed. A demand
shall only be deemed not likely to succeed and therefore excused if a majority of the Board of Trustees, or a majority of any committee
established to consider the merits of such action, is composed of Trustees who are not &#8220;independent trustees&#8221; (as that term
is defined in the DSTA). Unless a demand is not required pursuant to the foregoing, shareholders eligible to bring such derivative action
who hold at least 10% of the outstanding shares of the Fund must join in the request for the Board Trustees to commence such action and
the Board of Trustees must be afforded a reasonable amount of time to consider such shareholder request and to investigate the basis of
such claim. The Trustees shall be entitled to retain counsel or other advisers in considering the merits of the request and shall require
an undertaking by the shareholders making such request to reimburse the Trust for the expense of any such advisers in the event that the
Trustees determine not to bring such action. The Fund is aware that it is the view of the Staff of the SEC that such limitations do not
apply to claims under the federal securities laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Delaware Control Share Statute</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because the Fund is organized
as a Delaware statutory trust it is subject to the Control Share Statute contained in Subchapter III of the DSTA, which became automatically
applicable to listed closed-end funds, such as the Fund, upon its Effective Date of August&#160;1, 2022.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Control Share Statute
provides for a series of voting power thresholds above which shares are considered control shares. These thresholds are:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">10% or more, but less than 15% of all voting power;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">15% or more, but less than 20% of all voting power;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">20% or more, but less than 25% of all voting power;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">25% or more, but less than 30% of all voting power;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">30% or more, but less than a majority of all voting power; or</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 56.7pt"/><td style="width: 18pt">&#9679;</td><td style="text-align: justify">a majority or more of all voting power.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Voting power is defined by
the Control Share Statute as the power to directly or indirectly exercise or direct the exercise of the voting power of Fund shares in
the election of Trustees. Whether a voting power threshold is met is determined by aggregating the holdings of the acquirer as well as
those of its &#8220;associates,&#8221; as defined by the Control Share Statute.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Once a threshold is reached,
an acquirer has no voting rights under the DSTA or the governing documents of the Fund with respect to shares acquired in excess of that
threshold (i.e., the &#8220;control shares&#8221;) unless approved by shareholders. Approval by shareholders requires the affirmative
vote of two-thirds of all votes entitled to be cast on the matter, excluding shares held by the acquirer and its associates as well as
shares held by certain insiders of a Fund. The Control Share Statute provides procedures for an acquirer to request a shareholder meeting
for the purpose of considering whether voting rights shall be accorded to control shares. Further approval by a Fund&#8217;s shareholders
would be required with respect to additional acquisitions of control shares above the next applicable threshold level.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Control Share Statute
effectively allows non-interested shareholders to evaluate the intentions and plans of an acquiring person above each threshold level.</p>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Alternatively, the Board
of Trustees is permitted, but not obligated, to exempt specific acquisitions or classes of acquisitions of control shares, either in advance
or retroactively. The Board of Trustees has considered the Control Share Statute. As of the date hereof, the Board of Trustees has not
received notice of the occurrence of a control share acquisition nor has been requested to exempt any acquisition. Therefore, the Board
of Trustees has not determined whether the application of the Control Share Statute to an acquisition of Fund shares is in the best interest
of the Fund and its shareholders and has not exempted, and has no present intention to exempt, any acquisition or class of acquisitions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the Board of Trustees
receives a notice of a control share acquisition and/or a request to exempt any acquisition, it will consider whether the application
of the Control Share Statute or the granting of such an exemption would be in the best interest of the Fund and its shareholders. The
Fund should not be viewed as a vehicle for trading purposes. It is designed primarily for risk-tolerant long-term investors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Control Share Statute
does not retroactively apply to acquisitions of shares that occurred prior to the Effective Date. However, such shares will be aggregated
with any shares acquired after the Effective Date for purposes of determining whether a voting power threshold is exceeded, resulting
in the newly acquired shares constituting control shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Control Share Statute
requires shareholders to disclose to the Fund any control share acquisition within 10 days of such acquisition and, upon request, to provide
any information that the Board of Trustees reasonably believes is necessary or desirable to determine whether a control share acquisition
has occurred.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Some uncertainty around the
general application under the 1940 Act of state control share statutes exists as a result of recent federal and state court decisions
that have found that certain control share by-laws adopted by certain closed-end funds and the opting in by certain closed-end funds to
state control share statutes violated the 1940 Act. Additionally, in some circumstances uncertainty may also exist in how to enforce the
control share restrictions contained in state control share statutes against beneficial owners who hold their shares through financial
intermediaries. The Board of Trustees has considered the Control Share Statute and the uncertainty around the general application under
the 1940 Act of the state control share statutes and enforcement of state control share statues. The Board of Trustees intends to continue
to monitor developments relating to the Control Share Statute and the state control share statutes generally.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The foregoing is only a summary
of certain aspects of the Control Share Statute. Shareholders should consult their own legal counsel to determine the application of the
Control Share Statute with respect to their shares of the Fund and any subsequent acquisitions of shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">CLOSED-END
FUND STRUCTURE</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Closed-end funds differ from
open-end management investment companies (commonly referred to as &#8220;mutual funds&#8221;). Closed-end funds generally list their shares
for trading on a securities exchange and do not redeem their shares at the option of the shareholder. In contrast, mutual funds issue
securities redeemable at net asset value at the option of the shareholder and typically engage in a continuous offering of their shares.
Although mutual funds are subject to continuous asset in-flows and out-flows that can complicate portfolio management, closed-end funds
generally can stay more fully invested in securities consistent with the closed-end fund&#8217;s investment objective and policies. Accordingly,
closed-end funds have greater flexibility than open-end funds to make certain types of investments, including investments in illiquid
securities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Shares of closed-end funds
listed for trading on a securities exchange frequently trade at discounts to their net asset value, but in some cases trade at a premium.
The market price may be affected by net asset value, distribution levels (which are dependent, in part, on expenses), supply of and demand
for the shares, stability of distributions, trading volume of the shares, general market and economic conditions and other factors beyond
the control of the closed-end fund. The foregoing factors may result in the market price of the Fund&#8217;s Common Shares being greater
than, less than or equal to net asset value. The Board of Trustees has reviewed the Fund&#8217;s structure in light of its investment
objective and policies and has determined that the closed-end structure is in the best interests of the Fund&#8217;s shareholders. However,
the Board of Trustees may periodically review the trading range and activity of the Fund&#8217;s shares with respect to their net asset
value and may take certain actions to seek to reduce or eliminate any such discount. Such actions may include open market repurchases
or tender offers for the Fund&#8217;s Common Shares at net asset value or the Fund&#8217;s possible conversion to an open-end mutual fund.
There can be no assurance that the Board of Trustees will decide to undertake any of these actions or that, if undertaken, such actions
would result in the Fund&#8217;s Common Shares trading at a price equal to or close to net asset value per share of its Common Shares.</p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To convert the Fund to an
open-end investment company, the Declaration of Trust requires the favorable vote of a majority of the board of the Trustees followed
by the favorable vote of the holders of at least 75% of the outstanding shares of each affected class or series of shares of the Fund,
voting separately as a class or series, unless such amendment has been approved by 75% of the Trustees, in which case &#8220;a majority
of the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund will be required. The foregoing vote would satisfy
a separate requirement in the 1940 Act that any conversion of the Fund to an open-end investment company be approved by the shareholders.
Following any such conversion, it is possible that certain of the Fund&#8217;s investment policies and strategies would have to be modified
to assure sufficient portfolio liquidity. In the event of conversion, the Fund would be required to redeem any preferred shares then outstanding
(requiring in turn that it liquidate a portion of its investment portfolio) and the Common Shares would cease to be listed on the New
York Stock Exchange or other national securities exchanges or market systems. Shareholders of an open-end investment company may require
the investment company to redeem their shares at any time (except in certain circumstances as authorized by or permitted under the 1940
Act) at their net asset value, less such redemption charge, if any, as might be in effect at the time of redemption. In order to avoid
maintaining large cash positions or liquidating favorable investments to meet redemptions, open-end investment companies typically engage
in a continuous offering of their shares. Open-end investment companies are thus subject to periodic asset in-flows and out-flows that
can complicate portfolio management. The Fund&#8217;s Board of Trustees may at any time propose the Fund&#8217;s conversion to open-end
status, depending upon its judgment regarding the advisability of such action in light of circumstances then prevailing. However, based
on the determination of the Board of Trustees in connection with this initial offering of the Fund&#8217;s Common Shares that the closed-end
structure is desirable in light of the Fund&#8217;s investment objective and policies, it is highly unlikely that the Board of Trustees
would vote to convert the Fund to an open-end investment company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">REPURCHASE
OF COMMON SHARES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In recognition of the possibility
that the Fund&#8217;s Common Shares might trade at a discount to net asset value and that any such discount may not be in the interest
of the Fund&#8217;s Common Shareholders, the Board of Trustees, in consultation with the Investment Adviser, from time to time may, but
is not required to, review possible actions to reduce any such discount. The Board of Trustees also may, but is not required to, consider
from time to time open market repurchases of and/or tender offers for the Fund&#8217;s Common Shares, as well as other potential actions,
to seek to reduce any market discount from net asset value that may develop. After any consideration of potential actions to seek to reduce
any significant market discount, the Board of Trustees may, subject to its applicable duties and compliance with applicable U.S. state
and federal laws, authorize the commencement of a share-repurchase program or tender offer. The size and timing of any such share repurchase
program or tender offer will be determined by the Board of Trustees in light of the market discount of the Fund&#8217;s Common Shares,
trading volume of the Fund&#8217;s Common Shares, information presented to the Board of Trustees regarding the potential impact of any
such share repurchase program or tender offer, general market and economic conditions and applicable law. There can be no assurance that
the Fund will in fact effect repurchases of or tender offers for any of its Common Shares. The Fund may, subject to its investment limitation
with respect to borrowings, incur debt to finance such repurchases or a tender offer or for other valid purposes. Interest on any such
borrowings would increase the Fund&#8217;s expenses and reduce its net income.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There can be no assurance
that repurchases of the Fund&#8217;s Common Shares or tender offers, if any, will cause its Common Shares to trade at a price equal to
or in excess of their net asset value. Nevertheless, the possibility that a portion of the Fund&#8217;s outstanding Common Shares may
be the subject of repurchases or tender offers may reduce the spread between market price and net asset value that might otherwise exist.
Sellers may be less inclined to accept a significant discount in the sale of their Common Shares if they have a reasonable expectation
of being able to receive a price of net asset value for a portion of their Common Shares in conjunction with an announced repurchase program
or tender offer for the Fund&#8217;s Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although the Board of Trustees
believes that repurchases or tender offers generally would have a favorable effect on the market price of the Fund&#8217;s Common Shares,
the acquisition of Common Shares by the Fund will decrease its total assets and therefore will have the effect of increasing its expense
ratio and decreasing the asset coverage with respect to any preferred shares outstanding. Because of the nature of the Fund&#8217;s investment
objective, policies and portfolio, particularly its investment in illiquid or otherwise restricted securities, it is possible that repurchases
of Common Shares or tender offers could interfere with the Fund&#8217;s ability to manage its investments in order to seek its investment
objective. Further, it is possible that the Fund could experience difficulty in borrowing money or be required to dispose of portfolio
securities to consummate repurchases of or tender offers for Common Shares.</p>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">U.S.
FEDERAL INCOME TAX CONSIDERATIONS<sup>1</sup></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a discussion
of the U.S. federal income tax considerations generally applicable to the ownership and disposition of Common Shares of the Fund. A more
detailed discussion of the tax rules applicable to the Fund and its Common Shareholders can be found in the SAI that is incorporated by
reference into this Prospectus. This discussion is based upon current provisions of the Code, the Treasury regulations promulgated thereunder
and judicial and administrative authorities, all of which are subject to change or differing interpretations by the courts or the Internal
Revenue Service (&#8220;IRS&#8221;), possibly with retroactive effect. This discussion does not address any other U.S. federal tax considerations
(such as estate, gift or net investment taxes) or any state, local or non-U.S. tax considerations. No ruling has been or will be sought
from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or that a court would not
sustain, a position different from any of the tax aspects set forth below. This discussion assumes that you are taxable as a U.S. person
(as defined for U.S. federal income tax purposes) and that you hold Common Shares as capital assets for U.S. federal income tax purposes
(generally, assets held for investment). No attempt is made to present a detailed explanation of all U.S. federal, state, local and foreign
tax concerns affecting the Fund and its Common Shareholders (including Common Shareholders subject to special provisions of the Code).
The discussion set forth herein does not constitute tax advice. Investors are urged to consult their tax advisors to determine the tax
consequences to them of investing in the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Taxation of the Fund</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since its inception and through
the Fund&#8217;s fiscal year ended November&#160;30, 2017, the Fund was treated as a regular corporation, or a &#8220;C&#8221; corporation,
for U.S. federal income tax purposes and, as a result, unlike most investment companies, was subject to corporate income tax to the extent
the Fund recognized taxable income. In conjunction with certain changes to the Fund&#8217;s non-fundamental investment policies that became
effective on February&#160;20, 2018, the Fund has managed its portfolio in a manner intended to allow the Fund to qualify as, and elected
to be treated as, a RIC for U.S. federal income tax purposes beginning with the Fund&#8217;s fiscal year ending November&#160;30, 2018.
Except as otherwise expressly indicated, the remainder of this discussion assumes the Fund has qualified and will continue to qualify
for taxation as a RIC for its fiscal year ending November&#160;30, 2018, and thereafter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to qualify as a
RIC, the Fund must, among other things, satisfy certain income, asset diversification and distribution requirements. As long as it so
qualifies, and subject to the discussion of built-in gains below, the Fund will generally not be subject to U.S. federal income tax to
the extent that it distributes annually its investment company taxable income (which includes ordinary income and the excess of net short-term
capital gain over net long-term capital loss) and its &#8220;net capital gain&#8221; (<i>i.e.</i>, the excess of net long-term capital
gain over net short-term capital loss). The Fund intends to distribute at least annually substantially all of such income and gain. If
the Fund retains any investment company taxable income or net capital gain, it will be subject to U.S. federal income tax on the retained
amount at regular corporate tax rates. In addition, if the Fund fails to qualify as a RIC for any taxable year and relief is not available,
it will be subject to U.S. federal income tax on all of its income and gains at regular corporate tax rates. Furthermore, the Fund will
be subject to regular U.S. federal income tax on any built-in gains that existed in its assets as of the time of its conversion to a RIC,
to the extent such gains were recognized within five years of that time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Taxation of Common Shareholders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For each taxable year the
Fund is treated as a RIC for U.S. federal income tax purposes, distributions paid to you by the Fund from its investment company taxable
income are generally taxable to you as ordinary income to the extent of the Fund&#8217;s current and accumulated earnings and profits.
Certain properly reported distributions may, however, qualify (provided that holding period and other requirements are met by both the
Fund and the Common Shareholder) (i) for the dividends received deduction in the case of corporate Common Shareholders to the extent that
the Fund&#8217;s income consists of dividend income from U.S. corporations or (ii) in the case of individual Common Shareholders, as qualified
dividend income eligible to be taxed at a reduced maximum rate to the extent that the Fund receives qualified dividend income. Qualified
dividend income is, in general, dividend income from taxable domestic corporations and certain non-U.S. corporations. There can be no
assurance as to what portion of the Fund&#8217;s dividends will qualify for the dividends received deduction or for treatment as qualified
dividend income.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><sup>1</sup> NTD: Subject
to Skadden tax review.</p>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Distributions made to you
from an excess of net long-term capital gain over net short-term capital loss (&#8220;capital gain distributions&#8221;), including capital
gain distributions credited to you but retained by the Fund, are taxable to you as long-term capital gains if they have been properly
reported by the Fund, regardless of the length of time you have owned Common Shares. For individuals, long-term capital gains are generally
taxed at a reduced maximum rate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If, for any calendar year,
the Fund&#8217;s total distributions exceed both the current taxable year&#8217;s earnings and profits and accumulated earnings and profits
from prior years, the excess will generally be treated as a tax-free return of capital up to the amount of a Common Shareholder&#8217;s
tax basis in the Common Shares, reducing that basis accordingly. Such distributions exceeding the Common Shareholder&#8217;s basis will
be treated as gain from the sale or exchange of the Common Shares. When you sell your Common Shares, the amount, if any, by which your
sales price exceeds your basis in the Common Shares is gain subject to tax. Because a return of capital reduces your basis in the Common
Shares, it will increase the amount of your gain or decrease the amount of your loss when you sell the Common Shares. Generally, after
the end of each year, you will be provided with a written notice reporting the amount of ordinary dividend income, capital gain distributions
and other distributions (if relevant).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The sale or other disposition
of Common Shares will generally result in capital gain or loss to you which will be long-term capital gain or loss if the Common Shares
have been held for more than one year at the time of sale. Any loss upon the sale or exchange of Common Shares held for six months or
less will be treated as long-term capital loss to the extent of any capital gain dividends received by you (including amounts credited
to you as an undistributed capital gain distribution). Any loss realized on a sale or exchange of Common Shares will be disallowed if
other substantially identical shares are acquired (whether through the automatic reinvestment of distributions or otherwise) within a
61-day period beginning 30 days before and ending 30 days after the date of disposition of Common Shares. In such case, the basis of the
Common Shares acquired will be adjusted to reflect the disallowed loss. Present law taxes both long-term and short-term capital gain of
corporations at the rates applicable to ordinary income. For non-corporate taxpayers, under current law short-term capital gain is taxed
at the U.S. federal income tax rates applicable to ordinary income, while long-term capital gain generally is taxed at a reduced maximum
U.S. federal income tax rate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dividends and other taxable
distributions are generally taxable to Common Shareholders when paid. If, however, the Fund pays you a distribution in January that was
declared in the previous October, November or December to Common Shareholders of record on a specified date in one of such months, then
such distribution will be treated for tax purposes as being paid by the Fund and received by you on December&#160;31 of the year in which
the distribution was declared.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Backup Withholding</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may be required
to withhold, for U.S. federal backup withholding purposes, on all taxable distributions to any non-corporate holders of the Common Shares
who (1) do not furnish the Fund with their correct taxpayer identification number (in the case of individuals, generally their social
security number) or a certificate that such Common Shareholder is exempt from backup withholding, or (2) with respect to whom the IRS
notifies the Fund that such Common Shareholder has failed to properly report certain interest and dividend income to the IRS and to respond
to notices to that effect. Backup withholding is not an additional tax. Any amounts withheld from payments made to you may be refunded
or credited against your U.S. federal income tax liability, if any, provided that the required information is timely furnished to the
IRS. In addition, the Fund may be required to withhold on distributions to non-U.S. shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The foregoing is a general
and abbreviated summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the
Fund and its Common Shareholders. These provisions are subject to change by legislative, judicial or administrative action, and any such
change may be retroactive. A more complete discussion of the tax rules applicable to the Fund and its Common Shareholders can be found
in the SAI that is incorporated by reference into this Prospectus. Investors are urged to consult their tax advisors regarding the U.S.
federal, foreign, state and local tax consequences of investing in the Fund.</p>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">PLAN
OF DISTRIBUTION</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may sell up to $500,000,000
in aggregate initial offering price of Common Shares or Rights from time to time under this Prospectus and any related Prospectus Supplement
(1) directly to one or more purchases, including existing shareholders in a Rights offering; (2) through agents; (3) through underwriters;
(4) through dealers; or (5) pursuant to the Plan. Each Prospectus Supplement relating to an offering of securities will state the terms
of the offering, including:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the names of any agents, underwriters or dealers;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any sales loads or other items constituting underwriters&#8217; compensation;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any discounts, commissions, or fees allowed or paid to dealers or agents;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the public offering or purchase price of the offered Securities and the net proceeds the Fund will receive
from the sale; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any securities exchange on which the offered Securities may be listed.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the case of a Rights offering,
the applicable Prospectus Supplement will set forth the number of Common Shares issuable upon the exercise of each right and the other
terms of such rights offering.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Direct Sales</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may sell Securities
directly to, and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities
Act for any resales of the securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including
the Internet, to sell offered securities directly. The Fund will describe the terms of any of those sales in a Prospectus Supplement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">By Agents</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may offer Securities
through agents that the Fund may designate. The Fund will name any agent involved in the offer and sale and describe any commissions payable
by the Fund in the Prospectus Supplement. Unless otherwise indicated in the Prospectus Supplement, the agents will be acting on a best
efforts basis for the period of their appointment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">By Underwriters</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may offer and sell
Securities from time to time to one or more underwriters who would purchase the Securities as principal for resale to the public, either
on a firm commitment or best efforts basis. If the Fund sells Securities to underwriters, the Fund will execute an underwriting agreement
with them at the time of the sale and will name them in the Prospectus Supplement. In connection with these sales, the underwriters may
be deemed to have received compensation from the Fund in the form of underwriting discounts and commissions. The underwriters also may
receive commissions from purchasers of Securities for whom they may act as agent. Unless otherwise stated in the Prospectus Supplement,
the underwriters will not be obligated to purchase the Securities unless the conditions set forth in the underwriting agreement are satisfied,
and if the underwriters purchase any of the Securities, they will be required to purchase all of the offered Securities. The underwriters
may sell the offered Securities to or through dealers, and those dealers may receive discounts, concessions or commissions from the underwriters
as well as from the purchasers for whom they may act as agent. Any public offering price and any discounts or concessions allowed or reallowed
or paid to dealers may be changed from time to time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with an offering
of Common Shares, if a Prospectus Supplement so indicates, the Fund may grant the underwriters an option to purchase additional Common
Shares at the public offering price, less the underwriting discounts and commissions, within 45 days from the date of the Prospectus Supplement,
to cover any overallotments.</p>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">By Dealers</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may offer and sell
Securities from time to time to one or more dealers who would purchase the securities as principal. The dealers then may resell the offered
Securities to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set forth the
names of the dealers and the terms of the transaction in the Prospectus Supplement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">General Information</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Agents, underwriters or dealers
participating in an offering of Securities may be deemed to be underwriters, and any discounts and commission received by them and any
profit realized by them on resale of the offered Securities for whom they act as agent, may be deemed to be underwriting discounts and
commissions under the Securities Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may offer to sell
securities either at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at prices related to prevailing
market prices or at negotiated prices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To facilitate an offering
of Common Shares in an underwritten transaction and in accordance with industry practice, the underwriters may engage in transactions
that stabilize, maintain or otherwise affect the market price of the Common Shares or any other Security. Those transactions may include
overallotment, entering stabilizing bids, effecting syndicate covering transactions and reclaiming selling concessions allowed to an underwriter
or a dealer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">An overallotment in connection with an offering creates a short position in the common stock for the underwriter&#8217;s
own account.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing
or maintaining the price of the Common Shares.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the
price of the Common Shares by bidding for, and purchasing, the Common Shares or any other Securities in the open market in order to reduce
a short position created in connection with the offering.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession
in connection with an offering when the Common Shares originally sold by the syndicate member is purchased in syndicate covering transactions
or otherwise.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any of these activities may
stabilize or maintain the market price of the Securities above independent market levels. The underwriters are not required to engage
in these activities, and may end any of these activities at any time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with any Rights
offering, the Fund may also enter into a standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s)
will purchase Common Shares remaining unsubscribed for after the Rights offering.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any underwriters to whom
the offered Securities are sold for offering and sale may make a market in the offered Securities, but the underwriters will not be obligated
to do so and may discontinue any market-making at any time without notice. There can be no assurance that there will be a liquid trading
market for the offered Securities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under agreements entered
into with the Fund, underwriters and agents may be entitled to indemnification by the Fund and the Investment Adviser against certain
civil liabilities, including liabilities under the Securities Act, or to contribution for payments the underwriters or agents may be required
to make.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The underwriters, agents
and their affiliates may engage in financial or other business transactions with the Fund in the ordinary course of business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to a requirement
of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) the maximum compensation to be received by any FINRA member
or independent broker-dealer may not be greater than eight percent (8%) of the gross proceeds received by the Fund for the sale of any
securities being registered pursuant to SEC Rule&#160;415 under the Securities Act.</p>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The aggregate offering price
specified on the cover of this Prospectus relates to the offering of the Securities not yet issued as of the date of this Prospectus.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To the extent permitted under
the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time act as a broker or dealer and
receive fees in connection with the execution of portfolio transactions on behalf of the Fund after the underwriters have ceased to be
underwriters and, subject to certain restrictions, each may act as a broker while it is an underwriter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A Prospectus and accompanying
Prospectus Supplement in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree
to allocate a number of Securities for sale to their online brokerage account holders. Such allocations of Securities for internet distributions
will be made on the same basis as other allocations. In addition, Securities may be sold by the underwriters to securities dealers who
resell Securities to online brokerage account holders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">OTHER
SERVICE PROVIDERS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">U.S. Bancorp Global Fund
Services, located at 615 East Michigan Street, Milwaukee, Wisconsin 53202, has entered into a transfer agent servicing agreement with
the Fund. Under this agreement, U.S. Bank Global Fund Services serves as the Fund&#8217;s transfer agent, registrar and distribution disbursing
agent.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">U.S. Bank National Association,
which is located at 1555 N.&#160;River Center Drive, Suite 302, Milwaukee, Wisconsin 53212, acts as custodian of the Fund&#8217;s securities
and other assets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">U.S. Bancorp Global Fund
Services, the Administrator, which is located at 615 East Michigan Street, Milwaukee, Wisconsin 53202, serves as the Fund&#8217;s administrator
pursuant to a fund administration servicing agreement. Pursuant to this agreement, the Administrator provides the Fund with, among other
things, compliance oversight, financial reporting oversight and tax reporting. The Administrator acts as the Fund&#8217;s fund accountant.
The Administrator will assist in the calculation of the Fund&#8217;s net asset value. The Administrator will also maintain and keep current
the accounts, books, records and other documents relating to the Fund&#8217;s financial and portfolio transactions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">LEGAL
MATTERS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain legal matters will
be passed on for the Fund by Skadden, Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Ernst &amp; Young LLP, Dallas,
Texas, is the independent registered public accounting firm of the Fund and is expected to render an opinion annually on the financial
statements of the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">PRIVACY
POLICY</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to conduct its business,
the Fund collects and maintains certain non-public personal information about its shareholders with respect to their transactions in shares
of the Fund. This information includes:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">information the Fund receives from you on or in applications or other forms, correspondence, or conversations,
including, but not limited to, your name, address, phone number, social security number, assets, income and date of birth; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">information about your transactions with the Fund, its affiliates or others, including, but not limited
to, your account number and balance, payment history, parties to transactions, cost basis information and other financial information.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund does not disclose
any nonpublic personal information about you, the Fund&#8217;s other shareholders or the Fund&#8217;s former shareholders to third parties
unless necessary to process a transaction, service an account, or as otherwise permitted by law. To protect your personal information
internally, the Fund restricts access to nonpublic personal information about the Fund&#8217;s shareholders to those employees who need
to know that information to provide services to the Fund&#8217;s shareholders. The Fund also maintains certain other safeguards to protect
your nonpublic personal information.</p>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event that you hold
shares of the Fund through a financial intermediary, including, but not limited to, a broker-dealer, bank or trust company, the privacy
policy of your financial intermediary would govern how your nonpublic personal information would be shared with nonaffiliated third parties.</p>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="color: Red">The information in this
Statement of Additional Information is not complete and may be changed. The Fund may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This Statement of Additional Information is not an offer to
sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</span></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="color: Red">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><span style="color: Red"><b>Subject
to Completion, dated April 10, 2025</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">$500,000,000</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NXG Cushing<sup>&#174;</sup> Midstream Energy Fund</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Common Shares<br/>
Subscription Rights for Common Shares</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Statement of Additional Information</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">NXG Cushing<sup>&#174;</sup> Midstream
Energy Fund (the &#8220;Fund&#8221;) was formed as a Delaware statutory trust on May&#160;23, 2007 and is a non-diversified, closed-end
management investment company. The Fund&#8217;s investment objective is to obtain a high after-tax total return from a combination of
capital appreciation and current income. No assurance can be given that the Fund&#8217;s investment objective will be achieved.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">This Statement of Additional
Information (&#8220;SAI&#8221;) is not a prospectus, but should be read in conjunction with the prospectus for the Fund dated 	, 2025
(the &#8220;Prospectus&#8221;). Investors should obtain and read the Prospectus prior to purchasing common shares. A copy of the Prospectus
may be obtained, without charge, by calling the Fund at (214) 692-6334.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Prospectus and this SAI omit
certain of the information contained in the registration statement filed with the Securities and Exchange Commission (&#8220;SEC&#8221;).
The registration statement may be obtained from the Securities and Exchange Commission upon payment of the fee prescribed, or inspected
at the Securities and Exchange Commission&#8217;s office or via its website (<span style="text-decoration: underline">www.sec.gov</span>) at no charge. Capitalized terms used
but not defined herein have the meanings ascribed to them in the Prospectus.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund is managed by Cushing<sup>&#174;</sup>
Asset Management, LP d/b/a NXG Investment Management (the &#8220;Investment Adviser&#8221;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">This Statement of Additional Information is dated
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025.</p>


<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b></b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">TABLE OF CONTENTS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="width: 95%; text-indent: 0in">THE FUND</td>
    <td style="width: 5%; text-align: right; text-indent: 0in">S-1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">INVESTMENT STRATEGIES AND RISKS</td>
    <td style="text-align: right; text-indent: 0in">S-1</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-indent: 0in">STRATEGIC TRANSACTIONS</td>
    <td style="text-align: right; text-indent: 0in">S-3</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">INVESTMENT RESTRICTIONS</td>
    <td style="text-align: right; text-indent: 0in">S-3</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-indent: 0in">MANAGEMENT OF THE FUND</td>
    <td style="text-align: right; text-indent: 0in">S-4</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">PORTFOLIO MANAGEMENT</td>
    <td style="text-align: right; text-indent: 0in">S-5</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-indent: 0in">INVESTMENT MANAGEMENT AGREEMENT</td>
    <td style="text-align: right; text-indent: 0in">S-5</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">PORTFOLIO TRANSACTIONS AND BROKERAGE</td>
    <td style="text-align: right; text-indent: 0in">S-6</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-indent: 0in">U.S. FEDERAL INCOME TAX CONSIDERATIONS</td>
    <td style="text-align: right; text-indent: 0in">S-7</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">SERVICE PROVIDERS</td>
    <td style="text-align: right; text-indent: 0in">S-14</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-indent: 0in">GENERAL INFORMATION</td>
    <td style="text-align: right; text-indent: 0in">S-15</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-indent: 0in">FINANCIAL STATEMENTS</td>
    <td style="text-align: right; text-indent: 0in">S-17</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">THE
FUND</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund was formed as a Delaware
statutory trust on May&#160;23, 2007 and is a non-diversified, closed-end management investment company registered under the Investment
Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund commenced investment operations on August&#160;27, 2007.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">INVESTMENT
STRATEGIES AND RISKS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The sections below describe,
in greater detail than in the Prospectus, some of the different types of investments that may be made by the Fund and the investment practices
in which the Fund may engage. The Fund may make the following investments, among others, some of which are part of its principal investment
strategies and some of which are not. The principal risks of the Fund&#8217;s principal investment strategies are discussed in the Prospectus
and the Annual Report. The Fund may not buy all of the types of securities or use all of the investment techniques that are described.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Repurchase Agreements</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may engage in repurchase
agreements with broker-dealers, banks and other financial institutions to earn a return on temporarily available cash. A repurchase agreement
is a short-term investment in which the purchaser (<i>i.e.</i>, the Fund) acquires ownership of a security and the seller agrees to repurchase
the obligation at a future time and set price, thereby determining the yield during the holding period. Repurchase agreements involve
certain risks in the event of default by the other party. The Fund may enter into repurchase agreements with broker-dealers, banks and
other financial institutions deemed to be creditworthy by the Investment Adviser under guidelines approved by the Board of Trustees. The
Fund does not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation.
In the event of the bankruptcy or other default of a seller of a repurchase agreement, the Fund could experience both delays in liquidating
the underlying securities and losses including: (a) possible decline in the value of the underlying security during the period while the
Fund seeks to enforce its rights thereto; (b) possible lack of access to income on the underlying security during this period; and (c)
expenses of enforcing its rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Repurchase agreements are fully
collateralized by the underlying securities and are considered to be loans under the 1940 Act. The Fund pays for such securities only
upon physical delivery or evidence of book entry transfer to the account of a custodian or bank acting as agent. The seller under a repurchase
agreement will be required to maintain the value of the underlying securities marked-to-market daily at not less than the repurchase price.
The underlying securities (normally securities of the U.S. government, its agencies or instrumentalities) may have maturity dates exceeding
one year.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Reverse Repurchase Agreements</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A reverse repurchase agreement
involves the sale of a portfolio-eligible security by the Fund, coupled with its agreement to repurchase the instrument at a specified
time and price. Under a reverse repurchase agreement, the Fund continues to receive any principal and interest payments on the underlying
security during the term of the agreement. The Fund typically will segregate cash and/or liquid securities equal (on a daily mark-to-market
basis) to its obligations under reverse repurchase agreements. However, reverse repurchase agreements involve the risk that the market
value of securities retained by the Fund may decline below the repurchase price of the securities sold by the Fund which it is obligated
to repurchase. To the extent that positions in reverse repurchase agreements are not covered through the segregation of cash and/or liquid
securities at least equal to the amount of any purchase commitment, such transactions would be subject to the Fund&#8217;s limitations
on borrowings.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Rights and Warrants</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Warrants are in effect longer-term
call options. They give the holder the right to purchase a given number of shares of a particular company at specified prices within certain
periods of time. Rights are similar to warrants except that they have a substantially shorter term. The purchaser of a warrant expects
that the market price of the security will exceed the purchase price of the warrant plus the exercise price of the warrant, thus producing
a profit. Of course, since the market price may never exceed the exercise price before the expiration date of the warrant, the purchaser
of the warrant risks the loss of the entire purchase price of the warrant. Warrants generally trade in the open market and may be sold
rather than exercised.</p>


<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Warrants are sometimes sold in
unit form with other securities of an issuer. Units of warrants and common stock may be employed in financing young, unseasoned companies.
The purchase price of a warrant varies with the exercise price of the warrant, the current market value of the underlying security, the
life of the warrant and various other investment factors. Rights and warrants may be considered more speculative and less liquid than
certain other types of investments in that they do not entitle a holder to dividends or voting rights with respect to the underlying securities
nor do they represent any rights in the assets of the issuing company and may lack a secondary market.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Depositary Receipts</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Non-U.S. securities include American
Depositary Receipts (&#8220;ADRs&#8221;), European Depositary Receipts (&#8220;EDRs&#8221;), Global Depositary Receipts (&#8220;GDRs&#8221;)
and other similar global instruments. ADRs typically are issued by an American bank or trust company and evidence ownership of underlying
securities issued by a non-U.S. corporation. EDRs, which are sometimes referred to as Continental Depositary Receipts, are receipts issued
in Europe, typically by non-U.S. banks and trust companies, that evidence ownership of either non-U.S. or domestic underlying securities.
GDRs are depositary receipts structured like global debt issues to facilitate trading on an international basis. Unsponsored ADR, EDR
and GDR programs are organized independently and without the cooperation of the issuer of the underlying securities. As a result, available
information concerning the issuer may not be as current as for sponsored ADRs, EDRs and GDRs, and the prices of unsponsored ADRs, EDRs
and GDRs may be more volatile than if such instruments were sponsored by the issuer. Investments in ADRs, EDRs and GDRs present additional
investment considerations of non-U.S. securities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">When-Issued and Delayed Delivery
Transactions</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may purchase and sell
portfolio securities on a when-issued and delayed delivery basis. No income accrues to the Fund on securities in connection with such
purchase transactions prior to the date the Fund actually takes delivery of such securities. These transactions are subject to market
fluctuation; the value of the securities at delivery may be more or less than their purchase price, and yields generally available on
comparable securities when delivery occurs may be higher or lower than yields on the securities obtained pursuant to such transactions.
Because the Fund relies on the buyer or seller, as the case may be, to consummate the transaction, failure by the other party to complete
the transaction may result in the Fund missing the opportunity of obtaining a price or yield considered to be advantageous. When the Fund
is the buyer in such a transaction, however, it will segregate cash and/or liquid securities having an aggregate value at least equal
to the amount of such purchase commitments until payment is made unless the Fund intends to physically settle the transaction and the
transaction will settle within 35 days of its trade date, in which case the transaction will be treated as a derivatives transaction in
accordance with Rule&#160;18f-4 under the 1940 Act (the &#8220;Derivatives Rule&#8221;). The Fund will make commitments to purchase securities
on such basis only with the intention of actually acquiring these securities, but the Fund may sell such securities prior to the settlement
date if such sale is considered to be advisable. To the extent the Fund engages in when-issued and delayed delivery transactions, it will
do so for the purpose of acquiring securities for the Fund&#8217;s portfolio consistent with the Fund&#8217;s investment objectives and
policies and not for the purpose of investment leverage.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Since the market value of both
the securities or currency subject to the commitment and the securities or currency held as segregated assets may fluctuate, the use of
commitments may magnify the impact of interest rate changes on the Fund&#8217;s net asset value. A commitment sale is covered if the Fund
owns or has the right to acquire the underlying securities or currency subject to the commitment. A commitment sale is for cross-hedging
purposes if it is not covered, but is designed to provide a hedge against a decline in value of a security or currency which the Fund
owns or has the right to acquire. By entering into a commitment sale transaction, the Fund foregoes or reduces the potential for both
gain and loss in the security which is being hedged by the commitment sale.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Short Sales Against the Box</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may from time to time
make short sales of securities it owns or has the right to acquire. A short sale is &#8220;against the box&#8221; to the extent that the
Fund contemporaneously owns or has the right to obtain at no added cost securities identical to those sold short. In a short sale, the
Fund does not immediately deliver the securities sold and does not receive the proceeds from the sale. The Fund is required to recognize
gain from the short sale for U.S. federal income tax purposes at the time it enters into the short sale, even though it does not receive
the sales proceeds until it delivers the securities. The Fund is said to have a short position in the securities sold until it delivers
such securities at which time it receives the proceeds of the sale. The Fund may close out a short position by purchasing and delivering
an equal amount of the securities sold short, rather than by delivering securities already held by the Fund, because the Fund may want
to continue to receive interest and dividend payments on securities in its portfolio.</p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">STRATEGIC
TRANSACTIONS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The information contained under
the heading &#8220;Additional Information (Unaudited)&#8212;Additional Investment Policies&#8212;Strategic Transactions&#8221; in the
Fund&#8217;s Annual Report is incorporated herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">INVESTMENT
RESTRICTIONS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The information contained under
the heading &#8220;Additional Information (Unaudited)&#8212;Additional Investment Policies&#8212;Investment Restrictions&#8221; in the
Fund&#8217;s Annual Report is incorporated herein by reference.</p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">MANAGEMENT
OF THE FUND</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The information contained under
the following headings in the Fund&#8217;s Proxy Statement is incorporated herein by reference: &#8220;Proposal #1: Election of Trustees&#8212;Trustees
and Trustee Nominees;&#8221; &#8220;&#8212;Trustee Qualifications;&#8221; &#8220;&#8212;Board&#8217;s Leadership Structure;&#8221; &#8220;&#8212;Board&#8217;s
Role in Risk Oversight;&#8221; &#8220;&#8212;Board Committees;&#8221; &#8220;&#8212;Officers of the Funds&#8221; and &#8220;&#8212;Shareholder
Communications to the Trustees.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On January&#160;23, 2025, the
Board accepted the retirement of Ronald P. Trout as a Trustee of the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On January&#160;23, 2025, the
Board appointed John Musgrave, Chief Executive Officer and President of the Fund, as a Trustee of the Fund to fill the vacancy created
by the retirement of Mr.&#160;Trout. Mr.&#160;Musgrave serves as an Interested Trustee of the Fund as a result of his position as an officer
of the Fund&#8217;s investment adviser. Mr.&#160;Musgrave is a Class III Trustee.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">John H. Alban was previously
deemed to be an Interested Trustee of the Fund as a result of his prior position as an officer of the Fund&#8217;s investment adviser.
Because Mr.&#160;Alban has not had, at any time since the beginning of the last two completed fiscal years of the Funds, a material business
or professional relationship with the Fund&#8217;s investment adviser and is not otherwise defined as an &#8220;Interested Person&#8221;
(as defined in Section&#160;2(a)(19) of the Investment Company Act of 1940) of the Fund, Mr.&#160;Alban now serves as an Independent Trustee
of the Fund. On January&#160;23, 2025, Mr.&#160;Alban was appointed by the Board as a member of the Audit Committee of the Fund and the
Nominating and Corporate Governance Committee of the Fund.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Mr.&#160;Musgrave has served
as Chief Executive Officer and President of the Fund since 2023. Mr.&#160;Musgrave has also served as Chief Investment Officer of the
Investment Adviser since 2023 and previously served as Co-Chief Investment Officer and Managing Director of the Investment Adviser from
2016 to 2023. Based on his experience as Chief Executive Officer and President of the Fund and as an officer of the Investment Adviser,
Mr.&#160;Alban is experienced in financial, regulatory and investment matters.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Remuneration of Trustees and
Officers</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following table provides
information regarding compensation of the Trustees of the Fund and for the Fund Complex, each for the fiscal year ended November&#160;30,
2024. Officers of the Funds do not receive any compensation from the Funds. The Trustees do not receive any pension or retirement benefits
from the Fund Complex.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 11pt"><b>Trustee<sup>(1)</sup></b></span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Aggregate Estimated Compensation From Fund</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 11pt"><b>Pension or Retirement Benefits Accrued as Part of Fund Expenses<sup>(2)</sup></b></span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 11pt"><b>Estimated Annual Benefits Upon Retirement<sup>(2)</sup></b></span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 11pt"><b>Total Compensation from Fund and Fund Complex Paid to Trustees<sup>(3)</sup></b></span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: justify">Independent Trustees:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 44%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Brian R. Bruce</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">49,361</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center">None</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center">None</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">49,361</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Andrea N. Mullins</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46,020</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46,020</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-size: 11pt">John H. Alban<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 11pt">$	None</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 11pt">$	None</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Interested Trustee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-size: 11pt">John Musgrave<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 11pt">	None</span></td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: center">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 11pt">	None</span></td><td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">Trustees not entitled to compensation are not included in the table.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">The Fund does not accrue or pay retirement or pension benefits to Trustees as of the date of this SAI.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">As of the end of the most recently completed fiscal year. The &#8220;Fund Complex&#8221; includes the
Fund and each other registered investment company for which the Investment Adviser serves as investment adviser. As of the date of this
SAI, there are two funds (including the Fund) in the Fund Complex.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td style="text-align: justify">Through November&#160;30, 2024, Mr.&#160;Alban was considered and Interested Trustee of the Fund.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">Mr.&#160;Musgrave was appointed as a Trustee of the Fund on January&#160;23, 2025.</td></tr></table>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Trustee Share Ownership</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As of December&#160;31, 2024,
each Trustee of the Fund beneficially owned equity securities of the Fund and all of the registered investment companies in the family
of investment companies overseen by the Trustee in the dollar range amounts specified below.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; width: 41%; text-align: left"><b>Name of Trustee</b></td>
    <td style="border-bottom: Black 1pt solid; width: 30%">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Dollar Range of
    Equity Securities in the Fund</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 29%">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate Dollar
    Range of Equity Securities in All Registered Investment Companies Overseen by Trustee in Family of Investment Companies(1)</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b><i>Independent Trustees:</i></b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="text-align: left">John H. Alban</td>
    <td style="text-align: center">&#160;None</td>
    <td style="text-align: center">None</td></tr>
  <tr style="background-color: White">
    <td style="text-align: left">Brian R. Bruce</td>
    <td style="text-align: center">$10,001-$50,000</td>
    <td style="text-align: center">$10,001-$50,000</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="text-align: left">Andrea N. Mullins</td>
    <td style="text-align: center">$10,001-$50,000</td>
    <td style="text-align: center">$10,001-$50,000</td></tr>
  <tr style="background-color: White">
    <td style="text-align: left"><b><i>Interested Trustee:</i></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="text-align: left"><span style="font-size: 11pt">John Musgrave<sup>(2)</sup></span></td>
    <td style="text-align: center">More than $100,000</td>
    <td style="text-align: center">More than $100,000</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">The &#8220;Family of Investment Companies&#8221; includes the Fund and each other registered investment
company for which the Investment Adviser serves as investment adviser. As of the date of this SAI, there are two funds (including the
Fund) in the Family of Investment Companies.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">Mr.&#160;Musgrave was appointed as a Trustee of the Fund on January&#160;23, 2025.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As of December&#160;31, 2024,
the Trustees and officers of the Fund as a group owned less than 1% of the outstanding common shares of the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">PORTFOLIO
MANAGEMENT</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The information contained under
&#8220;Item&#160;13. Portfolio Managers of Closed-End Management Investment Companies&#8221; in the Fund&#8217;s Annual Report is incorporated
herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">INVESTMENT
MANAGEMENT AGREEMENT</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Cushing<sup>&#174;</sup> Asset
Management, LP d/b/a NXG Investment Management acts as the investment adviser to the Fund. The Investment Adviser&#8217;s principal business
address is One Energy Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Adviser provides
investment advisory services to the Fund pursuant to the terms of an Investment Advisory Agreement (the &#8220;Investment Management Agreement&#8221;),
dated August&#160;6, 2007, between the Investment Adviser and the Fund. The Investment Management Agreement has an initial term expiring
two years after the date of its execution, and may be continued in effect from year to year thereafter subject to the approval thereof
by (1) the Board of Trustees or (2) vote of a majority (as defined by the 1940 Act) of the outstanding voting securities of the Fund,
provided that in either event the continuance must also be approved by a majority of the Independent Trustees, by vote cast in person
at a meeting called for the purpose of voting on such approval.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Management Agreement
may be terminated at any time, without the payment of any penalty, upon 60 days&#8217; written notice by either party. The Fund may terminate
by action of the Board of Trustees or by a vote of a majority of the Fund&#8217;s outstanding voting securities (accompanied by appropriate
notice), and the Investment Management Agreement will terminate automatically upon its assignment (as defined in the 1940 act and the
rules thereunder). The Investment Management Agreement may also be terminated, at any time, without payment of any penalty, by the Board
of Trustees or by vote of a majority of outstanding voting securities, in the event that it is established by a court of competent jurisdiction
that the Investment Adviser or any principal, officer or employee of the Investment Adviser has taken any action that results in a breach
of the covenants of the Investment Adviser set out in the Investment Management Agreement. The Investment Management Agreement will provide
that the Investment Adviser will not be liable for any loss sustained by reason of the purchase, sale or retention of any security, whether
or not such purchase, sale or retention will have been based upon the investigation and research made by any other individual, firm or
corporation, if such recommendation will have been selected with due care and in good faith, except loss resulting from willful misfeasance,
bad faith or gross negligence on the part of the Investment Adviser in performance of its obligations and duties, or by reason of its
reckless disregard of its obligations and duties under the Investment Management Agreement.</p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Pursuant to the Investment Management
Agreement, the Investment Adviser is responsible for managing the portfolio of the Fund in accordance with its stated investment objective
and policies, makes investment decisions for the Fund, placing orders to purchase and sell securities on behalf of the Fund and managing
the other business and affairs of the Fund, all subject to the supervision and direction of the Fund&#8217;s Board of Trustees. Although
the Investment Adviser intends to devote such time and effort to the business of the Fund as is reasonably necessary to perform its duties
to the Fund, the services of the Investment Adviser are not exclusive, and the Investment Adviser provides similar services to other clients
and may engage in other activities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Pursuant to the Investment Management
Agreement, the Fund has agreed to pay the Investment Adviser a fee, payable at the end of each calendar month, at an annual rate equal
to 1.25% of the average weekly value of the Fund&#8217;s Managed Assets during such month (the &#8220;Management Fee&#8221;) for the services
and facilities provided by the Investment Adviser to the Fund. For purposes of the Management Fee, &#8220;Managed Assets&#8221; means
the total assets of the Fund, minus all accrued expenses incurred in the normal course of operations other than liabilities or obligations
attributable to investment leverage, including, without limitation, investment leverage obtained through (i) indebtedness of any type
(including, without limitation, borrowing through a credit facility or the issuance of debt securities), (ii) the issuance of shares of
preferred stock or other similar preference securities and/or (iii) the reinvestment of collateral received for securities loaned in accordance
with the Fund&#8217;s investment objective and policies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Pursuant to a fee waiver agreement
by and between the Fund and the Investment Adviser, effective February 1, 2025, the Investment Adviser has contractually agreed to waive
a portion of the management fee in an amount equal to 0.25% of the Fund&#8217;s Managed Assets through January 31, 2026.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Because the Management Fee is
based upon a percentage of the Fund&#8217;s Managed Assets, the Management Fee will be higher if the Fund employs leverage. Therefore,
the Investment Adviser will have a financial incentive to use leverage, which may create a conflict of interest between the Investment
Adviser and the Fund&#8217;s common shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Adviser also provides
such additional administrative services as the Fund may require beyond those furnished by the Administrator and furnishes, at its own
expense, such office space, facilities, equipment, clerical help, and other personnel and services as may reasonably be necessary in connection
with the operations of the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In addition, the Investment Adviser
pays the salaries of officers of the Fund who are employees of the Investment Adviser and any fees and expenses of Trustees of the Fund
who are also officers, directors, or employees of the Investment Adviser or who are officers or employees of any company affiliated with
the Investment Adviser and bears the cost of telephone service, heat, light, power, and other utilities associated with the services it
provides.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Advisory Fees Paid</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following summarizes the
investment advisory fees, less any fees waived by the Investment Adviser, paid pursuant to the investment advisory fee agreement in effect
during the last three fiscal years ended November&#160;30:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 24%; text-align: center"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 24%; text-align: center"><b>2023</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 24%; text-align: center"><b>2022</b></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-align: left"><b>Contractual Advisory Fee</b></td>
    <td style="text-align: center">$2,105,693</td>
    <td style="text-align: center">$1,286,476</td>
    <td style="text-align: center">$1,441,315</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><b>Fees Waived</b></td>
    <td style="text-align: center">$(421,139)</td>
    <td style="text-align: center">$(257,295)</td>
    <td style="text-align: center">$(288,263)</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-align: left"><b>Net Fee Paid</b></td>
    <td style="text-align: center">$1,684,554</td>
    <td style="text-align: center">$1,029,181</td>
    <td style="text-align: center">$1,153,052</td></tr>
  </table>
<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">PORTFOLIO
TRANSACTIONS AND BROKERAGE</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Subject to the oversight of the
Board of Trustees, the Investment Adviser is responsible for decisions to buy and sell securities for the Fund, the negotiation of the
commissions to be paid on brokerage transactions, the prices for principal trades in securities, and the allocation of portfolio brokerage
and principal business. It is the policy of the Investment Adviser to seek the best execution at the best security price available with
respect to each transaction in light of the overall quality of brokerage and research services provided to the Investment Adviser. In
selecting broker/dealers and in negotiating commissions, the Investment Adviser will consider, among other things, the firm&#8217;s reliability,
the quality of its execution services on a continuing basis and its financial condition.</p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;28(e) of the Securities
Exchange Act of 1934, as amended, permits an investment adviser, under certain circumstances, to cause an account to pay a broker or dealer
who supplies brokerage and research services a commission for effecting a transaction in excess of the amount of commission another broker
or dealer would have charged for effecting the transaction. Brokerage and research services include (a) furnishing advice as to the value
of securities, the advisability of investing, purchasing or selling securities, and the availability of securities or purchasers or sellers
of securities; (b) furnishing analyses and reports concerning issuers, industries, securities, economic factors and trends, portfolio
strategy, and the performance of accounts; and (c) effecting securities transactions and performing functions incidental to those transactions
(such as clearance, settlement and custody).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In light of the above, in selecting
brokers, the Investment Adviser may consider investment and market information and other research, such as economic, securities and performance
measurement research, provided by such brokers, and the quality and reliability of brokerage services, including execution capability,
performance, and financial responsibility. Accordingly, the commissions charged by any such broker may be greater than the amount another
firm might charge if the Investment Adviser determines in good faith that the amount of such commissions is reasonable in relation to
the value of the research information and brokerage services provided by such broker to the Investment Adviser or to the Fund. The Investment
Adviser believes that the research information received in this manner provides the Fund with benefits by supplementing the research otherwise
available to the Investment Adviser.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Adviser seeks
to allocate portfolio transactions equitably whenever concurrent decisions are made to purchase or sell securities on behalf of the Fund
and another advisory account. In some cases, this procedure could have an adverse effect on the price or the amount of securities available
to the Fund. In making such allocations between the Fund and other advisory accounts, the main factors considered by the Investment Adviser
are the investment objective, the relative size of portfolio holding of the same or comparable securities, the availability of cash for
investment and the size of investment commitments generally held, and the views of the persons responsible for recommending investments
to the Fund and such other accounts and funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Commissions Paid</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund paid approximately the
following commissions to brokers during the fiscal years shown:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Fiscal Year Ended November&#160;30</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">All Brokers</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Affiliated Brokers</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 70%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">789,107</td><td style="white-space: nowrap; width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">511,710</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">589,325</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Fiscal Year Ended November&#160;30, 2024 Percentages:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Commissions with affiliate to total transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Value of brokerage transactions with affiliate to total transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">None</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">During the fiscal period ended
November&#160;30, 2024, the Fund paid $341,661 in brokerage commissions on transactions totaling $8,541,514 to brokers selected primarily
on the basis of research services provided to the Investment Adviser.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">U.S.
FEDERAL INCOME TAX CONSIDERATIONS<span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><sup>1</sup></b></span></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following discussion is a
summary of the U.S. federal income tax considerations generally applicable to the ownership and disposition of Common Shares. This discussion
is based upon current provisions of the Code, the Treasury regulations promulgated thereunder and judicial and administrative authorities,
all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. This discussion does not address any other U.S. federal tax considerations (such as estate, gift, or
net investment taxes) or any state, local or non-U.S. tax considerations. No ruling has been or will be sought from the IRS regarding
any matter discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position different
from any of the tax aspects set forth below. Unless otherwise noted, this discussion assumes that the Common Shares are held by U.S. persons
and that Common Shareholders hold their Common Shares as capital assets for U.S. federal income tax purposes (generally, assets held for
investment). No attempt is made to present a detailed explanation of all U.S. federal income tax concerns affecting the Fund and its Common
Shareholders (including Common Shareholders that are subject to special provisions of the Code, such as financial institutions, insurance
companies, a partnership or other pass-through entity for U.S. federal income tax purposes, Common Shareholders whose &#8220;functional
currency&#8221; is not the U.S. dollar, tax-exempt organizations, a controlled foreign corporation or a passive foreign investment company,
dealers in securities or currencies, traders in securities or commodities that elect mark-to-market treatment, persons that will hold
Common Shares as a position in a &#8220;straddle,&#8221; &#8220;hedge&#8221; or as part of a &#8220;constructive sale&#8221; for federal
income tax purposes, persons subject to special rules or exemptions under the Foreign Investment in Real Property Tax Act of 1980, persons
that actually or constructively own or have owned a large position in the Fund, and, except as otherwise expressly indicated, non-U.S.
persons), and the discussions set forth here and in the Prospectus do not constitute tax advice. Investors are urged to consult their
tax advisors regarding the U.S. federal, state, local and foreign tax consequences of investing in the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><sup>1</sup></td><td style="text-align: left">NTD: Subject to Skadden tax review.</td></tr></table>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Taxation of the Fund</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Since its inception and through
the Fund&#8217;s fiscal year ended November&#160;30, 2017, the Fund was treated as a regular corporation, or a &#8220;C&#8221; corporation,
for U.S. federal income tax purposes and, as a result, unlike most investment companies, was subject to corporate income tax to the extent
the Fund recognized taxable income. In conjunction with certain changes to the Fund&#8217;s non-fundamental investment policies that became
effective on February&#160;20, 2018, the Fund has managed its portfolio in a manner intended to allow the Fund to qualify as, and the
Fund elected to be treated as, a RIC for U.S. federal income tax purposes beginning with the Fund&#8217;s fiscal year ending November&#160;30,
2018. Except as otherwise expressly indicated, the remainder of this discussion assumes the Fund has qualified, and will continue to qualify,
for taxation as a RIC for its fiscal year ending November&#160;30, 2018, and thereafter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In order to qualify to be taxed
as a RIC, the Fund must, among other things: (i) derive in each taxable year at least 90% of its gross income from the following sources,
which are referred herein as &#8220;Qualifying Income&#8221;: (a) dividends, interest (including tax-exempt interest), payments with respect
to certain securities loans, gains from the sale or other disposition of stock, securities, or foreign currencies, or other income (including,
but not limited to, gain from options, futures and forward contracts) derived with respect to its business of investing in such stock,
securities or currencies and (b) net income derived from interests in certain publicly traded partnerships that are treated as partnerships
for U.S. federal income tax purposes and derive less than 90% of their gross income from the items described in clause&#160;(a) above
(each a &#8220;Qualified Publicly Traded Partnership&#8221;), which includes most MLPs; and (ii) diversify its holdings so that, at the
end of each quarter of each taxable year (a) at least 50% of the value of the Fund&#8217;s total assets is represented by cash and cash
items, U.S. government securities, the securities of other RICs and other securities, with such other securities limited, in respect of
any one issuer, to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding
voting securities of such issuer and (b) not more than 25% of the value of the Fund&#8217;s total assets is invested in the securities
of (I) any one issuer (other than U.S. government securities and the securities of other RICs), (II) any two or more issuers (other than
RICs) that the Fund controls and that are determined to be engaged in the same business or similar or related trades or businesses or
(III) any one or more Qualified Publicly Traded Partnerships. The Fund may generate certain income that might not qualify as good income
for purposes of the 90% annual gross income requirement described above. The Fund will monitor the Fund&#8217;s transactions to endeavor
to prevent the Fund&#8217;s disqualification as a RIC.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Income from the Fund&#8217;s
investments in equity interests of partnerships that are not Qualified Publicly Traded Partnerships (if any) will be Qualifying Income
only to the extent it is attributable to items of income of such MLP that would be Qualifying Income if earned directly by the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund&#8217;s investments
in partnerships, including in Qualified Publicly Traded Partnerships, may result in the Fund being subject to state, local or foreign
income, franchise or withholding tax liabilities.</p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If the Fund fails to satisfy
the 90% annual gross income requirement or the asset diversification requirements discussed above in any taxable year, it may be eligible
for relief provisions if the failures are due to reasonable cause and not willful neglect and if a penalty tax is paid with respect to
each failure to satisfy the applicable requirements. Additionally, relief is provided for certain de minimis failures of the asset diversification
requirements where the Fund corrects the failure within a specified period. If the applicable relief provisions are not available or cannot
be met, all of the Fund&#8217;s income would be subject to corporate-level U.S. federal income tax as described below. The fund cannot
provide assurance that the Fund would qualify for any such relief should the Fund fail the 90% annual gross income requirement or the
asset diversification requirements discussed above.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">For each taxable year the Fund
is treated as a RIC for U.S. federal income tax purposes, subject to the discussion of built-in gains below the Fund generally will not
be subject to U.S. federal income tax on income and gains that it distributes each taxable year to its Common Shareholders, provided that
in such taxable year it distributes at least 90% of the sum of (i) its investment company taxable income (which includes, among other
items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss and other taxable income, other
than net capital gain (as defined below), reduced by deductible expenses) determined without regard to the deduction for dividends paid
and (ii) its net tax-exempt interest income (the excess of its gross tax-exempt interest income over certain disallowed deductions), if
any (the &#8220;Annual Distribution Requirement&#8221;). The Fund intends to distribute annually all or substantially all of such income
and gain on a timely basis. If the Fund retains any investment company taxable income or net capital gain (as defined below), it will
be subject to U.S. federal income tax on the retained amount at regular corporate tax rates. In addition, the Fund will be subject to
regular U.S. federal income tax or any built-in gains that existed in its assets as of the time of its conversion to a RIC, to the extent
such gains were recognized within five years of that time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may retain for investment
its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). However, if
the Fund retains any net capital gain or any investment company taxable income, it will be subject to a tax on such amount at regular
corporate tax rates. If the Fund retains any net capital gain, it may designate the retained amount as undistributed capital gains in
a notice to its Common Shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i) will be required
to include in income for U.S. federal income tax purposes its share of such undistributed net capital gain, (ii) will be entitled to credit
its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability, if any, and to claim refunds to the
extent that the credit exceeds such liability and (iii) will increase its tax basis in its Common Shares by the excess of the amount described
in clause&#160;(i) over the amount described in clause&#160;(ii). A Common Shareholder that is not subject to U.S. federal income tax
or otherwise is not required to file a U.S. federal income tax return would be required to file a U.S. federal income tax return on the
appropriate form in order to claim a refund for the taxes paid by the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Amounts not distributed on a
timely basis in accordance with a calendar year distribution requirement are subject to a nondeductible 4% U.S. federal excise tax at
the Fund level. To avoid the excise tax, the Fund must distribute (or be deemed to have distributed) during each calendar year an amount
at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gains or losses) for the calendar year
and (ii) 98.2% of its capital gains in excess of its capital losses (adjusted for certain ordinary losses) for a one-year period generally
ending on October&#160;31 of the calendar year (unless an election is made to use the Fund&#8217;s taxable year instead). In addition,
the minimum amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution
or over-distribution, as the case may be, from previous years. While the Fund intends to distribute any income and capital gain in the
manner necessary to minimize imposition of the 4% federal excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s
taxable income and capital gains will be distributed to avoid entirely the imposition of the tax. In that event, the Fund will be liable
for the tax only on the amount by which it does not meet the foregoing distribution requirement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Dividends and distributions will
be treated as paid during the calendar year if they are paid during the calendar year or declared by the Fund in October, November or
December of the year, payable to Common Shareholders of record on a date during such a month and paid by the Fund during January of the
following year. Any such dividend or distribution paid during January of the following year will be deemed to be received by Common Shareholders
on December&#160;31 of the year the dividend or distribution was declared, rather than when the dividend or distribution is actually received.</p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If the Fund were unable to satisfy
the 90% distribution requirement or otherwise were to fail to qualify as a RIC in any year, it would be taxed on all of its taxable income
in the same manner as an ordinary corporation and distributions to Common Shareholders would not be deductible by the Fund in computing
its taxable income.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">To qualify again to be taxed
as a RIC in a subsequent year following the Fund&#8217;s failure to qualify as a RIC, the Fund would be required to distribute to its
Common Shareholders its accumulated earnings and profits attributable to non-RIC years. In addition, if the Fund failed to qualify as
a RIC for a period greater than two taxable years, then, in order to qualify as a RIC in a subsequent year, the Fund would be required
to elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss
that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized
for a period of five years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Gain or loss on the sale of securities
by the Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain
or loss on the sale of securities held for one year or less will be short-term capital gain or loss. If the Fund realizes a net capital
loss, the excess of the Fund&#8217;s net short-term capital loss over the Fund&#8217;s net long-term capital gain is treated as a short-term
capital loss arising on the first day of the Fund&#8217;s next taxable year and the excess of the Fund&#8217;s net long-term capital loss
over the Fund&#8217;s net short-term capital gain is treated as a long-term capital loss arising on the first day of the Fund&#8217;s
next taxable year. If future capital gain is offset by carried forward capital losses, such future capital gain is not subject to Fund-level
U.S. federal income tax, regardless of whether they are distributed to Common Shareholders. Accordingly, the Fund does not expect to distribute
any such offsetting capital gain. A RIC cannot carry back or carry forward any net operating losses.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may decide to be taxed
as a regular corporation even if the Fund would otherwise qualify as a RIC if the Fund determines that treatment as a corporation for
a particular year would be in the Fund&#8217;s best interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Certain Fund Investments</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Certain of the Fund&#8217;s investment
practices are subject to special and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or
otherwise limit the allowance of certain losses or deductions (including the dividends received deduction), (ii) convert lower taxed long-term
capital gains or qualified dividend income into higher taxed short-term capital gains or ordinary income, (iii) convert ordinary loss
or a deduction into capital loss (the deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without
a corresponding receipt of cash, (v) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur,
(vi) adversely alter the characterization of certain complex financial transactions and (vii) produce income that will not qualify as
good income for purposes of the 90% annual gross income requirement described above. The Fund will monitor its transactions and may make
certain tax elections and may be required to borrow money or dispose of securities to mitigate the effect of these rules and prevent disqualification
of the Fund as a RIC.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Certain investment practices
could limit the Fund&#8217;s ability to make sufficient distributions to satisfy the Annual Distribution Requirement and to eliminate
the imposition of Fund-level income and excise taxes. For example, the MLPs in which the Fund intends to invest are expected to be treated
as partnerships for U.S. federal income tax purposes. The cash distributions received by the Fund from an MLP may not correspond to the
amount of income allocated to the Fund by the MLP in any given taxable year, and the amount of income allocated by an MLP to the Fund
may exceed the amount of cash received by the Fund from such MLP. In addition, certain other investments by the Fund may require the Fund
to recognize income or gains without a corresponding receipt of cash. Moreover, if the Fund utilizes leverage, it may be prevented by
1940 Act requirements or loan covenants from declaring and paying dividends in certain circumstances. For the foregoing reasons, among
others, the Fund may have difficulty making distributions to its Common Shareholders in the amounts necessary to satisfy the requirements
for maintaining its status as a RIC or avoiding U.S. federal income or excise taxes. Accordingly, the Fund may have to dispose of securities
under disadvantageous circumstances in order to generate sufficient cash to satisfy the distribution requirements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund expects that the income
derived by the Fund from the MLPs in which it invests will be Qualifying Income. If, however, an MLP in which the Fund invests is not
a Qualified Publicly Traded Partnership, the income derived by the Fund from such investment may not be Qualifying Income and, therefore,
could adversely affect the Fund&#8217;s status as a RIC. The Fund intends to monitor its investments in MLPs to prevent to disqualification
of the Fund as a RIC.</p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If the Fund invests in foreign
securities, its income from such securities may be subject to withholding and other non-U.S. taxes. The Fund will not be eligible to elect
to &#8220;pass through&#8221; to Common Shareholders of the Fund the ability to use the foreign tax deduction or foreign tax credit for
foreign taxes paid with respect to qualifying taxes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Taxation of U.S. Shareholders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">For purposes of this discussion,
a &#8220;U.S. shareholder&#8221; (or in this section, a &#8220;shareholder&#8221;) is a beneficial owner of Common Shares which is for
U.S. federal income tax purposes (1) an individual who is a citizen or resident of the United States, (2) a corporation (or other entity
taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state
thereof, or the District of Columbia, (3) an estate whose income is subject to U.S. federal income tax regardless of its source, or (4)
a trust if (a) a U.S. court is able to exercise primary supervision over the trust&#8217;s administration and one or more U.S. persons
are authorized to control all substantial decisions of the trust or (b) the trust has in effect a valid election to be treated as a domestic
trust for U.S. federal income tax purposes. If a partnership or other entity or arrangement classified as a partnership for U.S. tax purposes
holds the Common Shares, the tax treatment of the partnership and each partner generally will depend on the activities of the partnership
and the status of the partner. Partnerships acquiring Common Shares, and partners in such partnerships, should consult their tax advisors.
Prospective investors that are not U.S. shareholders should refer to the section &#8220;Non-U.S. shareholders&#8221; below and are urged
to consult their tax advisors with respect to the U.S. federal income tax consequences of an investment in the Fund&#8217;s Common Shares,
including the potential application of U.S. withholding taxes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Distributions paid by the Fund
from its investment company taxable income (as defined above) (dividends from investment company taxable income referred to hereinafter
as &#8220;ordinary income dividends&#8221;), whether paid in cash or reinvested in Common Shares, will generally be taxable to you as
ordinary income to the extent of the Fund&#8217;s current or accumulated earnings and profits. Certain properly reported distributions
may, however, qualify (provided that holding period and other requirements are met by both the Fund and U.S. shareholders) (i) for the
dividends received deduction in the case of corporate U.S. shareholders to the extent that the Fund&#8217;s income consists of dividend
income from U.S. corporations or (ii) in the case of individual U.S. shareholders, as qualified dividend income eligible to be taxed at
a reduced maximum rate to the extent that the Fund receives qualified dividend income. Qualified dividend income is, in general, dividend
income from taxable domestic corporations and certain foreign corporations. There can be no assurance as to what portion of the Fund&#8217;s
distributions will qualify for the dividends received deduction or for treatment as qualified dividend income.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Distributions made from net capital
gain, which is the excess of net long-term capital gains over net short-term capital losses (&#8220;capital gain dividends&#8221;), including
capital gain dividends credited to a U.S. shareholder but retained by the Fund, are taxable to U.S. shareholder as long-term capital gains
if they have been properly reported by the Fund, regardless of the length of time the U.S. shareholder has owned Common Shares of the
Fund. Net long-term capital gain of individuals is generally taxed at a reduced maximum rate. For corporate taxpayers, net long-term capital
gain is taxed at ordinary income rates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Subject to any future regulatory
guidance to the contrary, any distribution of income attributable to income from the Fund&#8217;s investment in an MLP will not qualify
for the 20% deduction for &#8220;qualified PTP income&#8221; that would generally be available to a non-corporate U.S. shareholder were
the shareholder to own such MLP directly. As a result, it is possible that a non-corporate U.S. shareholder will be subject to a higher
effective tax rate on any such distributions received from the Fund compared to the effective rate applicable to any income the U.S. shareholder
would receive if the shareholder invested directly in an MLP.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If, for any calendar year, the
Fund&#8217;s total distributions exceed both current earnings and profits and accumulated earnings and profits, the excess will generally
be treated as a tax-free return of capital up to the amount of a U.S. shareholder&#8217;s tax basis in the Common Shares, reducing that
basis accordingly. Such distributions exceeding the U.S. shareholder&#8217;s basis will be treated as gain from the sale or exchange of
the Common Shares. When you sell your Common Shares, the amount, if any, by which your sales price exceeds your basis in the Fund&#8217;s
Common Shares is gain subject to tax. Because a return of capital reduces your basis in the Common Shares, it will increase the amount
of your gain or decrease the amount of your loss when you sell the Common Shares, all other things being equal.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Generally, after the close of
its taxable year, the Fund will provide its U.S. shareholders with a written notice reporting the amount of any ordinary income dividends
or capital gain dividends and other distributions.</p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The sale or other disposition
of Common Shares will generally result in capital gain or loss to U.S. shareholders measured by the difference between the sale price
and the U.S. shareholder&#8217;s tax basis in its Common Shares. Generally, a U.S. shareholder&#8217;s gain or loss will be long-term
gain or loss if the Common Shares have been held for more than one year. Any loss upon the sale or exchange of Common Shares held for
six months or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited
as an undistributed capital gain) by the U.S. shareholder. Any loss a U.S. shareholder realizes on a sale or exchange of Common Shares
will be disallowed if the U.S. shareholder acquires other Common Shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after the U.S. shareholder&#8217;s sale or exchange of the Common Shares.
In such case, the basis of the Common Shares acquired will be adjusted to reflect the disallowed loss. Present law taxes both long-term
and short-term capital gains of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term capital
gain is taxed at the U.S. federal income tax rates applicable to ordinary income, while long-term capital gain generally is taxed at a
reduced maximum U.S. federal income tax rate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">U.S. shareholders may be entitled
to offset their capital gains with capital losses. There are several provisions of the Code affecting when capital losses may offset capital
gain, and limiting the use of losses from certain investments and activities. Accordingly, U.S. shareholders with capital losses are urged
to consult their tax advisors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">An investor should be aware that
if Common Shares are purchased shortly before the record date for any taxable distribution (including a capital gain dividend), the purchase
price likely will reflect the value of the distribution and the investor then would receive a taxable distribution likely to reduce the
trading value of such Common Shares, in effect resulting in a taxable return of some of the purchase price.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Dividends and other taxable distributions
will be taxable to you even though they are reinvested in additional Common Shares. The Fund has the ability to declare distributions
payable in cash or Common Shares at the election of each U.S. shareholder. As long as a large enough portion of such dividend is available
to be paid in cash (20% under current guidance) and certain requirements are met, the entire distribution will be treated as a dividend
for U.S. federal income tax purposes. As a result, U.S. shareholders will be taxed on 100% of the dividend in the same manner as a cash
dividend, even though most of the dividend was paid in Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Dividends and other distributions
paid by the Fund will generally be treated for U.S. federal income tax purposes as received by you at the time the dividend or distribution
is made. If, however, the Fund pays you a dividend in January that was declared in the previous October, November or December and you
were the U.S. shareholder of record on a specified date in one of such months, then such dividend will be treated for U.S. federal income
tax purposes as being paid by the Fund and received by you on December&#160;31 of the year in which the dividend was declared. In addition,
certain other distributions made after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid
by the Fund (except for purposes of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having
received such dividends in the taxable year in which the distributions were actually made.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Certain U.S. shareholders who
are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a
portion of their &#8220;net investment income,&#8221; which ordinarily includes dividends received from the Fund and capital gain from
the sale or other disposition of the Fund&#8217;s common shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Withholding at a rate of 30%
will be required on dividends in respect of Common Shares held by or through foreign accounts or foreign intermediaries if certain disclosure
requirements related to U.S. accounts or ownership are not satisfied. The Fund will not pay any additional amounts in respect to any amounts
withheld.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Taxation of Non-U.S. Shareholders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">For purposes of this discussion,
a &#8220;non-U.S. shareholder&#8221; is a beneficial owner of Common Shares, other than a partnership (or other entity or arrangement
treated as a partnership for U.S. federal income tax purposes), that is not a U.S. shareholder for U.S. federal income tax purposes. Whether
an investment in Common Shares is appropriate for a non-U.S. shareholder will depend on that non-U.S. shareholder&#8217;s particular circumstances.
An investment in Common Shares by a non-U.S. shareholder may have adverse tax consequences. Non-U.S. shareholders should consult their
tax advisors before investing in the Common Shares.</p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A non-U.S. shareholder generally
will be subject to U.S. federal withholding tax at a rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary
income dividends to the extent of the Fund&#8217;s current or accumulated earnings and profits (except as discussed below). Actual or
deemed distributions of the Fund&#8217;s net capital gain to a non-U.S. shareholder, and gains recognized by a non-U.S. shareholder upon
the sale of Common Shares, will generally not be subject to U.S. federal withholding tax and will not be subject to U.S. federal income
tax. Different tax consequences may result if (i) the non-U.S. shareholder is engaged in a trade or business in the United States (and,
if an income tax treaty applies, the non-U.S. shareholder&#8217;s income or gains are attributable to a permanent establishment maintained
by the shareholder in the United States), (ii) the non-U.S. shareholder is an individual that is present in the United States for 183
days or more during a taxable year and certain other conditions are met, or (iii) in the case of gain on the disposition of Common Shares,
the Fund is or has been a &#8220;United States real property holding corporation&#8221; (&#8220;USRPHC&#8221;) at any time within the
shorter of the five-year period ending on the date the Common Shares are sold or the period that such non-U.S. shareholder held the shares
(and as long as the Common Shares are treated as regularly traded on an established securities market, such non-U.S. shareholder owns
or owned (actually or constructively) more than five percent of the Common Shares at any time during the shorter of the two periods mentioned
above), or (iv) in the case of distributions that are attributable to the Fund&#8217;s gain on the disposition of a &#8220;U.S. real property
interest&#8221; (which may include equity securities in companies that own significant interests in U.S. real estate), the Fund is a &#8220;qualified
investment entity&#8221; (generally, an entity that either is a USRPHC or would be a USRPHC but for the operation of certain exceptions
to the definition thereof). The determination of whether the Fund is a USRPHC or qualified investment entity will depend on the exact
nature of its assets, and no assurances can be given in that regard. Though the Fund expects that its Common Shares will be treated as
&#8220;regularly traded&#8221; on an established securities market, no assurance can be given in this regard. Special certification requirements
apply to a non-U.S. shareholder that is a foreign partnership or a foreign trust, and such entities are urged to consult their tax advisors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Subject to the discussion of
FATCA below, properly reported dividends paid by the Fund to non-U.S. shareholders are generally exempt from U.S. federal withholding
tax where they (i) are paid in respect of the Fund&#8217;s &#8220;qualified net interest income&#8221; (generally, the Fund&#8217;s U.S.-source
interest income, other than certain contingent interest and interest from obligations of a corporation or partnership in which the Fund
is at least a 10% shareholder, reduced by expenses that are allocable to such income) or (ii) are paid in respect of the Fund&#8217;s
&#8220;qualified short-term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short-term capital gain over the Fund&#8217;s
long-term capital loss for such taxable year). In order to qualify for this exemption from withholding, a non-U.S. shareholder must comply
with applicable certification requirements relating to its non-U.S. status (including, in general, furnishing an IRS Form&#160;W-8BEN
or W8BEN-E or substitute form). In the case of Common Shares held through an intermediary, the intermediary may withhold even if the Fund
designates the payment as qualified net interest income or qualified short-term capital gain. Non-U.S. shareholders should contact their
intermediaries with respect to the application of these rules to their accounts. There can be no assurance as to what portion, if any,
of the Fund&#8217;s distributions would qualify for favorable treatment as &#8220;qualified net interest income&#8221; or &#8220;qualified
short-term capital gains.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Notwithstanding the foregoing,
under certain provisions of the Code referred to as &#8220;FATCA,&#8221; withholding at a rate of 30% will be required on dividends in
respect of Common Shares held by or through certain foreign financial institutions (including investment funds), unless such institution
enters into an agreement with the Treasury to report, on an annual basis, information with respect to interests in, and accounts maintained
by, the institution to the extent such interests or accounts are held by certain United States persons or by certain non-U.S. entities
that are wholly or partially owned by United States persons and to withhold on certain payments. Accordingly, the entity or entities through
which Common Shares are held will affect the determination of whether such withholding is required. Similarly, withholding at a rate of
30% will be required on dividends in respect of Common Shares held by an investor that is a non-financial non-U.S. entity that does not
qualify under certain exemptions, unless such entity either (i) certifies that such entity does not have any &#8220;substantial United
States owners&#8221; or (ii) provides certain information regarding the entity&#8217;s &#8220;substantial United States owners,&#8221;
which the applicable withholding agent will in turn provide to the Secretary of the Treasury. An intergovernmental agreement between the
United States and an applicable foreign country, or future Treasury regulations or other guidance, may modify these requirements. The
Fund will not pay any additional amounts to Common Shareholders in respect of any amounts withheld. Non-U.S. shareholders are encouraged
to consult with their tax advisors regarding the possible withholding implications of an investment in Common Shares.</p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Furthermore, if the Fund distributes
its net capital gains in the form of deemed rather than actual distributions (which the Fund may do in the future), a non-U.S. shareholder
will be entitled to a U.S. federal income tax credit or tax refund equal to the shareholder&#8217;s allocable share of the tax the Fund
pays on the capital gains deemed to have been distributed. In order to obtain the refund, the non-U.S. shareholder must obtain a U.S.
taxpayer identification number and file a federal income tax return even if the non-U.S. shareholder is not otherwise required to obtain
a U.S. taxpayer identification number or file a federal income tax return. For a corporate non-U.S. shareholder, distributions (both actual
and deemed), and gains realized upon the sale of Common Shares that are effectively connected with a U.S. trade or business (or, where
an applicable treaty applies, are attributable to a permanent establishment in the United States) may, under certain circumstances, be
subject to an additional &#8220;branch profits tax&#8221; at a 30% rate (or at a lower rate if provided for by an applicable tax treaty).
Accordingly, investment in Common Shares may not be appropriate for certain non-U.S. shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Backup Withholding</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund may be required to withhold,
for U.S. federal backup withholding purposes, on all taxable distributions to any non-corporate holders of Common Shares who (1) do not
furnish the Fund with their correct taxpayer identification number (in the case of individuals, generally their social security number)
or a certificate that such Common Shareholder is exempt from backup withholding, or (2) with respect to whom the IRS notifies the Fund
that such Common Shareholder has failed to properly report certain interest and dividend income to the IRS and to respond to notices to
that effect. A non-U.S. shareholder who is a nonresident alien individual, and who is otherwise subject to withholding of federal income
tax, may be subject to backup withholding of federal income tax on dividends unless the non-U.S. shareholder provides the Fund or the
dividend paying agent with an IRS Form&#160;W-8BEN or IRS Form&#160;W-8BEN-E (or an acceptable substitute form) or otherwise meets documentary
evidence requirements for establishing that it is a non-U.S. shareholder or otherwise establishes an exemption from backup withholding.
Backup withholding is not an additional tax. Any amounts withheld from payments made to a Common Shareholder may be refunded or credited
against such Common Shareholder&#8217;s U.S. federal income tax liability, if any, provided that the required information is generally
furnished to the IRS.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The foregoing is a general summary
of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its Common Shareholders.
These provisions are subject to change by legislative, judicial or administrative action, and any such change may be retroactive. Ordinary
income and capital gain dividends may also be subject to state, local and foreign taxes. Investors are urged to consult their tax advisors
regarding U.S. federal, state, local and foreign tax consequences of investing in the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">SERVICE
PROVIDERS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Administrator</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">U.S. Bancorp Global Fund Services,
the Administrator, which is located at 615 East Michigan Street, Milwaukee, Wisconsin 53202, serves as the Fund&#8217;s administrator
pursuant to a fund administration servicing agreement. Pursuant to this agreement, the Administrator provides the Fund with, among other
things, compliance oversight, financial reporting oversight and tax reporting. The Fund pays the Administrator a monthly fee computed
at an annual rate of 0.09% of the first $100 million of Managed Assets, 0.07% on the next $200 million of Managed Assets and 0.04% on
the balance of Managed Assets, subject to a minimum annual fee of $70,000. The Fund will also pay for the Administrator&#8217;s out-of-pocket
expenses. The Administrator also serves as fund accountant pursuant to a fund accounting servicing agreement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Custodian</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">U.S. Bank National Association
(the &#8220;Custodian&#8221;), Custody Operations, 1555 N.&#160;River Center Drive, Suite 302, Milwaukee, Wisconsin 53212, serves as custodian
for the Fund pursuant to the Custodian Agreement with the Fund (the &#8220;Custodian Agreement&#8221;). The Custodian and the Administrator
are affiliates of each other. Under the Custodian Agreement, the Custodian will be responsible for, among other things, receipt of and
disbursement of funds from the Fund&#8217;s accounts, establishment of segregated accounts as necessary, and transfer, exchange and delivery
of Fund portfolio securities.</p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Transfer Agent</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">U.S. Bancorp Global Fund Services,
located at 615 East Michigan Street, Milwaukee, Wisconsin 53202, has entered into a transfer agent servicing agreement with the Fund.
Under this agreement, U.S. Bancorp Global Fund Services serves as the Fund&#8217;s transfer agent, registrar and dividend disbursing agent.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">GENERAL
INFORMATION</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Additional Information</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Prospectus and this SAI constitutes
part of a Registration Statement filed by the Fund with the SEC under the Securities Act, and the 1940 Act. The Prospectus and this SAI
omit certain of the information contained in the Registration Statement, and reference is hereby made to the Registration Statement and
related exhibits for further information with respect to the Fund and the common shares offered hereby. Any statements contained in the
Prospectus and herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made
to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is
qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee
prescribed by its rules and regulations or free of charge through the SEC&#8217;s website (<i><span style="text-decoration: underline">http://www.sec.gov</span></i>).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Principal Holders</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As of the date of this SAI, to
the knowledge of the Fund, no person beneficially owned more than 5% of the voting securities of any class of equity securities of the
Fund, except as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; width: 40%; text-align: center"><b>Shareholder Name and Address</b></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><b>Class of <br/>
Shares</b></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><b>Share<br/>
Holdings</b></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><b>Percentage <br/>
Owned</b></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Sit Investment Associates, Inc.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Sit Fixed Income Advisors II, LLC</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">80 South Eighth Street, Suite 3300<sup>(1)</sup></p></td>
    <td style="text-align: left">Common Shares</td>
    <td style="text-align: left">292,675</td>
    <td style="text-align: left">7.3%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Philip Goldstein<sup>(2)</sup><br/>
    Andrew Dakos<br/>
    250 Pehle Ave. Suite 708</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Saddle Brook, NJ 07663</p></td>
    <td style="text-align: left">Common Shares</td>
    <td style="text-align: left">120,623</td>
    <td style="text-align: left">5.52%</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">Based on a Schedule&#160;13G filed on January&#160;3, 2025</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="text-transform: uppercase">(2)</span></td><td style="text-align: left">Based on Schedule&#160;13G filed on February&#160;13, 2023.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: -0.25in"><span style="text-transform: uppercase">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><b>Legal Matters</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Certain legal matters will be
passed on for the Fund by Skadden, Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois, in connection with the offering of the Securities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Independent registered public
accounting firm</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Ernst &amp; Young LLP, Dallas,
Texas, serves as the independent registered public accounting firm of the Fund and will annually render an opinion on the financial statements
of the Fund. The Fund&#8217;s audited financial statements appearing in the Fund&#8217;s annual report to shareholders for the period
ended November&#160;30, 2024, including accompanying notes thereto and the report of Ernst &amp; Young LLP thereon, have been incorporated
by reference herein in reliance on their report given on their authority as experts in accounting and auditing.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Proxy Voting Policy and Procedures
and Proxy Voting Record</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund has delegated authority
to vote proxies to the Investment Adviser, subject to the supervision of the Board of Trustees. Attached hereto as Appendix&#160;B is
the Proxy Voting Policy which is currently in effect as of the date of this Statement of Additional Information.</p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Proxy Voting Policy is subject
to change over time and investors seeking the most current copy of the Proxy Voting Policy should call the Fund toll free at (877) 965-7386.
The Fund&#8217;s most recent proxy voting record for the period ended June&#160;30 which has been filed with the SEC is available without
charge by calling the Fund toll free at (877) 965-7386.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Code of Ethics</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund and the Investment Adviser
have adopted a code of ethics under Rule&#160;17j -1 of the 1940 Act. This code permits personnel subject to the code to invest in securities,
including securities that may be purchased or held by the Fund. The code of ethics is available on the EDGAR Database on the SEC&#8217;s
website (<i><span style="text-decoration: underline">http://www.sec.gov</span></i>), and copies of this code may be obtained, after paying a duplicating fee, by electronic request
at the following e-mail address: <i><span style="text-decoration: underline">publicinfo@sec.gov</span></i>.</p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">FINANCIAL
STATEMENTS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Fund&#8217;s audited financial
statements, including accompanying notes thereto and the report of Ernst &amp; Young LLP thereon, appearing in the Fund&#8217;s Annual
Report are incorporated by reference in this Statement of Additional Information. Shareholder reports are available upon request and without
charge by calling toll-free (877) 965-7386, or you may obtain a copy of such reports from the SEC&#8217;s website (<i><span style="text-decoration: underline">http://www.sec.gov</span></i>)
or from the Fund&#8217;s website at <i><span style="text-decoration: underline">www.nxgim.com</span></i>. Information on, or accessible through, the Fund&#8217;s website is not
a part of, and is not incorporated into, this Statement of Additional Information, the Prospectus or any Prospectus Supplement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">Appendix&#160;A</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Description of Securities Ratings</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">STANDARD &amp; POOR&#8217;S CORPORATION</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A brief description of the applicable
Standard &amp; Poor&#8217;s Corporation (&#8220;S&amp;P&#8221;) rating symbols and their meanings (as published by S&amp;P) follows.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Issue Credit Ratings Definition</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A Standard &amp; Poor&#8217;s
issue credit rating is a forward-looking opinion about the creditworthiness of an obligor with respect to a specific financial obligation,
a specific class of financial obligations, or a specific financial program (including ratings on medium-term note programs and commercial
paper programs). It takes into consideration the creditworthiness of guarantors, insurers, or other forms of credit enhancement on the
obligation and takes into account the currency in which the obligation is denominated. The opinion reflects S&amp;P&#8217;s view of the
obligor&#8217;s capacity and willingness to meet its financial commitments as they come due, and may assess terms, such as collateral
security and subordination, which could affect ultimate payment in the event of default.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Issue credit ratings can be either
long-term or short-term. Short-term ratings are generally assigned to those obligations considered short-term in the relevant market.
In the U.S., for example, that means obligations with an original maturity of no more than 365 days&#8212;including commercial paper.
Short-term ratings are also used to indicate the creditworthiness of an obligor with respect to put features on long-term obligations.
The result is a dual rating, in which the short-term rating addresses the put feature, in addition to the usual long-term rating. Medium-term
notes are assigned long-term ratings.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Long-Term Issue Credit Ratings*</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Issue credit ratings are based,
in varying degrees, on S&amp;P&#8217;s analysis of the following considerations:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Likelihood of payment&#8212;capacity and willingness of the obligor to meet its financial commitment on
an obligation in accordance with the terms of the obligation.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Nature of and provisions of the obligation.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Protection afforded by, and relative position of, the obligation in the event of bankruptcy, reorganization,
or other arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Issue ratings are an assessment
of default risk, but may incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations
are typically rated lower than senior obligations, to reflect the lower priority in bankruptcy, as noted above. (Such differentiation
may apply when an entity has both senior and subordinated obligations, secured and unsecured obligations, or operating company and holding
company obligations.)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>AAA</b> An obligation rated
&#8216;AAA&#8217; has the highest rating assigned by S&amp;P. The obligor&#8217;s capacity to meet its financial commitment on the obligation
is extremely strong.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>AA</b> An obligation rated
&#8216;AA&#8217; differs from the highest-rated obligations only to a small degree. The obligor&#8217;s capacity to meet its financial
commitment on the obligation is very strong.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A</b> An obligation rated
&#8216;A&#8217; is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations
in higher-rated categories. However, the obligor&#8217;s capacity to meet its financial commitment on the obligation is still strong.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td style="text-align: justify">Plus (+) or minus (-) The ratings from &#8216;AA&#8217; to &#8216;CCC&#8217; may be modified by the addition
of a plus (+) or minus (-) sign to show relative standing within the major rating categories.</td></tr></table>


<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>BBB</b> An obligation rated
&#8216;BBB&#8217; exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely
to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>BB; B; CCC; CC</b>; and <b>C</b>
Obligations rated &#8216;BB&#8217;, &#8216;B&#8217;, &#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant
speculative characteristics. &#8216;BB&#8217; indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations
will likely have some quality and protective characteristics, these may be outweighed by large uncertainties or major exposures to adverse
conditions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>BB</b> An obligation rated
&#8216;BB&#8217; is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing uncertainties or exposure
to adverse business, financial, or economic conditions which could lead to the obligor&#8217;s inadequate capacity to meet its financial
commitment on the obligation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>B</b> An obligation rated
&#8216;B&#8217; is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;, but the obligor currently has the capacity to
meet its financial commitment on the obligation. Adverse business, financial, or economic conditions will likely impair the obligor&#8217;s
capacity or willingness to meet its financial commitment on the obligation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>CCC</b> An obligation rated
&#8216;CCC&#8217; is currently vulnerable to nonpayment, and is dependent upon favorable business, financial, and economic conditions
for the obligor to meet its financial commitment on the obligation. In the event of adverse business, financial, or economic conditions,
the obligor is not likely to have the capacity to meet its financial commitment on the obligation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>CC</b> An obligation rated
&#8216;CC&#8217; is currently highly vulnerable to nonpayment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>C A &#8216;C</b>&#8217; rating
is assigned to obligations that are currently highly vulnerable to nonpayment, obligations that have payment arrearages allowed by the
terms of the documents, or obligations of an issuer that is the subject of a bankruptcy petition or similar action which have not experienced
a payment default. Among others, the &#8216;C&#8217; rating may be assigned to subordinated debt, preferred stock or other obligations
on which cash payments have been suspended in accordance with the instrument&#8217;s terms or when preferred stock is the subject of a
distressed exchange offer, whereby some or all of the issue is either repurchased for an amount of cash or replaced by other instruments
having a total value that is less than par.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>D</b> An obligation rated
&#8216;D&#8217; is in payment default. The &#8216;D&#8217; rating category is used when payments on an obligation are not made on the
date due, unless Standard &amp; Poor&#8217;s believes that such payments will be made within five business days, irrespective of any grace
period. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of similar action if payments
on an obligation are jeopardized. An obligation&#8217;s rating is lowered to &#8216;D&#8217; upon completion of a distressed exchange
offer, whereby some or all of the issue is either repurchased for an amount of cash or replaced by other instruments having a total value
that is less than par.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>NR</b> This indicates that
no rating has been requested, that there is insufficient information on which to base a rating, or that S&amp;P does not rate a particular
obligation as a matter of policy.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Short-Term Issue Credit Ratings</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A-1</b> A short-term obligation
rated &#8216;A-1&#8217; is rated in the highest category by S&amp;P. The obligor&#8217;s capacity to meet its financial commitment on
the obligation is strong. Within this category, certain obligations are designated with a plus sign (+). This indicates that the obligor&#8217;s
capacity to meet its financial commitment on these obligations is extremely strong.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A-2</b> A short-term obligation
rated &#8216;A-2&#8217; is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations
in higher rating categories. However, the obligor&#8217;s capacity to meet its financial commitment on the obligation is satisfactory.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A-3</b> A short-term obligation
rated &#8216;A-3&#8217; exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more
likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation.</p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>B </b>A short-term obligation
rated &#8216;B&#8217; is regarded as vulnerable and has significant speculative characteristics. The obligor currently has the capacity
to meet its financial commitments; however, it faces major ongoing uncertainties which could lead to the obligor&#8217;s inadequate capacity
to meet its financial commitments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>C</b> A short-term obligation
rated &#8216;C&#8217; is currently vulnerable to nonpayment and is dependent upon favorable business, financial, and economic conditions
for the obligor to meet its financial commitment on the obligation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>D </b>A short-term obligation
rated &#8216;D&#8217; is in payment default. The &#8216;D&#8217; rating category is used when payments on an obligation are not made on
the date due, unless Standard &amp; Poor&#8217;s believes that such payments will be made within any stated grace period. However, any
stated grace period longer than five business days will be treated as five business days. The &#8216;D&#8217; rating also will be used
upon the filing of a bankruptcy petition or the taking of a similar action if payments on an obligation are jeopardized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SPUR</b> (S&amp;Ps Underlying
Rating) A SPUR rating is a rating of a stand-alone capacity of an issue to pay debt service on a credit-enhanced debt issue, without giving
effect to the enhancement that applies to it. These ratings are published only at the request of the debt issuer/obligor with the designation
SPUR to distinguish them from the credit-enhanced rating that applies to the debt issue. S&amp;P maintains surveillance of an issue with
a published SPUR.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Municipal Short-Term Note Ratings
Definitions</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A S&amp;P&#8217;s U.S. Municipal
note rating reflects S&amp;P&#8217;s opinion about the liquidity factors and market access risks unique to the notes. Notes due in three
years or less will likely receive a note rating. Notes with an original maturity of more than three years will most likely receive a long-term
debt rating. In determining which type of rating, if any, to assign, S&amp;P&#8217;s analysis will review the following considerations:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Amortization schedule &#8212; the larger the final maturity relative to other maturities, the more likely
it will be treated as a note; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Source of payment &#8212; the more dependent the issue is on the market for its refinancing, the more
likely it will be treated as a note.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Note rating symbols are as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SP-1</b> Strong capacity to
pay principal and interest. An issue determined to possess a very strong capacity to pay debt service is given a plus (+) designation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SP-2</b> Satisfactory capacity
to pay principal and interest, with some vulnerability to adverse financial and economic changes over the term of the notes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SP-3</b> Speculative capacity
to pay principal and interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Dual Ratings S&amp;P assigns
&#8220;dual&#8221; ratings to all debt issues that have a put option or demand feature as part of their structure. The first rating addresses
the likelihood of repayment of principal and interest as due, and the second rating addresses only the demand feature. The long-term rating
symbols are used for bonds to denote the long-term maturity and the short-term rating symbols for the put option (for example, &#8216;AAA/A-1+&#8217;).
With U.S. municipal short-term demand debt, note rating symbols are used with the short-term issue credit rating symbols (for example,
&#8216;SP-1+/A-1+&#8217;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The ratings and other credit
related opinions of S&amp;P and its affiliates are statements of opinion as of the date they are expressed and not statements of fact
or recommendations to purchase, hold, or sell any securities or make any investment decisions. S&amp;P assumes no obligation to update
any information following publication. Users of ratings and credit related opinions should not rely on them in making any investment decision.
S&amp;P&#8217;s opinions and analyses do not address the suitability of any security. S&amp;P&#8217;s Financial Services LLC does not
act as a fiduciary or an investment advisor. While S&amp;P has obtained information from sources it believes to be reliable, S&amp;P does
not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. Ratings and credit
related opinions may be changed, suspended, or withdrawn at any time.</p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Active Qualifiers (Currently
Applied and/or Outstanding)</p>

<p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>i </b>This suffix is used
for issues in which the credit factors, terms, or both, that determine the likelihood of receipt of payment of interest are different
from the credit factors, terms or both that determine the likelihood of receipt of principal on the obligation. The &#8216;i&#8217; suffix
indicates that the rating addresses the interest portion of the obligation only. The &#8216;i&#8217; suffix will always be used in conjunction
with the &#8216;p&#8217; suffix, which addresses likelihood of receipt of principal. For example, a rated obligation could be assigned
ratings of &#8220;AAAp NRi&#8221; indicating that the principal portion is rated &#8220;AAA&#8221; and the interest portion of the obligation
is not rated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>L</b> Ratings qualified with
&#8216;L&#8217; apply only to amounts invested up to federal deposit insurance limits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>p</b> This suffix is used
for issues in which the credit factors, the terms, or both, that determine the likelihood of receipt of payment of principal are different
from the credit factors, terms or both that determine the likelihood of receipt of interest on the obligation. The &#8216;p&#8217; suffix
indicates that the rating addresses the principal portion of the obligation only. The &#8216;p&#8217; suffix will always be used in conjunction
with the &#8216;i&#8217; suffix, which addresses likelihood of receipt of interest. For example, a rated obligation could be assigned
ratings of &#8220;AAAp NRi&#8221; indicating that the principal portion is rated &#8220;AAA&#8221; and the interest portion of the obligation
is not rated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>pi</b> Ratings with a &#8216;pi&#8217;
suffix are based on an analysis of an issuer&#8217;s published financial information, as well as additional information in the public
domain. They do not, however, reflect in-depth meetings with an issuer&#8217;s management and therefore may be based on less comprehensive
information than ratings without a &#8216;pi&#8217; suffix. Ratings with a &#8216;pi&#8217; suffix are reviewed annually based on a new
year&#8217;s financial statements, but may be reviewed on an interim basis if a major event occurs that may affect the issuer&#8217;s
credit quality.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>preliminary</b> Preliminary
ratings, with the &#8216;prelim&#8217; suffix, may be assigned to obligors or obligations, including financial programs, in the circumstances
described below. Assignment of a final rating is conditional on the receipt by S&amp;P of appropriate documentation. S&amp;P reserves
the right not to issue a final rating. Moreover, if a final rating is issued, it may differ from the preliminary rating.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings may be assigned to obligations, most commonly structured and project finance issues,
pending receipt of final documentation and legal opinions.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings are assigned to Rule&#160;415 Shelf Registrations. As specific issues, with defined
terms, are offered from the master registration, a final rating may be assigned to them in accordance with Standard &amp; Poor&#8217;s
policies.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings may be assigned to obligations that will likely be issued upon the obligor&#8217;s
emergence from bankruptcy or similar reorganization, based on late-stage reorganization plans, documentation and discussions with the
obligor. Preliminary ratings may also be assigned to the obligors. These ratings consider the anticipated general credit quality of the
reorganized or post-bankruptcy issuer as well as attributes of the anticipated obligation(s).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings may be assigned to entities that are being formed or that are in the process of being
independently established when, in S&amp;P&#8217;s opinion, documentation is close to final.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings may also be assigned to these entities&#8217; obligations.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Preliminary ratings may be assigned when a previously unrated entity is undergoing a well-formulated restructuring,
recapitalization, significant financing or other transformative event, generally at the point that investor or lender commitments are
invited. The preliminary rating may be assigned to the entity and to its proposed obligation(s). These preliminary ratings consider the
anticipated general credit quality of the obligor, as well as attributes of the anticipated obligation(s), assuming successful completion
of the transformative event. Should the transformative event not occur, S&amp;P would likely withdraw these preliminary ratings.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">A preliminary recovery rating may be assigned to an obligation that has a preliminary issue credit rating.</td></tr></table>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>sf</b> The (sf) suffix is
assigned to all issues and issuers to which a regulation, such as the European Union Regulation on Credit Rating Agencies, requires the
assignment of an additional symbol which distinguishes a structured finance instrument or obligor (as defined in the regulation) from
any other instrument or obligor. The addition of this suffix to a credit rating does not change the definition of that rating or our opinion
about the issue&#8217;s or issuer&#8217;s creditworthiness.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>t </b>This symbol indicates
termination structures that are designed to honor their contracts to full maturity or, should certain events occur, to terminate and cash
settle all their contracts before their final maturity date.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>unsolicited </b>Unsolicited
ratings are those credit ratings assigned at the initiative of S&amp;P and not at the request of the issuer or its agents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">MOODY&#8217;S INVESTORS SERVICE, INC.</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A brief description of the applicable
Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) rating symbols and their meanings (as published by Moody&#8217;s)
follows.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Global Rating Scales</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Ratings assigned on Moody&#8217;s
global long-term and short-term rating scales are forward-looking opinions of the relative credit risks of financial obligations issued
by non-financial corporates, financial institutions, structured finance vehicles, project finance vehicles and public sector entities.
Long-term ratings are assigned to issuers or obligations with an original maturity of one year or more and reflect both on the likelihood
of a default on contractually promised payments and the expected financial loss suffered in the event of default. Short-term ratings are
assigned to obligations with an original maturity of thirteen months or less and reflect both on the likelihood of a default on contractually
promised payments and the expected financial loss suffered in the event of default.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Moody&#8217;s differentiates
structured finance ratings from fundamental ratings (<i>i.e.</i>, ratings on nonfinancial corporate, financial institution and public
sector entities) on the global long-term scale by adding (sf) to all structured finance ratings. The addition of (sf) to structured finance
ratings should eliminate any presumption that such ratings and fundamental ratings at the same letter grade level will behave the same.
The (sf) indicator for structured finance security ratings indicates that otherwise similarly rated structured finance and fundamental
securities may have different risk characteristics. Through its current methodologies, however, Moody&#8217;s aspires to achieve broad
expected equivalence in structured finance and fundamental rating performance when measured over a long period of time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Global Long-Term Rating Scale</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Aaa </b>Obligations rated
Aaa are judged to be of the highest quality, subject to the lowest level of credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Aa </b>Obligations rated Aa
are judged to be of high quality and are subject to very low credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A </b>Obligations rated A
are judged to be upper-medium grade and are subject to low credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Baa </b>Obligations rated
Baa are judged to be medium-grade and subject to moderate credit risk and as such may possess certain speculative characteristics.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Ba </b>Obligations rated Ba
are judged to be speculative and are subject to substantial credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>B </b>Obligations rated B
are considered speculative and are subject to high credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Caa </b>Obligations rated
Caa are judged to be speculative of poor standing and are subject to very high credit risk.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>Ca </b>Obligations rated Ca
are highly speculative and are likely in, or very near, default, with some prospect of recovery of principal and interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>C </b>Obligations rated C
are the lowest rated and are typically in default, with little prospect for recovery of principal or interest.</p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><span style="text-decoration: underline">Note:</span></b> Moody&#8217;s
appends numerical modifiers 1, 2 and 3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation
ranks in the higher end of its generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking
in the lower end of that generic rating</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">category. Additionally, a &#8220;(hyb)&#8221;
indicator is appended to all ratings of hybrid securities issued by banks, insurers, finance companies and securities firms.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">By their terms, hybrid securities
allow for the omission of scheduled dividends, interest, or principal payments, which can potentially result in impairment if such an
omission occurs. Hybrid securities may also be subject to contractually allowable write-downs of principal that could result in impairment.
Together with the hybrid indicator, the long-term obligation rating assigned to a hybrid security is an expression of the relative credit
risk associated with that security.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">Global Short-Term
Rating Scale</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>P-1 </b>Issuers (or supporting
institutions) rated Prime-1 have a superior ability to repay short-term debt obligations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>P-2 </b>Issuers (or supporting
institutions) rated Prime-2 have a strong ability to repay short-term debt obligations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>P-3 </b>Issuers (or supporting
institutions) rated Prime-3 have an acceptable ability to repay short-term obligations. <b>NP </b>Issuers (or supporting institutions)
rated Not Prime do not fall within any of the Prime rating categories.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>Short-Term Obligation Ratings.
</i></b>While the global short-term &#8216;prime&#8217; rating scale is applied to US municipal tax-exempt commercial paper, these programs
are typically backed by external letters of credit or liquidity facilities and their short-term prime ratings usually map to the long-term
rating of the enhancing bank or financial institution and not the municipality&#8217;s rating. Other short-term municipal obligations,
which generally have different funding sources for repayment, are rated using two additional short-term rating scales (<i>i.e.</i>, the
MIG and VMIG scales discussed below).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Municipal Investment Grade
(MIG) scale is used to rate US municipal bond anticipation notes of up to three years maturity. Municipal notes rated on the MIG scale
may be secured by either pledged revenues or proceeds of a take-out financing received prior to note maturity. MIG ratings expire at the
maturity of the obligation, and the issuer&#8217;s long-term rating is only one consideration in assigning the MIG rating. MIG ratings
are divided into three levels&#8212;MIG1 through MIG3&#8212;while speculative grade short-term obligations are designated SG.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>MIG 1 </b>This designation
denotes superior credit quality. Excellent protection is afforded by established cash flows, highly reliable liquidity support, or demonstrated
broad-based access to the market for refinancing.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>MIG 2 </b>This designation
denotes strong credit quality. Margins of protection are ample, although not as large as in the preceding group.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>MIG 3 </b>This designation
denotes acceptable credit quality. Liquidity and cash-flow protection may be narrow, and market access for refinancing is likely to be
less well-established.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SG </b>This designation denotes
speculative-grade credit quality. Debt instruments in this category may lack sufficient margins of protection.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>Demand Obligation Ratings.
</i></b>In the case of variable rate demand obligations (VRDOs), a two-component rating is assigned; a long- or short-term debt rating
and a demand obligation rating. The first element represents Moody&#8217;s evaluation of risk associated with scheduled principal and
interest payments. The second element represents Moody&#8217;s evaluation of risk associated with the ability to receive purchase price
upon demand (&#8220;demand feature&#8221;), using a variation of the MIG rating scale, the Variable Municipal Investment Grade or VMIG
rating. The rating transitions on the VMIG scale differ from those on the Prime scale to reflect the risk that external liquidity support
generally will terminate if the issuer&#8217;s long-term rating drops below investment grade.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>VMIG 1 </b>This designation
denotes superior credit quality. Excellent protection is afforded by the superior short-term credit strength of the liquidity provider
and structural and legal protections that ensure the timely payment of purchase price upon demand.</p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>VMIG 2 </b>This designation
denotes strong credit quality. Good protection is afforded by the strong short-term credit strength of the liquidity provider and structural
and legal protections that ensure the timely payment of purchase price upon demand.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>VMIG 3 </b>This designation
denotes acceptable credit quality. Adequate protection is afforded by the satisfactory short-term credit strength of the liquidity provider
and structural and legal protections that ensure the timely payment of purchase price upon demand.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>SG </b>This designation denotes
speculative-grade credit quality. Demand features rated in this category may be supported by a liquidity provider that does not have an
investment grade short-term rating or may lack the structural and/or legal protections necessary to ensure the timely payment of purchase
price upon demand.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">Other Ratings
Symbols</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>e </b>Expected Ratings Indicator.
To address market demand for timely information on particular types of credit ratings, Moody&#8217;s has licensed to certain third parties
the right to generate &#8220;Expected Ratings.&#8221; Expected Ratings are designated by an &#8220;e&#8221; after the rating code, and
are intended to anticipate Moody&#8217;s forthcoming rating assignments based on reliable information from third party sources (such as
the issuer or underwriter associated with the particular securities) or established Moody&#8217;s rating practices (<i>i.e.</i>, medium
term notes are typically, but not always, assigned the same rating as the note&#8217;s program rating). Expected Ratings will exist only
until Moody&#8217;s confirms the Expected Rating, or issues a different rating for the relevant instrument. Moody&#8217;s encourages market
participants to contact Moody&#8217;s Ratings Desk or visit <span style="text-decoration: underline">www.moodys.com</span> if they have questions, or wish Moody&#8217;s to confirm
an Expected Rating.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>(P) </b>Provisional Ratings.
As a service to the market and at the request of an issuer, Moody&#8217;s will often assign a provisional rating when the assignment of
a final rating is subject to the fulfillment of contingencies but it is highly likely that the rating will become definitive after all
documents are received or an obligation is issued into the market. A provisional rating is denoted by placing a (P) in front of the rating.
Such ratings are typically assigned to shelf registrations under SEC rule&#160;415 or transaction-based structures that require investor
education. When a transaction uses a well-established structure and the transaction&#8217;s structure and terms are not expected to change
prior to sale in a manner that would affect the rating, a definitive rating may be assigned directly.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"># Refunded. Issues that are secured
by escrowed funds held in trust, reinvested in direct, non-callable US government obligations or non-callable obligations unconditionally
guaranteed by the US Government or Resolution Funding Corporation are identified with a # (hatch mark) symbol, <i>e.g.</i>, #Aaa.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>WR </b>Withdrawn. When Moody&#8217;s
no longer rates an obligation on which it previously maintained a rating, the symbol WR is employed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>NR </b>Not Rated. The symbol
NR is assigned to unrated obligations, issuers and/or programs. <b>NAV </b>Not Available. An issue that Moody&#8217;s has not yet rated
is denoted by the NAV symbol.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>TWR </b>Terminated Without
Rating. The symbol TWR applies primarily to issues that mature or are redeemed without having been rated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">FITCH RATINGS, INC.</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A brief description of the applicable
Fitch Ratings, Inc. (&#8220;Fitch&#8221;) ratings symbols and meanings (as published by Fitch) follows.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Rated entities in a number of
sectors, including financial and non-financial corporations, sovereigns and insurance companies, are generally assigned Issuer Default
Ratings (IDRs). IDRs opine on an entity&#8217;s relative vulnerability to default on financial obligations. The &#8220;threshold&#8221;
default risk addressed by the IDR is generally that of the financial obligations whose non-payment would best reflect the uncured failure
of that entity. As such, IDRs also address relative vulnerability to bankruptcy, administrative receivership or similar concepts, although
the agency recognizes that issuers may also make pre-emptive and therefore voluntary use of such mechanisms.</p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In aggregate, IDRs provide an
ordinal ranking of issuers based on the agency&#8217;s view of their relative vulnerability to default, rather than a prediction of a
specific percentage likelihood of default. For historical information on the default experience of Fitch-rated issuers, please consult
the transition and default performance studies available from the Fitch Ratings website.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">Long-Term
Credit Ratings Scales</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>AAA Highest credit quality.
</b>&#8216;AAA&#8217; ratings denote the lowest expectation of default risk. They are assigned only in cases of exceptionally strong capacity
for payment of financial commitments. This capacity is highly unlikely to be adversely affected by foreseeable events.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>AA Very high credit quality</b>.
&#8216;AA&#8217; ratings denote expectations of very low default risk. They indicate very strong capacity for payment of financial commitments.
This capacity is not significantly vulnerable to foreseeable events.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>A High credit quality. </b>&#8216;A&#8217;
ratings denote expectations of low default risk. The capacity for payment of financial commitments is considered strong. This capacity
may, nevertheless, be more vulnerable to adverse business or economic conditions than is the case for higher ratings.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>BBB Good credit quality. </b>&#8216;BBB&#8217;
ratings indicate that expectations of default risk are currently low. The capacity for payment of financial commitments is considered
adequate but adverse business or economic conditions are more likely to impair this capacity.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>BB Speculative</b>. &#8216;BB&#8217;
ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions
over time; however, business or financial flexibility exists which supports the servicing of financial commitments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>B Highly speculative. </b>&#8216;B&#8217;
ratings indicate that material default risk is present, but a limited margin of safety remains. Financial commitments are currently being
met; however, capacity for continued payment is vulnerable to deterioration in the business and economic environment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>CCC Substantial credit risk.
</b>Default is a real possibility.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>CC Very high levels of credit
risk. </b>Default of some kind appears probable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>C Exceptionally High Levels
of Credit Risk</b>. Default is imminent or inevitable, or the issuer is in standstill.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conditions that are indicative
of a &#8216;C&#8217; category rating for an issuer include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(a)</td><td style="text-align: justify">the issuer has entered into a grace or cure period following non-payment of a material financial obligation;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(b)</td><td style="text-align: justify">the issuer has entered into a temporary negotiated waiver or standstill agreement following a payment
default on a material financial obligation; or</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(c)</td><td style="text-align: justify">Fitch Ratings otherwise believes a condition of &#8216;RD&#8217; or &#8216;D&#8217; to be imminent or
inevitable, including through the formal announcement of a distressed debt exchange.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>RD Restricted default. </b>&#8216;RD&#8217;
ratings indicate an issuer that in Fitch&#8217;s opinion has experienced an uncured payment default on a bond, loan or other material
financial obligation but which has not entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up
procedure, and which has not otherwise ceased operating. This would include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(a)</td><td style="text-align: justify">the selective payment default on a specific class or currency of debt;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(b)</td><td style="text-align: justify">the uncured expiry of any applicable grace period, cure period or default forbearance period following
a payment default on a bank loan, capital markets security or other material financial obligation;</td></tr></table>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(c)</td><td style="text-align: justify">the extension of multiple waivers or forbearance periods upon a payment default on one or more material
financial obligations, either in series or in parallel; or</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(d)</td><td style="text-align: justify">execution of a distressed debt exchange on one or more material financial obligations.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>D Default. </b>&#8216;D&#8217;
ratings indicate an issuer that in Fitch Ratings&#8217; opinion has entered into bankruptcy filings, administration, receivership, liquidation
or other formal winding-up procedure, or which has otherwise ceased business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Default ratings are not assigned
prospectively to entities or their obligations; within this context, non-payment on an instrument that contains a deferral feature or
grace period will generally not be considered a default until after the expiration of the deferral or grace period, unless a default is
otherwise driven by bankruptcy or other similar circumstance, or by a distressed debt exchange.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#8220;Imminent&#8221; default
typically refers to the occasion where a payment default has been intimated by the issuer, and is all but inevitable. This may, for example,
be where an issuer has missed a scheduled payment, but (as is typical) has a grace period during which it may cure the payment default.
Another alternative would be where an issuer has formally announced a distressed debt exchange, but the date of the exchange still lies
several days or weeks in the immediate future.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In all cases, the assignment
of a default rating reflects the agency&#8217;s opinion as to the most appropriate rating category consistent with the rest of its universe
of ratings, and may differ from the definition of default under the terms of an issuer&#8217;s financial obligations or local commercial
practice.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><span style="text-decoration: underline">Note:</span></b> The modifiers
&#8220;+&#8221; or &#8220;-&#8221; may be appended to a rating to denote relative status within major rating categories. Such suffixes
are not added to the &#8216;AAA&#8217; Long-Term IDR category, or to Long-Term IDR categories below &#8216;B&#8217;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">Limitations
for the Issuer Credit Rating Scale:</p>

<p style="font: italic bold 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Specific limitations relevant
to the issuer credit rating scale include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not predict a specific percentage of default likelihood over any given time period.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the market value of any issuer&#8217;s securities or stock, or the likelihood
that this value may change.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the liquidity of the issuer&#8217;s securities or stock.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the possible loss severity on an obligation should an issuer default.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the suitability of an issuer as counterparty to trade credit.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on any quality related to an issuer&#8217;s business, operational or financial
profile other than the agency&#8217;s opinion on its relative vulnerability to default.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Ratings assigned by Fitch Ratings
articulate an opinion on discrete and specific areas of risk. The above list is not exhaustive, and is provided for the reader&#8217;s
convenience.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>Short-Term Ratings Assigned
to Issuers or Obligations in Corporate, Public and Structured Finance. </i></b>A short-term issuer or obligation rating is based in all
cases on the short-term vulnerability to default of the rated entity or security stream and relates to the capacity to meet financial
obligations in accordance with the documentation governing the relevant obligation. Short-Term Ratings are assigned to obligations whose
initial maturity is viewed as &#8220;short term&#8221; based on market convention. Typically, this means up to 13 months for corporate,
sovereign, and structured obligations, and up to 36 months for obligations in U.S. public finance markets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>F1: Highest short-term credit
quality. </b>Indicates the strongest intrinsic capacity for timely payment of financial commitments; may have an added &#8220;+&#8221;
to denote any exceptionally strong credit feature.</p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>F2: Good short-term credit
quality. </b>Good intrinsic capacity for timely payment of financial commitments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>F3: Fair short-term credit
quality. </b>The intrinsic capacity for timely payment of financial commitments is adequate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>B: Speculative short-term
credit quality. </b>Minimal capacity for timely payment of financial commitments, plus heightened vulnerability to near term adverse changes
in financial and economic conditions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>C: High short-term default
risk. </b>Default is a real possibility.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>RD: Restricted default. </b>Indicates
an entity that has defaulted on one or more of its financial commitments, although it continues to meet other financial obligations. Applicable
to entity ratings only.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>D: Default. </b>Indicates
a broad-based default event for an entity, or the default of a short-term obligation. <b><i>Limitations of the Short-Term Ratings Scale:</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Specific limitations relevant
to the Short-Term Ratings scale include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not predict a specific percentage of default likelihood over any given time period.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the market value of any issuer&#8217;s securities or stock, or the likelihood
that this value may change.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the liquidity of the issuer&#8217;s securities or stock.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on the possible loss severity on an obligation should an obligation default.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The ratings do not opine on any quality related to an issuer or transaction&#8217;s profile other than
the agency&#8217;s opinion on the relative vulnerability to default of the rated issuer or obligation.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Ratings assigned by Fitch Ratings
articulate an opinion on discrete and specific areas of risk. The above list is not exhaustive, and is provided for the reader&#8217;s
convenience.</p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">Appendix&#160;B</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">PROXY VOTING POLICY AND PROCEDURES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Cushing<sup>&#174;</sup> Asset
Management, LP (the &#8220;Investment Manager&#8221;) serves as the investment adviser and general partner, respectively, of certain the
investment accounts and pooled investment (each a &#8220;Client&#8221; and collectively, the &#8220;Clients&#8221;). Through these relationships
the Investment Manager is sometimes delegated the right to vote, on behalf of the Clients, proxies received from companies, the securities
of which are owned by the Clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Purpose</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Manager follows
this proxy voting policy (the &#8220;Policy&#8221;) to ensure that proxies the Investment Manager votes, on behalf of each Client, are
voted to further the best interest of that Client. The Policy establishes a mechanism to address any conflicts of interests between the
Investment Manager and the Client. Further, the Policy establishes how Clients may obtain information on how the proxies have been voted.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Determination of Vote</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Manager determines
how to vote after studying the proxy materials and any other materials that may be necessary or beneficial to voting. The Investment Manager
votes in a manner that the Investment Manager believes reasonably furthers the best interests of the Client and is consistent with the
Client&#8217;s investment philosophy as set forth in the relevant investment management documents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The major proxy-related issues
generally fall within five categories: corporate governance, takeover defenses, compensation plans, capital structure, and social responsibility.
The Investment Manager will cast votes for these matters on a case-by-case basis. The Investment Manager will generally vote in favor
of matters which follow an agreeable corporate strategic direction, support an ownership structure that enhances shareholder value without
diluting management&#8217;s accountability to shareholders and/or present compensation plans that are commensurate with enhanced manager
performance and market practices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Resolution of any Conflicts
of Interest</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If a proxy vote creates a material
conflict between the interests of the Investment Manager and a Client, the Investment Manager will resolve the conflict before voting
the proxies. The Investment Manager will either disclose the conflict to the Client and obtain a consent or take other steps designed
to ensure that a decision to vote the proxy was based on the Investment Manager&#8217;s determination of the Client&#8217;s best interest
and was not the product of the conflict.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Records</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Manager maintains
records of (i) all proxy statements and materials the Investment Manager receives on behalf of Clients; (ii) all proxy votes that are
made on behalf of the Clients; (iii) all documents that were material to a proxy vote; (iv) all written requests from Clients regarding
voting history; and (v) all responses (written and oral) to Clients&#8217; requests. Such records are available to the Clients (and owners
of a Client that is an investment vehicle) upon request.</p>


<!-- Field: Page; Sequence: 70; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PART&#160;C</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OTHER INFORMATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;25. Financial Statements and Exhibits</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(1)	Part&#160;A	Incorporated
by reference in the Prospectus included herein are the Registrant&#8217;s audited financial statements for the period ended November&#160;30,
2024, notes to such financial statements and the report of independent registered public accounting firm thereon, as contained in the
Trust&#8217;s Form&#160;N-CSR filed with the Securities and Exchange Commission on February&#160;10, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">	Part&#160;B	Incorporated
by reference in the Statement of Additional Information included herein are the Registrant&#8217;s audited financial statements for the
period ended November&#160;30, 2024, notes to such financial statements and the report of independent registered public accounting firm
thereon, as contained in the Trust&#8217;s Form&#160;N-CSR filed with the Securities and Exchange Commission on February&#160;10, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(2)&#160;Exhibits</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: left">&#160;</td>
    <td style="width: 0.25in; text-align: left">(a)</td>
    <td style="width: 0.3in; text-align: left">(i)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000134100411001114/ex3-1.htm">Second Amended and Restated Agreement and Declaration of Trust of Registrant(3)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(ii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99aii.htm">Amendment to the Second Amended and Restated Agreement and Declaration of Trust of Registrant(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(iii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000139834423014706/fp0084769-1_ex99252aiii.htm">Second Amendment to the Second Amended and Restated Agreement and Declaration of Trust of Registrant(5)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">(b)</td>
    <td style="width: 29px; text-align: left">(i)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99bi.htm">Amended and Restated By-Laws of Registrant(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(ii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99bii.htm">Amendment to the Amended and Restated By-Laws of Registrant(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(iii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000139834423014706/fp0084769-1_ex99252biii.htm">Second Amendment to the Amended and Restated By-Laws of Registrant(5)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(c)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(d)</td>
    <td style="text-align: justify">Form of Subscription Documents for Rights++</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(e)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407015549/h46856a2exv2wxey.htm">Dividend Reinvestment Plan of Registrant(1)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(f)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">(g)</td>
    <td style="width: 29px; text-align: left">(i)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407018774/h46856a3exv99wx2yxgy.htm">Investment Management Agreement between Registrant and Cushing&#174; Asset Management, LP (the &#8220;Investment Adviser&#8221;)(2)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(ii)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252gii.htm">Fee Waiver Agreement*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(h)</td>
    <td style="text-align: justify">Form of Underwriting/Sales/Dealer Manager Agreement++</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(i)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(j)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407018774/h46856a3exv99wx2yxjy.htm">Custody Agreement(2)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(k)(i)(1)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99ki1.htm">Transfer Agent Servicing Agreement(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: right">&#160;</td>
    <td style="width: 29px; text-align: left">(2)&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99ki2.htm">Amendment to Transfer Agent Servicing Agreement(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: center">&#160;</td>
    <td style="width: 29px; text-align: left">(ii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407018774/h46856a3exv99wx2yxkyx1y.htm">Fund Administration Agreement(2)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>


<!-- Field: Page; Sequence: 71; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: center">&#160;</td>
    <td style="width: 29px; text-align: left">(iii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407018774/h46856a3exv99wx2yxkyx3y.htm">Fund Accounting Servicing Agreement(2)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(l)</td>
    <td style="text-align: justify">Opinion and Consent of Skadden, Arps, Slate, Meagher &amp; Flom LLP+</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(m)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(n)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252n.htm">Consent of Independent Registered Public Accounting Firm*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(o)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(p)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000095013407018774/h46856a3exv99wx2yxpy.htm">Initial Stock Purchase Agreement(2)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(q)</td>
    <td style="text-align: justify">Not applicable</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(r)(i)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99ri.htm">Code of Ethics of the Registrant(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 24px; text-align: left">&#160;</td>
    <td style="width: 29px; text-align: left">(ii)</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1400897/000119312518187932/d594772dex99rii.htm">Code of Ethics of the Investment Adviser(4)</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(s)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252s.htm">Filing Fee Table*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(t)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252t.htm">Power of Attorney*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: left">(z)(i)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zi.htm">Form of Prospectus Supplement for Common Share Offering*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 53px; text-align: center">(ii)</td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zii.htm">Form of Prospectus Supplement for Rights Offering*</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">+</td><td style="text-align: justify">To be filed by pre-effective amendment.</td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">++</td><td style="text-align: justify">To be filed by post-effective amendment.</td>
</tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">(1)</td><td style="text-align: justify">Incorporated by reference to the Registrant&#8217;s Registration
Statement on Form&#160;N-2 under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended (Securities
Act File No.&#160;333- 143305 and Investment Company Act File No.&#160;811-22072), on Form&#160;N-2, filed on July&#160;20, 2007.</td>
</tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">(2)</td><td style="text-align: justify">Incorporated by reference to the Registrant&#8217;s Registration
Statement on Form&#160;N-2 under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended (Securities
Act File No.&#160;333- 143305 and Investment Company Act File No.&#160;811-22072), on Form&#160;N-2, filed on August&#160;23, 2007.</td>
</tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: left">(3)</td>
    <td style="text-align: justify">Incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Form&#160;8-K filed on May&#160;16, 2011.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: left">(4)</td>
    <td style="text-align: justify">Incorporated by reference to the Registrant&#8217;s Registration Statement on Form&#160;N-2 under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended (Securities Act File No.&#160;333- 225523 and Investment Company Act File No.&#160;811-22072), on Form&#160;N-2, filed on June&#160;8, 2018.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: left">(5)</td>
    <td style="text-align: justify">Incorporated by reference to the Registrant&#8217;s Registration Statement on Form&#160;N-2 under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended (Securities Act File No.&#160;333-273954 and Investment Company Act File No.&#160;811-22072), filed on August&#160;11, 2023.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 27px; text-align: left">(6)</td>
    <td style="text-align: justify">Incorporated by reference to Pre-Effective Amendment No.&#160;2 to the Registrant&#8217;s Registration Statement on Form&#160;N-2 under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended (Securities Act File No.&#160;333-273954 and Investment Company Act File No.&#160;811-22072), filed on October&#160;26, 2023.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;26. Marketing Arrangements</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The information contained under
the heading &#8220;Plan of Distribution&#8221; in this Registration Statement is incorporated herein by reference and any information
concerning any underwriters for a particular offering will be contained in the Prospectus Supplement related to that offering.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;27. Other Expenses of Issuance and Distribution</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following table sets forth
the estimated expenses to be incurred in connection with the offering described in this Registration Statement:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 85%; text-align: justify">SEC Fees</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 12%; text-align: right">10,000</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; text-align: justify">FINRA Fees</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">15,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="vertical-align: bottom; text-align: justify">Printing and Mailing Expenses</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">10,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; text-align: justify">Legal Fees</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">150,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="vertical-align: bottom; text-align: justify">Exchange Listing Fees</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">5,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; text-align: justify">Audit Fees</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">30,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: Gainsboro">
    <td style="vertical-align: bottom; text-align: justify">Miscellaneous Expenses</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">250,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-left: 10pt; text-align: justify">Total</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;&#160;&#160;&#160;470,000</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;28. Persons Controlled by or Under Common
Control with Registrant</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">None</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;29. Number of Holders of Securities</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 84%; text-align: left"><b>Title Class</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><b>Number of</b><br/>
<b>Record</b><br/>
<b>Shareholders</b><br/>
<b>as of</b><br/>
<b>March 17 , 2025</b></td></tr>
  <tr style="background-color: Gainsboro">
    <td style="vertical-align: bottom; text-align: left">Common shares of beneficial interest, par value $0.001 per share</td>
    <td style="vertical-align: top; text-align: center">4,311,003</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;30. Indemnification</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Article&#160;IV of the Registrant&#8217;s
Second Amended and Restated Agreement and Declaration of Trust provides as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;2. <span style="text-decoration: underline">Limitation
of Liability</span>. All persons contracting with or having any claim against the Trust or a particular Series shall look only to the assets
of the Trust or, as applicable, all Series or such particular Series for payment under such contract or claim; and neither the Trustees
nor, when acting in such capacity, any of the Trust&#8217;s officers, employees or agents, whether past, present or future, shall be personally
liable therefor. Every written instrument or obligation on behalf of the Trust or any Series shall contain a statement to the foregoing
effect, but the absence of such statement shall not operate to make any Trustee or officer of the Trust liable thereunder. Provided they
have exercised reasonable care and have acted under the reasonable belief that their actions are in the best interest of the Trust, the
Trustees and officers of the Trust shall not be responsible or liable for any act or omission or for neglect or wrongdoing of them or
any officer, agent, employee, investment adviser or independent contractor of the Trust, but nothing contained in this Declaration or
in the Delaware Act shall protect any Trustee or officer of the Trust against liability to the Trust or to Shareholders to which he would
otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the
conduct of his office.</p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;3. <span style="text-decoration: underline">Indemnification</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(a)&#160;Subject to the exceptions
and limitations contained in subsection&#160;(b) below:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(i)&#160;every person who is,
or has been, a Trustee or an officer, employee or agent of the Trust (including any individual who serves at its request as director,
officer, partner, employee, trustee, agent or the like of another organization in which it has any interest as a shareholder, creditor
or otherwise) (&#8220;Covered Person&#8221;) shall be indemnified by the Trust or the appropriate Series to the fullest extent permitted
by law against liability and against all expenses reasonably incurred or paid by him in connection with any claim, action, suit or proceeding
in which he becomes involved as a party or otherwise by virtue of his being or having been a Covered Person and against amounts paid or
incurred by him in the settlement thereof; and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(ii)&#160;as used herein, the
words &#8220;claim,&#8221; &#8220;action,&#8221; &#8220;suit,&#8221; or &#8220;proceeding&#8221; shall apply to all claims, actions, suits
or proceedings (civil, criminal, administrative, investigative, arbitration or other, including appeals), actual or threatened, and the
words &#8220;liability&#8221; and &#8220;expenses&#8221; shall include, without limitation, attorneys&#8217; fees, costs, judgments, amounts
paid in settlement, fines, penalties and other liabilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(b) No indemnification shall
be provided hereunder to a Covered Person:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(i)&#160;who shall have been
adjudicated by a court or body before which the proceeding was brought (A) to be liable to the Trust or its Shareholders by reason of
willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office, or (B) not
to have acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Trust;
or&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(ii)&#160;in the event of a settlement,
unless there has been a determination that such Covered Person did not engage in willful misfeasance, bad faith, gross negligence or reckless
disregard of the duties involved in the conduct of his office; (A) by the court or other body approving the settlement; (B) by at least
a majority of those Trustees who are neither Interested Persons of the Trust nor are parties to the matter based upon a review of readily
available facts (as opposed to a full trial-type inquiry); (C) by written opinion of independent legal counsel based upon a review of
readily available facts (as opposed to a full trial-type inquiry) or (D) by a vote of a majority of the Outstanding Shares entitled to
vote (excluding any Outstanding Shares owned of record or beneficially by such individual).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(c) The rights of indemnification
herein provided may be insured against by policies maintained by the Trust, shall be severable, shall not be exclusive of or affect any
other rights to which any Covered Person may now or hereafter be entitled, and shall inure to the benefit of the heirs, executors and
administrators of a Covered Person.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(d)&#160;To the maximum extent
permitted by applicable law, expenses in connection with the preparation and presentation of a defense to any claim, action, suit or proceeding
of the character described in subsection&#160;(a) of this Section may be paid by the Trust or applicable Series from time to time prior
to final disposition thereof upon receipt of an undertaking by or on behalf of such Covered Person that such amount will be paid over
by him to the Trust or applicable Series if it is ultimately determined that he is not entitled to indemnification under this Section;
provided, however, that either (i) such Covered Person shall have provided appropriate security for such undertaking, (ii) the Trust is
insured against losses arising out of any such advance payments or (iii) either a majority of a quorum of the Trustees who are neither
Interested Persons of the Trust nor parties to the matter, or independent legal counsel in a written opinion, shall have determined, based
upon a review of readily available facts (as opposed to a full trial-type inquiry) that there is reason to believe that such Covered Person
will not be disqualified from indemnification under this Section. Independent counsel retained for the purpose of rendering an opinion
regarding advancement of expenses and/or a majority of a quorum of the Trustees who are neither Interested Persons of the Trust nor parties
to the matter, may proceed under a rebuttable presumption that the Covered Person has not engaged in willful misfeasance, bad faith, gross
negligence or reckless disregard of the Covered Person&#8217;s duties to the Trust and were based on the Covered Person&#8217;s determination
that those actions were in the best interests of the Trust and its Shareholders; provided that the Covered Person is not an Interested
Person (or is an Interested Person solely by reason of being an officer of the Trust).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(e)&#160;Any repeal or modification
of this Article&#160;IV by the Shareholders, or adoption or modification of any other provision of the Declaration or By-Laws inconsistent
with this Article, shall be prospective only, to the extent that such repeal, or modification would, if applied retrospectively, adversely
affect any limitation on the liability of any Covered Person or indemnification available to any Covered Person with respect to any act
or omission which occurred prior to such repeal, modification or adoption. Any such repeal or modification by the Shareholders shall require
a vote of at least two-thirds of the Outstanding Shares entitled to vote and present in person or by proxy at any meeting of the Shareholders.</p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;4. <span style="text-decoration: underline">Indemnification
of Shareholders</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(a)&#160;If any Shareholder or
former Shareholder of the Trust (as opposed to a Shareholder or former Shareholder of any Series) shall be held personally liable solely
by reason of his being or having been a Shareholder and not because of his acts or omissions or for some other reason, the Shareholder
or former Shareholder (or his heirs, executors, administrators or other legal representatives or in the case of any entity, its general
successor) shall be entitled out of the assets belonging to the Trust to be held harmless from and indemnified against all loss and expense
arising from such liability. The Trust shall, upon request by such Shareholder, assume the defense of any claim made against such Shareholder
for any act or obligation of the Trust and satisfy any judgment thereon from the assets of the Series.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">(b)&#160;If any Shareholder or
former Shareholder of any Series shall be held personally liable solely by reason of his being or having been a Shareholder and not because
of his acts or omissions or for some other reason, the Shareholder or former Shareholder (or his heirs, executors, administrators or other
legal representatives or in the case of any entity, its general successor) shall be entitled out of the assets belonging to the applicable
Series to be held harmless from and indemnified against all loss and expense arising from such liability. The Trust, on behalf of the
affected Series, shall, upon request by such Shareholder, assume the defense of any claim made against such Shareholder for any act or
obligation of the Series and satisfy any judgment thereon from the assets of the Series.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;5. <span style="text-decoration: underline">No Bond Required
of Trustees</span>. No Trustee shall be obligated to give any bond or other security for the performance of any of his duties hereunder.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;6. <span style="text-decoration: underline">No Duty of
Investigation; Notice in Trust Instruments, Etc.</span> No purchaser, lender, transfer agent or other Person dealing with the Trustees or
any officer, employee or agent of the Trust or a Series thereof shall be bound to make any inquiry concerning the validity of any transaction
purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid,
loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, instrument,
certificate, Share, other security of the Trust or a Series thereof or undertaking, and every other act or thing whatsoever executed in
connection with the Trust shall be conclusively presumed to have been executed or done by the executors thereof only in their capacity
as Trustees under this Declaration or in their capacity as officers, employees or agents of the Trust or a Series thereof. Every written
obligation, contract, instrument, certificate, Share, other security of the Trust or a Series thereof or undertaking made or issued by
the Trustees may recite that the same is executed or made by them not individually, but as Trustees under the Declaration, and that the
obligations of the Trust or a Series thereof under any such instrument are not binding upon any of the Trustees or Shareholders individually,
but bind only the Trust Property or the Trust Property of the applicable Series, and may contain any further recital which they may deem
appropriate, but the omission of such recital shall not operate to bind the Trustees individually. The Trustees may maintain insurance
for the protection of the Trust Property or the Trust Property of the applicable Series, its Shareholders, Trustees, officers, employees
and agents in such amount as the Trustees shall deem adequate to cover possible tort liability, and such other insurance as the Trustees
in their sole judgment shall deem advisable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;7. <span style="text-decoration: underline">Reliance on
Experts, Etc.</span> Each Trustee, officer or employee of the Trust or a Series thereof shall, in the performance of his duties, powers and
discretions hereunder be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance
in good faith upon the books of account or other records of the Trust or a Series thereof, upon an opinion of counsel, or upon reports
made to the Trust or a Series thereof by any of its officers or employees or by the Investment Adviser, the Administrator, the Distributor,
the Principal Underwriter, Transfer Agent, selected dealers, accountants, appraisers or other experts or consultants selected with reasonable
care by the Trustees, officers or employees of the Trust, regardless of whether such counsel or expert may also be a Trustee.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Section&#160;18 of the Investment
Management Agreement between Registrant and Cushing<sup>&#174;</sup> Asset Management, LP provides as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">18. <span style="text-decoration: underline">Limitation of
Liability of the Fund and the Shareholders</span>. None of the Trustees, officers, agents or shareholders of the Fund will be personally
liable under this Agreement. The name &#8220;The Cushing&#174; MLP &amp; Infrastructure Total Return Fund&#8221; is the designation of
the Fund for the time being under the Amended and Restated Agreement and Declaration of Trust and all persons dealing with the Fund must
look solely to the property of the Fund for the enforcement of any claims against the Fund, as none of the Trustees, officers, agents
or shareholders assume any personal liability for obligations entered into on behalf of the Fund.</p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification for
liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant
to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;31. Business and Other Connections of the
Advisor</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Investment Adviser is not
engaged in any other business, profession, vocation or employment of a substantial nature. A description of any other business, profession,
vocation or employment of a substantial nature in which each limited partner or executive officer of the Investment Adviser is or has
been during the past two fiscal years engaged in for his or her own account or in his or her capacity as trustee, officer, or portfolio
manager of the Fund, is set forth in Part&#160;A and Part&#160;B of this Registration Statement in the sections entitled &#8220;Management
of the Fund&#8221; or in the Investment Adviser&#8217;s Form ADV, as filed with the SEC (SEC File No.&#160;801-63255), and which Form
ADV is incorporated herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;32. Location of Accounts and Records</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The accounts, books or other
documents required to be maintained by Section&#160;31(a) of the 1940 Act, and the rules promulgated under the 1940 Act, are kept by the
Registrant or its custodian, transfer agent, administrator and fund accountant. The Registrant is located at the following address: NXG
Cushing<sup>&#174;</sup> Midstream Energy Fund, One Energy Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206. The Fund&#8217;s
custodian is located at the following address: U.S. Bank National Association, 1555 N.&#160;River Center Drive, Suite 302, Milwaukee,
Wisconsin 53212. The Fund&#8217;s transfer agent, registrar and administrator is located at the following address: U.S. Bancorp Global
Fund Services, 615 East Michigan Street, Milwaukee, Wisconsin 53202.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;33. Management Services</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Not applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Item&#160;34. Undertakings</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">1.&#160;&#160;&#160;Not applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">2.&#160;&#160;&#160;Not applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">3.&#160;&#160;&#160;Registrant
undertakes:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">(a)</td>
    <td style="text-align: left">to file, during any period in which offers or sales are being made, a post-effective amendment to the registration statement:</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(1) &#160;&#160;&#160;&#160;&#160;to include
any prospectus required by Section&#160;10(a)(3) of the Securities Act;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(2) &#160;&#160;&#160;&#160;&#160;to reflect
in the prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume
and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee
Tables&#8221; table in the effective registration statement; and&#160;</p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(3) &#160;&#160;&#160;&#160;&#160;to include
any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material
change to such information in the registration statement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">Provided, however, that paragraphs a(1), a(2),
and a(3) of this section do not apply if the registration statement is filed pursuant to General Instruction A.2 of this Form and the
information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished
to the Commission by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference
into the registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration
statement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">(b)</td>
    <td style="text-align: left">that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of those securities at that time shall be deemed to be the initial bona fide offering thereof;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">(c)</td>
    <td style="text-align: left">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">(d)</td>
    <td style="text-align: left">that, for the purpose of determining liability under the Securities Act to any purchaser:</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;if
the Registrant is relying on Rule&#160;430B</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left; text-indent: 0.5in">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus filed by the Registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the
date the filed prospectus was deemed part of and included in the registration statement; and&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left; text-indent: 0.5in">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on
Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (x), or (xi) for the purpose of providing the information
required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the
earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities
in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is
at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities
in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date; or</p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;If
the Registrant is subject to Rule&#160;430C: Each prospectus filed pursuant to Rule&#160;424(b) under the Securities Act as part of a
registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses
filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first
used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">(e)</td>
    <td style="text-align: left">that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities:</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">The undersigned Registrant undertakes that
in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
the purchaser:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(1) &#160;&#160;&#160;&#160;&#160;&#160;&#160;any
preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule&#160;424
under the Securities Act;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(2) &#160;&#160;&#160;&#160;&#160;&#160;&#160;free
writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned
Registrants;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(3) &#160;&#160;&#160;&#160;&#160;&#160;&#160;the
portion of any other free writing prospectus or advertisement pursuant to Rule&#160;482 under the Securities Act relating to the offering
containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant;
and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">(4) &#160;&#160;&#160;&#160;&#160;&#160;&#160;any
other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">4.</td>
    <td style="text-align: left">Registrant undertakes that, for the purpose of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of the Registration Statement in reliance upon Rule&#160;430A and contained in the form of prospectus filed by the Registrant pursuant to Rule&#160;424(b)(1) under the Securities Act of 1933 shall be deemed to be a part of the Registration Statement as of the time it was declared effective.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">Registrant undertakes that, for the purpose of
determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be
deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time
will be deemed to be the initial bona fide offering thereof.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">5.</td>
    <td style="text-align: left">Registrant undertakes that, for the purpose of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">6.</td>
    <td style="text-align: left">Not applicable.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left"></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: left">&#160;</td>
    <td style="width: 48px; text-align: left">7.</td>
    <td style="text-align: left">Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any Statement of Additional Information constituting Part&#160;B of this Registration Statement.</td></tr>
  </table>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As required by the Securities
Act of 1933, as amended, and the Investment Company Act of 1940, as amended, this Registrant&#8217;s Registration Statement has been
signed on behalf of the Registrant, in the City of Dallas, State of Texas, on the 10th day of April, 2025</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td colspan="3" style="text-align: left">NXG CUSHING&#174; MIDSTREAM ENERGY FUND</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">By:&#160;&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">/s/ John Musgrave</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%; text-align: left">&#160;</td>
    <td style="width: 3%; text-align: left">&#160;</td>
    <td style="width: 3%; text-align: left">Name:&#160;&#160;</td>
    <td style="width: 34%; text-align: left">John Musgrave</td>
    <td style="width: 10%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">Title:</td>
    <td style="text-align: left">Trustee, Chief Executive Officer and President</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As required by the Securities
Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities set forth below
on the 10th day of April, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Principal Executive Officer</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%">/s/ John Musgrave</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">John Musgrave</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Trustee, Chief Executive Officer and President</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Principal Financial Officer</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%">/s/ Blake Nelson</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Blake Nelson</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Chief Financial Officer and Treasurer</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Trustees</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: left">*</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Brian R. Bruce</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Trustee</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: left">*</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">John H. Alban</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Trustee</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: left">*</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Andrea N. Mullins</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">Trustee</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; text-align: left">*</td>
    <td style="width: 96%; text-align: justify">Signed by Blake Nelson, an attorney-in-fact, pursuant to a power of attorney filed herewith.</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">By:</td>
    <td style="border-bottom: black 1pt solid; width: 30%">/s/ Blake Nelson</td>
    <td style="width: 65%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Blake Nelson</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Attorney-In-Fact</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">April 10, 2025</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="width: 8%; text-align: justify"><a href="fp0092922-1_ex99252gii.htm">(g)(ii)</a></td>
    <td style="width: 92%; text-align: justify"><a href="fp0092922-1_ex99252gii.htm">Fee Waiver Agreement</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="fp0092922-1_ex99252n.htm">(n)</a></td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252n.htm">Consent of Independent Registered Public Accounting Firm</a></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-align: justify"><a href="fp0092922-1_ex99252s.htm">(s)</a></td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252s.htm">Filing Fee Table</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="fp0092922-1_ex99252t.htm">(t)</a></td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252t.htm">Power of Attorney</a></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zi.htm">(z)(i)</a></td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zi.htm">Form of Prospectus Supplement for Common Share Offering</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zii.htm">(z)(ii)</a></td>
    <td style="text-align: justify"><a href="fp0092922-1_ex99252zii.htm">Form of Prospectus Supplement for Rights Offering</a></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"></p>


<!-- Field: Page; Sequence: 81; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 9pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kN1qAjEQhZ/Adxj2WjQb9Gbv7GKlVFtZpRSKF3F3Vgd3M5LEv0fqWzZuqNvSGgIhnDnfOUwUdaMJP1KFBt4fsikssd5XyiFkWKJBnaOfSJ+eE/Bvhhuyzijtmu+3MWXvQe8Z9uRw7YVm9EgWiwTEoC9kXw4hjpOBhPks6lz1lHVJBWpHqgKlC5gb3htCp8wlEJbqzJrrSxP1hsYS6wTingjyJ0gRS3jhozqx2VmYTtOo021OJ5oYPuz91PjsUF+dMK6w9nE2uNvbtMkP1nGdLFATmwXmB0PuMsN6jcarsZAyFiNx15eR3dmRtZyTX11xIrd9Lf36SG8sl6OiIOcrqMovqma92CqD9kYXv+gNCloWXGFwowGX0PIgACEQ4SMwV/80bD1NAJcZbbbuXokfCaGPTw2GPxlfUcKxtg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>fp0092922-1_ex99252gii.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Investment Management<br />
</b>4925 Greenville Avenue<br />
Suite 1310<br />
Dallas, Texas 75206</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">NXG Cushing<sup>&reg;</sup> Midstream Energy Fund</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">4925 Greenville Avenue</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Dallas, Texas 75206</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">This letter agreement (the &quot;<u>Agreement</u>&quot;)
confirms the temporary fee waiver by NXG Investment Management (Cushing MLP Asset Management, LP) (the &quot;<u>Adviser</u>&quot;) with
respect to the management fee payable in connection with the management of NXG Cushing<sup>&reg;</sup> Midstream Energy Fund (the &quot;<u>Fund</u>&quot;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">The Fund and the Adviser have entered into
an Investment Management Agreement, dated as of August 6, 2007 (the &quot;<u>Management Agreement</u>&quot;). Pursuant to the Management
Agreement, the Fund pays to the Adviser a monthly fee (the &quot;<u>Management Fee</u>&quot;) at an annual rate equal to 1.25% of the
Fund&rsquo;s Managed Assets (as defined in the Management Agreement).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<u>Fee
Waiver</u>. The Adviser has agreed to waive a portion of the Management Fee equal to 0.25% of the Fund&rsquo;s Managed Assets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2. <u>Effective
Date</u>. The fee waiver is effective as of February 1, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2in 0 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<u>Recoupment</u>.
Amounts waived by the Adviser are not subject to recoupment from the Fund in future years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2in 0 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2in 0 0; text-indent: 0.5in">4.&nbsp;<u>Term
and Termination</u>. This Agreement shall continue for a 12-month term. This Agreement will terminate automatically in the event of the
termination of the Management Agreement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.2in 0 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">5.&nbsp;<u>Governing
Law</u>. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware for contracts to be performed
entirely therein without reference to choice of law principles thereof and in accordance with the applicable provisions of the 1940 Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.05in 0 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%"><font style="font-size: 11pt"></font></td>
    <td style="width: 35%"><font style="font-size: 11pt">Very truly yours,</font></td>
    <td style="width: 15%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 1in">&nbsp;</td>
    <td><font style="font-size: 11pt; text-transform: uppercase">Cushing MLP Asset Management, LP</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 1in">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ Blake Nelson</font></td>
    <td><font style="font-size: 11pt">&nbsp;</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 1in">&nbsp;</td>
    <td><font style="font-size: 11pt">Name: Blake Nelson</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 1in">&nbsp;</td>
    <td><font style="font-size: 11pt">Title: Chief Financial Officer</font></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">Accepted and Agreed:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">NXG CUSHING<sup>&reg;</sup> MIDSTREAM ENERGY
FUND</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><font style="font-size: 11pt">By:</font></td>
    <td style="border-bottom: Black 1pt solid; width: 35%"><font style="font-size: 11pt">/s/ Blake Nelson</font></td>
    <td style="width: 60%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Name: Blake Nelson</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Title: Chief Financial Officer and Treasurer</font></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>3
<FILENAME>fp0092922-1_ex99252n.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consent of Independent Registered Public Accounting
Firm</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We consent to references to our firm under captions
&ldquo;Financial Highlights&rdquo;, &ldquo;Senior Securities&rdquo;, and &ldquo;Independent Registered Public Accounting Firm&rdquo; in
the Prospectus and &ldquo;Financial Statements&rdquo; and &ldquo;Independent Registered Public Accounting Firm&rdquo; in the Statement
of Additional Information each dated April 10, 2025 and each included in the Registration Statement (Form N-2, File No. 333-273954) of
NXG Cushing Midstream Energy Fund (the &ldquo;Registration Statement&rdquo;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also consent to the incorporation by reference
of our report dated January 29, 2025, with respect to the financial statements and financial highlights of NXG Cushing Midstream Energy
Fund included in the Annual Report (Form N-CSR) for the year ended November 30, 2024, into this Registration Statement, filed with the
Securities and Exchange Commission.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">/s/ Ernst &amp; Young LLP</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#9; &#9;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Dallas, Texas</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">April 10, 2025</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>fp0092922-1_ex99252s.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Exhibit (s) </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Calculation of Filing Fee Tables </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM N-2 </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Form Type)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Cushing Midstream Energy Fund</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><u>Table 1: Newly Registered and Carry Forward Securities
</u></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-top: Black 1pt solid; vertical-align: top; width: 8%; padding-left: 8pt; text-align: center; text-indent: -8pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Security<br />
Type</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><font style="font-size: 11pt"><b>Security<br />
Class<br />
Title</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Fee<br />
Calculation<br />
or Carry<br />
Forward<br />
Rule</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 6%; text-align: center"><font style="font-size: 11pt"><b>Amount<br />
Registered</b></font></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Proposed<br />
Maximum<br />
Offering<br />
Price Per<br />
Unit</b></font></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"><font style="font-size: 11pt"><b>Maximum<br />
Aggregate<br />
Offering Price</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><font style="font-size: 11pt"><b>Fee<br />
Rate</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><font style="font-size: 11pt"><b>Amount of<br />
Registration<br />
Fee</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Carry<br />
Forward<br />
Form<br />
Type</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Carry<br />
Forward<br />
File<br />
Number</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Carry<br />
Forward<br />
Initial<br />
effective<br />
date</b></font></td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; border-top: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-size: 11pt"><b>Filing Fee<br />
Previously<br />
Paid In<br />
Connection<br />
with<br />
Unsold<br />
Securities<br />
to be<br />
Carried<br />
Forward</b></font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="13" style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 8pt; text-align: center; text-indent: -8pt"><font style="font-size: 11pt">Newly Registered Securities</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 8pt; text-align: center; text-indent: -8pt"><font style="font-size: 11pt">Fees to be paid</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Equity</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Common Shares of Beneficial Interest</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Rule 457(o)</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">$500,000,000<sup>(1)</sup></font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">0.0001531</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">$ 76,550.00</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 8pt; text-align: center; text-indent: -8pt"><font style="font-size: 11pt">Fees to be paid</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Other</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Subscription Rights to Purchase Common Shares of Beneficial Interest</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">Rule 457(o)</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 8pt; text-align: center; text-indent: -8pt"><font style="font-size: 11pt">Fees Previously Paid</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>

<tr style="vertical-align: top; background-color: White">
    <td colspan="5" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><font style="font-size: 11pt">Total Offering Amounts</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">$ 500,000,000</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><font style="font-size: 11pt">$76,550.00</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td colspan="5" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><font style="font-size: 11pt">Total Fees Previously Paid</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="5" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><font style="font-size: 11pt">Total Fee Offsets</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt">N/A</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td colspan="5" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><font style="font-size: 11pt">Net Fee Due</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><font style="font-size: 11pt">$ 76,550.00</font></td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 11pt">(1)</font></td>
    <td><font style="font-size: 11pt">Estimated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, solely for the purpose of determining the registration fee.</font></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">&nbsp;</td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
<p style="margin: 0">&#160;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>5
<FILENAME>fp0092922-1_ex99252t.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG CUSHING MIDSTREAM ENERGY FUND</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>POWER OF ATTORNEY</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">That each of the undersigned officers
and trustees of NXG Cushing Midstream Energy Fund, a statutory trust formed under the laws of the State of Delaware (the &ldquo;Trust&rdquo;),
do constitute and appoint John Musgrave, Blake Nelson and Brad Mead as true and lawful attorneys and agents, with full power and authority
(acting alone and without the other) to execute in the name and on behalf of each of the undersigned as such officer or trustee, a Registration
Statement on Form N-2, including any pre-effective amendments and/or any post-effective amendments thereto, and any other filings in connection
therewith, and to file the same under the Securities Act of 1993, as amended, the Investment Company Act of 1940, as amended, or otherwise,
with respect to the registration and offering of the Trust&rsquo;s shares of beneficial interest, par value $0.001 per share; granting
to such attorney and agent full power of substitution and revocation in the premises; and ratifying and confirming all that such attorney
and agent may do or cause to be done by virtue of these presents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Power of Attorney may be
executed in multiple counterparts, each of which shall be deemed an original, but which taken together shall constitute one instrument.</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">&nbsp;</td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each of the
undersigned has executed this Power of Attorney as of this 23<sup>rd</sup> day of January, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 40%; border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ John Musgrave</font></td>
    <td style="width: 10%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">John Musgrave</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Trustee, Chief Executive Officer and President</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ Blake Nelson</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Blake Nelson</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Chief Financial Officer and Treasurer</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ John Alban</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">John H. Alban</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Trustee</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ Brian R. Bruce</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Brian R. Bruce</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Trustee</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><font style="font-size: 11pt">/s/ Andrea N. Mullins</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>Andrea N. Mullins</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 11pt">Trustee</font></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>
<p style="margin: 0">&#160;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>6
<FILENAME>fp0092922-1_ex99252zi.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="color: Red"><b>The information in this Prospectus Supplement
is not complete and may be changed. A Registration Statement relating to these securities has been filed with and declared effective
by the Securities and Exchange Commission. This Prospectus Supplement and the accompanying Prospectus is not an offer to sell these securities
and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="color: Red"><b>&nbsp;</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Red"><b>Subject to Completion,
dated [&#9679;]</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>FORM OF PRELIMINARY PROSPECTUS SUPPLEMENT TO BE USED IN CONNECTION WITH
OFFERINGS OF COMMON SHARES<font style="font-family: Times New Roman, Times, Serif"><sup>1</sup></font><br />
(to Prospectus dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025)</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-indent: 3.5in"><b>Shares</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Cushing<sup>&reg;</sup> Midstream Energy Fund</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Common Shares</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
Share</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Objective</i>. NXG Cushing<sup>&reg;</sup>
Midstream Energy Fund (the &ldquo;Fund&rdquo;) is a non-diversified, closed-end management investment company. The Fund&rsquo;s investment
objective is to obtain a high after-tax total return from a combination of capital appreciation and current income. There can be no assurance
that the Fund will achieve its investment objective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Strategy.</i> The Fund seeks to achieve
its investment objective by investing, under normal conditions, at least 80% of its Managed Assets (as defined in the accompanying Prospectus)
in a portfolio of midstream energy investments (the &ldquo;80% policy&rdquo;). For purposes of the Fund&rsquo;s 80% policy, the Fund considers
midstream energy investments to be investments that offer economic exposure to securities of midstream energy companies, which are companies
that provide midstream energy services, including the gathering, transporting, processing, fractionation, storing, refining and distribution
of natural resources, such as natural gas, natural gas liquids, crude oil refined petroleum products, biofuels, carbon sequestration,
solar, and wind. The Fund considers a company to be a midstream energy company if at least 50% of its assets, income, sales or profits
are committed to or derived from midstream energy services.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has previously qualified, and intends to continue
to qualify, to be treated as a regulated investment company (&ldquo;RIC&rdquo;) under the Internal Revenue Code of 1986, as amended (the
&ldquo;Code&rdquo;). The Fund pursues its investment objective by generally investing in master limited partnerships (&ldquo;MLPs&rdquo;)
up to the maximum extent permitted of a RIC under the Code. Accordingly, the Fund will, as of the end of each fiscal quarter, invest no
more than 25% of Managed Assets in securities of MLPs and other entities that are &ldquo;qualified publicly traded partnerships&rdquo;
under the Code.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund invests in equity and debt securities of midstream
energy companies, and invests in U.S. and non-U.S. securities and in issuers of any market capitalization size.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><sup>1</sup></td><td><font style="font-size: 11pt">In addition to the sections outlined in this form of prospectus supplement, each prospectus supplement
actually used in connection with an offering conducted pursuant to the registration statement to which this form of prospectus supplement
is attached will be updated to include such other information as may then be required to be disclosed therein pursuant to applicable law
or regulation as in effect as of the date of each such prospectus supplement, including, without limitation, information particular to
the terms of each security offered thereby and any related risk factors or tax considerations pertaining thereto. This form of prospectus
supplement is intended only to provide a rough approximation of the nature and type of disclosure that may appear in any actual prospectus
supplement used for the purposes of offering securities pursuant to the registration statement to which this form of prospectus supplement
is attached, and is not intended to and does not contain all of the information that would appear in any such actual prospectus supplement,
and should not be used or relied upon in connection with any offer or sale of securities.</font></td></tr></table>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">&nbsp;</td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><i>(continued on inside front cover)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>Investing in the Fund&rsquo;s Common Shares involves
certain risks. See &ldquo;Risks&rdquo; on page &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the accompanying Prospectus.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>Neither the Securities and Exchange Commission nor
any state securities commission has approved or disapproved of these securities or determined if this Prospectus Supplement or the accompanying
Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 11pt"><b>Total<font style="font-family: Times New Roman, Times, Serif"><sup>(1)</sup></font></b></font></td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 70%">Public offering price</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Underwriting discount</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left"><font style="font-size: 11pt">Proceeds, before expenses, to the Fund<sup>(2)</sup></font></td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 20pt">(1)</td><td>[The Fund has granted the underwriters an option to purchase up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common
Shares at the public offering price, less the sales load, within&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;days
of the date of this prospectus solely to cover overallotments, if any. If such option is exercised in full, the public offering price,
sales load, estimated offering expenses and proceeds, before expenses, to the Fund will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
respectively. See &ldquo;Underwriting.&rdquo;]</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 20pt">(2)</td><td>[Offering expenses payable by the Fund will be deducted from the Proceeds, before expenses, to the Fund. Total offering expenses (other
than sales load) are estimated to be $&#9;, which will be paid by the Fund.]</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>(continued from front cover)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>Investment Strategy (continued)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As an alternative to holding investments directly,
the Fund may obtain investment exposure through derivatives transactions intended to replicate, modify or replace the economic attributes
associated with investment in securities in which the Fund is permitted to invest directly. To the extent that the Fund invests in synthetic
investments with economic characteristics similar to investments in midstream energy companies, the market value (or, if market value
is unavailable, the fair value) of such investments will be counted for purposes of the Fund&rsquo;s policy of investing at least 80%
of its Managed Assets in a portfolio of midstream energy investments. For a discussion of derivative instruments in which the Fund may
invest, see &ldquo;Investment Objective and Policies&mdash;Additional Investment Practices&mdash;Strategic Transactions.&rdquo;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund invests, without limitation, in debt securities
rated, at the time of investment, at least (i) B3 by Moody&rsquo;s Investors Service, Inc. (&ldquo;Moody&rsquo;s&rdquo;), (ii) B- by Standard
&amp; Poor&rsquo;s Ratings Services (&ldquo;S&amp;P&rdquo;) or Fitch Ratings (&ldquo;Fitch&rdquo;), or (iii) a comparable rating by another
rating agency, and invests no more than 5% of its Managed Assets in debt securities rated below B3 by Moody&rsquo;s, B- by S&amp;P or
Fitch or a comparable rating by another rating agency. Therefore, the Fund may invest in below investment grade debt securities. A debt
security is considered below investment grade if it is rated below Baa3- by Moody&rsquo;s or below BBB- by S&amp;P or Fitch or a comparable
rating by another rating agency. Below investment grade debt securities are often referred to as &ldquo;high yield&rdquo; securities or
&ldquo;junk bonds.&rdquo; Below investment grade debt securities are regarded as having predominantly speculative characteristics with
respect to capacity to pay interest and to repay principal. Debt securities in which the Fund invests may be of any maturity.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>NYSE Listing.</i> The Fund&rsquo;s currently outstanding
Common Shares are, and the Common Shares offered by this Prospectus, will be, subject to notice of issuance, listed on the New York Stock
Exchange (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;SRV.&rdquo; As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the last reported sale price for the Fund&rsquo;s Common Shares on the NYSE was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per Common Share, and the net asset value of the Fund&rsquo;s Common Shares was $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per Common Share, representing a [discount/premium] to net asset value of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Prospectus Supplement, together with the accompanying
Prospectus, dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025, sets forth concisely the information
that you should know before investing in the Fund&rsquo;s Common Shares. You should read this Prospectus Supplement and the accompanying
Prospectus, which contains important information about the Fund before deciding whether to invest, and retain it for future reference.
A Statement of Additional Information, dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025, containing additional information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into
the accompanying Prospectus. You may request a free copy of the Statement of Additional Information, the table of contents of which is
on page&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the accompanying Prospectus, or request other information about the Fund (including
the Fund&rsquo;s annual and semi-annual reports) or make shareholder inquiries by calling (214) 629-6334 or by writing the Fund, or you
may obtain a copy (and other information regarding the Fund) from the SEC&rsquo;s website (www.sec.gov). Free copies of the Fund&rsquo;s
Prospectus, SAI, reports and any incorporated information will also be available from the Fund&rsquo;s website at www.nxgim.com.</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund&rsquo;s Common Shares do not represent a deposit
or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally insured
by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Capitalized terms used herein that are not otherwise
defined shall have the meanings assigned to them in the accompanying Prospectus.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The underwriters expect to deliver
the Common Shares to purchasers on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">This Prospectus Supplement is dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>TABLE OF CONTENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 95%">&nbsp;</td>
    <td style="width: 5%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>Page</b></font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt"><b>Prospectus Supplement</b></font></td>
    <td style="text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">PROSPECTUS SUPPLEMENT SUMMARY</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">SUMMARY OF FUND EXPENSES</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">CAPITALIZATION</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">USE OF PROCEEDS</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">RECENT DEVELOPMENTS</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">UNDERWRITERS</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">LEGAL MATTERS</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">ADDITIONAL INFORMATION</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt"><b>Prospectus</b></font></td>
    <td style="text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Prospectus Summary</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Summary of Fund Expenses</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Financial Highlights</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Senior Securities</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">The Fund</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Use of Proceeds</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Market and Net Asset Value Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Investment Objective and Policies</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">The Fund&rsquo;s Investments</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Use of Leverage</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Risks</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Management of the Fund</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Net Asset Value</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Distributions</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Dividend Reinvestment Plan</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Description of Shares</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Anti-Takeover Provisions in the Agreement and Declaration of Trust</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Certain Provisions of Delaware Law, the Agreement and Declaration of Trust and Bylaws</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Closed-End Fund Structure</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Repurchase of Common Shares</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">U.S. Federal Income Tax Considerations</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Plan of Distribution</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Other Service Providers</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Legal Matters</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Independent Registered Public Accounting Firm</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Additional Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Privacy Policy</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Table of Contents of the Statement of Additional Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORWARD-LOOKING STATEMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">This prospectus supplement contains or incorporates by reference forward-looking
statements, within the meaning of the federal securities laws, that involve risks and uncertainties. These statements describe the Fund&rsquo;s
plans, strategies, and goals and our beliefs and assumptions concerning future economic and other conditions and the outlook for the Fund,
based on currently available information. In this prospectus, words such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;expects,&rdquo;
&ldquo;objectives,&rdquo; &ldquo;goals,&rdquo; &ldquo;future,&rdquo; &ldquo;intends,&rdquo; &ldquo;seeks,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo;
&ldquo;could,&rdquo; &ldquo;should,&rdquo; and similar expressions are used in an effort to identify forward-looking statements, although
some forward-looking statements may be expressed differently. The Fund is not entitled to the safe harbor for forward-looking statements
pursuant to Section&nbsp;27A of the Securities Act of 1933, as amended.</p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS SUPPLEMENT SUMMARY</b></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>This is only a summary of information
    contained elsewhere in this Prospectus Supplement and the accompanying Prospectus. This summary does not contain all of the information
    that you should consider before investing in the Fund&rsquo;s Common Shares. You should carefully read the more detailed information contained
    in this Prospectus Supplement and the accompanying Prospectus and the Statement of Additional Information, dated</i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>,
    2025 (the &ldquo;SAI&rdquo;), especially the information set forth under the headings &ldquo;Investment Objective and Policies&rdquo;
    and &ldquo;Risks.&rdquo;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&nbsp;</i></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt; padding-right: 5.4pt; width: 35%; border-left: Black 1pt solid; padding-bottom: 6pt; text-indent: 0pt"><font style="font-size: 11pt"><b>The Fund</b></font></td>
    <td style="padding-right: 5.4pt; width: 65%; border-right: Black 1pt solid; padding-bottom: 6pt"><font style="font-size: 11pt">NXG Cushing<sup>&reg;</sup> Midstream Energy Fund (the &ldquo;Fund&rdquo;) is a non-diversified, closed-end management investment company registered under the 1940 Act that commenced investment operations on August&nbsp;27, 2007. The Fund&rsquo;s Investment Adviser is Cushing<sup>&reg;</sup> Asset Management, LP.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Investment Adviser</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt"><font style="font-size: 11pt">The Fund&rsquo;s investments are managed by its Investment Adviser, Cushing<sup>&reg;</sup> Asset Management, LP d/b/a NXG Investment Management, whose principal business address is One Energy Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206. The Investment Adviser is a wholly-owned investment advisory subsidiary of Swank Capital. The Investment Adviser was founded in 2003 and serves as investment adviser to registered and unregistered funds. As of December&nbsp;31, 2024, the Investment Adviser managed approximately $1.3 billion in assets.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Listing and Symbol</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt"><font style="font-size: 11pt">The Fund&rsquo;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus, will be, subject to notice of issuance, listed on the New York Stock Exchange (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;SRV.&rdquo; As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the last reported sale price for the Fund&rsquo;s Common Shares on the NYSE was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Common Share, and the net asset value of the Fund&rsquo;s Common Shares was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Common Share, representing a [premium/discount] to net asset value of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Distributions</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund intends to pay substantially all of its net investment income
    to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net long-term capital gains to Common
    Shareholders at least annually. The Fund expects that distributions paid on the Common Shares will consist primarily of (i) investment
    company taxable income, which includes, among other things, ordinary income, net short-term capital gain and income from certain hedging
    and interest rate transactions, (ii) net capital gain (which is the excess of net long-term capital gain over net short-term capital loss),
    and/or (iii) return of capital.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund&rsquo;s net investment income can vary significantly over time;
    however, the Fund seeks to maintain a more stable monthly distribution per share. The distributions paid by the Fund for any particular
    month may be more or less than the amount of net investment income for that monthly period.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">In any given year, there can be no guarantee the Fund&rsquo;s investment
    returns will exceed the amount of distributions. The Fund may distribute more than the entire amount of the net investment income earned
    in a particular period, in which case all or a portion of a distribution may be a return of capital. <b>The Fund&rsquo;s distributions
    have historically included, and may in the future include, a significant portion of return of capital. For the fiscal year ended November&nbsp;30,
    2024, the Fund&rsquo;s distributions were comprised of approximately 69% ordinary income, 31% long-term capital gains, and 0% return of
    capital. Accordingly, shareholders should not assume that the source of a distribution from the Fund is net income or profit, and the
    Fund&rsquo;s distributions should not be used as a measure of performance or confused with yield or income. </b>Return of capital is the
    return of a portion of the shareholder&rsquo;s original investment up to the amount of the Common Shareholder&rsquo;s tax basis in their
    Common Shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the Common
    Shareholder&rsquo;s potential gain, or reduce the Common Shareholder&rsquo;s potential loss, on any subsequent sale or other disposition
    of Common Shares.</p></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 35%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; width: 65%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Alternatively, the Fund may also distribute less than its net investment
    income in a particular period. The undistributed net investment income may be available to supplement future common share distributions.
    Undistributed net investment income is included in the Common Shares&rsquo; net asset value, and, correspondingly, distributions from
    net investment income will reduce the Common Shares&rsquo; net asset value.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">With each distribution that does not consist solely of net investment income,
    the Fund will issue a notice to shareholders that will provide estimated information regarding the amount and composition of the distribution.
    The amounts and sources of distributions reported in each notice will be estimated, are likely to change over time and are not provided
    for tax reporting purposes. The final determination of such amounts will be made and reported to shareholders after the end of the calendar
    year when the Fund determines its earnings and profits for the year. The actual amounts and sources of the amounts for accounting and
    tax reporting purposes will depend upon the Fund&rsquo;s investment experience during its full fiscal year and may be subject to changes
    based on tax regulations. The Fund will send each shareholder a Form&nbsp;1099-DIV for the calendar year that will tell shareholders how
    to report distributions for federal income tax purposes.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See &ldquo;Distributions&rdquo; in the accompanying Prospectus.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>The Offering</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>Common Shares Offered by the Fund</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&nbsp;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>Common Shares Outstanding after the Offering</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&nbsp;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The number of Common Shares offered and outstanding after the offering
    assumes the underwriters&rsquo; over-allotment option is not exercised. If the over-allotment option is exercised in full, the Fund will
    issue an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Shares and will have&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Shares outstanding after the Offering.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund&rsquo;s Common Shares have recently traded at a premium to net
    asset value (&ldquo;NAV&rdquo;) per share and the price of the Common Shares is expected to be above net asset value per share. Therefore,
    investors in this offering are likely to experience immediate dilution of their investment. Furthermore, shares of closed-end investment
    companies, such as the Fund, frequently trade at a price below their NAV. The Fund cannot predict whether its Common Shares will trade
    at a premium or a discount to NAV.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Risks</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">See &ldquo;Risks&rdquo; beginning on page &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the accompanying Prospectus for a discussion of factors you should consider carefully before deciding to invest in the Fund&rsquo;s Common Shares.</font></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="4" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 35%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Use of Proceeds</b></font></td>
    <td style="padding-right: 5.4pt; width: 65%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">The Fund intends to invest the net proceeds of the offering in accordance with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated that the Fund will be able to invest substantially all of the net proceeds of the offering in accordance with its investment objective and policies within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; months after the completion of the offering. Pending such investment, it is anticipated that the proceeds will be invested in cash, cash equivalents or other securities, including U.S. government securities or high quality, short-term debt securities. The Fund may also use the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses, although the Fund currently has no intent to issue Securities primarily for these purposes.</font></td></tr>
  </table>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SUMMARY OF FUND EXPENSES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following table contains information about the
costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (except as noted below) after giving effect to the anticipated net
proceeds of the Common Shares offered by this Prospectus Supplement and assuming the Fund incurs the estimated offering expenses. The
purpose of the table and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would
bear directly or indirectly.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 85%"><font style="font-size: 11pt"><b>Shareholder Transaction Expenses</b></font></td>
    <td style="width: 15%; text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Sales load (as a percentage of offering price)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Offering expenses borne by the Fund (as a percentage of offering price)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Dividend Reinvestment Plan fees (per transaction sales fee)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">15.00<sup>(1)</sup></font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 85%"><font style="font-size: 11pt"><b>Annual Expenses</b></font></td>
    <td style="width: 15%; border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><b>Percentage of Net Assets Attributable to Common Shares<sup>(2)</sup></b></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Management fees<sup>(3)(4)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Interest payments on borrowed funds<sup>(5)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Other expenses<sup>(6)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Total annual expenses</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(1)</sup></td><td>There will be no brokerage charges with respect to Common Shares issued directly by the Fund. However, each participant will pay a
pro rata share of brokerage commissions incurred in connection with open-market purchases. In addition, participants who request a sale
of shares through the Plan Agent are subject to a $15.00 per transaction sales fee and pay a brokerage commission of $0.12 per share sold.
The Fund&rsquo;s transfer agent serves as Plan Agent. Fees paid by the Fund to the transfer agent are included in &ldquo;Other expenses&rdquo;
below, which are ultimately borne by common shareholders. For additional information, see &ldquo;Distribution Reinvestment Plan&rdquo;
in the accompanying Prospectus.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(2)</sup></td><td>Based upon net assets attributable to common shares as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(3)</sup></td><td>The Fund pays the Investment Adviser an annual fee, payable monthly, in an amount equal to 1.25% of the Fund&rsquo;s average weekly
Managed Assets (net assets plus any assets attributable to Financial Leverage). The fee shown above is based upon outstanding Financial
Leverage of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Fund&rsquo;s Managed Assets (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s net assets attributable to common shares). If Financial Leverage of more than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s Managed Assets (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Fund&rsquo;s net
assets attributable to common shares) is used, the management fees, as a percentage of net assets attributable to common shares, would
be higher than as shown above.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(4)</sup></td><td>The Investment Adviser has contractually agreed to waive a portion of the management fee in an amount equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s Managed Assets through &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
The Fund&rsquo;s annual expenses after giving effect to such management fee waiver are:</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 85%; padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt"><b>Annual Expenses</b></font></td>
    <td style="width: 15%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>Percentage of Net Assets Attributable to Common Shares<sup>(2)</sup></b></font></td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-left: 20pt; text-indent: -0.1in"><font style="font-size: 11pt">Management fees<sup>(2)(3)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-indent: -0.1in"><font style="font-size: 11pt">Interest payments on borrowed funds<sup>(4)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-left: 20pt; text-indent: -0.1in"><font style="font-size: 11pt">Other expenses<sup>(5)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-indent: -0.1in"><font style="font-size: 11pt">Total annual expenses<sup>(3)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><sup>&nbsp;</sup></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(5)</sup></td><td>Based upon the Fund&rsquo;s outstanding borrowings as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million and the interest rate as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; %.</td></tr></table>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(6)</sup></td><td><sup>&ldquo;</sup>Other expenses&rdquo; are estimated based upon those incurred during the fiscal year ended &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
Other expenses do not include expense related to realized or unrealized investment gains or losses. See &ldquo;Management of the Fund&mdash;Fund
Expenses&rdquo; in the accompanying prospectus.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><sup>&nbsp;</sup></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Example</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following example illustrates the expenses that
you would pay on a $1,000 investment in Common Shares, assuming (1) &ldquo;Total annual expenses&rdquo; of &#9;% of net assets attributable
to Common Shares, (2) the sales load of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and estimated offering expenses
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and (3) a 5% annual return*:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%">&nbsp;</td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>1 Year</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>3 Years</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>5 Years</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>10 Years</b></font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 0.2in; text-indent: -0.2in"><font style="font-size: 11pt">Total Expenses Incurred</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><b>*</b></td><td><b>The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed. Moreover, the Fund&rsquo;s actual rate of return may be higher or lower than the hypothetical 5% return shown in the example.
</b>The example assumes that the estimated &ldquo;Other expenses&rdquo; set forth in the Annual Expenses table are accurate and that all
dividends and distributions are reinvested at net asset value.</td></tr></table>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>CAPITALIZATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">The following table sets forth the Fund&rsquo;s capitalization
at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">(i)</td><td style="text-align: justify">on a historical basis;</td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">(ii)</td><td>on an as adjusted basis to reflect the issuance of an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Common Shares pursuant to the Fund&rsquo;s Automatic Dividend Reinvestment Plan, and the application of the net proceeds from such issuances
of Common Shares; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">(iii)</td><td>on an as further adjusted basis to reflect the assumed sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of
Common Shares at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share in an offering under this Prospectus
Supplement and the accompanying Prospectus less the aggregate underwriting discount of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and estimated offering expenses payable by the Fund of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (assuming no
exercise of the underwriters&rsquo; over-allotment option).</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Actual</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As Adjusted (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As Further Adjusted (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Short-Term Debt:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 64%">Borrowings</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Common Shareholder&rsquo;s Equity:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Common Shares of beneficial interest, par value $0.01 per share; unlimited shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (actual), &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (as adjusted), and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (as further adjusted)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Net unrealized appreciation on investments, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated net realized gain on investments, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Accumulated net investment loss, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  </table>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>USE OF PROCEEDS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund estimates that the net proceeds to the Fund
from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million if the underwriters exercise their over-allotment option to purchase additional Common Shares in full), after deducting underwriting
discounts and commissions and estimated offering expenses borne by the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund intends to invest the net proceeds of the
offering in accordance with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated
that the Fund will be able to invest substantially all of the net proceeds of the offering in accordance with its investment objective
and policies within&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; months after the completion of the offering. Pending
such investment, it is anticipated that the proceeds will be invested in cash, cash equivalents or other securities, including U.S. government
securities or high quality, short-term debt securities. The Fund may also use the proceeds for working capital purposes, including the
payment of distributions, interest and operating expenses, although the Fund currently has no intent to issue Securities primarily for
these purposes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RECENT DEVELOPMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME, IF ANY]</p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNDERWRITERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME]</p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>LEGAL MATTERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Certain legal matters will be passed on by Skadden,
Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois, as special counsel to the Fund in connection with the offering of Common Shares.
Certain legal matters will be passed on by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, as special counsel to the underwriters in connection with the offering
of Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ADDITIONAL INFORMATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Prospectus Supplement and the accompanying Prospectus
constitute part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act. This Prospectus
Supplement and the accompanying Prospectus omit certain of the information contained in the Registration Statement, and reference is hereby
made to the Registration Statement and related exhibits for further information with respect to the Fund and the Common Shares offered
hereby. Any statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance,
reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each
such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment
of the fee prescribed by its rules and regulations or free of charge through the SEC&rsquo;s web site (http://www.sec.gov)</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="text-align: center; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;<img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><b>Shares</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Cushing<sup>&reg;</sup> Midstream Energy Fund</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Common Shares</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM OF</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;PROSPECTUS<br />
SUPPLEMENT</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->


<!-- Field: Page; Sequence: 14; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">&nbsp;</td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>7
<FILENAME>fp0092922-1_ex99252zii.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="color: Red"><b>The information in this Prospectus Supplement
is not complete and may be changed. A Registration Statement relating to these securities has been filed with and declared effective
by the Securities and Exchange Commission. This Prospectus Supplement and the accompanying Prospectus is not an offer to sell these securities
and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="color: Red"><b>&nbsp;</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Red"><b>Subject to Completion,
dated [&#9679;]</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>FORM OF PROSPECTUS SUPPLEMENT TO BE USED IN CONNECTION WITH RIGHTS OFFERINGS<font style="font-family: Times New Roman, Times, Serif"><sup>1</sup></font><br />
(to Prospectus dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025)</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 1.5in 0pt 0pt; text-align: right"><b>Common Shares</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Cushing<sup>&reg;</sup> Midstream Energy Fund</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Subscription Rights for Common Shares</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">NXG Cushing<sup>&reg;</sup> Midstream Energy Fund (the
&ldquo;Fund&rdquo;) is a non-diversified, closed-end management investment company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund is issuing [transferable/non-transferable]
rights (&ldquo;Rights&rdquo;) to its common shareholders of record (&ldquo;Record Date Shareholders&rdquo;) as of 5:00&nbsp;p.m., Eastern
time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(the &ldquo;Record Date&rdquo;), entitling
the holders of those Rights to subscribe for up to an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of the Fund&rsquo;s common shares of beneficial interest (the &ldquo;Offer&rdquo;). Record Date Shareholders will receive one Right for
each outstanding whole common share held on the Record Date. The Rights entitle their holders to purchase one new common share for every&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Rights held (1-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;). Any Record Date Shareholder
who is issued fewer than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rights may subscribe for
one full common share in the Offer. [In addition, Record Date Shareholders who fully exercise their Rights (other than those Rights that
cannot be exercised because they represent the right to acquire less than one common share) will be entitled to subscribe for additional
common shares of the Fund that remain unsubscribed as a result of any unexercised Rights. This over-subscription privilege is subject
to a number of limitations and subject to allotment.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The subscription price (the &ldquo;Subscription Price&rdquo;)
will be determined based upon a formula equal to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the &ldquo;Formula Price&rdquo;). The Offer will
expire at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
unless extended as described in this prospectus (the &ldquo;Expiration Date&rdquo;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Rights holders may not know the Subscription Price
at the time of exercise and will be required initially to pay for both the common shares subscribed for pursuant to the primary subscription
[and, if eligible, any additional common shares subscribed for pursuant to the over-subscription privilege] at the estimated Subscription
Price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per common share and, except in limited
circumstances, will not be able to rescind their subscription.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>Exercising your Rights and investing in the Fund&rsquo;s
common shares involves a high degree of risk. See &ldquo;Risks&rdquo; on page&#9;of the accompanying Prospectus.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>This offering will dilute the ownership interest
and voting power of the Common Shares owned by shareholders who do not fully exercise their Rights. Shareholders who do not fully exercise
their Rights should expect, upon completion of the offering, to own a smaller proportional interest in the Fund than before the offering.
Further, if the net proceeds per share from the offering are at a discount to the Fund&rsquo;s net asset value per share, this offering
will reduce the Fund&rsquo;s net asset value per share.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><sup>1</sup></td><td>This document is a form of prospectus supplement for an offering of common shares pursuant to subscription rights. In addition to
the sections outlined in this form of prospectus supplement, each prospectus supplement actually used in connection with an offering conducted
pursuant to the registration statement to which this form of prospectus supplement is attached will be updated to include such other information
as may then be required to be disclosed therein pursuant to applicable law or regulation as in effect as of the date of each such prospectus
supplement, including, without limitation, information particular to the terms of each security offered thereby and any related risk factors
or tax considerations pertaining thereto. This form of prospectus supplement is intended only to provide a rough approximation of the
nature and type of disclosure that may appear in any actual prospectus supplement used for the purposes of offering securities pursuant
to the registration statement to which this form of prospectus supplement is attached, and is not intended to and does not contain all
of the information that would appear in any such actual prospectus supplement, and should not be used or relied upon in connection with
any offer or sale of securities.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">&nbsp;</td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>Neither the Securities and Exchange Commission nor
any state securities commission has approved or disapproved of these securities or determined if this Prospectus Supplement or the accompanying
Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><i>(continued on following page)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><i>&nbsp;</i></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 11pt"><b>Total<sup>(1)</sup></b></font></td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 70%; text-align: left"><font style="font-size: 11pt">Estimated Subscription Price<sup>(2)</sup>&#9; </font></td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-size: 11pt">Estimated Sales Load<sup>(2)(3)</sup>&#9;</font></td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left"><font style="font-size: 11pt">Proceeds, before expenses, to the Fund<sup>(2)</sup>&#9;</font></td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><i>(notes on following page)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Common Shares are expected
to be delivered on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. If the offer is extended,
the Common Shares are expected to be delivered on or about &#9;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">This Prospectus Supplement is dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>(notes from previous page)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 40pt">(1)</td><td>Assumes that all Rights are exercised at the estimated Subscription Price. All of the Rights may not be exercised.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 40pt">(2)</td><td>Estimated on the basis of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 40pt">(3)</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
will act as dealer manager for the Offer (the &ldquo;Dealer Manager&rdquo;). The Fund has agreed to pay the Dealer Manager a fee for its
financial structuring and soliciting services equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Subscription Price per common share for each common share issued pursuant to the exercise of Rights, including the over-subscription
privilege. The Dealer Manager will reallow to broker-dealers in the selling group to be formed and managed by the Dealer Manager selling
fees equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Subscription Price per common
share for each common share issued pursuant to the exercise of Rights as a result of their selling efforts. In addition, the Dealer Manager
will reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of
Rights solicitation fees equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Subscription
Price per common share for each common share issued pursuant to the exercise of Rights as a result of their soliciting efforts, subject
to a maximum fee based on the number of common shares held by each broker-dealer through The Depository Trust Company (&ldquo;DTC&rdquo;)
on the Record Date. The fees and expenses of the Offer, including the Dealer Manager fee, will be borne by the Fund and indirectly by
all of its common shareholders, including those who do not exercise their Rights.]</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 40pt">(4)</td><td>Offering expenses borne by the Fund are estimated to be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>(continued from previous page)</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">NAV dilution resulting from the Offer is not currently
determinable because it is not known how many common shares will be subscribed for, what the net asset value or market price of the common
shares will be on the Expiration Date or what the Subscription Price will be. Any such dilution will disproportionately affect non-exercising
common shareholders. If the Subscription Price is substantially less than the then current net asset value, this dilution could be substantial.
However, assuming all of the common shares are sold at the estimated Subscription Price, the Fund&rsquo;s current net asset value per
common share would be reduced by approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; %. [The distribution to common shareholders of
transferable Rights, which themselves have intrinsic value, will afford non-participating Record Date Shareholders the potential of receiving
cash payment upon the sale of the Rights, receipt of which may be viewed as partial compensation for any dilution of their interests that
may occur as a result of the Offer. There can be no assurance that a market for the Rights will develop or, if such a market develops,
what the price of the Rights will be.] See &ldquo;Risks Related to the Offer&rdquo; in this prospectus supplement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Objective</i>. NXG Cushing<sup>&reg;</sup>
Midstream Energy Fund (the &ldquo;Fund&rdquo;) is a non-diversified, closed-end management investment company. The Fund&rsquo;s investment
objective is to obtain a high after-tax total return from a combination of capital appreciation and current income. There can be no assurance
that the Fund will achieve its investment objective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Strategy.</i> The Fund seeks to achieve
its investment objective by investing, under normal conditions, at least 80% of its Managed Assets (as defined in the accompanying Prospectus)
in a portfolio of midstream energy investments (the &ldquo;80% policy&rdquo;). For purposes of the Fund&rsquo;s 80% policy, the Fund considers
midstream energy investments to be investments that offer economic exposure to securities of midstream energy companies, which are companies
that engage provide midstream energy services, including the gathering, transporting, processing, fractionation, storing, refining and
distribution of natural resources, such as natural gas, natural gas liquids, crude oil refined petroleum products, biofuels, carbon sequestration,
solar, and wind. The Fund considers a company to be a midstream energy company if at least 50% of its assets, income, sales or profits
are committed to or derived from midstream energy services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund invests in equity and debt securities of midstream
energy companies, and invests in U.S. and non-U.S. securities and in issuers of any market capitalization size.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As an alternative to holding investments directly,
the Fund may obtain investment exposure through derivatives transactions intended to replicate, modify or replace the economic attributes
associated with investment in securities in which the Fund is permitted to invest directly. To the extent that the Fund invests in synthetic
investments with economic characteristics similar to investments in midstream energy companies, the market value (or, if market value
is unavailable, the fair value) of such investments will be counted for purposes of the Fund&rsquo;s policy of investing at least 80%
of its Managed Assets in a portfolio of midstream energy investments. For a discussion of derivative instruments in which the Fund may
invest, see &ldquo;Investment Objective and Policies&mdash;Additional Investment Practices&mdash;Strategic Transactions.&rdquo;</p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund invests, without limitation, in debt securities
rated, at the time of investment, at least (i) B3 by Moody&rsquo;s Investors Service, Inc. (&ldquo;Moody&rsquo;s&rdquo;), (ii) B- by Standard
&amp; Poor&rsquo;s Ratings Services (&ldquo;S&amp;P&rdquo;) or Fitch Ratings (&ldquo;Fitch&rdquo;), or (iii) a comparable rating by another
rating agency, and invests no more than 5% of its Managed Assets in debt securities rated below B3 by Moody&rsquo;s, B- by S&amp;P or
Fitch or a comparable rating by another rating agency. Therefore, the Fund may invest in below investment grade debt securities. A debt
security is considered below investment grade if it is rated below Baa3- by Moody&rsquo;s or below BBB- by S&amp;P or Fitch or a comparable
rating by another rating agency. Below investment grade debt securities are often referred to as &ldquo;high yield&rdquo; securities or
&ldquo;junk bonds.&rdquo; Below investment grade debt securities are regarded as having predominantly speculative characteristics with
respect to capacity to pay interest and to repay principal. Debt securities in which the Fund invests may be of any maturity.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has previously qualified, and intends to continue
to qualify, to be treated as a regulated investment company (&ldquo;RIC&rdquo;) under the Internal Revenue Code of 1986, as amended (the
&ldquo;Code&rdquo;). The Fund pursues its investment objective by generally investing in master limited partnerships (&ldquo;MLPs&rdquo;)
up to the maximum extent permitted of a RIC under the Code. Accordingly, the Fund will, as of the end of each fiscal quarter, invest no
more than 25% of Managed Assets in securities of MLPs and other entities that are &ldquo;qualified publicly traded partnerships&rdquo;
under the Code.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Listing and Symbol</i>. The Fund&rsquo;s currently
outstanding Common Shares are, and the Common Shares offered by the accompanying Prospectus, will be, subject to notice of issuance, listed
on the New York Stock Exchange (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;SRV.&rdquo; As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the last reported sale price for the Fund&rsquo;s Common Shares on the NYSE was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per Common Share, and the net asset value of the Fund&rsquo;s Common Shares was $ &#9; per Common Share, representing a [discount/premium]
to net asset value of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; %. [The Rights will be, subject
to notice of issuance, admitted for trading on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
under the symbol &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo; during the course
of the offer. Trading in the Rights on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; may be
conducted until the close of trading on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on the
last business day prior to the expiration date.]</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Prospectus Supplement, together with the accompanying
Prospectus, dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025, sets forth concisely the
information that you should know before investing in the Fund&rsquo;s Securities. You should read this Prospectus Supplement and the accompanying
Prospectus, which contains important information about the Fund, before deciding whether to invest, and retain it for future reference.
A Statement of Additional Information, dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025,
containing additional information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into the
accompanying Prospectus. You may request a free copy of the Statement of Additional Information, the table of contents of which is on
page&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the accompanying Prospectus, or request other
information about the Fund (including the Fund&rsquo;s annual and semi-annual reports) or make shareholder inquiries by calling (214)
629-6334 or by writing the Fund, or you may obtain a copy (and other information regarding the Fund) from the SEC&rsquo;s website (www.sec.gov).
Free copies of the Fund&rsquo;s Prospectus, SAI reports and any incorporated information will also be available from the Fund&rsquo;s
website at www.nxgim.com.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund&rsquo;s Securities do not represent a deposit
or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally insured
by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Capitalized terms used herein that are not otherwise
defined shall have the meanings assigned to them in the accompanying Prospectus.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><b>TABLE OF CONTENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 95%">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; width: 5%; text-align: center"><font style="font-size: 11pt"><b>Page</b></font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt"><b>Prospectus Supplement</b></font></td>
    <td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Prospectus Supplement Summary</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Summary of Fund Expenses</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Capitalization</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Use of Proceeds</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Recent Developments</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Terms of the Offer</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Risks Related to the Offer</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Legal Matters</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Independent Registered Public Accounting Firm</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Additional Information</font></td>
    <td style="text-align: left"><font style="font-size: 11pt">S-&nbsp;</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt"><b>Prospectus</b></font></td>
    <td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Prospectus Summary</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Summary of Fund Expenses</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Financial Highlights</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Senior Securities</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">The Fund</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Use of Proceeds</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Market and Net Asset Value Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Investment Objective and Policies</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">The Fund&rsquo;s Investments</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Use of Leverage</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Risks</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Management of the Fund</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Net Asset Value</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Distributions</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Dividend Reinvestment Plan</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Description of Shares</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Anti-Takeover Provisions in the Agreement and Declaration of Trust</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Certain Provisions of Delaware Law, the Agreement and Declaration of Trust and Bylaws</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Closed-End Fund Structure</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Repurchase of Common Shares</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">U.S. Federal Income Tax Considerations</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Plan of Distribution</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Other Service Providers</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Legal Matters</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Independent Registered Public Accounting Firm</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Additional Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Privacy Policy</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Table of Contents of the Statement of Additional Information</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">[ ]</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORWARD-LOOKING STATEMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">This prospectus supplement contains or incorporates by reference forward-looking
statements, within the meaning of the federal securities laws, that involve risks and uncertainties. These statements describe the Fund&rsquo;s
plans, strategies, and goals and our beliefs and assumptions concerning future economic and other conditions and the outlook for the Fund,
based on currently available information. In this prospectus, words such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;expects,&rdquo;
&ldquo;objectives,&rdquo; &ldquo;goals,&rdquo; &ldquo;future,&rdquo; &ldquo;intends,&rdquo; &ldquo;seeks,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo;
&ldquo;could,&rdquo; &ldquo;should,&rdquo; and similar expressions are used in an effort to identify forward-looking statements, although
some forward-looking statements may be expressed differently. The Fund is not entitled to the safe harbor for forward-looking statements
pursuant to Section&nbsp;27A of the Securities Act of 1933, as amended.</p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="6" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS SUPPLEMENT SUMMARY</b></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>This is only a summary of information
    contained elsewhere in this Prospectus Supplement and the accompanying Prospectus. This summary does not contain all of the information
    that you should consider before investing in the Fund&rsquo;s Common Shares. You should carefully read the more detailed information contained
    in this Prospectus Supplement and the accompanying Prospectus and the Statement of Additional Information, dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
    2025 (the &ldquo;SAI&rdquo;), especially the information set forth under the headings &ldquo;Investment Objective and Policies&rdquo;
    and &ldquo;Risks.&rdquo;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&nbsp;</i></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 28%; border-left: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt"><b>The Fund</b></font></td>
    <td style="padding-right: 5.4pt; width: 72%; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">NXG Cushing<sup>&reg;</sup> Midstream Energy Fund (the &ldquo;Fund&rdquo;) is a non-diversified, closed-end management investment company registered under the 1940 Act that commenced investment operations on August&nbsp;27, 2007.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Purpose of the Offer</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">[<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>]</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Important Terms of the Offer</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund is issuing [transferable/non-transferable] rights (&ldquo;Rights&rdquo;)
    to its Common Shareholders of record (&ldquo;Record Date Shareholders&rdquo;) as of <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>,
    on<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i> (the &ldquo;Record Date&rdquo;),
    entitling the holders of those Rights to subscribe for up to an aggregate of<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    of the Fund&rsquo;s common shares (the &ldquo;Shares&rdquo;) (the &ldquo;Offer&rdquo;). Record Date Shareholders will receive one Right
    for each outstanding whole common share held on the Record Date. The Rights entitle their holders to purchase one Share for every<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    Rights held (1-for-<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>). Fractional
    Shares will not be issued upon the exercise of Rights; accordingly, Rights may be exercised only in integer multiples of<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>,
    except that any Record Date Shareholder who is issued fewer than <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    Rights may subscribe, at the Subscription Price (defined below), for one full Share. Assuming the exercise of all Rights, the Offer will
    result in an approximately <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    % increase in the Fund&rsquo;s common shares outstanding. The Offer is not contingent upon any number of Rights being exercised. The subscription
    period commences on &#9;and ends at <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>,
    on<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>, unless otherwise extended
    (the &ldquo;Expiration Date&rdquo;). See &ldquo;The Offer&mdash;Important Terms of the Offer.&rdquo;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">[The Fund expects to declare a monthly common share distribution in <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>.
    Such distribution will not be payable with respect to Shares that are issued pursuant to the Offer after the record date for such distribution.]</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund will bear the expenses of the Offer and all such expenses will
    be borne indirectly by the Fund&rsquo;s Common Shareholders, including those who do not exercise their Rights. These expenses include,
    but are not limited to, [the dealer manager fee and reimbursement of dealer manager expenses], the expenses of preparing, printing and
    mailing the prospectus and Rights subscription materials for the Offer and the expenses of Fund counsel and the Fund&rsquo;s independent
    registered public accounting firm in connection with the Offer.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Important Dates to Remember</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Record Date:</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Subscription Period: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    *</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Final Date Rights Will Trade: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    *</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Expiration Date and Pricing Date: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    *</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Payment for Shares or Notice of Guarantees of Delivery Due: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Payment for Guarantees of Delivery Due: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Confirmation Mailed to Participants: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Final Payment for Shares Due: <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    &dagger;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">*&nbsp;&nbsp;&nbsp;&nbsp;Unless the Offer is extended.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&dagger;&nbsp;&nbsp;&nbsp;&nbsp;See &ldquo;The Offer&ndash;&ndash;Payment
    for Shares.&rdquo;</p></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="6" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 28%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Subscription Price</b></font></td>
    <td style="padding-right: 5.4pt; width: 72%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">The subscription price for the Shares (the &ldquo;Subscription Price&rdquo;) will be determined based on a formula equal to<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i> (the &ldquo;Formula Price&rdquo;). Because the Expiration Date of the subscription period will be <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i> (unless the subscription period is extended), Rights holders may not know the Subscription Price at the time of exercise and will be required initially to pay for both the Shares subscribed for pursuant to the primary subscription [and, if eligible, any additional Shares subscribed for pursuant to the over-subscription privilege] at the estimated Subscription Price of $<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i> per Share and, except in limited circumstances, will not be able to rescind their subscription. See &ldquo;The Offer&mdash;Subscription Price.&rdquo; </font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>[Oversubscription Privilege</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">Record Date Shareholders who exercise all the Rights issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Share) are entitled to subscribe for additional Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment. If sufficient remaining Shares are available following the primary subscription, all Record Date Shareholders&rsquo; over-subscription requests will be honored in full. Investors who are not Record Date Shareholders, but who otherwise acquire Rights pursuant to the Offer, are not entitled to subscribe for any Shares pursuant to the over-subscription privilege. If sufficient Shares are not available to honor all over-subscription requests, unsubscribed Shares will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of common shares of the Fund they owned on the Record Date. See &ldquo;The Offer&mdash;Over-Subscription Privilege.&rdquo;]</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>[Sale and Transferability of Rights</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Rights will be, subject to notice of issuance, admitted for trading
    on <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i> under the symbol<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    during the course of the Offer. Trading in the Rights on the<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    may be conducted until the close of trading on the&#9;on the last business day prior to the Expiration Date. The Fund will use its best
    efforts to ensure that an adequate trading market for the Rights will exist, although there can be no assurance that a market for the
    Rights will develop. Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels or
    sold through the Subscription Agent.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Record Date Shareholders who do not wish to exercise any of the Rights
    issued to them pursuant to the Offer may instruct the Subscription Agent to try to sell any unexercised Rights. Although the Rights are
    expected to trade on the <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    through the last business day prior to the Expiration Date, Subscription certificates representing the Rights to be sold through the Subscription
    Agent must be received by the Subscription Agent by 5:00&nbsp;p.m., Eastern time, on <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    (or, if the subscription period is extended, by 5:00&nbsp;p.m., Eastern time, on the <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i>
    business day prior to the extended Expiration Date). Upon the timely receipt by the Subscription Agent of appropriate instructions to
    sell Rights, the Subscription Agent will ask the Dealer Manager it if will purchase the Rights. If the Dealer Manager purchases the Rights,
    the sales price paid by the Dealer Manager will be based upon the then-current market price for the Rights. If the Dealer Manager declines
    to purchase the Rights of a Record Date Shareholder that have been duly submitted to the Subscription Agent for sale, the Subscription
    Agent will attempt to sell such Rights in the open market.</p></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="6" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 28%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; width: 72%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">Alternatively, the Rights evidenced by a subscription certificate may be transferred until the Expiration Date in whole or in part by endorsing the subscription certificate for transfer in accordance with the accompanying instructions. See &ldquo;The Offer&mdash;Sale and Transferability of Rights.&rdquo;]</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Method for Exercising Rights</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Rights are evidenced by subscription certificates that will be mailed to
    Record Date Shareholders (except as described below under &ldquo;The Offer&mdash;Requirements for Foreign Shareholders&rdquo;) or, if
    their common shares are held by Cede &amp; Co. or any other depository or nominee, to Cede &amp; Co. or such other depository or nominee.
    Rights may be exercised by completing and signing the subscription certificate and mailing it in the envelope provided, or otherwise delivering
    the completed and signed subscription certificate to the Subscription Agent, together with payment in full of the estimated Subscription
    Price for the Shares subscribed for. Completed subscription certificates and payments must be received by the Subscription Agent by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
    on the Expiration Date at the offices of the Subscription Agent. Rights also may be exercised by contacting your broker, banker, trust
    company or other intermediary, which can arrange, on your behalf, to guarantee delivery of payment and of a properly completed and executed
    subscription certificate. A fee may be charged for this service by your broker, bank, trust company or other intermediary. In addition,
    your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier than 5:00&nbsp;p.m., Eastern
    time, on the Expiration Date. See &ldquo;The Offer&mdash;Method for Exercising Rights&rdquo; and &ldquo;The Offer&mdash;Payment for Shares.&rdquo;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Rights holders who have exercised their Rights will have no right to rescind
    their subscription after receipt by the Subscription Agent of the completed subscription certificate together with payment for Shares
    subscribed for, except as described under &ldquo;The Offer.&rdquo;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Requirements for Foreign Shareholders</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">Subscription
certificates will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United
States includes the District of Columbia and the territories and possessions of the United States) (&ldquo;Foreign Shareholders&rdquo;).
The Subscription Agent will send a letter via regular mail to Foreign Shareholders to notify them of the Offer. The Rights of Foreign
Shareholders will be held by the Subscription Agent for their accounts until instructions are received to exercise the Rights. If instructions
have not been received by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; business days prior to the Expiration Date (or, if the subscription period is
extended, on or before the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; business day prior to the extended Expiration Date),
the Subscription Agent will ask the Dealer Manager if it will purchase the Rights of Foreign Shareholders. If the Dealer Manager declines
to purchase the Rights, the Subscription Agent will attempt to sell such Rights in the open market. The net proceeds, if any, from the
sale of those Rights will be remitted to these Foreign Shareholders. </font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>U.S. Federal Income Tax Considerations</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">We urge you to consult your own tax adviser with respect to the particular tax consequences of the Offer. See &ldquo;Terms of the Offer&mdash;U.S. Federal Income Tax Considerations&rdquo; for more information on the tax consequences of the Offer.</font></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="6" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 28%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>[Distribution Arrangements</b></font></td>
    <td style="padding-right: 5.4pt; width: 72%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (the &ldquo;Dealer Manager&rdquo;) will act as Dealer Manager for this Offer. Under the terms and subject to the conditions contained
    in the Dealer Manager Agreement among the Dealer Manager, the Fund and the Investment Adviser, the Dealer Manager will provide financial
    structuring services in connection with the Offer and will solicit the exercise of Rights and participation in the over-subscription privilege.
    The Fund has agreed to pay the Dealer Manager a fee for its financial structuring and soliciting services equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    % of the aggregate Subscription Price for the Shares issued pursuant to the exercise of Rights and the over-subscription privilege. The
    fees paid to the Dealer Manager and other expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders,
    including those who do not exercise their Rights. The Dealer Manager will reallow a portion of its fees to other broker-dealers who have
    assisted in soliciting the exercise of Rights. The Fund and the Investment Adviser have each agreed to indemnify the Dealer Manager for
    losses arising out of certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Prior to the expiration of the Offer, the Dealer Manager may independently
    offer for sale Shares it has acquired through purchasing and exercising the Rights, at prices it sets. Although the Dealer Manager may
    realize gains and losses in connection with purchases and sales of Shares, such offering of Shares is intended by the Dealer Manager to
    facilitate the Offer, and any such gains or losses are not expected to be material to the Dealer Manager. The Dealer Manager&rsquo;s fee
    for its financial structuring and soliciting services is independent of any gains or losses that may be realized by the Dealer Manager
    through the purchase and exercise of the Rights and the sale of Shares. See &ldquo;The Offer&mdash;Distribution Arrangements.&rdquo;]</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Investment Adviser</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">The Fund&rsquo;s investments are managed by its Investment Adviser, Cushing<sup>&reg;</sup> Asset Management, LP d/b/a NXG Investment Management, whose principal business address is One Energy Square, 4925 Greenville Avenue, Suite 1310, Dallas, Texas 75206. The Investment Adviser is a wholly-owned investment advisory subsidiary of Swank Capital. The Investment Adviser was founded in 2003 and serves as investment adviser to registered and unregistered funds. As of December&nbsp;31, 2024, the Investment Adviser managed approximately $[1.3] billion in assets.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Benefits to the Investment Adviser</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">The Investment Adviser will benefit from the Offer, in part, because the investment management fee paid by the Fund to the Investment Adviser is based on &ldquo;Managed Assets&rdquo; of the Fund. It is not possible to state precisely the amount of additional compensation the Investment Adviser will receive as a result of the Offer because it is not known how many Shares of the Fund will be subscribed for and because the proceeds of the Offer will be invested in additional portfolio securities which will fluctuate in value. However, assuming (i) all Rights are exercised, (ii) the Fund&rsquo;s average net asset value during the twelve-month period beginning &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per common share (the net asset value per common share on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) (iii) the Subscription Price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Share, and (iv) for purposes of this example, the Fund increases the amount of leverage it has outstanding (through the use of reverse repurchase agreements) while maintaining approximately the same percentage of total assets attributable to leverage, and after giving effect to the Dealer Manager fee and other estimated offering expenses, the Investment Adviser would receive additional investment management fees of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, for the twelve-month period beginning&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and would continue to receive additional investment management fees, as a result of the Offer, based on the Fund&rsquo;s Managed Assets attributable to the Shares issued in the Offer and related additional leverage, thereafter. </font></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="6" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 28%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Listing and Symbol</b></font></td>
    <td style="padding-right: 5.4pt; width: 72%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">The Fund&rsquo;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus, will be, subject to notice of issuance, listed on the New York Stock Exchange (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;SRV.&rdquo; As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the last reported sale price for the Fund&rsquo;s Common Shares on the NYSE was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Common Share, and the net asset value of the Fund&rsquo;s Common Shares was $&#9; per Common Share, representing a [premium/discount] to net asset value of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; %. [The Subscription Rights for Common Shares offered by this Prospectus Supplement and the accompanying Prospectus, will be, subject to notice of issuance, admitted for trading on the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; under the symbol &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo; during the course of the offer. Trading in the Rights on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; may be conducted until the close of business on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on the last business day prior to the expiration date.]</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Risks</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt"><font style="font-size: 11pt">See &ldquo;Risks&rdquo; beginning on page &#9;&nbsp;of this Prospectus Supplement and page&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;of the accompanying Prospectus for a discussion of factors you should consider carefully before deciding to invest in the Fund&rsquo;s Common Shares.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-left: 5.4pt; text-indent: 0pt; padding-bottom: 6pt"><font style="font-size: 11pt"><b>Use of Proceeds</b></font></td>
    <td style="padding-right: 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 6pt; padding-left: 5.4pt; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund estimates the net proceeds of the Offering to be approximately
    $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. This figure is based on the Subscription Price per Common Share of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    and assumes all new Common Shares offered are sold and that the expenses related to the Offering, estimated at approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
    are paid.</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Fund intends to invest the net proceeds of the offering in accordance
    with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated that the Fund will be
    able to invest substantially all of the net proceeds of the offering in accordance with its investment objective and policies within&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    months after the completion of the offering. Pending such investment, it is anticipated that the proceeds will be invested in cash, cash
    equivalents or other securities, including U.S. government securities or high quality, short-term debt securities. The Fund may also use
    the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses, although the Fund
    currently has no intent to issue Securities primarily for these purposes.</p></td></tr>
  </table>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SUMMARY OF FUND EXPENSES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following table contains information about the
costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (except as noted below)
after giving effect to the Offering, assuming that the Offer is fully subscribed resulting in the receipt of net proceeds from the Offer
of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million. If the Fund issues fewer Shares in the Offer and the
net proceeds to the Fund are less, all other things being equal, the total annual expenses shown would increase. The purpose of the table
and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 80%"><font style="font-size: 11pt"><b>Shareholder Transaction Expenses</b></font></td>
    <td style="width: 20%; text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 9pt"><font style="font-size: 11pt">Sales load (as a percentage of offering price)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">%<sup>(1)</sup></font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 9pt"><font style="font-size: 11pt">Offering expenses borne by the Fund (as a percentage of offering price)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">%<sup>(2)</sup></font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 9pt"><font style="font-size: 11pt">Dividend Reinvestment Plan fees (per transaction sales fee)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">$15.00<sup>(3)</sup></font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 80%"><font style="font-size: 11pt"><b>Annual Expenses</b></font></td>
    <td style="width: 20%; border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><b>Percentage of Net Assets Attributable to Common Shares<sup>(4)</sup></b></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Management fees<sup>(5)(6)</sup></font></td>
    <td style="font-size: 11pt; text-align: center">%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Interest expense<sup>(7)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Other expenses<sup>(8)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 10pt"><font style="font-size: 11pt">Total annual expenses</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(1)</sup></td><td>The Dealer Manager will receive a fee for its financial structuring and soliciting services equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the aggregate Subscription Price for Shares issued pursuant to the Offer. The Dealer Manager will reallow to broker-dealers in the
selling group to be formed and managed by the Dealer Manager selling fees equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Subscription Price per Share for each Share issued pursuant to the Offer as a result of their selling efforts. In addition, the
Dealer Manager will reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited
the exercise of Rights solicitation fees equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Subscription Price per
Share for each Share issued pursuant to the exercise of Rights as a result of their soliciting efforts, subject to a maximum fee based
on the number of Shares held by each broker-dealer through The Depository Trust Company (&ldquo;DTC&rdquo;) on the Record Date.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(2)</sup></td><td>The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(3)</sup></td><td>There will be no brokerage charges with respect to Common Shares issued directly by the Fund. However, each participant will pay a
pro rata share of brokerage commissions incurred in connection with open-market purchases. In addition, participants who request a sale
of shares through the Plan Agent are subject to a $15.00 per transaction sales fee and pay a brokerage commission of $0.12 per share sold.
The Fund&rsquo;s transfer agent serves as Plan Agent. Fees paid by the Fund to the transfer agent are included in &ldquo;Other expenses&rdquo;
below, which are ultimately borne by common shareholders. For additional information, see &ldquo;Distribution Reinvestment Plan&rdquo;
in the accompanying Prospectus.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(4)</sup></td><td>Based on net assets attributable to Common Shares during the period ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(5)</sup></td><td>The Fund pays the Investment Adviser an annual fee, payable monthly, in an amount equal to 1.25% of the Fund&rsquo;s average weekly
Managed Assets (net assets plus any assets attributable to Financial Leverage). The fee shown above is based upon outstanding Financial
Leverage of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of the Fund&rsquo;s Managed Assets (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s net assets attributable to common shares). If Financial Leverage of more than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s Managed Assets (or &#9;% of the Fund&rsquo;s net assets attributable to common shares) is used, the management fees
shown would be higher. Management fees calculated based on management fees earned for the year ended &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
divided by average net assets attributable to Common Shareholders for the period ended &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(6)</sup></td><td>The Investment Adviser has contractually agreed to waive a portion of the management fee in an amount equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of the Fund&rsquo;s Managed Assets through &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The Fund&rsquo;s annual expenses
after giving effect to such management fee waiver are:</td></tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 80%; padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt"><b>Annual Expenses</b></font></td>
    <td style="width: 20%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>Percentage of Net Assets Attributable to Common Shares<sup>(4)</sup></b></font></td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt">Management fees<sup>(2)(3)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt">Interest payments on borrowed funds<sup>(4)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt">Other expenses<sup>(5)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.1in; text-indent: -0.1in"><font style="font-size: 11pt">Total annual expenses<sup>(3)</sup></font></td>
    <td style="text-align: center"><font style="font-size: 11pt">%</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><sup>&nbsp;</sup></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><sup>(7)</sup></td><td>Based upon the Fund&rsquo;s outstanding borrowings as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million and the borrowing rate on the facility as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
%.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><sup>(8)</sup></td><td>Other expenses are estimated based upon those incurred during the fiscal year ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
Other expenses do not include expense related to realized or unrealized investment gains or losses. See &ldquo;Management of the Fund&mdash;Fund
Expenses&rdquo; in the accompanying prospectus.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Example</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As required by relevant SEC regulations, the following
Example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &ldquo;Total annual expenses&rdquo;
of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % of net assets attributable to Common Shares, (2) the sales load of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and estimated offering expenses of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;, and (3) a 5% annual return*:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="2" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%">&nbsp;</td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>1 Year</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>3 Years</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>5 Years</b></font></td>
    <td style="width: 12%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 11pt"><b>10 Years</b></font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 0.2in; text-indent: -0.2in"><font style="font-size: 11pt">Total Expenses Incurred</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td>
    <td style="text-align: center"><font style="font-size: 11pt">$</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><b>*</b></td><td><b>The Example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed</b>. <b>Moreover, the Fund&rsquo;s actual rate of return may be higher or lower than the hypothetical 5% return shown in
the Example.</b> The Example assumes that all dividends and distributions are reinvested at net asset value.</td></tr></table>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>CAPITALIZATION</b></p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">The following table sets forth the Fund&rsquo;s capitalization
at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left">(i)</td><td style="text-align: justify">on a historical basis;</td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">(ii)</td><td>on an as adjusted basis to reflect the issuance of an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Shares
pursuant to the Fund&rsquo;s Automatic Dividend Reinvestment Plan, and the application of the net proceeds from such issuances of Common
Shares; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">(iii)</td><td>on an as further adjusted basis to reflect the assumed sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of Rights to purchase Common Shares at a price of $&#9;per share in an offering under this Prospectus Supplement and the accompanying
Prospectus less the [aggregate underwriting discount of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and] estimated offering
expenses payable by the Fund of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Actual</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As Adjusted (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As Further Adjusted (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Short-Term Debt:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 55%">Borrowings</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&nbsp;</td><td style="white-space: nowrap; width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Common Shareholder&rsquo;s Equity:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Common Shares of beneficial interest, par value $0.01 per share; unlimited shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (actual), &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (as adjusted), and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding (as further adjusted)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Net unrealized appreciation on investments, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated net realized gain on investments, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left">Accumulated net investment loss, net of tax</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="white-space: nowrap; text-align: left">&nbsp;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>USE OF PROCEEDS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund estimates the net proceeds of the Offering
to be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. This figure is based on the Subscription Price per Common
Share of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and assumes all new Common Shares offered are sold and that the expenses
related to the Offering, estimated at approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, are paid.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund intends to invest the net proceeds of the
offering in accordance with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated
that the Fund will be able to invest substantially all of the net proceeds of the offering in accordance with its investment objective
and policies within&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; months after the completion of the offering. Pending such investment,
it is anticipated that the proceeds will be invested in cash, cash equivalents or other securities, including U.S. government securities
or high quality, short-term debt securities. The Fund may also use the proceeds for working capital purposes, including the payment of
distributions, interest and operating expenses, although the Fund currently has no intent to issue Securities primarily for these purposes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RECENT DEVELOPMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME, IF ANY]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TERMS OF THE OFFER</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Purpose of the Offer</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Offer may not be successful. The completion of
the Offer may result in an immediate dilution of the net asset value per common share for all existing Common Shareholders, including
those who fully exercise their Rights (as defined below).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Important Terms of The Offer</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund is issuing [transferable/non-transferable]
rights (&ldquo;Rights&rdquo;) to its Common Shareholders of record (&ldquo;Record Date Shareholders&rdquo;) as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the &ldquo;Record Date&rdquo;), entitling the holders of those
Rights to subscribe for up to an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of the Fund&rsquo;s common shares (the &ldquo;Shares&rdquo;) (the &ldquo;Offer&rdquo;). Record Date Shareholders will receive one Right
for each outstanding whole common share of the Fund held on the Record Date. The Rights entitle their holders to purchase one Share for
every &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rights held (1-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;).
Fractional Shares will not be issued upon the exercise of Rights; accordingly, Rights may be exercised only in integer multiples of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
except that any Record Date Shareholder who is issued fewer than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rights may subscribe,
at the Subscription Price (as defined on the next page), for one full Share. Assuming the exercise of all Rights, the Offer will result
in an approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % increase in the Fund&rsquo;s common shares outstanding.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[Record Date Shareholders who exercise all the Rights
issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Share) are
entitled to subscribe for additional Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain
limitations and subject to allotment. Investors who are not Record Date Shareholders, but who otherwise acquire Rights to purchase Shares
pursuant to the Offer, are not entitled to subscribe for any Shares pursuant to the over-subscription privilege. See &ldquo;&mdash;Over-Subscription
Privilege&rdquo; below. The distribution to Record Date Shareholders of transferable Rights may afford non-participating Record Date Shareholders
the opportunity to sell their Rights for some cash value, receipt of which may be viewed as partial compensation for any economic dilution
of their interests resulting from the Offer.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The subscription period commences on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and ends at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, Eastern time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
unless otherwise extended (the &ldquo;Expiration Date&rdquo;).</p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund expects to declare a monthly distribution
in &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. Such distribution will
not be payable with respect to Shares that are issued pursuant to the Offer after the record date for such distribution.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">For purposes of determining the maximum number of Shares
a Rights holder may acquire pursuant to the Offer, broker-dealers, trust companies, banks or others whose shares are held of record by
Cede &amp; Co., the nominee for the Depository Trust Company (&ldquo;DTC&rdquo;), or by any other depository or nominee, will be deemed
to be the holders of the Rights that are held by Cede &amp; Co. or such other depository or nominee on their behalf.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[The Rights are transferable and, subject to notice
of issuance, will be admitted for trading on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
under the symbol &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo; during the course of the Offer. Trading in the Rights
on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; may be conducted until the close of trading on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
on the last business day prior to the Expiration Date. See &ldquo;&mdash;Sale and Transferability of Rights.&rdquo; The Shares, once issued,
will be listed on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; under the symbol &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo;
The Rights will be evidenced by subscription certificates which will be mailed to Record Date Shareholders, except as discussed under
&ldquo;&mdash;Requirements for Foreign Shareholders.&rdquo;]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Rights may be exercised by filling in and signing the
subscription certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed subscription certificate
to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the subscription agent
for the Offer (the &ldquo;Subscription Agent&rdquo;), together with payment at the estimated Subscription Price for the Shares subscribed
for. For a discussion of the method by which Rights may be exercised and Shares may be paid for, see &ldquo;&mdash;Method for Exercising
Rights&rdquo; and &ldquo;&mdash;Payment for Shares.&rdquo;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[The Fund has retained &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ldquo;Dealer Manager&rdquo;)
to provide the Fund with financial structuring and soliciting services relating to the Offer, including advice with respect to the structure,
timing and terms of the Offer. In determining the structure of the Offer, the Board considered, among other things, using a fixed-pricing
versus a variable-pricing mechanism, the benefits and drawbacks of conducting a non-transferable versus a transferable rights offering,
the anticipated effect on the Fund and its existing Common Shareholders if the Offer is not fully subscribed, the anticipated dilutive
effects on the Fund and its existing Common Shareholders of the Offer and the experience of the Dealer Manager in conducting rights offerings.
The Board also considered that the Investment Adviser would benefit from the Offer because the advisory fee paid to the Investment Adviser
is based on the Fund&rsquo;s Managed Assets, which would increase as a result of the Offer. See &ldquo;&mdash;Benefits to the Investment
Adviser.&rdquo;]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Important Dates to Remember</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<table cellpadding="2" cellspacing="0" border="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: top">
    <td style="padding-left: 0.5in; width: 60%"><font style="font-size: 11pt">Record Date:</font></td>
    <td style="width: 40%; text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Subscription Period:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Final Date Rights Will Trade on the Exchange:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Expiration Date and Pricing Date:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Payment for Shares Due or Notices of Guarantees of Delivery Due:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Payment for Guarantees of Delivery Due:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Confirmation Mailed to Participants:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.5in"><font style="font-size: 11pt">Final Payment for Shares Due:</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">*&dagger;</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt">*</td><td>Unless the Offer is extended.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-indent: -20pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt">&dagger;</td><td>See &ldquo;&mdash;Payment for Shares.&rdquo;</td></tr></table>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Subscription Price</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The subscription price for the Shares (the &ldquo;Subscription
Price&rdquo;) will be determined based on a formula equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(the
&ldquo;Formula Price&rdquo;). In each case, net asset value will be calculated as of the close of trading on the NYSE on the applicable
day.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Because the Expiration Date of the subscription period
will be &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(unless the subscription period is extended), Rights holders may not know the Subscription Price at the time of exercise and will be required
initially to pay for both the Shares subscribed for pursuant to the primary subscription [and, if eligible, any additional Shares subscribed
for pursuant to the over-subscription privilege] at the estimated Subscription Price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
Share. See &ldquo;&mdash;Payment for Shares.&rdquo; A Rights holder will have no right to rescind his subscription after the Subscription
Agent has received a completed subscription certificate together with payment for the Shares subscribed for, except as provided under
&ldquo;&mdash;Notice of Net Asset Value Decline.&rdquo; The Fund does not have the right to withdraw the Rights or to cancel the Offer
after the Rights have been distributed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The net asset value per share of the Fund&rsquo;s common
shares at the close of business on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the last trading date prior to the date
of this prospectus on which the Fund determined its net asset value) was $&#9;, and the last reported sale price of a common share on
the NYSE on that day was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>[Over-Subscription Privilege</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Record Date Shareholders who exercise all the Rights
issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Share) are
entitled to subscribe for additional Shares that were not subscribed for by other holders of Rights at the same Subscription Price pursuant
to the over-subscription privilege, subject to certain limitations and subject to allotment. If sufficient remaining Shares are available
following the primary subscription, all Record Date Shareholders&rsquo; over-subscription requests will be honored in full. Investors
who are not Record Date Shareholders, but who otherwise acquire Rights pursuant to the Offer, are not entitled to subscribe for any Shares
pursuant to the over-subscription privilege. If sufficient Shares are not available to honor all over-subscription requests, unsubscribed
Shares will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of common shares of the
Fund they owned on the Record Date. The allocation process may involve a series of allocations in order to ensure that the total number
of Shares available for over-subscriptions is distributed on a pro rata basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Record Date Shareholders who are fully exercising their
Rights during the subscription period should indicate, on the subscription certificate that they submit with respect to the exercise of
the Rights issued to them, how many Shares they desire to acquire pursuant to the over-subscription privilege.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Banks, broker-dealers, trustees and other nominee holders
of Rights will be required to certify to the Subscription Agent, before any over-subscription privilege may be exercised with respect
to any particular beneficial owner, as to the aggregate number of Rights exercised during the subscription period and the number of Shares
subscribed for pursuant to the over-subscription privilege by such beneficial owner, and that such beneficial owner&rsquo;s primary subscription
was exercised in full. Nominee holder over-subscription forms will be distributed to banks, brokers, trustees and other nominee holders
of Rights with the subscription certificates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund will not offer or sell any Shares that are
not subscribed for during the subscription period or pursuant to the over-subscription privilege.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has been advised that one or more of the officers
or employees of the Investment Adviser may exercise all of the Rights initially issued to them and may request additional Shares pursuant
to the over-subscription privilege. An exercise of the over-subscription privilege by such persons will increase their proportionate voting
power and share of the Fund&rsquo;s assets.]</p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>[Sale and Transferability of Rights</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Rights will be, subject to notice of issuance,
admitted for trading on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
under the symbol &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo; during the course of the Offer. Trading in
the Rights on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; may be conducted until the close of trading on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
on the last business day prior to the Expiration Date. The Fund will use its best efforts to ensure that an adequate trading market for
the Rights will exist, although there can be no assurance that a market for the Rights will develop. Assuming a market exists for the
Rights, the Rights may be purchased and sold through usual brokerage channels or sold through the Subscription Agent.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Sales through the Subscription Agent. </i>Record
Date Shareholders who do not wish to exercise any or all of the Rights issued to them pursuant to the Offer may instruct the Subscription
Agent to try to sell any unexercised Rights. Although the Rights are expected to trade on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through
the last business day prior to the Expiration Date, subscription certificates representing the Rights to be sold by the Subscription Agent
must be received by the Subscription Agent on or before 5:00&nbsp;p.m., Eastern time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(or, if the subscription period is extended, by 5:00&nbsp;p.m., Eastern time, on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day prior to the extended Expiration Date).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Upon the timely receipt by the Subscription Agent of
appropriate instructions to sell Rights, the Subscription Agent will ask the Dealer Manager if it will purchase the Rights. The sale price
of any Rights sold to the Dealer Manager will be based upon the then-current market price for the Rights. The proceeds from each of such
sales to the Dealer Manager will be remitted to the Subscription Agent, which will hold such proceeds in an account segregated from the
Subscription Agent&rsquo;s own funds pending distribution to each selling Record Date Shareholder. It is expected that following each
such sale of Rights to the Dealer Manager, the proceeds from each such sale will be received by the Subscription Agent within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days of the sale and that the proceeds will then be remitted to the selling Record Date Shareholder within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days following the Expiration Date by the Subscription Agent.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Dealer Manager declines to purchase the Rights
of a Record Date Shareholder that have been duly submitted to the Subscription Agent for sale, the Subscription Agent will attempt to
sell such Rights in the open market. If the Rights can be sold in such manner, all of such sales will be deemed to have been effected
at the weighted-average price of all Rights sold by the Subscription Agent in such open market transactions throughout the subscription
period. The proceeds from such sales will be held by the Subscription Agent in an account segregated from the Subscription Agent&rsquo;s
own funds pending distribution to the selling Record Date Shareholders. It is expected that the proceeds of such open market sales will
be remitted by the Subscription Agent to the selling Record Date Shareholders within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days following the Expiration Date.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Subscription Agent will also attempt to sell (either
to the Dealer Manager or in open market transactions) all Rights that remain unclaimed as a result of subscription certificates being
returned by the postal authorities to the Subscription Agent as undeliverable as of the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day prior to the Expiration Date. The Subscription Agent will hold the proceeds from those sales for the benefit of those non-claiming
Common Shareholders until the proceeds are either claimed or revert to their state of residence.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">There can be no assurance that the Subscription Agent
will be able to complete the sale of any Rights, and neither the Fund nor the Subscription Agent have guaranteed any minimum sale price
for the Rights. If a Record Date Shareholder does not utilize the services of the Subscription Agent and chooses to use another broker-dealer
or other financial institution to sell Rights issued to that shareholder pursuant to the Offer, then the other broker-dealer or financial
institution may charge a fee to sell the Rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&nbsp;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Other Transfers</i>. The Rights evidenced by a subscription
certificate may be transferred in whole by endorsing the subscription certificate for transfer in accordance with the instructions accompanying
the subscription certificate. A portion of the Rights evidenced by a single subscription certificate (but not fractional Rights) may be
transferred by delivering to the Subscription Agent a subscription certificate properly endorsed for transfer, with instructions to register
such portion of the Rights evidenced thereby in the name of the transferee and to issue a new subscription certificate to the transferee
evidencing the transferred Rights. If this occurs, a new subscription certificate evidencing the balance of the Rights, if any, will be
issued to the Record Date Shareholder or, if the Record Date Shareholder so instructs, to an additional transferee. The signature on the
subscription certificate must correspond with the name as written upon the face of the subscription certificate in every particular, without
alteration or enlargement or any other change. A signature guarantee must be provided by an &ldquo;eligible guarantor institution&rdquo;
(as defined in Rule&nbsp;17Ad-15 of the Securities Exchange Act of 1934).</p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Record Date Shareholders wishing to transfer all or
a portion of their Rights should allow at least &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; business days prior to the
Expiration Date for: (i) the transfer instructions to be received and processed by the Subscription Agent; (ii) a new subscription certificate
to be issued and transmitted to the transferee or transferees with respect to transferred Rights and to the transferor with respect to
retained Rights, if any; and (iii) the Rights evidenced by the new subscription certificate to be exercised or sold by the recipients
of the subscription certificate. Neither the Fund nor the Subscription Agent nor the Dealer Manager shall have any liability to a transferee
or transferor of Rights if subscription certificates are not received in time for exercise or sale prior to the Expiration Date.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Except for the fees charged by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the information agent for the Offer (the &ldquo;Information Agent&rdquo;), the Subscription Agent and the Dealer Manager (which are expected
to be paid from the proceeds of the Offer by the Fund), all commissions, fees and other expenses (including brokerage commissions and
transfer taxes) incurred or charged in connection with the purchase, sale or transfer of Rights will be for the account of the transferor
of the Rights, and none of these commissions, fees or other expenses will be paid by the Fund, the Investment Adviser, the Information
Agent, the Subscription Agent or the Dealer Manager. Rights holders who wish to purchase, sell, exercise or transfer Rights through a
broker, bank or other party should first inquire about any fees and expenses that the holder will incur in connection with the transactions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund anticipates that the Rights will be eligible
for transfer through, and that the exercise of the primary subscription and the over-subscription may be effected through, the facilities
of DTC or the Subscription Agent until 5:00&nbsp;p.m., Eastern time, on the Expiration Date. Your broker, bank, trust company or other
intermediary may impose a deadline for transferring Rights earlier than 5:00&nbsp;p.m. Eastern time, on the Expiration Date.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Method for Exercising Rights</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Rights are evidenced by subscription certificates that
will be mailed to Record Date Shareholders (except as described under &ldquo;&mdash;Requirements for Foreign Shareholders&rdquo; below)
or, if their common shares are held by Cede &amp; Co. or any other depository or nominee on their behalf, to Cede &amp; Co. or such other
depository or nominee. Rights may be exercised by completing and signing the subscription certificate and mailing it in the envelope provided,
or otherwise delivering the completed and signed subscription certificate to the Subscription Agent, together with payment in full at
the estimated Subscription Price for the Shares subscribed for by the Expiration Date as described under &ldquo;&mdash;Payment For Shares.&rdquo;
Rights may also be exercised by contacting your broker, banker, trust company or other intermediary, which can arrange, on your behalf,
to guarantee delivery of payment and of a properly completed and executed subscription certificate pursuant to a notice of guaranteed
delivery by the close of business on the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day after the Expiration Date. A fee may be charged for this service. Completed subscription certificates and payments must be
received by the Subscription Agent by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date (unless delivery of subscription certificate and payment is effected by means of a notice of guaranteed
delivery as described below under &ldquo;&mdash;Payment for Shares&rdquo;) at the offices of the Subscription Agent at one of the addresses
set forth below under &ldquo;&mdash;Subscription Agent.&rdquo; Your broker, bank, trust company or other intermediary may impose a deadline
for transferring Rights earlier than 5:00&nbsp;p.m. Eastern time, on the Expiration Date. Fractional Shares will not be issued upon exercise
of Rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Shareholders who are Record Owners</i>. Shareholders
who are record owners of common shares can choose between either option set forth under &ldquo;&mdash;Payment For Shares.&rdquo; If time
is of the essence, option (2) will permit delivery of the subscription certificate and payment after the Expiration Date.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investors whose Common Shares are Held by a Nominee</i>.
Investors whose common shares are held by a nominee, such as a bank, broker, trustee or other intermediary, must contact that nominee
to exercise their Rights. In that case, the nominee will complete the subscription certificate on behalf of the investor and arrange for
proper payment by one of the methods set forth below under &ldquo;&mdash;Payment For Shares.&rdquo;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Nominees</i>. Nominees, such as banks, brokers,
trustees or depositories for securities, who hold common shares of the Fund for the account of others should notify the respective beneficial
owners of such common shares as soon as possible to ascertain those beneficial owners&rsquo; intentions and to obtain instructions with
respect to the Rights. If the beneficial owner so instructs, the nominee should complete the subscription certificate and submit it to
the Subscription Agent with the proper payment as described under &ldquo;&mdash;Payment For Shares.&rdquo;</p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[Banks, brokers, trustees and other nominee holders
of Rights will be required to certify to the Subscription Agent, before any over-subscription privilege may be exercised with respect
to any particular beneficial owner who is a Record Date Shareholder, as to the aggregate number of Rights exercised during the subscription
period and the number of Shares subscribed for pursuant to the over-subscription privilege by the beneficial owner, and that the beneficial
owner exercised all the Rights issued to it pursuant to the Offer.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Requirements for Foreign Shareholders. </i>Subscription
certificates will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United
States includes the District of Columbia and the territories and possessions of the United States) (&ldquo;Foreign Shareholders&rdquo;).
The Subscription Agent will send a letter via regular mail to Foreign Shareholders to notify them of the Offer. The Rights of Foreign
Shareholders will be held by the Subscription Agent for their accounts until instructions are received to exercise the Rights. If instructions
have not been received by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days prior to the Expiration Date (or, if the subscription period is extended, on or before the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day prior to the extended Expiration Date), the Subscription Agent will ask the Dealer Manager if it will purchase the Rights.
If the Dealer Manager declines to purchase the Rights, the Subscription Agent will attempt to sell such Rights in the open market. The
net proceeds, if any, from the sale of those Rights will be remitted to those Foreign Shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 4.5pt"><b>Subscription Agent</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 4.5pt"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
is the Subscription Agent for the Offer. The Subscription Agent will receive for its administrative, processing, invoicing and other services
a fee estimated to be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
plus reimbursement for all out-of-pocket expenses related to the Offer. The fees and expenses of the Subscription Agent are included in
the fees and expenses of the Offer and therefore will be borne by the Fund and indirectly by all Common Shareholders, including those
who do not exercise their Rights. Questions regarding the subscription certificates should be directed by mail to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
Shareholders may also subscribe for the Offer by contacting their broker dealer, trust company, bank or other nominee.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Completed subscription certificates must be sent together
with proper payment of the estimated Subscription Price for all Shares subscribed for in the primary subscription and the over-subscription
privilege (for Record Date Shareholders) to the Subscription Agent by one of the methods described below. Alternatively, Rights holders
may arrange for their financial intermediaries to send notices of guaranteed delivery by facsimile to DTC to be received by the Subscription
Agent prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date. Facsimiles should be confirmed by telephone at DTC. The Fund will accept only properly completed
and executed subscription certificates actually received at any of the addresses listed below, prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date, or by the close of business on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day after the Expiration Date following timely receipt of a notice of guaranteed delivery. See &ldquo;&mdash;Payment for Shares.&rdquo;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 54%; border-bottom: Black 1pt solid"><font style="font-size: 11pt">Subscription Certificate Delivery Method</font></td>
    <td style="width: 46%; border-bottom: Black 1pt solid"><font style="font-size: 11pt">Address/Number</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Notice of Guaranteed Delivery:</font></td>
    <td><font style="font-size: 11pt">Contact your broker-dealer, trust company, bank or other nominee to notify the Fund of your intent to exercise the Rights.</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">First Class Mail Only</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">(No Express Mail or Overnight Courier):</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Hand:</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Express Mail or Overnight Courier:</font></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund will honor only subscription certificates
received by the Subscription Agent prior to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern Time, on the Expiration Date at one of the addresses listed above. Delivery to an address other than those listed above will not
constitute good delivery.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Information Agent</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Information Agent for the Offer is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
If you have questions or need further information about the Offer, please write the Information Agent at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
or call &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
Any questions or requests for assistance concerning the method of subscribing for Shares or additional copies of this prospectus or subscription
certificates should be directed to the Information Agent. Shareholders may also contact their brokers or nominees for information with
respect to the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Information Agent will receive a fee estimated
to be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for its services, plus reimbursement for all out-of-pocket
expenses related to the Offer. The fees and expenses of the Information Agent are included in the fees and expenses of the Offer and therefore
will be borne by the Fund and indirectly by all of its Common Shareholders, including those who do not exercise their Rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Expiration of the Offer</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Offer will expire at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
unless the Fund extends the subscription period. Rights will expire on the Expiration Date and may not be exercised after that date. If
the Fund extends the subscription period, the Fund will make an announcement as promptly as practicable. This announcement will be issued
no later than 9:00&nbsp;a.m., Eastern time, on the next business day following the previously scheduled Expiration Date. Without limiting
the manner in which the Fund may choose to make this announcement, the Fund will not, unless otherwise required by law, have any obligation
to publish, advertise or otherwise communicate this announcement other than by making a release to the Dow Jones News Service or any other
means of public announcement as the Fund may deem proper.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Payment for Shares</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Rights holders who wish to acquire Shares pursuant
to the Offer may choose between the following methods of payment:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
A Rights holder can send the properly completed and executed subscription certificate together with payment for the Shares subscribed
for during the subscription period [and, if eligible, for any additional Shares subscribed for pursuant to the over-subscription privilege]
to the Subscription Agent based upon an estimated Subscription Price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
Share. A subscription will be accepted when payment, together with the executed subscription certificate, is received by the Subscription
Agent at one of the addresses set forth under &ldquo;--Subscription Agent&rdquo;, the payment and the properly completed and executed
subscription certificate must be received by the Subscription Agent by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date. The Subscription Agent will deposit all checks received by it for the purchase of Shares into a
segregated interest-bearing account of the Fund (the interest from which will belong to the Fund) pending proration and distribution of
Shares. A payment pursuant to this method must be in U.S. dollars by money order or check drawn on a bank located in the United States,
must be payable to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and must accompany a properly completed and executed subscription certificate for such subscription to be accepted.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(2) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Alternatively, a subscription will be accepted by the Subscription Agent if, by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date, the Subscription Agent has received a notice of guaranteed delivery by facsimile (telecopy) or otherwise
from a bank, a trust company or an NYSE member guaranteeing delivery of (i) payment of the full Subscription Price at the estimated Subscription
Price for the Shares subscribed for during the subscription period and, if eligible, any additional Shares subscribed for pursuant to
the over-subscription privilege and (ii) a properly completed and executed subscription certificate. The Subscription Agent will not honor
a notice of guaranteed delivery unless a properly completed and executed subscription certificate and full payment for the Shares at the
estimated Subscription Price are received by the Subscription Agent by the close of business on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;business
day after the Expiration Date.</p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On the confirmation date, which will be &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days following the Expiration Date, a confirmation will be sent by the Subscription Agent to each Rights holder exercising its
Rights (or, if a Rights holder&rsquo;s common shares are held by DTC or any other depository or nominee, to DTC and/or that other depository
or nominee) showing (i) the number of Shares acquired during the subscription period, (ii) the number of Shares, if any, acquired pursuant
to the over-subscription privilege, (iii) the per Share and total purchase price for the Shares and (iv) any additional amount payable
to the Fund by the Rights holder or any excess to be refunded by the Fund to the Rights holder, in each case based on the Subscription
Price as determined on the Expiration Date. Any additional payment required from a Rights holder must be received by the Subscription
Agent within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; business days after the confirmation date (&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
unless the subscription period is extended). Any excess payment to be refunded by the Fund to a Rights holder will be mailed by the Subscription
Agent to such Rights holder as promptly as practicable. All payments by a Rights holder must be in U.S. dollars by money order or check
drawn on a bank located in the United States and payable to &ldquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&rdquo;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Whichever of the two methods described above is used,
issuance and delivery of the Shares subscribed for are contingent upon actual payment for such Shares. No certificates will be issued
or delivered with respect to Shares issued and sold in the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Rights holders who have exercised their Rights will
have no right to rescind their subscription after receipt of the completed subscription certificate together with payment for Shares by
the Subscription Agent, except as described under &ldquo;&mdash;Notice of Net Asset Value Decline&rdquo; below.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If a Rights holder who acquires Shares during the subscription
period [or pursuant to the over-subscription privilege (for Record Date Shareholders)] does not make payment of any amounts due by the
Expiration Date or the date payment is due under a notice of guaranteed delivery, the Fund reserves the right to take any or all of the
following actions through all appropriate means: (i) find other Record Date Shareholders for the subscribed and unpaid-for Shares; [(ii)
apply any payment actually received by the Fund toward the purchase of the greatest whole number of Shares that could be acquired by the
Rights holder upon exercise of such Rights acquired during the subscription period or pursuant to the over-subscription privilege;] and/or
(iii) exercise any and all other rights or remedies to which the Fund may be entitled, including, without limitation, the right to set
off against payments actually received by it with respect to such subscribed Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The method of delivery of completed subscription certificates
and payment of the Subscription Price to the Subscription Agent will be at the election and risk of exercising Rights holders, but if
sent by mail it is recommended that such forms and payments be sent by registered mail, properly insured, with return receipt requested,
and that a sufficient number of days be allowed to ensure delivery to the Subscription Agent and clearance of payment by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
Eastern time, on the Expiration Date. Because uncertified personal checks may take at least &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days to clear, exercising Rights holders are strongly urged to pay, or arrange for payment, by means of certified or cashier&rsquo;s
check with the Right holder&rsquo;s name and Subscription Agent account number identified on the check.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">All questions concerning the timeliness, validity,
form and eligibility of any exercise of Rights will be determined by the Fund, which determinations will be final and binding. The Fund,
in its sole discretion, may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it
may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until
substantially all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. The Fund will
not be under any duty to give notification of any defect or irregularity in connection with the submission of subscription certificates
or incur any liability for failure to give such notification.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Notice of Net Asset Value Decline</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has, pursuant to the SEC&rsquo;s regulatory
requirements, undertaken to suspend the Offer until the Fund amends this prospectus if, after &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the effective date of the Fund&rsquo;s registration statement relating to the offer, the Fund&rsquo;s net asset value declines more than
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% from the Fund&rsquo;s net asset value as of that date. In that event, the Expiration Date will be extended and the Fund will notify
Record Date Shareholders of any such decline and permit Rights holders to cancel their exercise of Rights.</p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Delivery of Shares</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Participants in the Fund&rsquo;s dividend reinvestment
plan (the &ldquo;Plan&rdquo;) will have any Shares acquired pursuant to the Offer credited to their shareholder dividend reinvestment
accounts in the Plan. Common Shareholders whose shares are held of record by DTC or by any other depository or nominee on their behalf
or their broker-dealers&rsquo; behalf will have any Shares acquired during the subscription period credited to the account of DTC or other
depository or nominee. No certificates will be issued or delivered with respect to Shares issued and sold in the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>U.S. Federal Income Tax Consequences</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Employee Plan Considerations</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[TO COME]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Benefits to the Investment Adviser</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Investment Adviser will benefit from the Offer,
in part, because the investment advisory fee paid by the Fund to the Investment Adviser is based on the Fund&rsquo;s Managed Assets. It
is not possible to state precisely the amount of additional compensation the Investment Adviser will receive as a result of the Offer
because it is not known how many Shares of the Fund will be subscribed for and because the proceeds of the Offer will be invested in additional
portfolio securities which will fluctuate in value. However, assuming (i) all Rights are exercised, (ii) the Fund&rsquo;s average daily
net asset value during the twelve-month period beginning &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per common share (the net asset value per common share on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(iii) the Subscription Price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per Share, and (iv) for purposes of this example, the Fund increases the amount of leverage outstanding while maintaining approximately
the same percentage of total assets attributable to leverage, and after giving effect to Dealer Manager fee and other estimated offering
expenses, the Investment Adviser would receive additional investment advisory fees of approximately $&#9; for the twelve-month period
beginning &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
and would continue to receive additional investment advisory fees as a result of the Offer, based on the Fund&rsquo;s Managed Assets attributable
to the Shares issued in the Offer and related additional leverage, thereafter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Investment Considerations and Dilution</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Upon completion of the Offer, Common Shareholders who
do not exercise their Rights fully will own a smaller proportional interest in the Fund than would be the case if the Offer had not been
made. Furthermore, if you do not participate in the Over-Subscription Privilege, if it is available, your percentage ownership may also
be diluted.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition, because the Subscription Price per Share
is likely to be less than the Fund&rsquo;s net asset value per common share, the Offer will likely result in a dilution of the Fund&rsquo;s
net asset value per common share for all Common Shareholders, irrespective of whether they exercise all or any portion of their Rights.
Although it is not possible to state precisely the amount of such a decrease in value, because it is not known at this time what the Subscription
Price will be, what the net asset value per common share will be on the Expiration Date or what proportion of Shares will be subscribed
for, the dilution could be substantial.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The impact of the Offer on NAV per share is shown by
the following example, assuming a $[ ] Subscription Price and assuming full exercise of the Rights:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="2" cellspacing="0" border="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif">
  <tr style="vertical-align: top">
    <td style="width: 80%"><font style="font-size: 11pt"><b>Example:</b><sup>(1)</sup></font></td>
    <td style="width: 20%; text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">NAV<sup>(2)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 11pt">$[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Subscription Price</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">$[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: Gainsboro">
    <td><font style="font-size: 11pt">Reduction in NAV ($)<sup>(3)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 11pt">$[ ]</font></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><font style="font-size: 11pt">Reduction in NAV ($)</font></td>
    <td style="text-align: right"><font style="font-size: 11pt">$[ ]</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(1)</sup></td><td>Assumes that all Rights are exercised</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(2)</sup></td><td>Assumes that the Fund&rsquo;s net asset value on the Expiration Date is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per common share (the net asset value per common share on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;).</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 20pt"><sup>(3)</sup></td><td>Assumes $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in estimated offering expenses and Dealer Manager fee of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Record Date Shareholders will experience a decrease
in the net asset value per common share held by them, irrespective of whether they exercise all or any portion of their Rights.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[The distribution of transferable Rights, which may
themselves have value, will afford non-participating Common Shareholders the potential of receiving a cash payment upon the sale of the
Rights, receipt of which may be viewed as partial compensation for the economic dilution of their interests, although there can be no
assurance that a market for the Rights will develop.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RISKS RELATING TO THE OFFER</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Dilution Risk</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As a result of this Offer, it is anticipated that even
if you fully exercise your Rights, you should expect to incur immediate economic dilution and, if you do not exercise all of your Rights,
you will incur voting dilution. Further, both the sales load and the expenses associated with the Offer paid by the Fund will immediately
reduce the NAV of each Common Shareholder&rsquo;s common shares. To the extent that the number of Common Shares outstanding after the
Offer will have increased proportionately more than the increase in the size of the Fund&rsquo;s net assets, you will, at the completion
of the Offer, experience immediate dilution of net asset value. The percentage increase in common shares outstanding that will occur if
all the Rights are exercised is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%. In addition, if the Subscription Price for the
Offer is less than the Fund&rsquo;s net asset value per share as of the Expiration Date, you would experience additional immediate dilution
of net asset value as a result of the Offer. If the Subscription Price is substantially less than the current net asset value per share
at the expiration of the Offer, such dilution could be substantial. It is anticipated that the existing Common Shareholders will experience
immediate dilution even if they fully exercise their Rights. In addition, whether or not you exercise your Rights, you will experience
a dilution of net asset value of the common shares because you will indirectly bear the expenses of this Offer, which include, among other
items, SEC registration fees, printing expenses and the fees assessed by service providers (including the cost of the Fund&rsquo;s counsel
and independent registered public accounting firm). This dilution of net asset value will disproportionately affect Common Shareholders
who do not exercise their Rights. The Fund cannot state precisely the amount of any decrease because it is not known at this time how
many common shares will be subscribed for or what the net asset value or market price of the Fund&rsquo;s common shares will be on the
Expiration Date or what the Subscription Price will be. For example, based on the Fund&rsquo;s net asset value and market price on &#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the Subscription Price would be less than net asset value and there would be dilution. Assuming full exercise of the Rights being offered
at the Subscription Price and assuming that the Expiration Date were &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
it is estimated that the per share dilution resulting from the Offer, as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition to the economic dilution described above,
if you do not exercise all of your Rights, you will incur voting dilution as a result of this Offer. This voting dilution will occur because
you will own a smaller proportionate interest in the Fund after the Offer than you owned prior to the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[The fact that the Rights are transferable may reduce
the effects of dilution as a result of the Offer. Rights holders can transfer or sell their Rights. The cash received from the sale of
Rights may be viewed as partial compensation for any possible dilution. There can be no assurances, however, that a market for the Rights
will develop or that the Rights will have any value in that market.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Increase in Share Price Volatility; Decrease in Share Price</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Offer may result in an increase in trading of the
Common Shares, which may increase volatility in the market price of the Common Shares. The Offer may result in an increase in the number
of shareholders wishing to sell their Common Shares, which would exert downward price pressure on the price of Common Shares.</p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Under-Subscription</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">It is possible that the Offer will not be fully subscribed.
Under-subscription of the Offer could have an impact on the net proceeds of the Offer and whether the Fund achieves any benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Risks of Acquiring Rights to Purchase Common Shares</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Shares of closed-end funds such as the Fund frequently
trade at a discount to net asset value. Since inception, the Fund&rsquo;s Common Shares have frequently traded at a discount in relation
to NAV. See &ldquo;Description of Common Shares.&rdquo; If the Formula Price is less than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
% of net asset value on the Expiration Date, then the Subscription Price will likely be greater than the market price of a Common Share
on that date. In addition, the Formula Price, even if above &#9;% of net asset value, may still be above the market price of a Common
Share on the Expiration Date. If either event occurs, the Rights will have no value, and a person who exercises Rights will experience
an immediate loss of value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">There can be no assurance that a market for the Rights
will develop or, if such a market develops, what the price of the Rights will be. Changes in market conditions may result in the Common
Shares purchasable upon exercise of the Rights being less attractive to investors at the Expiration Date. This may reduce or eliminate
the value of the Rights. Investors who receive or acquire Rights may find that there is no market to sell Rights that they do not wish
to excise.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><b>PLAN OF DISTRIBUTION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>Distribution Arrangements</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
will act as Dealer Manager for this Offer. Under the terms and subject to the conditions contained in the Dealer Manager Agreement among
the Dealer Manager, the Fund and the Investment Adviser, the Dealer Manager will provide financial structuring and solicitation services
in connection with the Offer and will solicit the exercise of Rights and participation in the Over-Subscription Privilege. The Offer is
not contingent upon any number of Rights being exercised. The Dealer Manager will also be responsible for forming and managing a group
of selling broker-dealers (each a &ldquo;Selling Group Member&rdquo; and collectively the &ldquo;Selling Group Members&rdquo;), whereby
each Selling Group Member will enter into a Selling Group Agreement with the Dealer Manager to solicit the exercise of Rights and to sell
Common Shares purchased by the Selling Group Member from the Dealer Manager. In addition, the Dealer Manager will enter into a Soliciting
Dealer Agreement with other soliciting broker-dealers (each a &ldquo;Soliciting Dealer&rdquo; and collectively the &ldquo;Soliciting Dealers&rdquo;)
to solicit the exercise of Rights. See &ldquo;&mdash;Compensation to Dealer Manager&rdquo; for a discussion of fees and other compensation
to be paid to the Dealer Manager, Selling Group Members and Soliciting Dealers in connection with the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund and the Investment Adviser have each agreed
to indemnify the Dealer Manager for losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer
Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated
by the Dealer Manager Agreement except for any act of willful misfeasance, bad faith or gross negligence of the Dealer Manager or reckless
disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Prior to the expiration of the Offer, the Dealer Manager
may purchase Rights in the open-market and may purchase Rights offered to it by the Subscription Agent from electing Record Date Shareholders,
that remain unclaimed as a result of subscription certificates being returned by the postal authorities and/or unexercised Rights of Record
Date Shareholders whose record addresses are outside the United States that are held by the Subscription Agent and for which no instructions
are received. The Dealer Manager may purchase such Rights as principal or act as agent on behalf of its clients for the purchase (and
resale) of such Rights. The Dealer Manager is authorized to exercise Rights it acquires prior to the expiration of the Offer for delivery
of Common Shares prior to the expiration of the Offer at a subscription price equal to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].
Prior to the expiration of the Offer, the Dealer Manager may independently offer for sale Common Shares it has acquired through purchasing
and exercising the Rights to the public or to Selling Group Members at the offering price set by the Dealer Manager from time to time.</p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Although the Dealer Manager may realize gains and losses
in connection with purchases and sales of Common Shares, such offering of Common Shares is intended by the Dealer Manager to facilitate
the Offer, and any such gains or losses are not expected to be material to the Dealer Manager. The Dealer Manager&rsquo;s fee for its
financial structuring and soliciting services is independent of any gains or losses that may be realized by the Dealer Manager through
the purchase and exercise of the Rights and the sale of Common Shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Record Date Shareholders who do not wish to exercise
any or all of their Rights may instruct the Subscription Agent to try to sell any Rights they do not intend to exercise themselves. Although
Rights are expected to trade on the NYSE through the last business day prior to the Expiration Date, Subscription certificates evidencing
the Rights to be sold by the Subscription Agent must be received by the Subscription Agent on or before 5:00&nbsp;p.m., Eastern time,
on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(or, if the subscription period is extended, on or before 5:00&nbsp;p.m., Eastern time, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days prior to the extended Expiration Date). Upon the timely receipt by the Subscription Agent of appropriate instructions to
sell Rights, the Subscription Agent will ask the Dealer Manager if it will purchase the Rights. If the Dealer Manager purchases the Rights,
the sales price paid by the Dealer Manager will be based upon the then-current market price for the Rights. The proceeds from each of
such sales to the Dealer Manager will be remitted to the Subscription Agent, which will hold such proceeds in an account segregated from
the Subscription Agent&rsquo;s own funds pending distribution to each selling Record Date Shareholder. It is expected that following each
such sale of Rights to the Dealer Manager, the proceeds from each such sale will be received by the Subscription Agent within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days of the sale and that the proceeds will then be remitted to the selling Record Date Shareholder within &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business days following the Expiration Date by the Subscription Agent.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In the ordinary course of their businesses, the Dealer
Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Investment Adviser and their
affiliates. In addition, in the ordinary course of their businesses, the Dealer Manager and/or its affiliates may, from time to time,
own securities of the Fund or its affiliates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The principal business address of the Dealer Manager
is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.]</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Compensation to Dealer Manager</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">[Pursuant to the Dealer Manager Agreement, the Fund,
has agreed to pay the Dealer Manager a fee for its financial structuring and solicitation services equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%
of the aggregate Subscription Price for Shares issued pursuant to the Offer and the Over-Subscription Privilege.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Dealer Manager will reallow to Selling Group Members
in the Selling Group to be formed and managed by the Dealer Manager selling fees equal to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%
of the Subscription Price for each Common Share issued pursuant to the Offer or the Over-Subscription Privilege as a result of their selling
efforts. In addition, the Dealer Manager will reallow to Soliciting Dealers that have executed and delivered a Soliciting Dealer Agreement
and have solicited the exercise of Rights, solicitation fees equal to &#9;% of the Subscription Price for each Common Share issued pursuant
to the exercise of Rights as a result of their soliciting efforts, subject to a maximum fee based on the number of Common Shares held
by such Soliciting Dealer through DTC on the Record Date. Fees will be paid to the broker-dealer designated on the applicable portion
of the subscription certificates or, in the absence of such designation, to the Dealer Manager.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition, the Fund, has agreed to pay the Dealer
Manager an amount up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; as a partial reimbursement of its expenses incurred in
connection with the Offer. The fees described above are one-time fees payable on each date on which the Fund issues Common Shares after
the Expiration Date with respect to the Dealer Manager, and on or before the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
business day following the day the Fund issues Common Shares after the Expiration Date with respect to a Selling Group Member or Soliciting
Dealer. The Fund will also pay expenses relating to the printing or other production, mailing and delivery expenses incurred in connection
with materials related to the Offer, including all reasonable out-of-pocket fees and expenses, if any and not to exceed $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
incurred by the Dealer Manager, Selling Group Members, Soliciting Dealers and other brokers, dealers and financial institutions in connection
with their customary mailing and handling of materials related to the Offer to their customers. No other fees will be payable by the Fund
or the Investment Adviser to the Dealer Manager in connection with the Offer.]</p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>LEGAL MATTERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Certain legal matters will be passed on by Skadden,
Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois, as special counsel to the Fund in connection with the Offer. Certain legal matters
will be passed on by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, as special counsel to the Dealer Manager in connection with
the Offer.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
serves as the independent registered public accounting firm of the Fund and will annually render an opinion on the financial statements
of the Fund.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ADDITIONAL INFORMATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Prospectus Supplement and the accompanying Prospectus
constitute part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act. This Prospectus
Supplement and the accompanying Prospectus omit certain of the information contained in the Registration Statement, and reference is hereby
made to the Registration Statement and related exhibits for further information with respect to the Fund and the Common Shares offered
hereby. Any statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance,
reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each
such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment
of the fee prescribed by its rules and regulations or free of charge through the SEC&rsquo;s web site (http://www.sec.gov).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><div align="LEFT"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="fp0092922-1_01.jpg" alt="" style="height: 95px; width: 500px"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 1in"><font style="font-size: 14pt"><b>Rights</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NXG Cushing<sup>&reg;</sup> Midstream Energy Fund</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Subscription Rights to Purchase Common Shares</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM OF</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS<br />
SUPPLEMENT</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="LEFT"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 27; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>srv-20250410.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6I5s7xRiXgOn8uCb39cSaqN6bPtyZN76YkxsGd2fcl6vy0pRb+7NiZEmhpGwREB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srv="http://cushingcef.com/20250410" elementFormDefault="qualified" targetNamespace="http://cushingcef.com/20250410">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="srv-20250410_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="srv-20250410_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="srv-20250410_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="srv_SeniorSecurityMember" name="SeniorSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" name="RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="srv_AdditionalRisksofRightsMember" name="AdditionalRisksofRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>srv-20250410_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_SeniorSecurityMember" xlink:label="loc_srvSeniorSecurityMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_srvSeniorSecurityMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" xlink:label="loc_srvRisksAssociatedwithOfferingsofAdditionalCommonSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_srvRisksAssociatedwithOfferingsofAdditionalCommonSharesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_AdditionalRisksofRightsMember" xlink:label="loc_srvAdditionalRisksofRightsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_srvAdditionalRisksofRightsMember" order="100" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>srv-20250410_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_SeniorSecurityMember" xlink:label="srv_SeniorSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srv_SeniorSecurityMember" xlink:to="srv_SeniorSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srv_SeniorSecurityMember_lbl" xml:lang="en-US">Senior Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" xlink:label="srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" xlink:to="srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember_lbl" xml:lang="en-US">Risks Associated with Offerings of Additional Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_AdditionalRisksofRightsMember" xlink:label="srv_AdditionalRisksofRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srv_AdditionalRisksofRightsMember" xlink:to="srv_AdditionalRisksofRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srv_AdditionalRisksofRightsMember_lbl" xml:lang="en-US">Additional Risks of Rights [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>srv-20250410_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_SeniorSecurityMember" xlink:label="loc_srvSeniorSecurityMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_srvSeniorSecurityMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember" xlink:label="loc_srvRisksAssociatedwithOfferingsofAdditionalCommonSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_srvRisksAssociatedwithOfferingsofAdditionalCommonSharesMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srv-20250410.xsd#srv_AdditionalRisksofRightsMember" xlink:label="loc_srvAdditionalRisksofRightsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_srvAdditionalRisksofRightsMember" xlink:type="arc" order="10" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>fp0092922-1_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fp0092922-1_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #'!!L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH 050UXXT:^(."('.?3Y35\5GZ_\
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MGDTM%% !1110 9(Z'%=!X?\ B#XD\+S1OIFM7MH(SE8TG;9QV*YQCZBN?HH
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M5CB(G[J<'[W>@#Z*HKPO]G']H#4?C5=ZQ%?:=;V*621NA@).[<2.<GVKW2@
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MQ_Q*?KZ\]J_2_P"'WCS3/B-X6L];TN4/!.H+1YRT3=U;W!H(.GHHHH ****
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M+"YM9-DT$D3CLZX(YK]<1IUJ  +:(8Z8C%4-2\):+J]N\-YI=I<1L,$/"O\
M/&: N?DM2U^A7C3]D#P'XGCD>RM9-$NR"5>T;Y-Q]5.?T(KY@^*7[*7BWX>)
M+=VL7]N:6G)N+1#N4=RR<XQ]:"CQ2BAE*-A@01P0>#0!F@!&KZ9_8ZTGQ_)X
M@^UZ5.UMX55\79N@6ADQV09^][C\:I?L]_LKWOCQK?7?$T<EEH.0\4!^5[H>
MH]%/K^5?<NC:+8^'],M]/TZVCM+.!0D<,8P%'2@EFA1110(**** $/2J&O\
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M=VNX[9(R>N/4>OM[U^E/AGQ+I_B_0K/5],G6XLKN,21NIS^!]QT(KX>_:$^
M']@>'-*\9Z#;D:?/:Q&_@09$,A4?.!Z'O[FJO[*_Q[;X=:VF@:Q.Q\/WS@*[
M$G[-(> P]CW% ,_0 C-?DYXY_P"1YU[_ +"$_P#Z,-?J]#,EQ&DD;!XW4,K
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MKU[JU_*T]W=RM)(['))S_(<5[S^V'\7O^$Q\6)X:TV<OI>F-B0H?EEF[G/<
M8'YUY5XT^&=SX(\(>'-2OMT=WJZO.L1XV1@@+D>IY/Y4#/?_ -@7_D(^*_\
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M2R[%2U^R_P!/\CU,+7^Q(]IU.R74M.N;1V*I/&T3,O4!ACC\Z_,;XS_"V_\
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M$NSP_?EB%E9LP.,\?-V//<=NM?0-AK6GZI;I/:WD%Q"XRKQR @T#V/S/\?\
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MKS3]H/\ Y+9XQ_[",O\ Z%7W5^SIJ%I%\%_"J274*.+-,JTB@C\,T!T/ _\
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MI^)/$NFZ6WABTB%W.L1D6Y<E03R<8H"S/KRBBB@04444 (>E4-?_ .0-??\
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M?H7HD;0Z19QNI1TB564]0<5=VB@#% "T444 %%%% !1110 4444 ?E[\?/\
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MSNP2&6;R)">RL/\ $"OTS!R*"6+1110(*\>_:S_Y(3XB_P"V7_HQ:]AKQ_\
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M(K&,MA1@W$8!)0^X[?E7T#2$ T ?D%-%);S/%*C1R(Q5D88((Z@CU%-KZO\
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M+X>_Z_(_YURM=5\*_P#DHOA[_K\C_G0!^JU%%%! 4444 (>E4-?_ .0-??\
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M;B6V\*(-$L <+<,H:=_4\@@#\*\G'Q(^(NNN]U'K&LW.X_,\+.5^GRC'Y5]
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M22-QD,IX(-?G9^TI\#)_A1XG>ZLT9_#]\Y:VDQGRF)R8S[CMQW%?HW7-^/O
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M .AF@.A[?7A?[7/Q'/@?X9SV5M+Y>H:N3;1XZA,?.?H1D?C7N3<"OSH_:O\
MB2?'OQ.N;>WDWZ=I0^RP%3PQZLQ'KDD?A0"W,+]GOX='XE?$W3+&5-]A"_VF
MY)&044YP?KC'XU]R_M ?#J'Q[\*M3TZ&+_2;2+S[4(H+!D&0H^H&*^5_V7_C
M-X-^$&GZG)K,=XVJWLH4R01!@L2@8'4=\U[PW[:GPY92I.ID$$'_ $4?_%4
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MQO-I\[.(U8RV5XN1YB=F'N.*!(^N?VX_^226?_82C_\ 07KR3]A#_DHVN?\
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MEN=9N-375;EH?+AQ#L\HG[QZGJ.* //!^P F/^1O_P#)'_[91_PP"G_0W_\
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MX.1ZYJM\!?V:Y/@OXDO=4;6EU$7-M]G\L0[<?,#G.?:@H]XHHHH)/!/VSO\
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MV(KD_P#A27@;_H5],_\  =?\*!W/RWVM_=-&UO[IK]2/^%)>!?\ H5M-_P#
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M -P_E1Y3_P!P_E7Z"_\ "I_"/_0O6/\ WX7_  H_X5/X1_Z%ZQ_[\+_A6?\
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M &?;-?3_ (!^$GA?X:V0@T/2X8' PUS(N^9OJYY_#-=GC%+0(**** "BBB@
MHHHH 0]*H:__ ,@:^_ZX/_Z":OGI5#7_ /D#7W_7!_\ T$US8C^#/T8GL?*7
M[,'_ "5/4/\ KE)_,U]>#K^%?(?[,'_)4]0_ZY2?S-?7@Z_A7Q?!G_(M?^*1
MRX;X/F+1117WIUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'I5#7_P#D
M#7W_ %P?_P!!-7STJAK_ /R!;[_K@_\ Z":YL1_!GZ,3V/E+]F#_ )*GJ'_7
M*3^9KZ\'7\*^0_V8/^2IZA_URD_F:^O!V^E?%\&?\BY_XI'+AO@^8M%%%?>G
M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 )WJEK$37&E7D: ;FA<#MR0:
M**QJJ\))]@/GCX!?#?7/"WQ"O+[4+>..WDCDPRRJQZ^@-?28HHKY[(,+3P>#
MY*6UV]3GH*T!U%%%?3G0%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 10, 2025</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Nov. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001400897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="text">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NXG Cushing Midstream Energy Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Energy Square<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4925 Greenville Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 1310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">692-6334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="text">From
time to time after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesTableTextBlock', window );">Senior Securities [Table Text Block]</a></td>
<td class="text"><p id="xdx_A88_ecef--SeniorSecuritiesTableTextBlock_z3mHiEfZZW01" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">SENIOR
SECURITIES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table sets
forth information about the Fund&#8217;s outstanding senior securities as of the end of each fiscal period indicated. The information
in this table for the fiscal years ended November&#160;30, 2024, November&#160;30, 2023, November&#160;30, 2022, November&#160;30, 2021
and November&#160;30, 2020 is derived from the Fund&#8217;s financial statements audited by Ernst &amp; Young LLP, independent registered
public accounting firm for the Fund, whose report on such financial statements, together with the financial statements of the Fund, are
included in the Fund&#8217;s Annual Report and are incorporated herein by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Fiscal Period Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Title of<br/> Security</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> Principal<br/> Amount<br/> Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asset<br/> Coverage<br/> Per<br/> $1,000 of<br/> Principal<br/> Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="width: 57%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center">Borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecef--SeniorSecuritiesAmt_iI_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zZyQBp7Szl4b" style="width: 12%; text-align: right">48,315,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zpAsqnlRqb9h" style="width: 12%; text-align: right">5,035</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2023</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zFy7RYsW6u73" style="text-align: right">19,315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zaZTr8qbkCw4" style="text-align: right">5,391</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2022<sup>*</sup></td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecef--SeniorSecuritiesAmt_iI_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____zOeMYYV2Ksw7" style="text-align: right">7,315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____ztR7tWujnGPf" style="text-align: right">13,736</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2021</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zn41P3dDbVt9" style="text-align: right">33,715,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zq5kkxC4I4E4" style="text-align: right">3,399</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2020</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z1AY1TOuYhy5" style="text-align: right">13,915,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLEvuH7fmmqc" style="text-align: right">5,287</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2019</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecef--SeniorSecuritiesAmt_iI_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zYIhi3KYKMYe" style="text-align: right">28,915,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z9sUhBht5Ykg" style="text-align: right">3,411</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2018</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesAmt_iI_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z5zv93OOwz3i" style="text-align: right">26,050,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLdx0SMcCs6j" style="text-align: right">3,932</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2017</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecef--SeniorSecuritiesAmt_iI_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zy1xARDXqA2c" style="text-align: right">33,650,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zdDPD6RTk705" style="text-align: right">3,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: Gainsboro">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2016</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecef--SeniorSecuritiesAmt_iI_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zt2sdQb6pB17" style="text-align: right">49,454,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zxQ7bxjZxB1k" style="text-align: right">3,021</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">November&#160;30, 2015</td><td>&#160;</td>
    <td style="text-align: center">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z374dTwUUhi6" style="text-align: right">43,369,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zJYhi2abQNm8" style="text-align: right">3,136</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: left; text-indent: -0.1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td id="xdx_F08_zMiOvlhfUtJl" style="width: 0.25in">*</td><td id="xdx_F18_zO7tK8jc9Jyf" style="text-align: left">On November&#160;30, 2022 the Fund reduced its borrowings by paying down $22 million outstanding under its
borrowing facility. As a result of the timing of this transaction, the Fund&#8217;s balance sheet as of November&#160;30, 2022 includes
an amount due to the Fund&#8217;s custodian of $22 million, which amount was eliminated when the pay down process was completed on December&#160;1,
2022.</td></tr></table>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><b></b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="text"><p id="xdx_A87_ecef--InvestmentObjectivesAndPracticesTextBlock_zkb5ExMH65f5" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">INVESTMENT
OBJECTIVE AND POLICIES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Investment Objective and Policies&#8221; in the Fund&#8217;s Annual
Report is incorporated herein by reference.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="text"><p id="xdx_A84_ecef--RiskFactorsTableTextBlock_zL8dDfNudWIf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">RISKS</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Investors should consider
the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment
risk, including the possible loss of your entire investment. A Prospectus Supplement relating to an offering of the Fund&#8217;s securities
may identify additional risk associated with such offering.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information contained
under the heading &#8220;Additional Information (Unaudited)&#8212;Risks&#8221; in the Fund&#8217;s Annual Report is incorporated herein
by reference.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Additional risk factors associated
with offerings pursuant to this Prospectus include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<div id="xdx_980_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--RisksAssociatedwithOfferingsofAdditionalCommonSharesMember_zXYqrxuEB7v7">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Risks Associated with
Offerings of Additional Common Shares.</i> The voting power of current Common Shareholders will be diluted to the extent that current
Common Shareholders do not purchase Common Shares in any future offerings of Common Shares or do not purchase sufficient Common Shares
to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#8217;s per
Common Share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds were
fully invested as planned. If the Fund sells Common Shares at a price below net asset value per share pursuant to the consent of Common
Shareholders, shareholders will experience a dilution of the aggregate net asset value per Common Share because the sale price will be
less than the Fund&#8217;s then-current net asset value per Common Share. Similarly, were the expenses of the offering to exceed the amount
by which the sale price exceeded the Fund&#8217;s then current net asset value per Common Share, shareholders would experience a dilution
of the aggregate net asset value per Common Share. This dilution will be experienced by all shareholders, irrespective of whether they
purchase Common Shares in any such offering. See &#8220;Description of Shares&#8212;Common Shares&#8212;Issuance of Additional Common
Shares.&#8221;</p>

</div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<div id="xdx_985_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--AdditionalRisksofRightsMember_zj2X4bNOS2A4">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Additional Risks of Rights.
</i>There are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion
of such an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering,
a shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price per share is below the net asset value per share of the Fund&#8217;s Common Shares
on the expiration date, a shareholder will experience an immediate dilution of the aggregate net asset value of such shareholder&#8217;s
Common Shares if the shareholder does not participate in such an offering and the shareholder will experience a reduction in the net asset
value per share of such shareholder&#8217;s Common Shares whether or not the shareholder participates in such an offering. Such a reduction
in net asset value per share may have the effect of reducing market price of the Common Share. The Fund cannot state precisely the extent
of this dilution (if any) if the shareholder does not exercise such shareholder&#8217;s Rights because the Fund does not know what the
net asset value per share will be when the offer expires or what proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per Common Share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i)&#160;such shareholders participate in the Rights offering
and (ii)&#160;the Fund&#8217;s net asset value per Common Share is above or below the subscription price on the expiration date of the
Rights offering. In addition to the economic dilution described above, if a Common Shareholder does not exercise all of their rights,
the Common Shareholder will incur voting dilution as a result of this rights offering. This voting dilution will occur because the Common
Shareholder will own a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is
a risk that changes in market conditions may result in the underlying Common Shares purchasable upon exercise of the subscription rights
being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription
rights. If investors exercise only a portion of the rights, the number of Common Shares issued may be reduced, and the Common Shares may
trade at less favorable prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable
or&#160;non-transferable&#160;rights. In a&#160;non-transferable&#160;rights offering, Common Shareholders who do not wish to exercise
their rights will be unable to sell their rights. In a transferrable rights offering, the Fund will use its best efforts to ensure an
adequate trading market for the rights; however, investors may find that there is no market to sell rights they do not wish to exercise.</p>

</div>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="text"><p id="xdx_A8F_ecef--CapitalStockTableTextBlock_zKjjMrb2nddj" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">DESCRIPTION
OF SHARES</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a brief
description of the terms of the securities which may be issued by the Fund. This description does not purport to be complete and is qualified
by reference to the Fund&#8217;s governing documents. The Fund is a statutory trust organized under the laws of Delaware pursuant to a
Certificate of Trust dated May&#160;23, 2007, as filed with the State of Delaware on May&#160;23, 2007 and as amended through the date
hereof.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityTitleTextBlock', window );">Security Title [Text Block]</a></td>
<td class="text"><p id="xdx_A8E_ecef--SecurityTitleTextBlock_z5O1RghUR4ze" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Common Shares</p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund is authorized to
issue an unlimited number of Common Shares of beneficial interest, par value $0.001 per share. <span id="xdx_901_ecef--SecurityVotingRightsTextBlock_c20250410__20250410_zkQSRM4jhudc">Each Common Share has one vote.</span> Pursuant
to the Declaration of Trust, when issued and paid for in accordance with the terms of this offering, will be fully paid and non-assessable.
The Declaration of Trust provides that the Board of Trustees will have the power to cause shareholders to pay expenses of the Fund by
setting off charges due from shareholders from declared but unpaid distributions owed the shareholders and/or by reducing the number of
Common Shares owned by each respective shareholder. No expenses have been paid or are being paid pursuant to such provision, and the Board
of Trustees has no intention to cause expenses to be paid pursuant to such provision, which in any event may only be utilized to the extent
permitted by the 1940 Act.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund intends to hold
annual meetings of shareholders so long as the Common Shares are listed on a national securities exchange and such meetings are required
as a condition to such listing. <span id="xdx_90F_ecef--SecurityPreemptiveAndOtherRightsTextBlock_c20250410__20250410_zRerANUHKql2">All Common Shares are equal as to distributions, assets and voting privileges and have no conversion,
preemptive or other subscription rights.</span> The Fund will furnish annual and semi-annual reports, including financial statements, to all
holders of its shares.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unlike open-end funds, closed-end
funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy
additional Common Shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise.
Shares of closed-end funds frequently trade on an exchange at prices lower than net asset value. Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), distribution stability, net
asset value, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond
the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than net asset value in
the future. The Common Shares are designed primarily for long-term investors, and you should not purchase the Common Shares if you intend
to sell them soon after purchase.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Issuance of Additional
Common Shares. </i>The provisions of the 1940 Act generally require that the public offering price (less underwriting commissions and
discounts) of common shares sold by a closed-end investment company must equal or exceed the net asset value of such company&#8217;s common
shares (calculated within 48 hours of the pricing of such offering), unless such sale is made with the consent of a majority of its common
shareholders. The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of
Common Shares at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions. If such consent is obtained,
the Fund may, contemporaneous with and in no event more than one year following the receipt of such consent, sell Common Shares at price
below net asset value in accordance with any conditions adopted in connection with the giving of such consent. Additional information
regarding any consent of Common Shareholders obtained by the Fund and the applicable conditions imposed on the issuance and sale by the
Fund of Common Shares at a price below net asset value will be disclosed in the Prospectus Supplement relating to any such offering of
Common Shares at a price below net asset value. Until such consent of Common Shareholders, if any, is obtained, the Fund may not sell
Common Shares at a price below net asset value. Because the Fund&#8217;s advisory fee is based upon average Managed Assets, the Investment
Adviser&#8217;s interest in recommending the issuance and sale of Common Shares at a price below net asset value may conflict with the
interests of the Fund and its Common Shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund will not sell Common
Shares at a price below its net asset value per Common Share (including with shareholder approval or pursuant to rights to purchase Common
Shares) under this Prospectus or an accompanying prospectus supplement without first filing a new post-effective amendment to the registration
statement if the cumulative dilution to the Fund&#8217;s net asset value per share from offerings under the registration statement exceeds
15%.</p>




<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="text">Each Common Share has one vote.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityPreemptiveAndOtherRightsTextBlock', window );">Security Preemptive and Other Rights [Text Block]</a></td>
<td class="text">All Common Shares are equal as to distributions, assets and voting privileges and have no conversion,
preemptive or other subscription rights.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherSecuritiesTableTextBlock', window );">Other Securities [Table Text Block]</a></td>
<td class="text"><p id="xdx_A8B_ecef--OtherSecuritiesTableTextBlock_zZNDztHwgjNf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_908_ecef--WarrantsOrRightsCalledTitleTextBlock_c20250410__20250410_zKPBI4wQFAG9">Subscription Rights to
Purchase Common Shares</span></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Fund may issue subscription
rights to holders of Common Shares to purchase Common Shares. Subscription rights may be issued independently or together with any other
offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with
a subscription rights offering to holders of Common Shares, the Fund would distribute certificates evidencing the subscription rights
and a Prospectus Supplement to our common or preferred shareholders as of the record date that we set for determining the shareholders
eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer
to the actual terms of such subscription rights which will be set forth in the subscription rights agreement and/or subscription certificate
relating to such subscription rights. The Fund may only conduct a subscription rights offering to the extent that the Board of Trustees
makes a good faith determination that the offering would result in a net benefit to existing shareholders.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The applicable Prospectus
Supplement would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the period of time the offering would remain open (which will be open a minimum number of days such that
all record holders would be eligible to participate in the offering and will not be open longer than 120 days);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the exercise price for such subscription rights (or method of calculation thereof);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the number of such subscription rights issued in respect of each Common Share;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the extent to which such subscription rights are transferable and the market on which they may be traded
if they are transferable;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
or exercise of such subscription rights;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the date on which the right to exercise such subscription rights will commence, and the date on which
such right will expire (subject to any extension);</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and
the terms of such over-subscription privilege;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any termination right the Fund may have in connection with such subscription rights offering;</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">the expected trading market, if any, for rights; and</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">any other terms of such subscription rights, including exercise, settlement and other procedures and limitations
relating to the transfer and exercise of such subscription rights.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Exercise of Subscription
Rights. </i>Each subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such
exercise price as in each case is set forth in, or be determinable as set forth in the Prospectus Supplement relating to the subscription
rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such
subscription rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription
rights would become void.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon expiration of the rights
offering and the receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust
office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable,
the Common Shares purchased as a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer
any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through
a combination of such methods, as set forth in the applicable Prospectus Supplement</p>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: left">&#160;</p>

<div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Transferable Rights Offering</i>.
Subscription rights issued by the Fund may be transferrable. The terms of a transferrable rights offering will fully protect shareholders&#8217;
preemptive rights, if any, and will not discriminate among shareholders (except for the possible de minimis effect of not issuing fractional
rights). The distribution to Common Shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating
Common Shareholders the potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation
for any dilution of their interests that may occur as a result of the rights offering. In a transferrable rights offering, Fund management
will use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights.
However, there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price
of the transferable rights will be. In a transferrable rights offering, the subscription ratio will not be less than 1-for-3, that is
the holders of Common Shares of record on the record date of the rights offering will receive one right for each outstanding Common Share
owned on the record date and the rights will entitle their holders to purchase one new Common Share for every three rights held (provided
that any Common Shareholder who owns fewer than three Common Shares as of the record date may subscribe for one full Common Share). Assuming
the exercise of all rights, such a rights offering would result in an approximately 331&#8260;3% increase in the Fund&#8217;s Common Shares
outstanding.</p>

</div>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_WarrantsOrRightsCalledTitleTextBlock', window );">Warrants or Rights, Called Title</a></td>
<td class="text">Subscription Rights to
Purchase Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember', window );">Risks Associated with Offerings of Additional Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Risks Associated with
Offerings of Additional Common Shares.</i> The voting power of current Common Shareholders will be diluted to the extent that current
Common Shareholders do not purchase Common Shares in any future offerings of Common Shares or do not purchase sufficient Common Shares
to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#8217;s per
Common Share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds were
fully invested as planned. If the Fund sells Common Shares at a price below net asset value per share pursuant to the consent of Common
Shareholders, shareholders will experience a dilution of the aggregate net asset value per Common Share because the sale price will be
less than the Fund&#8217;s then-current net asset value per Common Share. Similarly, were the expenses of the offering to exceed the amount
by which the sale price exceeded the Fund&#8217;s then current net asset value per Common Share, shareholders would experience a dilution
of the aggregate net asset value per Common Share. This dilution will be experienced by all shareholders, irrespective of whether they
purchase Common Shares in any such offering. See &#8220;Description of Shares&#8212;Common Shares&#8212;Issuance of Additional Common
Shares.&#8221;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=srv_AdditionalRisksofRightsMember', window );">Additional Risks of Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Additional Risks of Rights.
</i>There are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion
of such an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering,
a shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price per share is below the net asset value per share of the Fund&#8217;s Common Shares
on the expiration date, a shareholder will experience an immediate dilution of the aggregate net asset value of such shareholder&#8217;s
Common Shares if the shareholder does not participate in such an offering and the shareholder will experience a reduction in the net asset
value per share of such shareholder&#8217;s Common Shares whether or not the shareholder participates in such an offering. Such a reduction
in net asset value per share may have the effect of reducing market price of the Common Share. The Fund cannot state precisely the extent
of this dilution (if any) if the shareholder does not exercise such shareholder&#8217;s Rights because the Fund does not know what the
net asset value per share will be when the offer expires or what proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per Common Share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i)&#160;such shareholders participate in the Rights offering
and (ii)&#160;the Fund&#8217;s net asset value per Common Share is above or below the subscription price on the expiration date of the
Rights offering. In addition to the economic dilution described above, if a Common Shareholder does not exercise all of their rights,
the Common Shareholder will incur voting dilution as a result of this rights offering. This voting dilution will occur because the Common
Shareholder will own a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is
a risk that changes in market conditions may result in the underlying Common Shares purchasable upon exercise of the subscription rights
being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription
rights. If investors exercise only a portion of the rights, the number of Common Shares issued may be reduced, and the Common Shares may
trade at less favorable prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable
or&#160;non-transferable&#160;rights. In a&#160;non-transferable&#160;rights offering, Common Shareholders who do not wish to exercise
their rights will be unable to sell their rights. In a transferrable rights offering, the Fund will use its best efforts to ensure an
adequate trading market for the rights; however, investors may find that there is no market to sell rights they do not wish to exercise.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Energy Square<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4925 Greenville Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 1310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">John Musgrave<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=srv_SeniorSecurityMember', window );">Senior Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,315,000<span></span>
</td>
<td class="nump">$ 19,315,000<span></span>
</td>
<td colspan="2" class="nump">$ 7,315,000<span></span>
</td>
<td class="nump">$ 33,715,000<span></span>
</td>
<td class="nump">$ 13,915,000<span></span>
</td>
<td class="nump">$ 28,915,000<span></span>
</td>
<td class="nump">$ 26,050,000<span></span>
</td>
<td class="nump">$ 33,650,000<span></span>
</td>
<td class="nump">$ 49,454,000<span></span>
</td>
<td class="nump">$ 43,369,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,035<span></span>
</td>
<td class="nump">$ 5,391<span></span>
</td>
<td colspan="2" class="nump">$ 13,736<span></span>
</td>
<td class="nump">$ 3,399<span></span>
</td>
<td class="nump">$ 5,287<span></span>
</td>
<td class="nump">$ 3,411<span></span>
</td>
<td class="nump">$ 3,932<span></span>
</td>
<td class="nump">$ 3,407<span></span>
</td>
<td class="nump">$ 3,021<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On November&#160;30, 2022 the Fund reduced its borrowings by paying down $22 million outstanding under its
borrowing facility. As a result of the timing of this transaction, the Fund&#8217;s balance sheet as of November&#160;30, 2022 includes
an amount due to the Fund&#8217;s custodian of $22 million, which amount was eliminated when the pay down process was completed on December&#160;1,
2022.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityPreemptiveAndOtherRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityPreemptiveAndOtherRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesCvgPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 3<br> -Subparagraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesCvgPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_WarrantsOrRightsCalledTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_WarrantsOrRightsCalledTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=srv_AdditionalRisksofRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=srv_AdditionalRisksofRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=srv_SeniorSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=srv_SeniorSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>14</ContextCount>
  <ElementCount>46</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fp0092922-1_n2ixbrl.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="N-2" isN2Prospectus="true" isUsgaap="true" original="fp0092922-1_n2ixbrl.htm">fp0092922-1_n2ixbrl.htm</File>
    <File>srv-20250410.xsd</File>
    <File>srv-20250410_def.xml</File>
    <File>srv-20250410_lab.xml</File>
    <File>srv-20250410_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fp0092922-1_01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fp0092922-1_n2ixbrl.htm": {
   "nsprefix": "srv",
   "nsuri": "http://cushingcef.com/20250410",
   "dts": {
    "inline": {
     "local": [
      "fp0092922-1_n2ixbrl.htm"
     ]
    },
    "schema": {
     "local": [
      "srv-20250410.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "srv-20250410_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "srv-20250410_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "srv-20250410_pre.xml"
     ]
    }
   },
   "keyStandard": 46,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 3,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 14,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 200,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 37,
    "http://xbrl.sec.gov/dei/2023": 36
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-10",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fp0092922-1_n2ixbrl.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-10",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fp0092922-1_n2ixbrl.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "srv_AdditionalRisksofRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cushingcef.com/20250410",
     "localname": "AdditionalRisksofRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Risks of Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "srv_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cushingcef.com/20250410",
     "localname": "RisksAssociatedwithOfferingsofAdditionalCommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Associated with Offerings of Additional Common Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "srv_SeniorSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cushingcef.com/20250410",
     "localname": "SeniorSecurityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001398344-25-006954-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001398344-25-006954-xbrl.zip
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M@QYY3JMQ\>MF$GKK!L6!#MSF0.THSK@IGS1VRPW33Z"F->A#F58)@7#[%W3
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M.>;X-Z'%:QOZ\U,W)GN-N<N*D\_>83(0=,-DT71IPUF89IBX&.>0:55=S/I
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M4';D3PK";*B#>AI#BW)J(A]"=:G6TP',D),A^1&JRVR(#JQUH5X'TX'U,W1
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MZ((03*@A250>SWG(&(@71C%4G[0#3M:D@:/RN>'BIF10J7:Q$[3)*2"#_,"
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M8:QHW3.O3851_SCQ&1GBJ1/:FBG.WQ!C5=GD7?%++!636R3"0YRM^X'DH-S
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MGB'TUH QVQJU?+VWW]+V.AY#NZ06@UW;@BW=+/&'<X+).I<80L-*T1XQD$K
M.&GP?U'B5>QU$QJP./336H2.#2;@MM"XP)ZADN*27IL5%8R6;J]OZS[6M#BR
MFNHT[G'+A'^4FR/6:C]H1Y=V^@.\!D9YW@.CU<5L8[)S,CSM7#X_+=>\+W*'
M*>_QTDA$+11S:3P?(T?-UE=4:X/%5-<<Z5GTV+M4O9^3G3KS<(DZ<]()D\5Q
MQN+9&]T*HL],CXECW2W!J9,+<@%IN86D;-NE0Q@"NMV^O3@@<$H"&_;STJ#P
M[.=;16G]$,/!>L^]+F(]'>" QW9$?93M?9D/4G+RA31P5!K\8@\:%6R:A'4?
MNAV%6=,.35F@\-]:,H4T*K>[[L5OG?FFWF'M65D*G<FDI**Y4:/QJ.ZOL<Q2
MHIR@WFTC3A;="(P=:CG*6J"57&FE,C>I/Z(A'FMQ$V"@>*YN"@=F3#:+BPQ7
MQ=5<B^YE>Q[A\SF\F6HZBU5!&'Z$$\GMM@&#F5\:AA^8,A7S?6?$-+"R,)DX
MSE@D.BGB-^-V2LZMW<3654;[NY<LO"BOO?. V?7-27A^\)6\0YCWDTZ3.EW,
MR](V5Y,-!0YB"'XXXWQ\FF/-T.;/*S6'95JO2B:SZ_+N,O/&DIGV-(B)4TK$
M(-D8/WG/'K$G'NI=40V;\P&<#.@+?P0H,7*OC=#Q5/<LP5C)Z^2-ND\U9%&O
MA2;UZW+9V9QOR9K(P>"DF#K+6NU8?Q'O1\5[G)G:JG8E\^M^U*%>%&<^V7N)
M)O@3MCLG%BB=Y;C1@&;-V1O,?_?]FRCYHLU=W;!@'X-UY!<3Q>[8SO-2W!$0
M*VO;;]!R:$<?\:+R6_R]+SZOC<?57703O@\DS< V&(96X-9%G3DFK?!J2 +%
M$+?YS&=RI;9MX3GTGLW6S(L/\[NG!3;AY1F8T!**Q-#O*JXOF ='31DR I3'
MN'UZ$#_((+]W74^BU5LWQ%&3/A.5WH,@:(?:.6E $I\V$G#:^GWVF'NIG(_H
MB;<I8SO7F:1IS]D/\O9ZB65!.!6UR_B]E!"9U]1Q\H7!<Y..+FP+0.)+B='N
M";GVOJ/+M0GU@X&)5$J-S9T,Y^XQ/7;]N@%"7D<%Q8284.SQ??U64/SCY2OG
MVNODH4[FY@3(S"(&O]:"%!W1@NS:M\H:B@\>%6+[K?V%Y4HHM5"9*H$7BMVH
M\\:I*#E4GLVM"[^S5*BW35RL53Q0VSM*C%>M[#%IMO6E[0F1S7-<4KM->MD^
M-<(20EU'(FY41<Y!A%><6/I+M4+O;:@HYX@H=V3 ?EG]1!LZ6'].//7X]'41
M6>P9.N".CA>"'ZGS\W/W].TX-S3OYN5L?'!'(KO3Q-=GFM3/OHZ4HTTT'!]]
M(%.-S^7A:Q15:9%WGQ[>8F?"8^2@?/J2:Z7[5FM'>WKGMG65%Y!H^8X%N 'M
M.QTH;WL]]=)K%BWL$)K79R7S_I5$\X>]@,VT\'#TS<6&3Y5XVLN[AQ.G+:HB
MU!NO11G0KK'&+-+BR!<H)OC\?B:GK\?9(3P3T<R'6D_TK2JMH"*AU2J9"?['
MO(1:;6#CI.RE.[:"W?9R#\)XNYA)HY5$+ X6I>M=\,WK@UMU>8PP7WNXF$7A
M[=A9F@#MN[@@T?%CSX?SBZL!7Y_5I*XSS:M9/&>()V<QO.F!GZ)-(J5_Z&K/
M;$+,\Z=_WC"5V2ZNJHOB@BAGB]H.7M^:WB#0 4F3:.Q?<_C*_>P'3AVSVHF[
MLG>K1G;C,JPR>"^O&^R>[K&G T^PLQ949BTZ0%ZUWX.-G3KM2D ]<\F2SCQU
MT7B7C69O.X$>MX%O+[%1R7!\CL@!2-X<,:UH$CL(W/O#52,(&8))T@.D7*"3
M$IGJ7G+,\LG%"LU7ES+F1>-=2CUWU,B*';104*1N3M"!*$7WD91/=ZJCA$6C
M;S3"NL.^W$E4PH%<2 <Z&B3QV+9EW&!5W%=VFV8AWO,*UW]E=G44-6[ 'XXV
M0JO!R)]Q#=2ZCZ ]A<R/H>4!&VP?G(@-\$-$]-6,72T6UA'/Z"Y3$SQ3QU0?
MZA+YM&@LY>FGNL^##S8VO5[CLN2F1>.2SS.-D7VRJ">)0@0=:.P;X-,/)OD&
M(U['=IV/.7X=;W-$EJM:*+>)SSSQ+8VUB36^+;T7U"<[DKE3:SC9AHI(MO>_
M\[N>%L +;802[A.7VK%CIXX(#59FR#\^4FU7>])E,H?BQAP4NM1&!T3@4SUG
MB4E6K.XBX]:XY[XAW'0@VW8%WA+W[$$#E/@@:-[]7N:5FH" ,\J7/5/-D=:W
M/KZZV,3&+%[ON>N"BZ&DH;CHP)C&)!TP4@&^Z>MDF7DS$R/<LCN4@T-;\HJ:
M;'C+F(]2NBUBD1KN-O(4DP]G!2<^J-Y(ZQ,6F1]=0;>J'1RFF()R?A)-Y?]Q
M$(-?.(\PPH])G-#)_RRQSWIW-LQXE"(+Y4,M'\?0@6GK@?\XJ"1O:N8=U,(@
MA+Q7B;I[@P[TY6/_&GY5Y-V6V>FG/9JW=WE";M_.KFS 7J)J#(R_,JUP[?+C
M%)0K?1R_^)J:[@S>/$VCEM@##!V7F /A&U$EJ^)0XF75RLFNCP_T?_$=?#IC
MTWY,2G^7,!J!U ]L:7:2*_\!O?%U6/)98^K$HG67Y)'N%/0WT=%1:/4T)05+
M1L4=:"&4\@(=K DL)=1V]/U1];&VI=XCJ<_>.(@/\T"+]!D)U2\)7"V"]E/I
M)S(F<(8=!*D &[&GI8G8,ZA[28EI"'G"N?'I[@W<VB*7;BCBO2X'L+<92^6K
MJ(NFC2B]"K)QNVNY(BD:S?:6-<PU"CEN3\O'34>-U.@XKH\(L5DF7 :;W&3;
MV4E1^H9UQHJL-4@3%BM8BXH=X:T9+.FJ,LH,4WD21W<L)C-IIC)HZI,\$+'$
MZ^+V0&&5FE"*&M,&E9,*D%1>YRV-)YYU"/%=TQF_[*+PNJE:U(6 Z:F8W7PZ
M\\G\O%/[0WWW8.1U$K);[&&+!-[(AM953@?0IV&;8W2 DQEYVS%P?Y;GB;Y7
M;TE)D[C!+^E4^;Z1M^7$I+D2HV[[M:RV;_)=O.92AT\.A\/O(<<%3_4CCJ?G
MUL2>(E]VD0^#UIV=FZA#[?'5Q,ZU(R7LG$T-RJV92GVVD^S9^L&@032C28,-
M__-3@X;\DDF((.7"J93?PUJ#/KV(:7OJ4; Q'90@4%0C.XC6=."N':KO'71_
M'17%X+<-G5NB9, $0<,]!Z=R?CZZV:"/ZG(A>%.?R/S9&!&>DY/CGQL.JLWK
M-$%4ES:^@QH)YK6=&Z7OOWA'H;?,*>I_+!9%%50JR@D# 9RQBOK\Z.OLD1HK
MY;UM!=,_.VH")4:77#<4\!JH*'&YD&)-5SQU.Z,Z363K1?:+OL\;'3[P//\>
M(KF1Y-IJP3WEEO51TL$S2N*4OMMDA=IG31[H\^>V#@0S7'L^OJ9M/U@V3X3A
MT/*]CF_*KJ=OH<[?3&?YMZ5+\=?_HAZQ)U'WO ]4D;QT  ..;(X>\J6EV5\+
MGIIOW&0_> 2G-Z2XZ"T,%PO4L3O^2F0,TS!W52@TZK[2Q;)1?()V//!W"VX_
M^K>_V2)4HM6*:?OB4FX2 1.I>WNV>/-H8,3F=6QRY5"U0>\YS%WQ1A]'UW9,
M;":4K\Y42DHS^'J9@A?$^>P7\0(*2]#H)9KO;(-$4*G4F!6J-G'*^PMNUC/$
MY.ZGYU9&R&"?.),UH^#]1DCD5N#V#4<SRZ<)@@/EK73@FRO;69,:S,)4_64L
M@X-&JPG$R!';^-EP.%/Q[.8X>J8_2I)@4\:V*7RO6X3-D+JE%ZJTXB\L>NVA
M0WZE@J@;GY8P9Q[ ^7P'LZJ;IYCW_+9+S+MZ^.-0%AV/[" KVVOUCMKF7[[>
M<;TAZ7X)8PWTLBW 7TR+T!1788((%[^B7QFQ \(=GAY^3UW$3N_JF2-S.G,O
M*#8>-F;73\?#-MSQ^A:,@:D6O"N6T'6]2^:]_#[>ZJMZX6<DZUON('9!16 5
M8CB*0:A_M/?(0FQX!WA)=AU[V\3L1R+9KF@W8N)/P81TH2SS]Z5^>#4F[DWJ
M@B,4& *UIWPKG<2QM>F9X-3B5:H\9=4>7$Q<_8G.N$&.T#/Q8.X;_J $::(I
M#U&\<&MZKI=?6+@_"A^.['XS0]XKZ>;@!-UA HZ31%CA_T][7QX/Y=OV/5FB
M+$-ER3:*0I(0LLU8JI'2B)^D9)(B)+*4&#,H1)CHAY(L6;)/]FPS]J42(A/*
MF!EE9T:,B]G>\7ON^_X\]WT_S^=]W[^>/][WC_.O:_E<YWD<YW%\O^=YG-^+
M%[T]$PPJW\9D?8WX: C1!6\0"L($#X#6<\"]&KEA#[,T['H.*I:5MPD$[QO?
MJF<TL+,+W[6\I]=%^N$_.S39U2<$RBM5N0_RT/D"\8/RM-WEFIO%O2<Y?UXT
MASB@/T-J[]'6[F?MIZ/Z#V?FP'V+=/H>B[HAV5EP?49T3*YOR15XL)?I X/5
MHIMIAT7+P/X^JRJR.!L R30/J2;_$65F_'OIRD.8?N+HE6/-2PH2]UK;6.J'
M>^9:I'X3(@B^$.&09.58YR3?W>OO_?1F8A>:$IRJ9KD@25-]BH3XJXK+DYZR
MJX4.YDE)\1&DJY'94!AST0E6CK*A$6*3L^V)BUJ@A5_G\[8&A1 7+[2YHV@&
M6;8H)A4[<:Z-HY!(&?H2?I_FSR>6'/Y X1?^.O"*>2'D(P7Q\NY&]EBH^\WP
ME 'U_8'=U,P,(?=XX.5/+&0!?TX(NQ3@JSPMF=50X9WZHEKZQEDUU:P+7NKJ
M_\V:'^Q_9LT/=8 9I(#ZJXRP%V/\"3A *T"KLV3IG9*=A/&T^N/?G3]^K\I+
M>;EF-+=6#IO(YMBX9G-!KBJ;Q#QTFS)$&$B'_5Z7X42-@'.G8-4]72+8QQA)
M,M,M1<OX)_YCF BXZ7G$MW4!]"GB.!("U1IGZ0-^]XHG;!7J-TJGOY5DQGA
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MUP]OC ;_QW]VPVL8[MC_ E!+ P04    " "<BHI::/?Y,YH%  !X&P  &@
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M100DCLQ2VDP>;B*W9>16:-,\^B>W\W=Y]>:#V^NI9I41/XHQ,I%=9LLM9>O
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M;$@JW^"WVE%U.%K%ON[5BM[_LJ^)_0]02P,$%     @ G(J*6IS"E6+5!0
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MQ 0Z"1:BVD[(TM@VK S-6A)GR42KQ!^'N0R&D+Q0DH92!QX#]D, @2N\V!1
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MS<.SG,@;NOC*I'8" 7[R$B K?8>^D#[-7@S7P;OAY2KE-R(](^(R8DK<4,J
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MLNA*$FEDG$Q+YJ@MHR="36 K U3$$\JV!!A W*/GT!\5TR-5Q=DH3'6>XY<
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M-[S#2ENUIUZYIR)_?F\:IS6]=I-*GR,Z&S0NWO9CKMS4'I4,NARB-7B8U@T
M!E^[7K\.NVO$R?3TZ;TC<4DAE?@=,O\;SMH^$K^A?(.O7[*K%\RNMI&NT7TD
M;D<#@/@L',J(%G<D+IR^Y&VY"!'9GI?+E-.W4M[>2ZIV]:G:$WQ/$_10ETR9
M3%E$)R$<:SB!5-43MF '=$T*RU>TA_&6;NI0U)@S9&7@AE%,PJ9&S*#E@,&-
M3U","EW9KGYVB+FJ :@>26I:0^CG=J1KRG#I)M/\[1-_ ^8P/02$BVH6 6MB
MOF/$C+[T6F*)MA0?0^"-Y*7 P@T"J8M1DH#U%?9)/&=]]5C7?Z*#A"J@J))%
MU6Z9^EU$,"U_".KB^IKNZ@!""SATS[GC&$%?.@&YZ, T@ /(/A?XHC^C_</S
MPJ!B+G^E0(>=T>33DTN(P) D>P!<Z6,3%E85\H?*RI6(R")%PD-=8Q5L;/MG
MI1OVDA:^"FGAU;]@2C]-;T6;_LVI*^Z_J(5/J!:^Z(6/HQ=R!G_CXUF3FX)>
MW#8O;F^6W@DS.Q7V*<B=DC<+="3()5%-/",SZU-48E1Y"OOAP7RI[@>O9M56
MS-'NMJS> DEHK$!BC@1H.O#S93_/ 409RR]"-34_>,+Y7&P1Q03\65G:I>US
M;SZ?GS>N_YA[!?/D@]]L/]TVJ?7@P?[T^>)$-/]UU;RX:=ZLY@+ON87'C:O3
MV\;9Z?\VL,/Q:BYI@3W[?-/D7L^7Q\WFR;>Q5=?-8SQ>)\W?FF>75^<L8%9Q
M78OLU\5)\_KWZ]/;YO6*+NJ>FW76_+5Q)LX;MZN[H@6VZ12V"9C?"=+A=?/7
MTQM87?-$7'W^>'9Z+!K'QY>?+VY/+WX5GTZOSU=SU??<Q\;)R2ER1MC,TPML
M(?]M\<F<"O)\] Y;:^J#ECRZ+]C3G_^G^/<3JAN\(HP/4<2LJ1+T5W6)]]R[
M3YC.U?8<7_P3X/01UI5=VB*[)P,OC*PF&:NZMGMNFPYQK.IR%M$Y8@J2Z[J9
M55W9/3?JG//K,=IS ?]2&BY[X.Q$@55=["(ZR:P$^55=ZX(GL)!T3O4$J[K$
MQ4_EF<2:3O30K.;*[FN[8:.I55W+ KMTGLU L/)85G6!]]RL M]<U54ML&TG
M5FOZE27'>^[6B8=-/H'?7TNKSN#*=[XE(7<BXW;D#73C4CWC9S77=U\3.TB\
M[5OGBZ1:_BMLVAJKFDOB+(UN)+.<UQ,:7&A:N-Y&:9RL*B(6V.ACU:O00@.L
M\D3ZSA!S2\Z<86U.I- 7'T=PX[="*,<\@Z<)ZR++^":)TC:F'J_J^A;8_VMI
M.H# 1A9&>JWF*N^YB]1R7^>.G=*@$''K?(6UVHV@5W6Q"VPIBB(ZQ);P7=7E
MW7,O+RG+3Y6E,L_"23*KNKH%-N],=H%,SYTD6>%UW7/73@-7#B0EX:F9PE26
MISKOX724E"N:/GE1?U77O,!>EM=,K.H"[^T3]^Z<]HB]'M^2/_Q65[. @##5
M+'/6PSP2&DQOF^>8>OB2XOE(>*81U+\WKD^VSRXO_P>CI#>WC=OF>:698DM?
MG,I5+9WVD!4;AI%=J13GR^/@>((QXV[[8?B%"L',F(M8MY.S4^3U>5=%"W:1
M/AHW-<Z\5^W>N<D[V3YIH!J_<PN'6VXH;EXE7+*I6[*D#&L *AM.Z5/=4O04
MJ6[H^&IV5TKM&CS94:59<9SVN22*"D5E1)"KRLBL'Y"I*LO&0YI*3IR@ QC)
M%6#7UM=:3LP%[UGY?5;>956 U8'Q%3OE 3KAV,5FW* J=G< )=CV ':FIHO>
MU5>TJ+OQSSDGWWQL>CZ8Z6YC=Q"RBA\R0HJ?JK%WQ8]I$&?Q0QK35OBL[XS&
M &MC%>W8$WNY3ZG04+4W@@5&,F:+&RUM/7K(H2D[843U".AHPD*&(@D+FX(=
M'_O.='LX=+$_1NTV!:I.$NK56+KC48N$@)LZ6>V?L*:$)L7YIE!$Q$Y'BAZ.
M>XRX#'?BBX"@K2DSJER/><+>3PTC3[-SU6@G/ 9P?]\> SAGRO>;EY3OITOY
MOGO)^)X[X_M9I4^7M*:?HE.9%T?<S7W2UTBZ)0J9>NU2M* 96<-:$5H> ,5$
M^HK?-+78[;W'^I,7\Y@R!V2SR??)-95 J)0^!3Q?^K$<TB!O/5]O_K80N48#
M]';]SCD'@#$PQ2X7NO_50SM=M.$3;,4[TCTO)#<6<[')A%\H<S<889@>A SS
M_?R]*K Q4E4%5$ *-5X%-JG(M2RZ:9QFS=JHJ95'U;K%P6P8H^3N)%E?HQX@
MD0I+YVX@J#4G! 6_L(<C9:T!O:<Y+?JP\NOOXW\HJ3W14R^8ZQW4WZ#RH3]4
MG%)]JJ6C57]2RBO'IXN01I-?S6"F;P'+ATP4?48:YE2 WUH 3^+])1#/@N_B
M7[^*XS0&TZQ+7?=_C&3WB/ONBW/3%;/)73&YTX=%S\P)5 LN&J"$PW==K.V-
MU?AKGH2Y+:E%GTDN*!EI'64>RXSH=P_?[)#62DP*ITRAUI,;B1T.S)!).#F-
MM N$IW5@;/>S\U-]O.69=7@:[IT78YE]/!$1G#20Y4;4Q-G5^)C"A2AW/A+,
M4T0IM1<)<R%J,*/8;,PL2+?5T^K8+MK=8]&VZZL>E:T1]>D97TKM7ELLW->M
MUX[ (V(]RKYFV /BSKH-BE8:@PR+8^Q&A*8?$M5E(/7YN<%!X[(FWAR"7/@U
MDC*X ZM7B@9-:0>.FF+SEMW]W9V:. '!X "7O95?P5#[Z6!OYRW3<3GI.@@+
MB)+M<!CDSX>#%V'3B#AM@5SWE$YR,\0F$ZKUP<0G8ZNU#CIZV6B&T[2OVOA$
MV$K9B<?>Q$VEK,/,+AOK@TZ*G215-[X3V9;]EHSXQ.[O4H.N-S4UQGX,'KW#
MV<A7;-SUPVY]7[0 E1Y/'*6N;"6#1+^-$ZJ:.1)B;ZC9X>J>T-+6DH6.#T_8
M65*L8F-))OZ5[.,H*F_CN$3(BDT<5>_&U[J9XV,T<:R0 4VLDIYZN&>PK:4P
MJ$(VXC)XT[PXR0%>@8V3ZT=.SFW=B!BE*W9A9(-.V=NHA2"%Y68"8&:,LKS#
M',ERY[O8#"V +Y(>/,RU\4GA -WLT.I_;8%CKI?4L@D!\$- !O8VP@;**/%%
ME^(Y!@(&* >&Z8[.[?IRKFL5-F"U/ <?3PM1'*APX)%CDW<!'@K,#+#J^:2,
M8/_U#$?:1\)V0>)\52$11)QN?\GM!BF  V_HJN@+AIBZU+D0=I^&NJJ;$ =Q
M#WCI.!)4\W/*5Z*N>GJL<$^Z70IC:?O9])K&Z%%NC(1J^8YOR3UZ4W=G5&,<
MVJ@3PGHG;PG-/)H$+IA2\5;- /3:M'N/9))&E(RD+JU79-/G0XP5'A\C$TJ/
M!RPC (:,2BLP1K DV]PJG)"#G?R55Z,7#K&>P#H&%%M"LNYC@) [/Y+7*6:G
M<-F9(ME!O2>9PDOHV1[5TU&MT 8.<N_4=R(&AAZM8S_T3KA0C=9R5.^O/@H>
M30'CRV;9#D=*@PF0>:&[LKN)K @PT06#/Q CZ?!.1+Q_+6R9EK6Z&U<'BB>>
MJ5CQ"3PL:JI:AK4")S3L")%N<;UL?@$=.VK7:CU%JROC^(<5V"Y(Q]ICM16U
MK(%\&Y,YB=%':IZ(2M-U\M2E*,(I.:7"<@\9M.06J>@<N\N! IR$$>H+U-^/
M^)_+"A@//^!H.H>FU?<U=$1G1\B&L@2:3TJU[("&!.P&-U3P=)P+.'F6F;:3
M.3C?U,8W-G^ AD00P,TC&M"&",I9;V\/7XTS[/W=5Y.$%B]YYU6V B4P]#(P
MTXVZN?JCFMU3-M:>:?2,4V1?9C-UXC"-V'0H;%^NTRK%;*6A%YQ0$X4=+S%Z
M,(,R!1L6""T5C<9 +"9%T,0B   HC5S!&-^C*>9!AZZC9L4TKT'G8?2!8Z&"
M=5W<2R5R['/%2[,(@%:=8<>:6.%U/>ZC;,X'3RW,'\:B@"\\!N2V:#FQI_/]
M/<4F<SJ!&36F>F.[*:R9LAK,[;"?*O!>=H2(]!4RE:90P_[5Q$.Z.,U''Y=(
MXGG-@![3>*RY0IB/YBEZ4WV0";(92\YN1$E=$R&S1U0-*5Z;L!UG.GL"95 W
M3A.**::&UTM\XY.3TO86BI9.C_D?3&\)O/N2"+!@(L#-]K14@$;DM+SV>!K
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M^\P:BFFULH [>W!\Q-\IL*R$$E),7I\K6_:UA80FBBVE*F?! (WZTC",J!.
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MR^%&^;7GM3PNJC8):#9$Q6%;!GUZJ:73J]?7&)ZZ: 0C]M)P>^EL@7@!'V7
M1Z ;!8)9?N>Q"XU*04?"#=MI7X^'P@8></)E'+,QK)P9DA!"8UAHL)<7H+.F
M+8$QY9!D(Z<=#D;X#G)UF)<PF6#^7Z!Q,P.;VI4Q1,\CWVY35ETT 2+E43&(
M0&#(@='Q>*]Q"^!S+Y()C2RCRPWL[,C0BYT$B6H7$K84AI6G5Q$X-FA4[@MB
MD6IRM\#N)^W(:_'I0#BBU%<#O2/9Q; T;P?01R2I[HT'L>5FDL$K3";S4+9$
M#+Q:;/:29/#N]>OA<%B/9;O>#>^VYM2D]U\TZ2?2I ^_!TUZ:CLH6L8O&V?-
M3[<;9>2V7T)N^P3<O?I!O<F:LLUJVI:C*KW6A9M'[3U8.9BA]3S\!>./+JO5
MN^_KIM2=JQ5Y_:Z(HS:L9+"S<[AWN+>WO?M_.[OUOP;=#?3@_K)A***G2CT.
M#P9?S0X=[.P,OI:!KT!]\T#,E.M0H*NI,1W3=+7[[,K,+7[H0@CHBW_]*H[3
MN =\F)O2@KPYXIZTXMQS0<1)IR^:@8RZ(U(ZGMGZ\B-4'@WV^SUL@19YQ'2Q
M^B-<E7YX3X:_B7N/=IJX_%39KL^PTJZN+V^NFL>WGV_>MR+Q&MYW\_GJZJR)
MP90EP_!XPN![H=!Y96+U9)0CE550DG9G*$EO*E*29I@C;X[$)>6/Q._$F1,G
M+S;)@C;)]+L>8DG,[35_D*QXW0K=$?4*ZR5]_\/_ U!+ P04    " "<BHI:
M?6FJF<-]  #30@, &@   &9P,# Y,CDR,BTQ7V5X.3DR-3)Z:6DN:'1M[+UY
M<]M6MB_Z/ZOX'7!]XI3413&2;">QG4Z58LMIWQL/SY*[;Y[+]0HB-R6T08 -
M@)+9G_ZM:4^82%&D1#HZ7<>Q)6!C#VNO>?W6+_]KF Z*V40%%\4X_K7;^<7\
M5X5#^&^ __=+$16Q^O67'_B_\-L?Y->_G*7#69 7LUC]_<$H38IGP<'^I A.
MH['*@[?J*OB0CL.DQS_H!2<JBT8/X$5X=5)Z[V#>>\^#<9B=1\FS8/_!K[_@
M6WJ$01JGV;/@@QK"+\Y^/;U0092,TFP<%E&:P-^#XB+*@_=9FD_4H)CFP<ET
M,HG56"5%MP._2=(B&*1C^%&A@C 9PI=FP9D*!A=A<JZ&_> (!C^/\B+C$4^*
ML*"W@TS%\*/D/"A2^(C*59"KP32+B@@6<A'F,(I*@E$4JV%P%147-/I0#>(P
M@Y^HT0CF$UVJ;N=LAN_#2LW;^.3Q5YY"\"(=CZ,\AX_W@]/&Q= [.$PXP.6$
MR0RGYCPJ:PV3((5/9SCK7,5Q9>K=#HXD3^=I' TB6J7[XMET5ETR[#5\-?@W
M_#L?1@/:K:L+E2F:%K^;9D$>QDH//U'9."H*V.9??C@#*L.3A?],UDTFWR=G
M^>3YJK_Y/"C4UV(OC*-S^.< #D5E[?,XF9[]&TX'M_0%TR!L6J_;&0*-#8-/
MW__/TQ]_>OK\\RU-U-^7U1S"V:^OWGUX$[Q[%;S_\.[D_?&+TX\GP<G']^__
M.'YS_/8T.'T7_'8<?#PY?AF\?AN\>/?V+3SR^MW;X%^O3_\1?'C]^S].3^#M
M5\<?7K_]_<3;2_S[WB@<1_'LV3RV\TL^G?QZ\,L/^!^]DV=9\ .L<0<VW[DF
MM/6\#YOY)Y#'X?[AD]W5GM(")W]X<PJ+QN=!G@U@R,G^_M/#IX>'>P?_W_Y!
M_]^3\P=!&!=_?_! ?_1"1><7\-FG3R9?GP/_'!87SX(G^_N3KP_6.46]#ROX
M #QZT'\"7!'_!O_O?S##Y='6(W]'P7(!<B%?X:G.6<KC53",M__W]^#%-+\
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MM5+K4S@5_(6+AF_Q**.[N43Z#O/GK^.1J"G8$6ZO>>63_F.WZ^K/#]NYY?-
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M4H'YT5^;RWTE#_8NZ[L7K^UNK^MVX-/:2ILQMN>7+[./H-M!K"E<&C*EB<0
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MPK5<LK UB::,CAB)@9G1&(V(%!-V.Z;;:J[35)Q)P,<B06 %<IIFTM^V#+F
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M$9(KVTAT\'?E?A,@URC!7.?0 E2;B5;QJ5\[SY;AJ9L-VAK"V^'(FILSH!D
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M8"5U[+GD0:\('+?1JI='Z21U C^N3>/<%A]QH\JP6(=EJJGVRYG]%M".(;>
MZY456F,!DS*;3HM<MR3]F$3DDRMH\!W1+')R&J'!*D*6'^MVY#F./3+B6O"2
MRD<XU^I%&@.51:$AN@)-6]%TR I)<1H<H125QIO";K!C0>";7+^[TI^R*0D>
MK"9$8 8U $V=RPC+ \[I-N*.X7[5#:X1,EAQ&I>!(2RMPB_D?4%>M*DR"]7O
MR":#?B\*G$ZL]W-:,R<[I60:N&J2^U*W(V#6!1="N:ZJ37)(W6B\%19:Y*V)
M&L&UJM"]\O@;>DJ7JAA?1UTTV,;+E"$N6B<8+%0F>(H97@D54',"A<WD-;D5
MNGK"PPJN+X_&!VI9[U;*E\?])Z04EAK(T':O*W)HOWDK$<J[BSE$^1P>[DJ'
M)G(7)DRO4"/K(9;D -,.T2KOZ:Q#;$=-$+C<T]+JNKK4!M,M,;1A(VF<9$2P
M"5_I1_'L9JCI-^3SDWB*>"31^ R1E8P7G[)%I\5>.MJ;I -&Z)'$%>IL;E,B
MG=VL)KFTN/LSI562H4%N:AS ZY2=,;\V* YIEB@WL8A[<"=#4-P&14SA,5Q.
M37&<VX^=F S[E 4 I\&Q]_\@TB")>]3SL^&\V*_Q\!"09V:C,*+7W-7AW_]Y
M.W_V2QJGB5_[,.5>=J$3RI9T!C*L ZY_*T6PR@EI.H=A*V6C?&"14*\N5N&>
M 9+1@$DNQ479]6>",W,2&I!/U%O:HN1<+Z$,O?+:_"8[K<GFVVVI+JOWY)?"
MLH2)!?HZR:=X5NYYU.T0U=EX@9"56[QI(AY234T666);%#LUJF[FP2@<Y-$X
M8G<S)L65DO1K;"J-]F5TY#N4?PL&9_4B768^X%Z]LD85J\D%'E18X#:4L?G
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M&$D&*)T_U@IPZ9M.-=-?XKFSQ^P<# 48G?U4E"WK-V]!UFW;2]BJ W)'$<R
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MU?[91 4W$0W\O_Y/H#&5M*B]_?[A+=4>-^6$:L!J&(44 ^O/H2#X0A=9 Y?
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MO/[MX^GK=V_7FIC1D'A_2WH?)7 X64Q'#(E,&)?K__2M+/'3)DA<+7<YUVM
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M3R]!2E8F_FR-^%M9Q$OWYE]02P,$%     @ G(J*6E8/_ELJ?0$ LSX) !<
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M[VU($@U 9)*8\G88('# YM8E9RK?A/:*^!;O'/C6&8U=AEQ7S)(8F,\4^I-
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MP<^SBIEG*EA!AB$<"H80*Q#BR@+JT(DIGR?T/[#3ZM5'Y_+#Y@)X0B)&_38
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MKSB[G#B[F<#9-G Z@.SR0^!?1T-QG<ZPS5=J'[]86X?V<741LDY.S8Q< )]
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ME+ 7TUU3/PIYXLZBQ8/$J7=1#F.74W[H<L]!S&'?<&<-JS]T&.YSI!^ &1\
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MDSZ?=<X[\V],]:$GE;<SY[^WZ9CF!J+VR-OQN4N,#E!YO]T^F'\S'@I'WF8
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M\YHDN1/CR)^7D+4 SXHF?18?_=8+4MR;KXK[(RGN+U%M?XB'_@NE(F*P?K)
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M 8D&_C4UA]9;A:Y26R)_$L+?B_3YUK9+.]F:WT_O6ZQMEBK-)?!QUNNES66
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M*1:/:$!W\KDIK/:.=O>(N>UN5<);&T&C.]?H>XL*-WW"XN@L>M0A^G,M,"C
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MI>E[[J@C2'B_#!=L6!%KZ@F6F#1 56"UV.#<N&!3]J"7_ [+![*Z6LS=7A7
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MF;$V0E9#I0[F"T>ZMA?_1%V428J(-+!@58;%^;[L9)HF4&^EV]SR6VA4? &
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M[<"-AZT/8G@T'C\\%;R#"FRBS>R)Y+%=3@Y_TM5\M^UVO&[GO:V<5 ZKTY]
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MW'.5(+8(*A1/#[O[XW3K44]>/*@A?J&>3%_MU!+CB+!$4B^M#L JG[)DJ2"
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MO9]):/U<T5 'Q>)05%(ETJR3%G50DNY6L"W' =T1D4!^&$5I/#ES?U*W;$3
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M;<!R<FY7)XG[AE"G 'J;$N=NE"S@\JE2AL>*9F69 +5B<S:R%S^@D]+ZD6R
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MR\IV#J LUDLI+^'F]J)M75>V=JU]74[\>T,/-FLD,7>K%-TUMMVY+/-+V"-
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MF8FE,?"\8Q0/742LYV/NW+F(7FA?L;*')ZG,&)MQ0X-=HHC/S <3%\IU8"?
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M?BPOIX*<^C47>@:_?03!B?L"()UD]<% S:T#=<P*[DX<!0BMBV=WI1[IV?6
M-8HD;#@5<C5P83VUV5!C<Z+W/LC8N*-C+NNI;_]@$R9(B[3DJ *:NVD!X9QX
MUC'"FZI6])$-%_FL]NRLZ?ZJKDFO?U97VO<.7V4:7X5+2N44C;?GY^> Q$#L
M>U&DB:JU"((^3%_1\91:G!>&0U 5TQ%X[7$R><2S;&U_=@38E:OY\2VG6$N;
M W*BQ.V&7#:-QS_,.# +?3CUA5)? P%M.%H(+8.3,D-^.T+RP+]D@N2<X([6
M]D$T52NA-X/<(/#@4Q0N-'Y:BCLQOA(<<'0*>GNY><JKBU4["4JA"&,'7:Y?
M!/0RQ)Z2#G 4Y/"*3:  J6ZG]@EAP(#G95K'^R10Y_@MSJ\G "E7H^A9OKX=
MD>?RW!.H.J/64NVD/QB1M.[0*+GISFYZH" %F.-9>X<Y+$UD4 LH7OL2C(88
MOTNP5(@BCW"5=#>28#Q'ZC'D)8B8H'Q0A5E*'_!Q%V]R0I4P%'#@71/FR%[D
MSBC3R#VX*E@?P^'OQ[S%97IQZ1[3<23B<VH9D!XG064T0:K!H 'KT4CXIN#T
MW%!P)=_=@>.T)5E;7'J%WWVUR;!8IW8"=\%C;_#X8W24B0E1"JT<<(IQ4B>5
M-)*P#[;/Y?X<HQGS47G0"K7VPAA8'+80$2,/RA:IIXBS]J PV47N<NO1%3VS
M<94&[QE5;)1 KQXKQ7:S_,LQ'+@B=!9=STW5:(!EGVL?;&48<&-!99#@ K7#
MIPJ#HGLN#,+80WVT<"R-X\^)D2^$#2AY(W])S7WNVQ7,K^')R8RCCS#JFHV-
M>9 JO1"(AC1;P2^S5Q/7$OG25(94KSHR2MVL5@72D:LL\TP&HEL-];+QJBW0
MQH*)@-FW"ZLS1XV8EH:>WP+Y$[1& J\%7(AI)HF\/:L34#[+!3 ?A.[>Q+"-
MR!B%VE>P,DC/M*7C: [P1"%;M4Z78&IUP@MA9VB;8"5K."\ZK._=3:(EQ*(I
MV!#$?R5Z3% KOF>0?#_W37)H4"KLF<F72U"3*16#"@;79+#[H=B;C JY_.,-
MC(^ ,K7[\6.[/T^JPFI!*Y>XKBZ#1G)E\ 3"OJ&X^)',.0]*!Y>]Y4#8CM[;
M@R=G!)M_H5TM<KE!X("P6-=\L$+!KS2[+Y_N("5;@)M'/SX&E6ZOC.$W. F4
M<Z%6C!CNHC2DF "JE#UHTTF"'28OJ7Q$,-!DE)2]<,H8)0%;= J%(]Q&JK%3
M.P!J8IY+3CA(0NO=K3\=8UE W &?0:&X$FO+IJ7W)L!:@*0P_+UM*^$VUAN[
MW<MTWTCN9?.4,,2N!V;<\"I&VG[(T0>3&T0W7?&M4FPHV+4O[LHZ+)6_<O]^
M)VE,17W*&1&A:FAH@:9.3H4$J.PN1X7822^Z%*@I:Z4VM4X/HF"(-087JI'L
MJ9%'G2-G'+D[,$5/MU:VQMS%O,!,7X_/U%:[,SA>:_ND'0&O3:Y:N3!.K:Z\
MSN]D]<S/W^X]JOSM[LXZ@?M]$KAN5V:NIEA3<3#7F2N))WH8;^CSH:O<?5U\
M[&MQ-(5U4M;]%-ZJ4JX921(*K @N2P$"W(AYUH3OK!M@XMU2."&]62PNJV82
M]7ZQ8NI!BE$"'D.43/TZ::_M%,^.:ZZ7*\;YG<@ <8'U4JQ&@.Q=PWD/V-!Z
MQO$%X025?H)$D#>P9(1N+,D![RFFY,8-FXCSX9ZW&(O )@&-A@ ^@@-"?#L-
M^>XFM:E'HQ=<0F@ICZ\:V.W^+Z*6M\_%CMZNQ4&&'%5GP%  D;F]S5J8><-1
M71$-MX,JM@6D;W7>-F%?H@N$43#DTB;8J?VWYVL>Q;Z+:&V$CF+?H!&0G_>D
M IT\8 I4'.6CZ;B?QO:+]G%:B,.?F< E9E<N4A42)G+0Y$86-'SOQM--*R!5
M 5!:Z^0@81,]B=CS8?I%)]XD!=K=U%L%&QU#OP.J4I7,&C[*QP142P9I]:U(
M<$+.^\+U;/B78VX&KAZ$UZ@"/M765P"B.'[XG/ZF^@7P_@%6FBRJ&-B-TJ$'
M)]>9#R%*:2?-;K:!H0<LYLX?GW>QP#/Q.[@T10$LDE33- (Z=30]B:!<W>K>
MJ%]A8/L1NCC88#V'=/5I%FE=JYZ)L1# OO,OZQ7#PX3"U^S1 3^E(UZJ/<LX
M>B:R1L,KMD,NF7@ OD^=H9]Y*.6AD50(AW0F7,,><'<[LF_@[MXVP@M.!(%"
M_1V0WM0U7BG/1=(_!_)G>6"%]T&,!7VCZ$JJO<9N(\(Q;NH<X\$X&R<UJH0Y
M?5DTK7@<Q.':,F+AS)HP@3#)H98)LQ]$BA <E36>EN6R&>X1VZP#''6$+W4!
M6;#B7-7Q8OQ[,]KP\1IF(KSM(8Y]$K(O2$");*'&LU#6BTW<*S2S'R7G\6L@
M0 11"3PK-4M;;1,V43(R-#N463Z%)$']W2'K4UM*3IK\Y,6M +;M2&+-$VQA
M@)AA*/]+:B!(@WDXY^)+$F,C8!IP[<09*>6-_R#XAGW@"4]A'445'X#K&[M^
M$S-]7%)@YN7C9'-B]0<$$%VE:5,'A;,8L'O4R49TB:Z\WFB/B(]J9\1@>)$*
M^\,!*;.J,2*L7>E.#6K'R*%>8XBA"$?!.+[!\IQ"6@!V?)Y,W)RW;:O 3"-'
MB<0-(K2]]AD1*9:C/)P=3 .SV+6T.R'?L*,>1C* <15QE6HKO*=9+Q&PM=R6
MV64_,$1.=$_7ZNEL+"C#I=:(-T)Y.H\CQ(AUX]9*S^C1 84#ST0:OVA458L>
M=J>O:;^2?7JN?&KLPZB/'!Y<3JY.I1YQTWKUW+@S+KN^STC]C8<T-M5M\*[0
M7T!O)LDN*JQ&QTRXLV#T",#6IN8QH0_(-3)8<VO%HIM30*LH#-/ZLTDT3M2N
M<2@%$M3V3^(9ZK76A3<.V2?/K9]SQ RP"EM+M?( ZX3A@]Q]+R]FY@(PS=G
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M5,=%&&QEE>@BA8_"<OD:Y_*WMQ_>GA[^;HX_O/MX^O[PT_''#TLTN@=S?5V
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M)9*7JU'9%\L>LY9W"O@TW!(F1'3I6(/GA*^5 =39WJE3"U(:)F&7)B2D0&>
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M4WJ#/3%S1L0"2S"NAXJ&)KBCWDJ]H931'PO,!: PKHDAQV#$*X(8.XF>[L\
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MG#VP^$2GG=]T84 5SQ(N%S3A209+!X^E0:[8>GWB??))DDC#Z"]JW<>8?;V
M$5Q-J,T2D9%QD5)F/U5Z%R%;F#<C^V.8)&/64P +L\8OHB*!FJMXB!Z3]T0P
M^>[XT]$_HM/#3\<??CM;(3K)=RF<.J<2/@C((_%O-=+(,F"-[.:+Q'LWHR7D
MB;Q/KD3IK(!5=-C=<CKN0QSAG-G)RO;.AP0C;F,O9)Y"L# 2.P8FM7;MFET=
M'F%_56<%4=.$M+>>,)93&_&,-X[?G$*O _@?9&!,N)TFCE^%*J1NZFHZ@F?[
M?+]BV&LE9O3-?:TH >"RO+1;1ZH3Y6Y"%G"#7J?0[:C@K/&?0Q1D)+WM-)#7
MF*.'292 [35WZH4Z<Y6DMR8=,7W9X\?^8*2LE#Z<^JM9OZ='4X-E<1*HZYX,
MW[[)+L30ZF)VA:Z<"U>4E^E$M[NRAB6D4DJ/BL/($]#V#HBH_P):1+%:EE/5
ME>J-X\^(E]L"I+W0%U2N^^N5M4&MG5/,P#O"DD/DBTG BTE+5Z(Y/U_\[%'E
MBY^O5K[X^RJ_8ZL\+BZ*Y *Y&G'K<#8':U"+(<=6LL]<92$"[:*U7OB=\H$^
MO[SKT^)V580TDI?DB7/?FV$ZD(,O-JYMXB0I0-Y@\D/>4$=E"EW +U.(/6!5
M?BT0SPSXJ, @1&#/69 D^P \]K8X_45?V /4/:09 ;P.*M@%(E+?KHX?IND%
MR\J>$N#5B)WLNS@&AW9TG?3MHY:*9O"[YG@<XZ )FC24<XF:5R(+=7AX&/V#
MJ05K*5L#YC.7>7&C>5_D)0Z6IFJA4%@LNTF?W]S+/" ZQI(-:P(!"!,35<D-
MG'8<1W& D1A:\50S SD!E6C5=I!K_@2OP6PRW:-BK=-,HY3M 0S'+?R;XG!D
M5X &+Y,$=Q)U/%A"U^5^I2'ZL\X,Q>(  ]HV3APZI$&) "ZIXTYL$09A]*"+
M:LL=+;3<IK'<$ =0'<?L LM10%C,]1+C=F_ ,_1>Y[4UMZQMZ[+>;0&Y!;NC
MA$,9J&UB*%7K11FP^%I= ^4%/21%1!,V6%O>U%$?0,+8Z[*( ,N<CZT:=T':
MDL[^M/0(\',\RI'+QO<K6R6A>/WZ-2'QYHB%O:8N&&X',Z YE(_0?P/R/Z)H
M'J%&^&II,;& R2"QMNC:PSA0=/QQ0.PC@D.B\:S<^D=G'L&%JCYRR]ZYZA *
M@/P\G)Z=OC^L?D]!(.C,#TCR9>TH?89AD5N6T2"5-D!@?O8,W_H>+S_6J[])
M>5@(6"@YYL\0,U(#E%QFOZ/]K%DQB<!C(J0_#-7!?&5@/2$[ #N%@19(RXB+
M20BA LB^,79#HG%B%"(^3X!C/H$TC+7HWK6J@E"?4$?C<5(I<0A4"V7BI[ZG
M PPE/#V&287H_5@*AT$NG$R!"^8$,<FN4GM2(1QEM<3BZ.@H.NO@N45_@8.(
MF :R:P@XRMP:_+0!5VZRE#5-E>0>CV?(9-)S!L(/H(_/*8!:)A.L[)\4>1]3
M8"LV=UAUX[U!-%I_QSF$<*RX\78.Z;12<I=:+9%QIMW^<)4B%KT7,::,<7MI
M26T=[,:V0QFM5%KP*+"%I4T\JF^KYJDM$*OY(W'T'$);0?0<S(HS%L!C^7 !
MID?<S7<CWERHDZ^2;TB*8\!<X%\Q(.('F+:%[(9T(*'T&ZRH3HR@"+@SO"V=
M\O.ZH_-WEH'^MY"!*AE#TA )JR_RBI'*,62?(N$,1WT8Q1=%0A7 7D1B,9^,
M2NW=)BCVN6M9^<ZR,EA,5L(L@>_?U$]&T!,);#CG=(%.X$/A](V<"E9D^'?N
M5Q1@58>PT8>P3VT+D0[F:R&C 3GN+)]F@\2K(.B"S'E?K)]/;LA)7,Y^\M_1
M=CA] RC"JD@Q=NV24LI!<XO4ZKBSAJ#$<18Y' =U7J9VBZ0_7/(*V*A<:EP.
MBD / &55+QKEV+&/&TR+;C!MN@&=0'+'!<05Z"N?,[>J943X$YT[!Y(HG3SO
M<:48YR!D#"Q>UREB+;>F$X.,5D/[)41Q$@[![X-!0JG'2>+) :SA2+"!![)Y
MV@S'QZS*[F#ZE E .)!AHDT\77(76='9$"H02X'ARGZU-FJ6V*@1U8/\<3,J
M\Y@IH!K;MV37]@(C%^F]2!*L+N@G,4&CZB:PB3OT&A \@EK#J!+DA;F0HO2L
MT@V%M[C5/!]A\_Q1(6Q>K"+"YC%OX 4M3>J>6R69,*Z/[>Y*)T 5C\X'1>T;
M>[.D"NK6?0ELC]+L>*Z586>,R2TAX@/63$FQ(4A+Q*-1,EK[* \@.</%)">Y
ML2K6(;0Z/8(NB>A GB[E:G]'$_*-1$P#G^'.+H/XCLX?U)[#-[/D3;<E'RE+
M'JILG2'?,.(EE;-*@5Z)BNL"3>+5) R6D6Y9=MI'3&[!V'2*EJ=!!_J?A5.=
M<N5V[/:EO3!PB AQ7ZXM#3^PH*JD$L>D +(-9@*! ($VW*C\U<.Z8;C]H'&@
M[]Q.5>>>+P MPUB7,;BWY47-/)QFU"S>/2PMC9>986%G))/^-BRX3@H=/CLM
M!M,QQ,P&)'Y(5C(G9K$TZ,M[?"F"^8\Y_".<#CS)QE<'%[ RCE4W'PQBM RN
M 9[><M[#EL:*(JM-TG&L*KNDT!NK'DIL7825UB[HQ$X[PH@@:Y'<$-6LZ2?R
MNDQ'3*$9#HJ9XDT4]G1X,A2R 'J(/F43[XD#Z8JL/J(R<BXN!$C^0$AC:I^V
M;0XS$JMXA(R Z,!*94+K"$D+ GB1 V;#.6)'@\;- (I<V.OEV*1@+Q1\F1(2
MYY"RCV>X_Z^3Q/?Z2L? .0%/.)_"OET):0;(NIT=1*CV:H0 E"8;!AI6JDC*
M-JBZG(VQYY+.RPH<V"*?%#BUM;9II/7*"DM5A$VD8(X#:+<VS?"\Q)2=XW<A
MSMY9C9[2<PF$Z%RJPD? .=:U:_8$3Z?26D\#5$GY@($9U,3!"&')2HC'5[7Y
M^Z3ZVY6&]>;?16%R8-W^:DM^)50 ND^;(RK-!:7I2B#LL51-2SFQQ_$_\Z(F
M7]#Z)$("!^00ODF(!A\-A"&_H>("K1 #[O#T6(8EXDHI]KS]K\B @8RD-0#1
M$MICW[<V 1!0M*.,\-YP15Y0K$"U"AW1YL=?JW FP=N1GR_'#V184OF,#!BO
MI-?&&J%PG][\?_S;RV?/7_Z\D$?O"99+:=C$=5@Z2*\JL-1QI8NQKI#@<Q9=
MH*T.:%"VOY;3NU^O?M?JN^)B1>P$Y.*)!/EKYHCJ2XF8A7SPV<&[O( 8)E8"
MI"<^#*WP)4X?KP5D(0'Q9*!Y*QUZBW2LU_L'7F\"$$/?'OM#A$XJ+GY68_,I
M+XE8R[G*XF"O%__'7?QR"D$<*M_0KBEXT8-\"B%FXN@$"U 1#Z\7_0===#CN
MN?R,?%EA>JVK>8GG]P2>@U2&NO8'HMOGT)HM]R7_<^(R4/51+4!GLIRB]1TI
M;"B5(&7<PN3CJ)VEU(NR1FIVH3EDD53$0^+L_+A(XE(ZR%!58-RWMKT]Y\M*
M2GJ3F\L8AG65N$ O<T<,%5FLW?Y./LP@SZQ;@,BUE0E&!9U=9:4.)=EC15B:
MZMHI^Z@B>6GF" CM!)\ 2], Y_E,F"^'7(>%16#4Q>50DZM[-N1F._94*#Q2
M#*<:+OAG!>^?T<T?Y#A'A3T)DS$.>P.![WB, R:5X2*LK@C,_GN<))52#GGX
M_?%@D!=#A!ZX4*L0K=+7$#>D-))TU,3^.=M1R^P'E =V% U"(H-!68045:Y!
M/=":0%2_E"@@3A.&:"4<Z%A1V&$B>:=Q?/)$T.C_  E7R6U#=_>CL97$RY(+
MXV39C6.0Z@5M,^KD?? W>M+^,_VDVGS^L7VV37Q? YYT<>T>(@.[!"V(WNV^
M<DP;C9X6)JBX9@[XI%3]3^"V-*N*-"L!P:B+&R'R$78A:*U@I0BR:\Z-$=Y:
MV-GX.#*<P^V$'!1<X_3M0B11+QX5A.WE:D'8'JJIT+N]5\1)<,MFP6N^;F<L
M80KB7F=V_U7T+DY;^I2%,PNFV-=-+";DF:9AQ2;Y]2M-J:"FVK1Q;+RW1@
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M>V/[=I%AMRG8[E4Q%_4<U1,9VR2T+(ZG[,:R>^SS63%HE8<VY/<61G>+(UX
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MH[%Y1/(IT)_ET?5*->/G+U!+ P04    " "<BHI:1JD:>1X#  ".$   %
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M"[_D3 P;[J='-2";+J$;4\V:@>,M:"?UBE1]4@O#*OES?Q?% \@H9L*E+8;
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M<# P.3(Y,C(M,5]E>#DY,C4R9VEI+FAT;5!+ 0(4 Q0    ( )R*BEHS8#Z
MKP(  !@)   8              "  55E  !F<# P.3(Y,C(M,5]E>#DY,C4R
M;BYH=&U02P$"% ,4    " "<BHI:/\S(V;$%   ^-@  &
M@ $Z:   9G P,#DR.3(R+3%?97@Y.3(U,G,N:'1M4$L! A0#%     @ G(J*
M6IS"E6+5!0  KAL  !@              ( !(6X  &9P,# Y,CDR,BTQ7V5X
M.3DR-3)T+FAT;5!+ 0(4 Q0    ( )R*BEKH%?32RS   (-5 0 9
M      "  2QT  !F<# P.3(Y,C(M,5]E>#DY,C4R>FDN:'1M4$L! A0#%
M  @ G(J*6GUIJIG#?0  TT(# !H              ( !+J4  &9P,# Y,CDR
M,BTQ7V5X.3DR-3)Z:6DN:'1M4$L! A0#%     @ G(J*6E8/_ELJ?0$ LSX)
M !<              ( !*2,! &9P,# Y,CDR,BTQ7VXR:7AB<FPN:'1M4$L!
M A0#%     @ G(J*6@V!AHB5 P  ]0X  !               ( !B* " '-R
M=BTR,#(U,#0Q,"YX<V102P$"% ,4    " "<BHI:1JD:>1X#  ".$   %
M            @ %+I ( <W)V+3(P,C4P-#$P7V1E9BYX;6Q02P$"% ,4
M" "<BHI:$RPW']L"  #F#@  %               @ &;IP( <W)V+3(P,C4P
M-#$P7VQA8BYX;6Q02P$"% ,4    " "<BHI:/#+%W<H"  !N#   %
M        @ &HJ@( <W)V+3(P,C4P-#$P7W!R92YX;6Q02P4&      P #  R
) P  I*T"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>fp0092922-1_n2ixbrl_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srv="http://cushingcef.com/20250410"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="srv-20250410.xsd" xlink:type="simple"/>
    <context id="AsOf2025-04-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
        </entity>
        <period>
            <startDate>2025-04-10</startDate>
            <endDate>2025-04-10</endDate>
        </period>
    </context>
    <context id="From2025-04-102025-04-10_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-10</startDate>
            <endDate>2025-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2022-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="AsOf2021-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="AsOf2020-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="AsOf2019-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="AsOf2018-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="AsOf2017-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="AsOf2016-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-30</instant>
        </period>
    </context>
    <context id="AsOf2015-11-30_custom_SeniorSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:SeniorSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-11-30</instant>
        </period>
    </context>
    <context id="From2025-04-102025-04-10_custom_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">srv:RisksAssociatedwithOfferingsofAdditionalCommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-10</startDate>
            <endDate>2025-04-10</endDate>
        </period>
    </context>
    <context id="From2025-04-102025-04-10_custom_AdditionalRisksofRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">srv:AdditionalRisksofRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-10</startDate>
            <endDate>2025-04-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-04-10" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2025-04-10" id="Fact000004">N-2</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-04-10" id="Fact000005">0001400897</dei:EntityCentralIndexKey>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2025-04-10" id="xdx2ixbrl0047">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityInvCompanyType contextRef="AsOf2025-04-10" id="Fact000011">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement contextRef="AsOf2025-04-10" id="Fact000012">true</dei:DocumentRegistrationStatement>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2025-04-10" id="Fact000013">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2025-04-10" id="Fact000014">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2025-04-10" id="Fact000015">27</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName contextRef="AsOf2025-04-10" id="Fact000016">NXG Cushing Midstream Energy Fund</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-04-10" id="Fact000017">One Energy Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-04-10" id="Fact000018">4925 Greenville Avenue</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-04-10" id="Fact000019">Suite 1310</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-04-10" id="Fact000020">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-04-10" id="Fact000021">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-04-10" id="Fact000022">75206</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-04-10" id="Fact000023">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-04-10" id="Fact000024">692-6334</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000025">John Musgrave</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000026">One Energy Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000027">4925 Greenville Avenue</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000028">Suite 1310</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000029">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000030">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2025-04-102025-04-10_dei_BusinessContactMember"
      id="Fact000031">75206</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2025-04-10" id="Fact000032">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2025-04-10" id="Fact000033">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2025-04-10" id="Fact000034">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2025-04-10" id="Fact000035">true</cef:PrimaryShelfFlag>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2025-04-10" id="Fact000036">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:EffectiveUponFiling462e contextRef="AsOf2025-04-10" id="Fact000037">false</dei:EffectiveUponFiling462e>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2025-04-10" id="Fact000038">true</dei:EffectiveWhenDeclaredSection8c>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2025-04-10" id="Fact000039">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:AdditionalSecurities462b contextRef="AsOf2025-04-10" id="Fact000040">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="AsOf2025-04-10" id="Fact000041">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="AsOf2025-04-10" id="Fact000042">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2025-04-10" id="Fact000043">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2025-04-10" id="Fact000044">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2025-04-10" id="Fact000045">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2025-04-10" id="Fact000046">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-04-10" id="Fact000048">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2025-04-10" id="Fact000049">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:SeniorSecuritiesTableTextBlock contextRef="AsOf2025-04-10" id="Fact000050">&lt;p id="xdx_A88_ecef--SeniorSecuritiesTableTextBlock_z3mHiEfZZW01" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;SENIOR
SECURITIES&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The following table sets
forth information about the Fund&#x2019;s outstanding senior securities as of the end of each fiscal period indicated. The information
in this table for the fiscal years ended November&#160;30, 2024, November&#160;30, 2023, November&#160;30, 2022, November&#160;30, 2021
and November&#160;30, 2020 is derived from the Fund&#x2019;s financial statements audited by Ernst &amp;amp; Young LLP, independent registered
public accounting firm for the Fund, whose report on such financial statements, together with the financial statements of the Fund, are
included in the Fund&#x2019;s Annual Report and are incorporated herein by reference.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Fiscal Period Ended&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Title of&lt;br/&gt; Security&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;br/&gt; Principal&lt;br/&gt; Amount&lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asset&lt;br/&gt; Coverage&lt;br/&gt; Per&lt;br/&gt; $1,000 of&lt;br/&gt; Principal&lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: Gainsboro"&gt;
    &lt;td style="width: 57%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecef--SeniorSecuritiesAmt_iI_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zZyQBp7Szl4b" style="width: 12%; text-align: right"&gt;48,315,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20241130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zpAsqnlRqb9h" style="width: 12%; text-align: right"&gt;5,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zFy7RYsW6u73" style="text-align: right"&gt;19,315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20231130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zaZTr8qbkCw4" style="text-align: right"&gt;5,391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: Gainsboro"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2022&lt;sup&gt;*&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecef--SeniorSecuritiesAmt_iI_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____zOeMYYV2Ksw7" style="text-align: right"&gt;7,315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20221130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_fKg_____ztR7tWujnGPf" style="text-align: right"&gt;13,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zn41P3dDbVt9" style="text-align: right"&gt;33,715,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20211130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zq5kkxC4I4E4" style="text-align: right"&gt;3,399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: Gainsboro"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecef--SeniorSecuritiesAmt_iI_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z1AY1TOuYhy5" style="text-align: right"&gt;13,915,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20201130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLEvuH7fmmqc" style="text-align: right"&gt;5,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecef--SeniorSecuritiesAmt_iI_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zYIhi3KYKMYe" style="text-align: right"&gt;28,915,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20191130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z9sUhBht5Ykg" style="text-align: right"&gt;3,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: Gainsboro"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecef--SeniorSecuritiesAmt_iI_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z5zv93OOwz3i" style="text-align: right"&gt;26,050,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20181130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zLdx0SMcCs6j" style="text-align: right"&gt;3,932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2017&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecef--SeniorSecuritiesAmt_iI_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zy1xARDXqA2c" style="text-align: right"&gt;33,650,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20171130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zdDPD6RTk705" style="text-align: right"&gt;3,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: Gainsboro"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2016&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecef--SeniorSecuritiesAmt_iI_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zt2sdQb6pB17" style="text-align: right"&gt;49,454,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20161130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zxQ7bxjZxB1k" style="text-align: right"&gt;3,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;November&#160;30, 2015&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecef--SeniorSecuritiesAmt_iI_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_z374dTwUUhi6" style="text-align: right"&gt;43,369,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecef--SeniorSecuritiesCvgPerUnit_iI_pid_uUSDPShares_c20151130__us-gaap--StatementClassOfStockAxis__custom--SeniorSecurityMember_zJYhi2abQNm8" style="text-align: right"&gt;3,136&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: left; text-indent: -0.1in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td id="xdx_F08_zMiOvlhfUtJl" style="width: 0.25in"&gt;*&lt;/td&gt;&lt;td id="xdx_F18_zO7tK8jc9Jyf" style="text-align: left"&gt;On November&#160;30, 2022 the Fund reduced its borrowings by paying down $22 million outstanding under its
borrowing facility. As a result of the timing of this transaction, the Fund&#x2019;s balance sheet as of November&#160;30, 2022 includes
an amount due to the Fund&#x2019;s custodian of $22 million, which amount was eliminated when the pay down process was completed on December&#160;1,
2022.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;




&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="text-transform: uppercase"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</cef:SeniorSecuritiesTableTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2024-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">48315000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2024-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000052"
      unitRef="USDPShares">5035</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000053"
      unitRef="USD">19315000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">5391</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">7315000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000056"
      unitRef="USDPShares">13736</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">33715000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000058"
      unitRef="USDPShares">3399</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">13915000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">5287</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000061"
      unitRef="USD">28915000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000062"
      unitRef="USDPShares">3411</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">26050000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000064"
      unitRef="USDPShares">3932</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000065"
      unitRef="USD">33650000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000066"
      unitRef="USDPShares">3407</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">49454000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000068"
      unitRef="USDPShares">3021</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-11-30_custom_SeniorSecurityMember"
      decimals="0"
      id="Fact000069"
      unitRef="USD">43369000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-11-30_custom_SeniorSecurityMember"
      decimals="INF"
      id="Fact000070"
      unitRef="USDPShares">3136</cef:SeniorSecuritiesCvgPerUnit>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2025-04-10" id="Fact000072">&lt;p id="xdx_A87_ecef--InvestmentObjectivesAndPracticesTextBlock_zkb5ExMH65f5" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;INVESTMENT
OBJECTIVE AND POLICIES&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The information contained
under the heading &#x201c;Additional Information (Unaudited)&#x2014;Investment Objective and Policies&#x201d; in the Fund&#x2019;s Annual
Report is incorporated herein by reference.&lt;/p&gt;

</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock contextRef="AsOf2025-04-10" id="Fact000073">&lt;p id="xdx_A84_ecef--RiskFactorsTableTextBlock_zL8dDfNudWIf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;RISKS&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Investors should consider
the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment
risk, including the possible loss of your entire investment. A Prospectus Supplement relating to an offering of the Fund&#x2019;s securities
may identify additional risk associated with such offering.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The information contained
under the heading &#x201c;Additional Information (Unaudited)&#x2014;Risks&#x201d; in the Fund&#x2019;s Annual Report is incorporated herein
by reference.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Additional risk factors associated
with offerings pursuant to this Prospectus include:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;div id="xdx_980_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--RisksAssociatedwithOfferingsofAdditionalCommonSharesMember_zXYqrxuEB7v7"&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Risks Associated with
Offerings of Additional Common Shares.&lt;/i&gt; The voting power of current Common Shareholders will be diluted to the extent that current
Common Shareholders do not purchase Common Shares in any future offerings of Common Shares or do not purchase sufficient Common Shares
to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#x2019;s per
Common Share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds were
fully invested as planned. If the Fund sells Common Shares at a price below net asset value per share pursuant to the consent of Common
Shareholders, shareholders will experience a dilution of the aggregate net asset value per Common Share because the sale price will be
less than the Fund&#x2019;s then-current net asset value per Common Share. Similarly, were the expenses of the offering to exceed the amount
by which the sale price exceeded the Fund&#x2019;s then current net asset value per Common Share, shareholders would experience a dilution
of the aggregate net asset value per Common Share. This dilution will be experienced by all shareholders, irrespective of whether they
purchase Common Shares in any such offering. See &#x201c;Description of Shares&#x2014;Common Shares&#x2014;Issuance of Additional Common
Shares.&#x201d;&lt;/p&gt;

&lt;/div&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;div id="xdx_985_ecef--RiskTextBlock_c20250410__20250410__cef--RiskAxis__custom--AdditionalRisksofRightsMember_zj2X4bNOS2A4"&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Additional Risks of Rights.
&lt;/i&gt;There are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion
of such an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering,
a shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price per share is below the net asset value per share of the Fund&#x2019;s Common Shares
on the expiration date, a shareholder will experience an immediate dilution of the aggregate net asset value of such shareholder&#x2019;s
Common Shares if the shareholder does not participate in such an offering and the shareholder will experience a reduction in the net asset
value per share of such shareholder&#x2019;s Common Shares whether or not the shareholder participates in such an offering. Such a reduction
in net asset value per share may have the effect of reducing market price of the Common Share. The Fund cannot state precisely the extent
of this dilution (if any) if the shareholder does not exercise such shareholder&#x2019;s Rights because the Fund does not know what the
net asset value per share will be when the offer expires or what proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per Common Share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i)&#160;such shareholders participate in the Rights offering
and (ii)&#160;the Fund&#x2019;s net asset value per Common Share is above or below the subscription price on the expiration date of the
Rights offering. In addition to the economic dilution described above, if a Common Shareholder does not exercise all of their rights,
the Common Shareholder will incur voting dilution as a result of this rights offering. This voting dilution will occur because the Common
Shareholder will own a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is
a risk that changes in market conditions may result in the underlying Common Shares purchasable upon exercise of the subscription rights
being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription
rights. If investors exercise only a portion of the rights, the number of Common Shares issued may be reduced, and the Common Shares may
trade at less favorable prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable
or&#160;non-transferable&#160;rights. In a&#160;non-transferable&#160;rights offering, Common Shareholders who do not wish to exercise
their rights will be unable to sell their rights. In a transferrable rights offering, the Fund will use its best efforts to ensure an
adequate trading market for the rights; however, investors may find that there is no market to sell rights they do not wish to exercise.&lt;/p&gt;

&lt;/div&gt;




&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

</cef:RiskFactorsTableTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-04-102025-04-10_custom_RisksAssociatedwithOfferingsofAdditionalCommonSharesMember"
      id="Fact000074">

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Risks Associated with
Offerings of Additional Common Shares.&lt;/i&gt; The voting power of current Common Shareholders will be diluted to the extent that current
Common Shareholders do not purchase Common Shares in any future offerings of Common Shares or do not purchase sufficient Common Shares
to maintain their percentage interest. If the Fund is unable to invest the proceeds of such offering as intended, the Fund&#x2019;s per
Common Share distribution may decrease and the Fund may not participate in market advances to the same extent as if such proceeds were
fully invested as planned. If the Fund sells Common Shares at a price below net asset value per share pursuant to the consent of Common
Shareholders, shareholders will experience a dilution of the aggregate net asset value per Common Share because the sale price will be
less than the Fund&#x2019;s then-current net asset value per Common Share. Similarly, were the expenses of the offering to exceed the amount
by which the sale price exceeded the Fund&#x2019;s then current net asset value per Common Share, shareholders would experience a dilution
of the aggregate net asset value per Common Share. This dilution will be experienced by all shareholders, irrespective of whether they
purchase Common Shares in any such offering. See &#x201c;Description of Shares&#x2014;Common Shares&#x2014;Issuance of Additional Common
Shares.&#x201d;&lt;/p&gt;

</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-04-102025-04-10_custom_AdditionalRisksofRightsMember"
      id="Fact000075">

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Additional Risks of Rights.
&lt;/i&gt;There are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion
of such an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering,
a shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price per share is below the net asset value per share of the Fund&#x2019;s Common Shares
on the expiration date, a shareholder will experience an immediate dilution of the aggregate net asset value of such shareholder&#x2019;s
Common Shares if the shareholder does not participate in such an offering and the shareholder will experience a reduction in the net asset
value per share of such shareholder&#x2019;s Common Shares whether or not the shareholder participates in such an offering. Such a reduction
in net asset value per share may have the effect of reducing market price of the Common Share. The Fund cannot state precisely the extent
of this dilution (if any) if the shareholder does not exercise such shareholder&#x2019;s Rights because the Fund does not know what the
net asset value per share will be when the offer expires or what proportion of the Rights will be exercised. If the subscription price
is substantially less than the then current net asset value per Common Share at the expiration of a rights offering, such dilution could
be substantial. Any such dilution or accretion will depend upon whether (i)&#160;such shareholders participate in the Rights offering
and (ii)&#160;the Fund&#x2019;s net asset value per Common Share is above or below the subscription price on the expiration date of the
Rights offering. In addition to the economic dilution described above, if a Common Shareholder does not exercise all of their rights,
the Common Shareholder will incur voting dilution as a result of this rights offering. This voting dilution will occur because the Common
Shareholder will own a smaller proportionate interest in the Fund after the rights offering than prior to the rights offering. There is
a risk that changes in market conditions may result in the underlying Common Shares purchasable upon exercise of the subscription rights
being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription
rights. If investors exercise only a portion of the rights, the number of Common Shares issued may be reduced, and the Common Shares may
trade at less favorable prices than larger offerings for similar securities. Subscription rights issued by the Fund may be transferable
or&#160;non-transferable&#160;rights. In a&#160;non-transferable&#160;rights offering, Common Shareholders who do not wish to exercise
their rights will be unable to sell their rights. In a transferrable rights offering, the Fund will use its best efforts to ensure an
adequate trading market for the rights; however, investors may find that there is no market to sell rights they do not wish to exercise.&lt;/p&gt;

</cef:RiskTextBlock>
    <cef:CapitalStockTableTextBlock contextRef="AsOf2025-04-10" id="Fact000076">&lt;p id="xdx_A8F_ecef--CapitalStockTableTextBlock_zKjjMrb2nddj" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;DESCRIPTION
OF SHARES&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The following is a brief
description of the terms of the securities which may be issued by the Fund. This description does not purport to be complete and is qualified
by reference to the Fund&#x2019;s governing documents. The Fund is a statutory trust organized under the laws of Delaware pursuant to a
Certificate of Trust dated May&#160;23, 2007, as filed with the State of Delaware on May&#160;23, 2007 and as amended through the date
hereof.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

</cef:CapitalStockTableTextBlock>
    <cef:SecurityTitleTextBlock contextRef="AsOf2025-04-10" id="Fact000077">&lt;p id="xdx_A8E_ecef--SecurityTitleTextBlock_z5O1RghUR4ze" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;Common Shares&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The Fund is authorized to
issue an unlimited number of Common Shares of beneficial interest, par value $0.001 per share. &lt;span id="xdx_901_ecef--SecurityVotingRightsTextBlock_c20250410__20250410_zkQSRM4jhudc"&gt;Each Common Share has one vote.&lt;/span&gt; Pursuant
to the Declaration of Trust, when issued and paid for in accordance with the terms of this offering, will be fully paid and non-assessable.
The Declaration of Trust provides that the Board of Trustees will have the power to cause shareholders to pay expenses of the Fund by
setting off charges due from shareholders from declared but unpaid distributions owed the shareholders and/or by reducing the number of
Common Shares owned by each respective shareholder. No expenses have been paid or are being paid pursuant to such provision, and the Board
of Trustees has no intention to cause expenses to be paid pursuant to such provision, which in any event may only be utilized to the extent
permitted by the 1940 Act.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The Fund intends to hold
annual meetings of shareholders so long as the Common Shares are listed on a national securities exchange and such meetings are required
as a condition to such listing. &lt;span id="xdx_90F_ecef--SecurityPreemptiveAndOtherRightsTextBlock_c20250410__20250410_zRerANUHKql2"&gt;All Common Shares are equal as to distributions, assets and voting privileges and have no conversion,
preemptive or other subscription rights.&lt;/span&gt; The Fund will furnish annual and semi-annual reports, including financial statements, to all
holders of its shares.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Unlike open-end funds, closed-end
funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy
additional Common Shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise.
Shares of closed-end funds frequently trade on an exchange at prices lower than net asset value. Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), distribution stability, net
asset value, relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond
the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than net asset value in
the future. The Common Shares are designed primarily for long-term investors, and you should not purchase the Common Shares if you intend
to sell them soon after purchase.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Issuance of Additional
Common Shares. &lt;/i&gt;The provisions of the 1940 Act generally require that the public offering price (less underwriting commissions and
discounts) of common shares sold by a closed-end investment company must equal or exceed the net asset value of such company&#x2019;s common
shares (calculated within 48 hours of the pricing of such offering), unless such sale is made with the consent of a majority of its common
shareholders. The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of
Common Shares at a price below the Fund&#x2019;s then-current net asset value, subject to certain conditions. If such consent is obtained,
the Fund may, contemporaneous with and in no event more than one year following the receipt of such consent, sell Common Shares at price
below net asset value in accordance with any conditions adopted in connection with the giving of such consent. Additional information
regarding any consent of Common Shareholders obtained by the Fund and the applicable conditions imposed on the issuance and sale by the
Fund of Common Shares at a price below net asset value will be disclosed in the Prospectus Supplement relating to any such offering of
Common Shares at a price below net asset value. Until such consent of Common Shareholders, if any, is obtained, the Fund may not sell
Common Shares at a price below net asset value. Because the Fund&#x2019;s advisory fee is based upon average Managed Assets, the Investment
Adviser&#x2019;s interest in recommending the issuance and sale of Common Shares at a price below net asset value may conflict with the
interests of the Fund and its Common Shareholders.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The Fund will not sell Common
Shares at a price below its net asset value per Common Share (including with shareholder approval or pursuant to rights to purchase Common
Shares) under this Prospectus or an accompanying prospectus supplement without first filing a new post-effective amendment to the registration
statement if the cumulative dilution to the Fund&#x2019;s net asset value per share from offerings under the registration statement exceeds
15%.&lt;/p&gt;




</cef:SecurityTitleTextBlock>
    <cef:SecurityVotingRightsTextBlock contextRef="AsOf2025-04-10" id="Fact000078">Each Common Share has one vote.</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityPreemptiveAndOtherRightsTextBlock contextRef="AsOf2025-04-10" id="Fact000079">All Common Shares are equal as to distributions, assets and voting privileges and have no conversion,
preemptive or other subscription rights.</cef:SecurityPreemptiveAndOtherRightsTextBlock>
    <cef:OtherSecuritiesTableTextBlock contextRef="AsOf2025-04-10" id="Fact000080">&lt;p id="xdx_A8B_ecef--OtherSecuritiesTableTextBlock_zZNDztHwgjNf" style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_908_ecef--WarrantsOrRightsCalledTitleTextBlock_c20250410__20250410_zKPBI4wQFAG9"&gt;Subscription Rights to
Purchase Common Shares&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The Fund may issue subscription
rights to holders of Common Shares to purchase Common Shares. Subscription rights may be issued independently or together with any other
offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with
a subscription rights offering to holders of Common Shares, the Fund would distribute certificates evidencing the subscription rights
and a Prospectus Supplement to our common or preferred shareholders as of the record date that we set for determining the shareholders
eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer
to the actual terms of such subscription rights which will be set forth in the subscription rights agreement and/or subscription certificate
relating to such subscription rights. The Fund may only conduct a subscription rights offering to the extent that the Board of Trustees
makes a good faith determination that the offering would result in a net benefit to existing shareholders.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The applicable Prospectus
Supplement would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the period of time the offering would remain open (which will be open a minimum number of days such that
all record holders would be eligible to participate in the offering and will not be open longer than 120 days);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the exercise price for such subscription rights (or method of calculation thereof);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of such subscription rights issued in respect of each Common Share;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the extent to which such subscription rights are transferable and the market on which they may be traded
if they are transferable;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
or exercise of such subscription rights;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the date on which the right to exercise such subscription rights will commence, and the date on which
such right will expire (subject to any extension);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and
the terms of such over-subscription privilege;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;any termination right the Fund may have in connection with such subscription rights offering;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the expected trading market, if any, for rights; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;any other terms of such subscription rights, including exercise, settlement and other procedures and limitations
relating to the transfer and exercise of such subscription rights.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Exercise of Subscription
Rights. &lt;/i&gt;Each subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such
exercise price as in each case is set forth in, or be determinable as set forth in the Prospectus Supplement relating to the subscription
rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such
subscription rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription
rights would become void.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Upon expiration of the rights
offering and the receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust
office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable,
the Common Shares purchased as a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer
any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through
a combination of such methods, as set forth in the applicable Prospectus Supplement&lt;/p&gt;




&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;i&gt;Transferable Rights Offering&lt;/i&gt;.
Subscription rights issued by the Fund may be transferrable. The terms of a transferrable rights offering will fully protect shareholders&#x2019;
preemptive rights, if any, and will not discriminate among shareholders (except for the possible de minimis effect of not issuing fractional
rights). The distribution to Common Shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating
Common Shareholders the potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation
for any dilution of their interests that may occur as a result of the rights offering. In a transferrable rights offering, Fund management
will use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights.
However, there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price
of the transferable rights will be. In a transferrable rights offering, the subscription ratio will not be less than 1-for-3, that is
the holders of Common Shares of record on the record date of the rights offering will receive one right for each outstanding Common Share
owned on the record date and the rights will entitle their holders to purchase one new Common Share for every three rights held (provided
that any Common Shareholder who owns fewer than three Common Shares as of the record date may subscribe for one full Common Share). Assuming
the exercise of all rights, such a rights offering would result in an approximately 331&#x2044;3% increase in the Fund&#x2019;s Common Shares
outstanding.&lt;/p&gt;

&lt;/div&gt;

</cef:OtherSecuritiesTableTextBlock>
    <cef:WarrantsOrRightsCalledTitleTextBlock contextRef="AsOf2025-04-10" id="Fact000081">Subscription Rights to
Purchase Common Shares</cef:WarrantsOrRightsCalledTitleTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000055"
          xlink:label="Fact000055"
          xlink:type="locator"/>
        <link:footnote id="Footnote000071" xlink:label="Footnote000071" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On November&#160;30, 2022 the Fund reduced its borrowings by paying down $22 million outstanding under its
borrowing facility. As a result of the timing of this transaction, the Fund&#x2019;s balance sheet as of November&#160;30, 2022 includes
an amount due to the Fund&#x2019;s custodian of $22 million, which amount was eliminated when the pay down process was completed on December&#160;1,
2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000055"
          xlink:to="Footnote000071"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000056"
          xlink:label="Fact000056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000056"
          xlink:to="Footnote000071"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
